The genetic and molecular analysis of primary ciliary dyskinesia. by Castleman, V.H.
THE GENETIC AND MOLECULAR 
ANALYSIS OF PRIMARY CILIARY 
DYSKINESIA
Victoria Helen Castleman
A thesis submitted for the degree of Doctor of Philosophy in the
University of London
May 2008
General and Adolescent Paediatric Unit 
Institute of Child Health 
University College London
UMI Number: U591441
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Disscrrlation Publishing
UMI U591441
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
I, Victoria H. Castleman, confirm that the work presented in this thesis is my own. 
Where information has been derived from other sources, I confirm that this has been 
indicated in the thesis.
Abstract
Primary Ciliary Dyskinesia (PCD) is a recessively inherited disorder caused by cilia 
and sperm flagella dysmotility associated with axoneme ultrastructural defects. 
Symptoms include recurrent respiratory tract infections, sinusitis, bronchiectasis, 
subfertility, and laterality defects due to defective embryonic nodal cilia. PCD is 
genetically heterogeneous and two genes, DNAIl and DNAH5, account for 38% of 
cases.
To identify new PCD genes, genome wide linkage screens were undertaken in 
consanguineous PCD families using homozygosity mapping: (1) five Pakistani 
families with missing inner and outer dynein arms; (2) two Arabic families with 
central pair agenesis and no dextrocardia.
Three disease loci were mapped on chromosome llq23.3-24.3 and 17q21.31-22 
(Pakistani), and chromosome 6p21.31-21.1 (Arabic), with peak multipoint LOD 
scores of 3.6, 6.0 and 6.7, respectively.
Comparative bioinformatic analysis identified 7 positional candidate genes which 
were subjected to mutational analysis. A 3 bp deletion in C6ORF206 at 6p21.31-21.1 
was revealed in affected Arabic PCD individuals, resulting in a predicted in-frame 
loss of a C-terminal lysine residue, K268. The protein encoded by C6ORF206 was 
identified as homologous to the Chlamydomonas reinhardtii radial spoke head 
protein, RSP9.
Functional work was undertaken to determine if the K268del mutation was 
pathogenic. RSP9 is mutated in the paralysed flagella Chlamydomonas mutant, p fl 7, 
and transformation of p f l l  with wild-type RSP9 rescued motility. However 
transformation of p f l l  with RSP9 R261del (equivalent to human K268del) rescued 
motility to a lower level, resulting in an ineffective swimming stroke.
Expression of RSP9 was investigated by in situ hybridisation, and zebrafish RSP9 
knock-down morphants were created to investigate its role in vertebrate ciliary 
function. Although expressed at the vertebrate embryonic node, knockdown of RSP9 
function did not affect laterality in zebrafish, however it did cause dysfunction of the 
nasal cilia.
This data suggests that C6ORF206/RSP9 functions as a ciliary protein in ciliated 
organisms and that the K268del mutation likely causes PCD without situs inversus.
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1 CHAPTER ONE
17
Not waving but drowning
“Nobody heard him, the dead man.
But still he lay moaning:
I was much further out than you thought 
And not waving but drowning.
Poor chap, he always loved larking 
And now he's dead 
It must have been too cold for him his heart gave way. 
They said.
Oh, no no no, it was too cold always 
(Still the dead one lay moaning)
I was much too far out all my life 
And not waving but drowning.”
Stevie Smith, 1957
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1.1 Introduction
Primary Ciliary Dyskinesia (PCD) (OMIM 242650) is a genetically inherited disease 
characterised by abnormalities in ciliary ultrastructure and function and consequent 
reduced mucociliary clearance (Bush et al., 2007). PCD affects the upper and lower 
respiratory tracts and results in recurrent/persistent respiratory infections, sinusitis 
and otitis media (van’s Gravesande and Omran, 2005). Male subfertility is also 
present as a result of immotile sperm flagella (Geremek and Witt, 2004), and 
randomised left-right axis determination (usually situs inversus -  complete mirror 
image reversal of internal organs) which is presumed to be due to ineffective 
embiyonic nodal cilia (Essner et al., 2002). Usually clinical manifestations begin in 
the first year of life and respiratory problems often progress to permanent lung 
damage (bronchiectasis) (Coren et al., 2002).
This study involves the molecular genetic investigation of PCD. First, ciliary 
structure and function is described then the clinical features, diagnostic and genetic 
aspects of PCD with a summary of the current status of genetic research and the 
technical advances that have had an impact upon disease gene identification.
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PART I: STRUCTURE AND FUNCTION OF CILIA
1.1.1 The role of cilia in the human body
Cilia are hair-like structures 5-7 |am in length (Afzelius et ah, 1985) extending from 
the surface of epithelial cells (Figure 1.1). Cilia evolved from flagella, which 
appeared early in evolution to provide unicellular organisms with motility in water 
(Ibanez-Tallon et al., 2003). Cilia are structurally related to flagella and are present 
on most cells of the body, including respiratory epithelial cells, sinuses and middle 
ear, brain ependyma and female fallopian tubes (Pan et al., 2005). Cilia perform a 
diverse array of biological functions including beating movement to move fluid 
across the surface of cells and a sensory role to detect and assess the surrounding 
environment of the cell. Respiratory epithelial cilia are important in mucociliary 
clearance and move mucus up towards the throat for swallowing. Motile cilia lining 
the ependymal epithelium beat to move cerebrospinal fluid. Cilia lining the fallopian 
tubes act to propel oocytes towards the womb for fertilisation. Cilia in the efferent 
ductules of the testes propel immature sperm to the vas deferens, where they mature 
and become motile upon growth of a single motile flagellum. Monocilia are present 
transiently in the embryonic node and are involved in creating the nodal flow that 
breaks the left-right asymmetry in laterality determination (Nonaka et al., 1998).
Figure 1.1: Respiratory epithelial cilia
Cilia are found on most cells of the body, including those lining the trachea as shown by electron 
microscopy in this figure. Goblet cells are also present in the trachea and secrete mucus, which is then 
propelled up into the throat by the whip-like movement of cilia and is then swallowed.
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1.1.2 Classification of cilia types
There are at least eight categories of cilia in the human body. These all have an 
invariant basic pattern -  nine microtubule doublets in a ring (described in more detail 
in section 1.1.4), but differ in several details including length, beat pattern and 
structure including presence or absence of central microtubules, motor dynein 
proteins and associated structural components (Table 1.1). Motile cilia and flagella 
have been retained and employed for a number of biological functions, including left- 
right axis determination, cerebrospinal fluid flow, mucociliary clearance (Ibanez- 
Tallon et al., 2003) and spermatozoa motility (Sapiro et al., 2002). Non-motile or 
sensory cilia function in various sensory roles including retinal, auditory and renal 
physiology, for example olfactory cilia present in odour receptors and cilia present in 
the kidney (Salisbury, 2004). Modified cilia are found in retinal rod cells and form a 
“connecting cilium” between the inner and outer segments (Arendt et al., 2004).
Malfunctioning of any one of the different types of cilia can have consequences on 
normal physiology (Table 1.1). The most prominent abnormality involving motile 
cilia is PCD and the clinical phenotype of PCD patients correlates with the tissues and 
parts of the body in which their dysmotile cilia are found.
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Table 1.1: Categories of cilia in the hum an body. Adapted from Afzelius, 2004. 9+2 refers to axoneme structure o f 9 peripheral microtubules and a central pair. 9+0 refers to 
axoneme structure o f 9 peripheral microtubules and no central pair.
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1.1.3 Introduction to Chlamydomonas reinhardtii as a PCD 
mode! organism
Chlamydomonas reinhardtii (Figure 1.2) is a eukaryotic biflagellate unicellular alga, 
which propels itself through water using its two flagella (Lefebvre and Silflow, 1999). 
These flagella have a similar ultrastructure and high conservation of protein 
homology to human respiratory cilia and sperm flagella. Chlamydomonas is therefore 
a key organism that has historically contributed extensively to the understanding of 
human cilia structure and function. Much current knowledge of axonemal protein 
composition and organisation arises from studies in Chlamydomonas. They have 
been used extensively in genetic and biochemical analysis as a model for the 
investigation of cilia function and assembly (Pazour et al., 2005), aided by the 
analysis of the Chlamydomonas genome, which has advanced understanding of this 
eukaryotic cell and revealed genes associated with flagella function (Merchant et al., 
2007). This model is advantageous because it has a haploid genome so that genetic 
mutations are fully expressed and are not masked by wild type genes.
Mutants with dysmotile or paralysed flagella are fully viable and are easily detected 
by their reduced motility. The flagella proteome has been completed and showed 
motor and signal transduction proteins with homologues associated with human 
disease, such as cystic kidney disease, male sterility and hydrocephalus (Pazour et al.,
2005). Furthermore, some unexplained components were found to be part of the 
Chlamydomonas proteome, suggesting that the complexity of the axoneme is greater 
than originally thought. Many Chlamydomonas mutants which demonstrate a lack of 
flagella movement have been screened for mutations and genetic loci and from this a 
list of candidate genes and chromosomal locations have been suggested for the 
mapping of genes that cause PCD (Geremek and Witt, 2004).
Figure 1.2: Biflagellate algae Chlamydomonas reinhardtii. 
Image adapted from
www.botany.hawaii.edu/BOT201/Algae/Bot%
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1.1.4 The structure of cilia
The eukaryotic cilium is a dynamic structure consisting of over 250 proteins 
(Dutcher, 1995; Pazour et al., 2005) that is variable in length depending upon location 
in the body (Table 1.1). The protein composition of the core ultrastructure of 
cilia/flagella, known as the axoneme, has been well studied and also visualised by 
electron microscopy (EM) and more recently by electron tomography (Nicastro et al., 
2006). The motile ciliary axoneme consists of 9 peripheral outer doublet 
microtubules that surround a central pair (Figure 1.3A). This is known as the 9+2 
structure. Each peripheral doublet is constructed from an A and a B tubule, 
composed of 13 and 11 tubulin protofilaments, respectively. These protofilaments 
consist of heterodimers of a and p tubulin, which are the most abundant proteins (70 
% total protein mass) in the cilium (Cosson, 1996). Each outer doublet is attached to 
two rows of dynein arms (inner and outer), discussed in Section 1.1.4.2.1. Radial 
spokes create a link between the peripheral and central pair of microtubules and are 
thought to play both a structural and signalling role in ciliary beating (Yang et al.,
2006), discussed further in Section 1.1.4.2.2. The dynein regulatory complex (DRC) 
is thought to coordinate the activity of the dyneins and is located at the base of the 
radial spokes in close association with the inner dynein arms (Gardner et al., 1994). 
Nexin links link the peripheral microtubules and restrict the extent of the sliding 
(Cosson, 1996). The underlying ciliary ultrastructure has a direct influence on the 
whip-like waveform of cilia that is effective for mucociliary clearance and disruption 
of this structure affects the motility and therefore the function of these structures 
(Ibanez-Tallon et al., 2003).
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Figure 1.3: Diagrammatic representation of the structure of the flagella/ciliary axoneme and transmission electron microscopy of a cilium in cross-section.
A) Ciliary axoneme - diagram obtained from Gartner and Hiatt, Colour atlas o f histology,3rd ed. Lippincott Williams & Wilkins, 2000. Nine outer doublet microtubules formed of 
an A-microtubule and a B-microtubule arranged around a central pair. Inner and outer dynein arms are directed towards the next microtubule pair. Radial spokes connect the 
central pair and peripheral microtubules. Nexin links provide structural links between outer microtubules. B) EM of cilium in cross section, obtained from Google Images, 
reference www.sun.melanschool.org. C) Longitudinal view of a peripheral pair of microtubules with associated proteins -  taken from El Zein et al, TRENDS in Genetics, 2004. 
Outer dynein arms (red) spaced every 24 nm (short arrow), inner dynein arms form different complexes (pink, grey, blue and yellow) with a 96 nm repeat (long arrow), radial 
spokes (brown) are located along the axoneme with 96 nm periodicities. Dynein regulatory complex (orange) is involved in regulation of IDAs via radial spoke interactions.
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1.1.4.1 Microtubules
Microtubules are cylindrical structures made up of alternating heterodimers of a- and 
p- tubulin (Mandelkow and Mandelkow, 1995) (Figure 1.3). Microtubules exist in 
two forms, those found in the ciliary axoneme and those found in the mitotic spindle 
of dividing cells (Brinkley, 1997). They are dynamic structures that grow from 
microtubule organising centres (MTOCs) such as basal bodies and centrosomes 
(Wade et al., 1998) (Figure 1.3). Cilia and flagella formation begins when the basal 
body docks to the plasma membrane and serves as a template for axoneme assembly. 
The axoneme and the surrounding ciliary membrane, which is continuous with the 
plasma membrane, projects from the cell body in a process known as 
compartmentalised ciliogenesis accomplished by intraflagellar transport (IFT) 
(Section 1.1.6) (Scholey, 2008). The cilium therefore elongates and creates a separate 
compartment that is separated from the cytoplasm by transition fibres. By contrast, in 
cytosolic ciliogenesis, (e.g. in Drosophila sperm cells) the entire axoneme is 
assembled inside the cell and is later extruded (Baker et al., 2004). Microtubules 
have an inherent polarity, whereby the “plus end” grows faster than the “minus end” 
and in the case of axonemal microtubules, the plus end is always located at the tip of 
the cilium.
Tubulin is the major component of microtubules and is a highly conserved protein of 
approximately 450 amino acids. As mentioned previously, it exists in 2 major 
isoforms in the microtubules of the ciliary axoneme, a and p. Tubulin protein 
undergoes post-translational modifications prior to integration into the ciliary 
axoneme, however knowledge on this is as yet limited.
1.1.4.1.1 The axoneme central microtubule pair
Regulation of motile 9 + 2 cilia and flagella depend on interactions between the radial 
spokes and the central pair apparatus (Smith and Lefebvre, 1997; Mitchell, 2004). 
Studies of the axoneme central pair microtubules have used a wide range of species 
including flagella isolated from Chlamydomonas reinhardtii (Goodenough and 
Heuser, 1985). The central pair are orientated with respect to the central pair of
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adjacent cilia and this determines the direction of the ciliary beat (Mitchell, 2004) 
(Smith and Yang, 2004). The central pair of microtubules (Cl and C2) (Figure 1.4) 
are structurally and biochemically asymmetric. Each individual microtubule of the 
central pair are made up of 13 tubulin protofilaments and have a distinct protein 
composition from that of the outer doublets; they are more like cytoplasmic than 
axonemal microtubules in their lability, in that they more readily undergo change or 
breakdown (Dutcher, 1995). Thin section EM of Chlamydomonas flagella revealed 
that the central pair are surrounded by specific protein projections that appear to wrap 
around the central microtubules (Figure 1.4). The longer projections around the Cl 
microtubule repeat along the axoneme with 32 nm repeat periodicities, whereas the 
smaller C2 projections repeat every 16 nm (Mitchell, 2004).
Comparison of the structural relationships within central pair complexes from wild 
type and central pair mutant Chlamydomonas strains has provided a model of radial 
spoke interaction with sites on the central pair (Mitchell, 2004). During the flagella 
bend, the central pair twists so that the Cl microtubule is closest to the doublets on 
the outside of the bend. This allows the central pair projections to interact with the 
radial spokes attached to the active dyneins, while the other central pair projections 
interact with the radial spokes on doublets with inactive dyneins. It has therefore 
been suggested that specific projections associated with the Cl and C2 microtubules 
contribute to regulating motility (Wargo et al., 2005) (Lechtreck and Witman, 2007) 
by regulating dynein through interactions with radial spokes and microtubule 
associated proteins.
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Figure 1.4: Diagrammatic representation of the Chlamydomonas flagellar central pair.
Taken from Mitchell, 2003 (Mitchell, 2003) Central pair apparatus viewed longitudinally. Proteins 
associated with Cl microtubule are la, lb, Ic and Id. Proteins associated with C2 microtubule are 2a, 
2b and 2c. sh indicates protein sheath, la, lb , 2a and 2b projections (pink and blue) run perpendicular 
to the central pair axis at the radial spoke interaction surface. Green colour indicates microtubule 
bridges that connect the two microtubules.
1.1.4.2 Microtubule associated proteins (MAPs)
Microtubule associated proteins (MAPs) is the term given to other structural 
components of cilia. They include proteins that are involved in the maintenance of 
axonemal structure during the bending of the cilia, such as nexin links that connect 
adjacent outer doublet microtubules (Figure 1.3) and tektin filaments that are found at 
the junction between the A and B tubules of the outer microtubule doublets (Pimer 
and Linck, 1994). Radial spokes are MAPs connecting the peripheral and central 
microtubules and are discussed in detail is Section 1.1.4.2.2.
The dynein arms are the best characterised of all the MAPs and are divided into two 
types: inner and outer arm dyneins. They are large molecular motors that were first 
isolated from Tetrahymena cilia (Asai and Wilkes, 2004). They provide the cilium 
with the force for propulsion of its coordinated bending (Asai and Wilkes, 2004).
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1.1.4.2.1 MAPs: Dyneins
Axonemal dyneins repeats have been extensively studied in Chlamydomonas, 
accounting for 15 % of the total protein mass of the Chlamydomonas flagellum 
(Porter and Johnson, 1989) (Witman and Minervini, 1982). Dyneins are multisubunit 
ATPase motor protein complexes that occur periodically along the length of each of 
the nine peripheral A microtubules, in two rows (as inner and outer dynein arms) 
(Woolley, 2000). The outer and inner dynein arms have been shown to be 
functionally distinct as well as of different composition and they play separate roles 
in the generation of the ciliary beat. Outer dynein arm docking complexes (ODA- 
DCs) attach outer dynein arms to the peripheral A-microtubules and repeat with 24 
nm periodicity along the length of microtubules (Takada et al., 2002). Irmer dynein 
arms attach to microtubules in doublet or triplet groups every 96 nm (Smith and Sale, 
1992) by specialised adaptor molecules that designate the precise location of each 
inner arm subform (Smith and Sale, 1992). The dynein arms function by reversibly 
binding to the adjacent B-microtubule and using ATP hydrolysis to provide the 
energy for sliding along microtubule filaments (Wemmer and Marshall, 2004). This 
sliding is converted into ciliary bending by the constraints of connecting proteins such 
as the radial spokes, although the exact mechanism that produces the ciliary 
waveform is not yet entirely understood (Woolley, 2000).
The Chlamydomonas outer dynein arms (Figure 1.5) are large complexes that contain 
three dynein heavy chains (HCs) of molecular mass >500 kDa (a, p and y), two or 
more intermediate chains (ICI and IC2) and four to eight light chains (LCs). The N- 
terminals of HCs bind to ICs and LCs. The globular C-terminals of HCs consist of 
six AAA (ATPases Associated diverse cellular Activities) domains arranged in a 
hexameric ring with a short extension that binds to microtubules in an ATP-sensitive 
manner. This globular head contains the first P-loop, which provides the nucleotide 
binding site where ATP binds. Four other P-loops exist in dynein HCs, although the 
function of these is not yet known. It has been suggested that they allow regulation of 
the dynein molecule. There are six IC isoforms that have specific functions in the 
dynein complex, functioning to regulate HC activity and allow the attachment of the 
dynein arm to microtubules (Witman, 1992) (Lo et al., 2006). LCs are thought to 
function in both outer arm assembly and motor function (DiBella et al., 2005).
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Analysis of human homologues of proteins associated with Chlamydomonas outer 
arm, revealed that a total of 24 human genes are thought to encode outer arm subunits 
and/or components necessary for assembly and that 12 out of 14 known 
Chlamydomonas outer arm subunits have at least one likely orthologue in humans 
(Pazour et al., 2006).
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Figure 1.5: Chlamydomonas flagellar Outer Dynein Arm (ODA)
The a, p, and y heavy chains of the outer arms are labelled a, P, and y, respectively. The dynein 
intermediate chains (78 and 69) are shown and eight light chains are indicated by small circles. The 
ODA-DC is not shown in this figure but is attached to the ICs (Ibanez-Tallon 2003).
Figure 1.6: Chlamydomonas flagellar Inner Dynein Arm (IDA)
The IDA is more variable than the ODA; there are at least 8 HCs organized into seven isoforms; either 
double headed light orange) composed o f 2 HC ( la  and ip), 3 1C (97, 138 and 140) and three LCs, or 
single headed (darker orange) of which the exact isoforms has not yet been established. The IDAs 
interact with the radial spokes via the dynein regulatory complex (DRC), which is not shown in this 
figure but is located in close proximity on the outer microtubule to the base of the IDA (Ibanez-Tallon 
2003).
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The composition of the inner dynein arm (IDA) (Figure 1.6) is more variable and is 
less well understood, as they are more heterogeneous and more complex than the 
outer dynein arms and are difficult to image in electron microscopy (EM). Three 
inner arm structures (II, 12 and 13) are thought to exist and these are distinguished on 
the basis of their HC composition and their location relative to radial spokes (Pipemo 
et al., 1990). IDAs that are located at the base of the second radial spoke in the 
axoneme are in close association with the dynein regulatory complex (DRC) that is 
thought to mediate signals between the radial spokes and the dynein arms (Gardner et 
al., 1994).
Multiple isoforms of human dyneins are produced by different genes rather than 
alternative splicing of a number of particular genes, and the functional specificity of 
dyneins is achieved by the assembly of different isoforms of dynein subunits 
(Milisav, 1998). Using database searching and analysis it was predicted 12 genes are 
closely related to Chlamydomonas inner dynein arm subunits (Pazour et al., 2006).
Immunofluorescent studies using probes to stain tubulin and heavy chain dyneins 
DNAH5, DNAIl and DNAH9 has shown that dynein arm composition differs 
between cilia and sperm flagella and that it is not uniform along the length of the 
axoneme (Fliegauf et al., 2005).
1.1.4.2.2 MAPs: The radial spoke complex
The radial spokes (RS) are ubiquitous components of 9+2 cilia and flagella. They are 
T-shaped structures with a “head” and a “stalk” component (Figure 1.7). They are 
attached by the stalk end to the A-microtubule of the peripheral doublets and 
reversibly bind via the head to projections of the central pair (Goodenough and 
Heuser, 1985; Warner and Satir, 1974). Radial spokes are present in pairs or triplet 
groups located at periodic 96 nm intervals, in exact measure with the inner dynein 
arms, along the length of the ciliary axoneme (Warner and Satir, 1974). They play an 
essential role in the control of dynein arm activity by transducing signals from the 
central pair to the dynein arms via the dynein regulatory complex (DRC), although 
the exact mechanism is not yet understood (Wemmer and Marshall, 2004). Flagellar 
movement is inhibited when radial spokes are missing or there are defects in the
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central pair (Smith and Lefebvre, 1997). However, the central pair-radial spoke 
interactions are thought to propagate the cilia bend and direction and the radial spoke- 
inner dynein arm interactions are thought to play a role in the velocity of the bend 
(Brokaw et al., 1982). In addition, it has been shown that ciliary motility is partially 
regulated by phosphorylation and that the central pair-radial spoke complex controls 
the phosphorylation of the dynein arms, thereby modulating the flagellar waveform 
(Walczak and Nelson, 1994).
The Chlamydomonas reinhardtii flagella radial spoke complex was shown to contain 
at least 23 proteins, 18 of which make up the stalk and 5 make up the head (Yang et 
al., 2006) (Figure 1.7). In Chlamydomonas it has been observed that lack of one of 
the radial spoke head subunits results in a complete breakdown of the head complex 
and therefore absence of the five spoke head proteins within flagella (Yang et al., 
2006). A proportion of the protein subunits have Ca^ ,^ AKAP and nucleotide-binding 
domains that are thought to function in signal transduction. Among the 18 
Chlamydomonas spoke proteins characterised so far, 12 have apparent homologues in 
humans, suggesting that this component has been conserved at the molecular level 
throughout evolution. The importance of the radial spoke in ciliary and flagellar 
motility is highlighted by the paralysed or abnormal flagellar motility phenotypes 
observed in Chlamydomonas reinhardtii mutants lacking the entire radial spoke 
complex or just the spoke head.
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Figure 1.7: Model for the radial spoke structure.
A) Diagrammatic representation of a cilia cross section demonstrating the 9+2 arrangement of 
microtubules and the location of MAPs.
B) Diagrammatic representation of the Chlamydomonas radial spoke complex, illustrating probable 
locations of the 23 radial spoke proteins (RSPl-23), based on studies o f mutants and analysis of the 
spoke complex. * indicates newly identified RSPs. Peripheral microtubule doublet is on the left, one 
of the central pair on the right. RSPs 18 and 19 are not placed due to insufficient evidence indicating 
their location within the radial spoke. Radial spoke structure fi-om (Yang et al., 2006).
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1.1.5 Ciliary beat pattern and mucociliary clearance
Respiratory tract cilia beat in a coordinated manner in order to generate a series of 
waves which are essential for continuous mucociliary clearance that is an important 
host defence mechanism against inhaled pathogens (Chilvers and O'Callaghan, 2000). 
It is generally thought that respiratory cilia have a rigid forward effective stroke 
which penetrates the mucus layer and thrusts it forward, followed by a backward 
recovery stroke during which the cilium bends under the mucus layer and repositions 
itself for the next beat (Cosson, 1996). Analysis of rabbit trachea epithelial cilia 
revealed that during the recovery stroke, the cilium sweeps sideways and backwards 
in a clockwise direction that propagates adjacent cilia to beat, causing a ciliary 
metachronal wave (Sanderson and Sleigh, 1981). Analysis of human respiratory tract 
cilia movement in two planes using slowed down digital high speed video imaging 
showed that these cilia beat forwards and backwards (Figure 1.8) with a maximal 
deviation of less than 5°, with an average beat frequency of 11 Hz (Chilvers and 
O'Callaghan, 2000). Nodal cilia movement is discussed in Section 1.1.7.
Figure 1.8: D iagramm atic representation o f the side view of human respiratory cilia beat 
pattern.
Adapted from Chilvers and O’Callaghan (2000).
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1.1.6 Intraflagellar Transport (IFT)
IFT is the process by which cilia and flagella are assembled and maintained using bi­
directional transport of molecular motors and their cargo proteins. IFT was first 
observed as motility that was unrelated to dynein-based flagella motility in the 
axoneme of Chlamydomonas (Kozminski et ah, 1993). Kozminski et al. observed 
particles of varying sizes moving in the anterograde and retrograde direction 
(Kozminski et al., 1993). It is known that the anterograde movement of IFT particles 
is powered by the kinesin-II molecular motor (heterotrimeric kinesin, KIF3) (Cole, 
1999), whereas the retrograde transport is powered by the cytoplasmic dynein lb/2 
motor (Porter et al., 1999) (Figure 1.9). IFT could also provide a mechanism 
whereby the cell senses the presence or absence of its cilia and therefore controls 
transcription of required ciliary genes (Sloboda, 2002). In addition, it is thought to 
act in signal transduction by transporting extracellular signals to the cell body 
(Sloboda, 2002). It is at the flagella tip complex (FTC) that cargo loading and 
unloading, and motor protein regulation occur (Sloboda, 2005) (Pedersen et al., 
2006).
Figure 1.9: Diagrammatic representation o f Intraflagellar Transport (IFT).
Taken from (Badano et al., 2006) IFT particles (blue) are transported along the outer mlcrotubule 
doublets (OM) under the ciliary membrane towards the ciliary tip (anterograde) by kinesin and back to 
the basal body (retrograde) by cytoplasmic dynein.
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1.1.7 The role of motile cilia in left-right axis determination
The leftward flow of extra-embryonic fluid has been shown to be critical for the 
determination of laterality in fish, rabbit and mouse embryos (Hirokawa et al., 2006). 
This leftward flow is thought to be produced by motile cilia in the mouse embryonic 
node, present transiently at ~7.5 days postcoitum (Nonaka et al., 1998). This subset 
of cilia at the node lack the central pair and have a 9+0 structure (Bellomo et al., 
1996) (Table 1.1 and Figure 1.1 OB). They have a circular beat pattern and all rotate 
in a clockwise direction that creates the leftward flow of fluid that is thought to 
induce breaking of body symmetry and determine laterality (Okada et al., 2005; 
Nonaka et al., 1998). KIF3B-deflcient mice lack nodal cilia and exhibit randomised 
left-right asymmetry, unlike wild type controls that had nodal cilia and normal body 
situs, thus providing evidence that this nodal flow is required for determination of 
correct body asymmetry during development (Nonaka et al., 1998). Exactly how 
nodal flow is interpreted to create left-right asymmetry is not completely understood, 
but it has been postulated that the leftward flow produces an asymmetric distribution 
of Ca^  ^ and exogenously induced proteins and the creation of morphogen gradients 
(Okada et al., 2005; Nonaka et al., 1998; Takeda et al., 1999; McGrath and 
Brueckner, 2003). The nodal vesicular parcel (NVP) model predicts that vesicles 
filled with morphogens (such as Sonic hedgehog or retinoic acid) are transported 
leftwards by the nodal flow and smashed open by force to release their contents 
(Tanaka et al., 2005). It has been hypothesised that a subpopulation of immotile cilia 
that are abundant near the edges of the node detect this Ca^Vmorphogen gradient 
either by chemical or mechanical stimulation and induce downstream signalling 
cascades that break bilaterality (Tabin and Vogan, 2003) (Figure 1.1 OA). Similar 
laterality breaking mechanisms have also been proposed for zebraflsh, involving the 
Kupffer’s vesicle (Essner et al., 2005).
Situs inversus (complete organ reversal) occurs in approximately 50 % of patients 
with the ciliary disease. Primary Ciliary Dyskinesia (PCD) (Afzelius, 1976) and a 
further 6 % of cases demonstrate heterotaxy {situs ambiguous) giving rise to more 
complex phenotypes including cardiac abnormalities (Kennedy et al., 2007). 
Laterality defects in PCD are proposed from model organisms that reflects a loss of 
nodal ciliary ftmction during embryogenesis.
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Figure 1.10: Cilia generate and sense nodal flow for left-right body axis determination during embryogenesis.
A) Adapted from (Yost, 2003). Motile cilia on the cells in the centre o f  the node (white rectangles) generate fluid flow that is 
detected either by mechanostimulation or chemostimulation o f sensory cilia at the periphery o f the node (blue ovals). The fluid 
flow is proposed to cause a change in Ca^^ gradient or to transport nodal vesicular parcels (NVPs) (white circles) that are 
smashed open by force to release morphogens at the edge o f  the node and this is detected by sensory cilia. B) Taken from 
(Hirokawa et al., 2006). The ultrastructure o f  mouse nodal cilia as viewed by electron microscopy (EM ) and schematic 
representation. Nodal cilia lack the central pair o f  microtubules so have a 9+0 arrangement.
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PART II: CILIA AND DISEASE
1.2 Ciliopathies
Cilia are present on almost all polarised cell types of the human body. Dysfunction of 
cilia can affect many different organ systems, resulting in cilia-related disorders 
known collectively as the ciliopathies (Figure 1.11). Although all ciliopathies arise 
from defective cilia, the range of symptoms can vary significantly (Table 1.2). 
Ciliopathies can affect either single organs or can exist as multi-organ disorders 
which are phenotypically variable and overlap with other disease manifestations 
(Badano et al., 2006), including exencephaly (Katsanis, 2006), retinitis pigmentosa 
(RP) (Krawczynski and Witt, 2004), nephronophthisis (Saunier et al., 2005) and 
polycystic kidneys (Pazour, 2004), as well as disorders associated with developmental 
defects such as Bardet-Biedl syndrome (BBS), oral-facial digital syndrome type I 
(OFDl) and Meckel-Gruber Syndrome (MKS types 1-3).
Non-motile, sensory cilia and are thought to detect environmental signals by various 
cilia-specific receptors, ion channels and signalling molecules that are present in the 
ciliary membrane. Signalling through receptor-dependent pathways such as sonic 
hedgehog (SHH), platelet-derived growth factor receptor (PDGFR) and non- 
canonical Wnt pathways are mediated through cilia and defects in these pathways can 
cause developmental defects (Fliegauf et al., 2007). Loss of the Hedgehog (Hh) 
signalling pathway can cause several birth defects, including polydactyly, craniofacial 
defects and skeletal malformations (McMahon et al., 2003), which resemble the 
developmental defects observed in IFT-mutant mice (Zhang et al., 2003). Therefore, 
cilia-related signalling pathways mediated by IFT are thought to contribute to 
embryonic development.
Bardet-Biedl syndrome (BBS) is a disease associated with ciliary dysfunction. BBS 
affects development and is commonly associated with features including cystic 
kidneys, polydactyly, mental retardation and obesity. Twelve BBS proteins have 
been identified to date, BBSl-12 (Table 1.2) and all of those tested have been shown 
to localise to ciliated cells and tissues. Mice with defective proteins homologous to 
human BBSl, BBS4 and BBS6 exhibit phenotypes resembling those observed in the
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mutants of the non-canonical Wnt pathway. These phenotypes include open eyelids, 
neural tube defects and disrupted cochlear stereociliary bundles (Torban et al., 2004b; 
Torban et al., 2004a). Studies in zebrafish and mouse revealed that the protein LTAP 
(also known as VANGL2) is involved in Wnt signalling and colocalises with BBS 
proteins to the basal body and cilia axoneme. Thus providing further evidence that 
cilia are involved in Wnt signalling and therefore ciliary dysfunction can result in 
developmental defects.
A similar example is Alstrom syndrome (ALMS), in which patients present with a 
number of phenotypes similar to those observed in BBS patients, including RP, 
obesity and diabetes, but also develop deafiiess and do not have polydactyly. ALMS 
is caused by mutations mALMSl, a gene which was identified by breakpoint analysis 
of an ALMS patient with a familial balanced reciprocal chromosome translocation 
(Hearn et al., 2002), and the protein was shown to localise to both the centrosome and 
basal bodies in a pattern very similar to BBS proteins (Hearn et al., 2005).
Oral-Facial-Digital syndrome type 1 (OFDl) is an X-linked disorder characterised by 
malformations of the face, oral cavity and digits with polycystic kidneys and in some 
cases defects of the central nervous system. OFDl was shown to be caused by 
mutations in OFDl (Ferrante et al., 2001). The OFDl protein localises to both the 
centrosomes and basal bodies, suggesting that this disease may also be related to cilia 
dysfunction.
Further evidence that ciliary dysfunction contributes to neural tube defects is 
provided by the fact that mutations in MKSl and MKS2, which encode the ciliary 
components MKSl and meckelin (Dawe et al., 2007; Smith et al., 2006), are 
associated with a disorder associated with neural tube defects (encephaloceles), 
Meckel-Gruber syndrome (MKS types 1-3). Recent studies in Xenopus laevis 
embryos have shown that vertebrate Wnt pathway proteins Intumed (Int) and Fuzzy 
(Fuz) are essential for ciliogenesis (Park et al., 2006), and MKS proteins are 
implicated in this pathway (Smith et al. 2006).
Animal models have supported the link between cilia dysfunction and renal cyst 
formation. In addition to the Tg73T^^ mouse model of autosomal recessive
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polycystic kidney disease (ARPKD), in the congenital polycystic kidney {cpK) mouse, 
cystin, the protein product of cpk, is present in the cilia of renal epithelial cells (Hou 
et al., 2002). In autosomal dominant PKD, (ADPKD), mutations have been found in 
PKDl and PKD2 (Mochizuki et al., 1996). The products of these two genes are 
polycystin 1 and 2, respectively, which interact with each other and are thought to be 
part of a Ca^  ^channel localised in the primary cilium of renal epithelial cells. It has 
been suggested that both proteins function as mechanosensors of extracellular fluid 
flow that function by regulating Ca^  ^ flux and that renal primary cilia might act as 
environmental sensors to regulate cell growth and differentiation. Therefore, 
dysfimction of these cilia results in abnormal cell proliferation and consequent cyst 
formation (Nauli et al., 2003). Nephronophthisis (NPHP) is an autosomal recessive 
cystic kidney disease, for which five genes have been cloned (NPHP 1-5). Analysis 
of their protein products has provided a strong link between cilia function and the 
pathogenesis of the disease (Hildebrandt and Zhou, 2007).
Vertebrate photoreceptors are polarised sensory neurons composed of an inner and an 
outer segment connected by a highly specialised 9 + 0 connecting cilium. All 
components necessary for the assembly, maintenance and continuous turnover of the 
outer segment are transported via the connecting cilium by IFT. In mice, targeted 
mutations that affect IFT cause retinal degeneration (Marszalek et al., 2000). A link 
between human retinal degeneration and dysfunction of the connecting cilium has 
been suggested due to the fact mutations in RPGR (Retinitis Pigmentosa GTPase 
regulator) account for 20 % of cases of retinitis pigmentosa (RP) and the protein 
localises to the connecting cilium (Hong et al., 2003). In addition, retinal 
degeneration is a feature of BBS (Katsanis et al., 2000) and as previously mentioned, 
all BBS proteins are thought to have cilia-related function.
These syndromes all affect sensory cilia function. This study will focus on a disease 
caused by the dysfunction of motile cilia, including those lining the respiratory tract, 
that are essential for mucus transport and airway clearance. Primary Ciliary 
Dyskinesia (PCD).
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Figure 1.11: Phenotypic outcomes of ciliary defects.
Defects o f cilia motility lead to Primary Ciliary Dyskinesia (PCD) and Kartagener Syndrome (KS). 
Defects in specific receptors in the ciliary membrane cause polycystic kidney syndrome (PKD). 
Defects in IFT have been linked to retinitis pigmentosa (RP). Perturbation of basal body proteins 
results in structural and functional or IFT defects caused by dysfunctional signalling cascades, which 
then can cause a variety of syndromes, nephronophthisis (NPHP) or pleiotropic disorders such as 
Bardet-Biedl syndrome (BBS), Alstrom syndrome (ALS), oral-facial digital type 1 syndrome (OFDl) 
or Mekel-Gruber syndrome (MKS).
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Table 1.2: Diseases associated with defects in sensory cilia function.
Adapted from (Marshall, 2008)
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1.2.1 Primary Ciliary Dyskinesia (PCD)
Primary Ciliary Dyskinesia (PCD) is a genetic condition caused by inherited defects 
affecting motile cilia function. PCD patients have a range of ciliary defects in a 
number of tissues and severity of the disease ranges from mild symptoms to severe 
disease requiring lung transplantation (Carretero Gracia et al., 2000). The 
pathogenesis of the disease phenotype reflects the distribution of defective respiratory 
epithelial cilia that results in ineffective mucociliary clearance of the upper airway 
causing sinusitis, and the lower airways causing chronic inflammatory damage 
(bronchiectasis). Defective sperm flagella and dysmotility of cilia lining the fallopian 
tubes causes male or female subfertility, respectively. In addition, dysmotility of the 
motile cilia in the ependymal cell layer surrounding the brain ventricles, results in a 
reduction in cerebrospinal fluid flow and occasionally causes the development of 
hydrocephalus associated with PCD (Picco et al., 1993; Jabourian et al., 1986; Kosaki 
et al., 2004). Defects of nodal ciliary motility can also lead to left-right symmetry 
defects (usually situs inversus) and left-right axis determination is randomised in 
patients diagnosed with PCD. In addition, PCD has been associated with other 
abnormalities including heterotaxy and congenital heart disease (Bush, 1998) 
(Kennedy et al., 2007) and an association between motile cilia dysfimction and 
retinitis pigmentosa (RP) and a mental retardation syndrome (OFDl) has also been 
made (Moore et al., 2005; Budny et al., 2006).
1.2.1.1 History of PCD
Initially, patients with a triad of symptoms, bronchiectasis, sinusitis and situs inversus 
were diagnosed as having Kartagener syndrome (KS) (OMIM 244400). Further 
research showed that this applied to only a subset of individuals with ciliary defects 
since not all had situs inversus and thus the term immotile cilia syndrome was used 
(Afzelius, 1976). However, cilia were not necessarily immotile but were sometimes 
dysmotile or had reduced motility and a residual amount of ciliary function was 
observed in some patients. Therefore the term Primary Ciliary Dyskinesia (PCD) was 
introduced in 1981 as an all-encompassing term to describe those people with 
abnormalities in the structure and function of cilia, resulting in sinusitis and 
bronchiectasis, either with or without laterality defects (Sleigh, 1981).
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1.2.1.2 Clinical presentation of PCD
Clinical symptoms are very variable among PCD patients, ranging from severe 
neonatal distress and ensuing disease severity, to a delay in diagnosis sometimes until 
adulthood. A lack of coordinated ciliary movement in the respiratory tract results in 
reduced mucociliary clearance, causing in sinusitis, rhinitis and/or otitis media, as 
well as recurrent bacterial respiratory infections leading to chronic progressive 
inflammatory lung damage and the development of bronchiectasis (Bush et al., 2007). 
The first presentation of the disease may be unexplained tachypnea in newborn 
babies, neonatal pneumonia, respiratory distress syndrome, chronic rhinitis, mirror- 
image reversal of body organs {situs inversus) and/or rarely, hydrocephalus. In some 
cases, the ciliary defect may become more obvious in cases of male subfertility due to 
dysmotile or immotile spermatozoa flagella (Munro et al., 1994). Female subfertility 
due to dysmotile cilia lining the oviduct is less frequently observed (Afzelius and 
Eliasson, 1983).
Approximately 50 % of PCD patients present with situs inversus and this reflects the 
dysfunction of motile cilia in the embryonic node (Section 1.1.7). However, it has 
recently been shown that at least 6.3 % of patients with PCD have heterotaxy (or situs 
ambiguous, where situs cannot be determined) associated with more severe defects 
including cardiovascular abnormalities (Kennedy et al., 2007). In fact, the prevalence 
of congenital heart disease is 200-fold higher in PCD patients than the general 
population, so it has been suggested that people with chronic coronary heart disease 
(CHD) should be screened for PCD (Kennedy et al., 2007).
Although the beat frequency of nasal cilia was shown not be associated with brain 
abnormalities (Roth et al., 1988), there are a number of patients who have been 
identified with hydrocephalus and dysmotile cilia (Picco et al., 1993). In fact, mice 
with mutations in the PCD gene DNAH5 (Section 1.2.1.6), have severe hydrocephalus 
due to reduced ependymal flow, which is associated with the closure of the cerebral 
aqueduct during brain development (Ibanez-Tallon et al., 2004).
In a study where 55 cases of PCD were diagnosed, the symptomatic history of 
patients was documented to highlight the predominant clinical features of the disease 
(Table 1.3).
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Table 1.3: Clinical sym ptom s o f  PCD.
Modified from (Coren et al., 2002). 55 cases o f  PCD were diagnosed and important symptoms 
documented. Most individuals had multiple symptoms, typically a combination o f  both upper and 
lower airway disease.
1.2.1.3 Diagnosis of PCD
Diagnosis is based on the presence of typical clinical phenotypes (Table 1.3) and 
specific ultrastructural defects of cilia as identified by electron microscopy (EM). 
Diagnosing PCD is challenging and requires a clinical phenotype that is compatible 
with clinical tests: ciliary ultrastructural analysis, immunofluorescent staining, ciliary 
beat assessment, saccharin test and nasal oxide measurements.
Due to limited knowledge about the disease, PCD is often not considered in the 
diagnosis of patients and as such, diagnosis of PCD is seen to cluster around areas 
where specialist centres exist. The National Specialist Commissioning Advisory 
Group (NSCAG) has funded three national diagnostic centres for PCD. The mean 
age of diagnosis was found to be 4.4 years old in a paediatric PCD clinic in 55 cases, 
despite the presence of neonatal respiratory distress, situs inversus and rhinitis (Coren 
et al., 2002). However, despite up to three quarters of PCD patients displaying 
significant symptoms shortly after birth (Bush et al., 1998) (de longh and Rutland, 
1995) some patients are not diagnosed until later in life.
1.2.1.3.1 Ultrastructure analysis by EM
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Electron microscopy should ideally be the standard method for diagnosing PCD, in 
order to identify ultrastructural defects in patients cilia (Bush et al., 1998). However, 
this is a relatively expensive test and so a broader diagnosis is considered before this 
test is pursued. In addition, it should be noted that cilia ultrastructure and beat 
frequency are often disrupted by infection and smoking so cilia ideally need to be 
cultured in specialist centres in order to get rid of the secondary ciliary defects before 
EM is performed. Different ultrastructural defects responsible for PCD result in 
predictable dyskinetic or static beat patterns. Recognition of these can help in the 
diagnostic evaluation of patients suspected of having PCD (Chilvers et al., 2003). 
The first ultrastructural defects documented by EM showed absent dynein arms of 
immotile respiratory cilia and sperm flagella (Afzelius, 1976). Since then a number 
of other phenotypic variations have been noted, including changes in organisation of 
microtubules within the axoneme and missing radial spokes (Schneeberger et al.,
1980). The most common ultrastructural defect remain that of the outer dynein arms 
that can now be related to genetic mutations in at least two dynein genes (Noone et 
al., 2004). For a proportion of cases, no defect can be found at the EM level.
1.2.1.3.2 Ciliary beat testing
Ideally, ciliary motility is also assessed to diagnose PCD (Chilvers et al., 2003). The 
time taken for a patient to taste saccharin after a drop has been placed on the inferior 
nasal turbinate is a basic measure of ciliary beat frequency (Palmblad et al., 1984). 
The slower the movement, the more likely it is that the patient has dysfunctional cilia. 
This method works on the basis that cilia move the saccharin to the tongue. The 
recent advent of high resolution digital high speed video imaging has allowed the 
precise beat pattern of cilia to be analysed and utilised in diagnostic procedures 
(Schipor et al., 2006).
1.2.1.3.3 Nitric Oxide (NO) testing
In PCD, nasally exhaled nitric oxide (NO) is unexplainably low (Bodini et al., 2008; 
Noone et al., 2004). NO is thought to be involved in both the regulation of ciliary 
motility and host defence. A study by Karadag et al. suggested that measurement of 
nasal NO may be a useful screening test for primary ciliary dyskinesia (Karadag et
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al., 1999) and this has been introduced into most PCD clinics. It has been shown that 
the unaffected parents of PCD patients expected to be heterozygous for the mutation 
associated with PCD, had lower than expected NO levels in the range between that of 
normal, healthy subjects and those with PCD (Noone et al., 2004).
It has been noted that caffeine intake may cause a significant decrease in exhaled NO 
(Bruce et al., 2002). It has been shown that inhalation of L-arginine increases NO in 
ciliated epithelial cells and leads to a faster CBF (Loukides et al., 1998). However, 
this is considered a justified tool in the diagnosis of PCD (Wodehouse et al., 2003) 
and is a routine test used in clinics, although it is not possible to test children younger 
than about 5 years of age (Piacentini et al., 2008).
1.2.1.3.4 Immunofluorescence testing
Detection and intracellular localization of heavy chain dynein, DNAH5, has been 
observed in respiratory tract epithelial cells by immunofluorescent microscopy along 
with another heavy chain dynein DNAH9 (Fliegauf et al., 2005). PCD patients with 
mutations in DNAH5 either had no DNAH5 staining or mis-localised staining present 
at the basal bodies, implying that the protein is unable to enter the axoneme. This 
approach is not in routine clinical use, but could be used in diagnosis of PCD if a 
panel of antibodies directed towards the products of known PCD genes is developed 
and may one day present a quicker diagnostic method than EM. Patients with outer 
dynein arm defects, but no DNAH5 mutations can also show DNAH5 mis-localisation 
so a small antibody panel could be developed to detect most axonemal defects.
1.2.1.3.5 Mutational analysis o f candidate genes
Mutational analysis has demonstrated that an estimated 28 % of PCD families with 
outer dynein arm defects carry mutations in the DNAH5 gene and that mutations in 
the DNAIl gene account for approximately 13 % of PCD cases (Homef et al., 2006a). 
Therefore mutational analysis of these genes in PCD patients with corresponding 
ultrastructural defects is offered, although only in the USA at present, and only for 
detecting common mutations (Section 1.3.2.2). Although the genetics of PCD are 
slowly being revealed, the multiple phenotypes and the more than 200 proteins
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present in the ciliary axoneme mean that it is likely to be some time before such 
genetic tests are widely used in diagnostic examination. This is partly for economic 
reasons, especially as dyneins are very large genes.
1.2.1.4 Ultrastructural defects in PCD patients
Electron micrographs (EMs) of cilia or sperm flagella reveal a number of possible 
ultrastructural abnormalities that cause PCD (Table 1.4) (Afzelius, 1985). These 
include absence or deficiency of outer and/or inner dynein arms, shortened dynein 
arms, absent inner dynein arms and nexin links (causes disorganisation of the 
axoneme), absent radial spokes (the central pair are off centre), absence of one or 
both of the central pair (although this can be caused by some medications), defect of 
orientation of the central pair, absence of microtubules in the axoneme, absent 
axoneme, or abnormal ciliary function despite a normal axonemal ultrastructure 
(Palmblad et al., 1984). Mutations in the gene encoding a heavy chain dynein, 
DNAHll, were shown to be associated with a normal axonemal structure in a German 
PCD family with dysmotile respiratory cilia (Schwabe et al., 2008) and a patient with 
immotile respiratory cilia (Bartoloni et al., 2002). The most common defects (96% of 
PCD patients reported) involve either or both the outer and inner arms (Afzelius,
1981) (Horvath et al., 2005). In addition, abnormal orientation or length of cilia has 
been reported (Afzelius et al., 1985). Secondary abnormalities, such as microtubule 
defects and compound cilia can arise as a result of infection, smoking or pollution and 
occur in up to 10% of a normal person’s cilia, which can confuse the diagnosis of 
PCD (McAuley and Anand, 1998) (Meeks and Bush, 2000).
Different ultrastructural defects observed by EM have been shown to be responsible 
for different cilia beat patterns in PCD, observed by digital high speed video imaging 
(Chilvers et al., 2003). Those with either outer or inner and outer dynein arm defects 
had a high proportion of immotile cilia, or cilia with only a slight flickering beat 
pattern. PCD patients with an abnormal ciliary beat pattern of a stiff forward stroke 
with reduced amplitude, were shown to be have an inner dynein arm defect or a radial 
spoke defect associated with an inner arm defect. Two patients with radial spoke 
defects had a circular beat pattern and a higher than normal beat frequency. A ciliary 
transposition defect was associated with an oval gyrating pattern. Recognition of
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such beat patterns might aid in the diagnostic evaluation of patients suspected of 
having PCD.
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Table 1.4: Overview o f  the ultrastructural abnorm alities o f respiratory epithelial cilia from PCD patients.
(Adapted from Meeks, 1998 and Afzelius 2004)
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1.2.1.5 Treatment and prognosis of PCD
No treatments exist as yet to correct cilia dysfunction, however, management of the 
disease is important for the clinical course and includes enhancement of mucociliary 
clearance by chest percussion, aerobic exercise and bronchodilators in some patients 
(Bush et al., 1998). Antibiotic treatment given promptly upon respiratory tract 
infection or sinusitis can prevent lung damage. A tympanotomy can help children 
with ear infection and sinus drainage can relieve symptoms in the short term 
(Palmblad et al., 1984). Patients with severe bronchiectasis and end-stage lung 
disease are considered for lung transplantation if respiratory failure looks likely 
(Palmblad et al., 1984).
Most patients with PCD have a normal life span, although the rate of disease 
progression can vary and morbidity, rather than mortality, can be considerable if PCD 
is incorrectly managed (Bush et al., 1998). Patients diagnosed later on in life and 
who had therefore received less treatment than those diagnosed during childhood, 
found that PCD had a greater impact on their health in the second half of their life, 
resulting in significant morbidity and restriction of a normal lifestyle (McManus et 
al., 2003). Therefore, early diagnosis and treatment would improve symptoms and 
impact of the condition on patients. More widespread knowledge would lead to an 
earlier diagnosis and therefore improve the prognosis of PCD patients.
1.2.1.6 Model organisms of PCD
A naturally occurring phenotype similar to PCD occurs in pigs and dogs, except that 
hydrocephalus is a common feature (De et al., 2004) (Roperto et al., 1993) (Roperto 
et al., 1994). Naturally occurring or transgenic mouse mutants with features of PCD 
exist, which include /v//v, inv/inv and hpy/hop mutants (Brueckner et al., 1989) 
(Handel and Kennedy, 1984) (Yokoyama et al., 1993). In iv/iv mice, the Ird (for left- 
right dynein) gene was found to be mutated, which is the human homologue of which 
is DNAHll encoding outer dynein heavy chain 11. iv/iv mice have a 50 % incidence 
of laterality defects and immotile nodal cilia, however no respiratory cilia 
abnormalities have been identified and as previously mentioned DNAHll is not yet 
associated with a specific ciliary defect in PCD patients. The inv murine model has
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100 % laterality defects, although it also has no ciliary abnormalities and further work 
is required before the role of this gene is fully understood. The hpy and hop mouse 
models have respiratory cilia and sperm flagella abnormalities, thus the males are 
infertile, however no laterality defects are present. The gene responsible for these 
phenotypes has not yet been cloned but is thought to map to chromosome 6 (were the 
cytogenentic band is syntenic to human chromosome 12) (Bryan, 1983).
A mouse Dnah5 knock out model has been created by gene targeting and this shows a 
phenotype very similar to PCD patients, in that they develop respiratory problems 
because of low mucociliary clearance and half have laterality defects (Ibanez-Tallon 
et al., 2002). In addition the Dnah5 mice have hydrocephalus unlike the DNAH5 
patients, likely due to a difference in brain structure between species.
The WIC-Hyd rat model is shown to have an X-linked recessive inheritance and these 
mice display respiratory and ependymal ciliary defects, as well as situs inversus 
(Torikata et al., 1991). More recently, the Foxjl knockout mice with a mutation in 
the forkhead box transcription factor, have been shown to lack 9+2 cilia, whereas 9+0 
cilia are present in the embryonic node (Zhang et al., 2004). This is due to lack of 
transcription of essential basal body components involved in anchoring the basal 
body to the cytoskeleton and results in a failure of axonemal formation (Gomperts et 
al., 2004). As a result, mice show random determination of the left-right axis 
(Tamakoshi et al., 2006) and ciliary genes are down-regulated.
Mice homozygous for the nml054 mutation in the gene encoding the novel primary 
ciliary dyskinesia protein 1 (Pcdpl) develop phenotypes associated with PCD (Lee et 
al., 2008). Homozygous mutants present fatal perinatal hyrocephalus. Heterozygotes 
have an accumulation of mucus in the sinus cavity and male infertility, due to slow 
respiratory cilia beat frequency and absence of mature sperm flagella, respectively. 
Immunohistochemistry showed that the Pcdpl protein localises to sperm flagella, 
respiratory epithelial cell cilia and brain ependymal cells in both mice and humans 
(Lee et al., 2008). This model is therefore an important tool for the study of the 
molecular genetics and pathogenesis of PCD.
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1.2.1.6.1 Zebrafish as a model organism
Zebrafish are used as vertebrate disease models primarily because of their 
experimental and genetic amenability. Zebrafish embryos develop with a transparent 
chorion and development can therefore be optically observed. In addition, they 
produce many offspring (up to 200 eggs per female fish per week) and development 
is rapid. The cost of keeping fish is significantly lower than keeping mice. 
Therefore, many experiments can be performed on a single clutch and live 
manipulations and observations can be carried out from fertilisation.
Zebrafish are useful in a number of genetic manipulation experiments, including gain- 
and loss-of-function techniques (Holley et al., 2002). RNA injection can be 
performed at particular times and locations in the embryo to assess gene function. 
Alternatively, modified antisense oligonucleotides, or morpholinos, can be injected 
into zebrafish embryos to knock down the function of genes by steric blocking of 
RNA splicing or translation and thereby model a specific human gene defect. A 
number of zebrafish mutants have been produced by genetic manipulation that are 
good models of human disease (Lieschke and Currie, 2007), including ones with cilia 
defects displaying phenotypes such as hydrocephalus and cystic kidneys (Kramer- 
Zucker et al., 2005). Targeted knockdown of zebrafish heavy chain dynein (dhc9) 
results in the formation of kidney cysts due to reduced pronephric fluid flow 
(Sullivan-Brown et al., 2008). In addition, zebrafish have a fluid-filled organ called 
the Kupffer’s vesicle (KV), which is analogous to the human embryonic node and is 
involved in left-right axis patterning (Essner et al., 2002). The similarities between 
the phenotypes observed in zebrafish caused by defects in motile cilia and the clinical 
presentation of PCD in humans mean that zebrafish can serve as a useful vertebrate 
model system for understanding cilia motility and PCD in humans.
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PART III: GENETICS OF PCD
1.3 Inheritance of PCD
The incidence of PCD is estimated at 1 in 20,000 live births (Meeks and Bush, 2000), 
although difficulties in diagnosis and the overlap in clinical phenotype with other 
chronic airway diseases suggests that this is an underestimate (Noone et ah, 2004). 
PCD is an autosomal recessive (AR) disorder (Afzelius, 1998) (Bush et ah, 1998), 
although rare cases of X-linked or autosomal dominant (AD) PCD have been reported 
(Krawczynski and Witt, 2004) (Moore et ah, 2005) (Narayan et ah, 1994). As for 
most AR disorders, the incidence of PCD is increased in isolated, inbred populations. 
It is genetically heterogeneous condition, in agreement with cilia complexity and the 
fact that a defect of any of the >250 ciliary components could theoretically result in 
dysmotile cilia.
1.3.1 Identification of candidate genes for PCD
1.3.1.1 Genetic linkage analysis for positional cloning
Disease loci with a Mendelian pattern of inheritance can be mapped using 
polymorphic genetic markers such as microsatellites (di-, tri- or tetra- nucleotide 
repeats) and single nucleotide polymorphisms (SNPs) within affected families. A 
disease locus is positioned in the genome by being closely linked to genetic markers 
that have been genotyped at regular intervals across the whole genome (Botstein et 
ah, 1980) and are not shared between affected and non-affected individuals within a 
single family pedigree.
1.3.1.2 Homozygosity mapping
Homozygosity mapping is an efficient strategy for the identification of positional 
candidate human genes that cause recessively inherited traits by the identification of 
genotypes of informative DNA polymorphisms, such as microsatellites and SNPs, in 
affected offspring of consanguineous families (Lander and Botstein, 1987). With the
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complete sequencing of the human genome (Venter et al., 2001) (Lander et al., 2001) 
a large number of microsatellites and SNPs have been identified for use in this 
technique.
The homozygosity mapping method works to identify how the genetic information 
and therefore disease loci have been inherited (Shen et al., 2005) (Puffenberger et al., 
2004), based on the fact that affected offspring of a consanguineous marriage will 
have inherited a region on the chromosome spanning the disease locus that is 
homozygous by descent (HBD) (the same ancestral disease chromosome from each 
parent) (Teebi and El-Shanti, 2006). A region HBD that is shared amongst affected 
offspring and not unaffected offspring may be considered as containing the disease 
locus (Farrall, 1993). One affected individual fi-om a first cousin marriage has been 
shown to contain the equivalent genetic information to a non-consanguineous family 
with three affected siblings (Ott, 1999). The power of a consanguineous family 
resource therefore allows the number of individuals required for genotyping to be 
reduced and makes it possible to map rare recessive diseases for which it is difficult 
to collect adequate numbers of nuclear families with affected offspring and where 
heterogeneity exists. However, problems with this technique may arise if more than 
one region of excess homozygosity is identified (since 1/16 of the genome is HBD in 
a first cousin marriage (Farrall, 1993) and genotyping must be performed on the 
parents in order to ensure marker informativity (Miano et al., 2000).
The identification of the PCD gene, DNAH5, resulted from a genome-wide linkage 
analysis using homozygosity mapping, and mutational analysis of the dynein heavy 
chain gene within the candidate interval (Omran et al., 2000).
1.3.1.3 Statistical analysis of linkage analysis
Genetic pedigree data generated by homozygosity mapping is analysed using linkage 
analysis programmes such as GENEHUNTER (Kong and Cox, 1997) or MERLIN 
(Abecasis et al., 2002), which calculate LCD scores, using an approximate multipoint 
calculation that ignores the unlikely possibility of a large number of recombinants. 
The LCD score is the logarithm of the odds that the loci are linked rather than 
segregate randomly with a recombination fraction of 0.5, i.e. it is used to calculate the
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probability that the pedigree arises randomly or by genetic linkage (Morton, 1955). 
To be significant, it is generally accepted that a LOD score >3 must be achieved.
1.3.1.4 Structural components of cilia as candidate genes for PCD
Many candidate genes exist for PCD, several of which have been unsuccessfully 
screened and several in which mutations have been identified (Section 1.3.2.2). 
Model systems for PCD have provided us with a number of candidate PCD genes, as 
described in Section 1.2.1.6., however, the human genes for these candidates have not 
all been identified. The structural components of the ciliary axoneme and basal body 
and the genes that control their expression and assembly are good candidates for 
PCD. For example, DNAIl, the gene for an outer dynein arm intermediate chain, is a 
homologue of the Chlamydomonas IC78 and on a candidate gene basis was found to 
be mutated in a number of patients with outer dynein arm defects. Also, DNAHll 
found to be mutated in a putative case of PCD, was screened on a candidate gene 
basis since it is the human homologue of the mouse Ird gene in the iv/iv model. Since 
the most common ciliary ultrastructural defects seen in PCD patients affect the inner 
and/or outer dynein arms, each of which is made up of a number of dynein subunits, 
dynein genes are considered as good candidates genes for PCD. The identification of 
homologues of Chlamydomonas radial spoke proteins in humans indicates that this 
component is conserved at the molecular level and therefore provides new candidate 
genes for PCD in patients with radial spoke defects.
Defects in radial spokes are known to cause PCD (Sturgess et al., 1979) (Antonelli et 
al., 1982) although no gene(s) have yet been identified as disease-causing in patients 
lacking all or part of the radial spokes. Among the 18 Chlamydomonas radial spoke 
proteins characterised so far, 12 have apparent homologues in humans, suggesting 
that this component has been conserved at the molecular level throughout evolution 
(Yang et al., 2006). The importance of the radial spoke in ciliary and flagellar 
motility is highlighted by the paralysed or abnormal flagellar motility phenotypes 
observed in Chlamydomonas reinhardtii mutants lacking the entire radial spoke 
complex or just the spoke head. A more complete understanding of the assembly, 
components and function of the radial spokes in the ciliary axoneme would assist in 
the identification of such genes.
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1.3.1.5 Candidate genes for PCD in the genome
1.3.1.5.1 Genomic analysis o f cilia
Based on the hypothesis that the ancestral eukaryote was a ciliated organism and that 
cilia, and therefore cilia-related genes, have been lost throughout evolution in some 
species, Avidor-Reiss et al used a comparative genomics approach to predict the 
genes required to build cilia. It was assumed that during evolution, genetic 
information of biological processes and organelles that no longer exist is not 
preserved. By comparing the genomes of ciliated and non-ciliated organisms a 
number of proteins involved in the biogenesis and maintenance of the structure and 
function of cilia were identified. Genomes ifrom organisms that use 
compartmentalised ciliogenesis (where the basal body docks to the cell membrane 
and the axoneme and ciliary membrane buds out from this) were compared to the 
genome of organisms that use cytosolic ciliogenesis (where the axoneme is first 
assembled inside the cytosol and is then extruded). Using Drosophila as a model 
system, a novel family of proteins involved in compartmentalised ciliogenesis 
(OSEGs) were reported (vidor-Reiss et al., 2004).
In a similar approach, the proteome of the non-ciliated Arabidopsis was subtracted 
from the proteome of the ciliated organisms Chlamydomonas and Homo sapiens (Li 
et al., 2004). These comparisons yielded 6 8 8  proteins in the flagella apparatus and 
basal body (FABB) proteome. These were validated as ciliary components against 
known Chlamydomonas genes, transcriptional regulation of flagella genes and by use 
of RNA interference techniques (Li et al., 2004).
1.3.1.5.2 Transcriptomic analysis o f cilia
Using oligonucleotide microarrays. Stoic et al analysed genes induced during 
regeneration of flagella in Chlamydomonas (Stoic et al., 2005). When the 
Chlamydomonas flagella is removed and allowed to regenerate, transcription of 
flagella structural genes is up-regulated 3 to 12 fold. Genes that are up-regulated 
upon deflagellation are proposed as likely to be structural components of the
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flagellum and also genes whose products are important for regulation of flagella 
assembly. This approach showed that only 85 out of a total of 220 genes induced had 
previously been implicated with cilia or flagella and the rest had not previously been 
connected with flagella function. Any genes that were up-regulated after 
deflagellation are knocked out using RNA interference and the subsequent phenotype 
examined (e.g. slow swimming, paralysis, or absence of flagella). Five of the six 
non-up-regulated genes were shown by RNA interference to cause flagella defects.
1.3.1.5.3 Proteomic analysis o f cilia
In a proteomic study of human bronchial epithelial cilia, 2D/1D-PAGE and 
sequencing of proteins by liquid chromatography/tandem mass spectrometry was 
used along with analysis using Lys-C digestion and subsequent sequencing. Over 
200 potential axonemal proteins that matched ESTs were identified, including known 
PCD genes DNAH5 and DNAIl, as well as the homologue of the zebrafish polycystic 
kidney disease gene qilin (Ostrowski et al., 2002).
Studies of the Chlamydomonas flagella predicted that the axoneme contains 360 true 
and 292 potential flagella proteins (Pazour et al., 2005), this indicated that cilia 
contain more than the approximated 250 proteins than originally thought and had 
higher complexity.
An RNAi based interrogation of the Trypanosome flagella proteome (TbFP) resulted 
in defective flagella in this species. In addition, comparison of the TbFP with that of 
other eukaryotes revealed a number of Trypanosome specific proteins. Some genes in 
the TbFP are homologues of known ciliary disease genes and 34 of the genes were 
mapped to known ciliary-disease loci, thus are considered potential disease causing 
candidates (Broadhead et al., 2006). Therefore the proteomic analysis of cilia can be 
used in the identification of candidate genes for PCD.
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1.3.2 The history of PCD gene and loci identification
1.3.2.1 PCD loci
The extensive genetic heterogeneity underlying PCD corresponds to the clinical 
heterogeneity and the complex structure and regulation of cilia function (Leigh,
2003). Several different loci have been reported to be linked PCD and respiratory 
defects caused by motile cilia dysfunction have been found in conjunction with other 
defects such as polycystic kidney disease (PKD) and Senior Loken syndrome (Otto et 
al., 2005). It has been suggested that it is possible in some families that PCD might 
be inherited as a digenic disorder, whereby two mutations in two different genes 
cause the PCD phenotype, however this is yet to be proven (Blouin et al., 2000).
An early genome wide linkage scan on 31 multiplex PCD families with a variety of 
ultrastructural defects carried out by Blouin et al. suggested no major single gene 
locus, but several putative PCD loci were suggested on chromosomes 3p, 4p, 5p, 8 q, 
16p, 17q and 19q (Blouin et al., 2000), thus providing further evidence of the 
predicted heterogeneity of the disease.
In 1992, affected individuals from 2 unrelated families with Immotile Cilia Syndrome 
(ICS) with an ultrastructural defect of random microtubule arrangement in the cilia 
axoneme, were found to share a PCD susceptibility locus within the HLA complex on 
chromosome 6  (Bianchi et al., 1992).
A total genome scan was performed at University College London (UCL) in five 
PCD families from Saudi Arabia, with similar ultrastructural defects of absent outer 
dynein arms, and a putative PCD locus was defined on chromosome 19ql3.3 (Meeks 
et al., 2000). This region is gene rich and contains a large cluster of zinc finger 
genes. Mutations in the zinc finger transcription factor, Z/C5, were been previously 
reported to cause X-linked laterality defects (Gebbia et al., 1997). However, although 
a number of chromosome 19ql3.3 candidate genes sequenced in the linked families 
in this laboratory, no mutations have yet been identified.
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Another UCL genome-wide linkage scan was carried out on two PCD families from 
two different, isolated populations: the Faroe Islands and the Israeli Druze population 
in Israel (Jeganathan et ah, 2004). The use of families from isolated and therefore 
inbred populations, with similar ultrastructural PCD phenotypes reduces the risk of 
genetic heterogeneity (Miano et ah, 2000) (Teebi and El-Shanti, 2006). The Faroe 
Island families showed ultrastructural defects of absent outer dynein arms (one 
patient out of eleven had situs inversus). The Druze families had a partial loss of 
inner dynein arm (six out of seven patients displayed situs inversus). Three out of 
four Druze families were linked to a locus on 15ql3.1-15.1 and all seven out of eight 
Faroe Island families were linked to chromosomal locus 16pl2.1-13.1, thus 
demonstrating locus heterogeneity again, despite being very isolated populations. No 
obvious genes associated with axonemal function were found in the regions identified 
and this study emphasises the difficulties in mapping PCD genes caused by the 
underlying genetic heterogeneity.
In a genome-wide search for a common locus in 52 Kartagener Syndrome (KS) 
families and 18 PCD families (no situs inversus), significant linkage to a 3.5cM 
region on chromosome 15q24-25, with a maximum LOD score of 4.34, was found in 
60 % of the KS (but not the PCD) families (Geremek et al., 2006). This locus has 
since been refined to 1.8 Mb and the 18 genes within the region and 3 nearby were 
sequenced for mutations in 7 KS probands (Geremek et al., 2008). Sixty SNPs were 
identified, none of which were thought to be disease causing.
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1.3.2.2 PCD genes
1.3.2.2.1 DNAIl
The first PCD gene identified was DNAIl on chromosome 9pl3-21, the gene 
encoding outer dynein arm intermediate chain 1 (Table 1.5). Two loss of function 
DNAIl mutations were found in a patient lacking outer dynein arms (Pennarun et al., 
1999). This gene was excluded in 5 families with similar phenotypes, providing 
evidence of locus heterogeneity. Guichard et al studied 3 independent patients and 2 
of their siblings who had PCD and situs solitus (Guichard et al., 2001). One of these 
patients and his brother were heterozygous for a splice defect caused by a T-insertion 
at position 3 of the intron 1 donor site (IVSl+2_3insT), which prevents splicing and 
results in a truncated protein. This is the most common PCD mutation in DNAIl and 
has occurred in 4 out of 8 patients, who also have laterality defects. The patients also 
had another mutation in which a transition mutation (G—^A) occurred at position 
1543 in exon 16 (Guichard et al., 2001). This resulted in a conserved glycine (seen in 
DNAIl homologues Chlamydomonas IC78 and sea urchin ICI), that possibly acts as 
an N-myristoylation site, being changed for a serine. Other mutations reported in this 
gene include insertion of 4 nucleotides in exon 5 which causes a fi-ameshift, a 12bp 
deletion in exon 17 which truncates the protein and removes a conserved 
phenylalanine at position 556. In addition a G ^ C  transversion at position 1874 
which causes a missense mutation and a G-^A transition at 1875, which causes a 
nonsense mutation, are both present at a conserved tryptophan residue in a WD repeat 
motif and is thought to result in incorrect folding of the protein (Guichard et al.,
2001).
In a separate study, DNAIl was found not to be linked in 5 out of 7 unrelated PCD 
families with an outer dynein arm defect, based on the results of intragenic SNPs and 
DNA sequencing (Zariwala et al., 2001). In this study, two novel mutations at codon 
568 were detected in DNAIl -  a nonsense mutation leading to a truncated protein and 
a missense mutation at the same conserved residue (Zariwala et al., 2001). Homef et 
al demonstrated that DNAIl mutations account for approximately 13 % of all cases of 
PCD with reported outer dynein arm defects (Homef et al., 2006a). Zariwala et al 
identified DNAIl mutations, including 12 novel mutations, in 9 % (16 out of 179
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families) PCD patients. Most of the DNAIl mutations identified occurred as a 
common founder mutation (IVSl+2_3insT), representing a mutation “hot spot” 
(Homef et al., 2006b).
1.3.2.2.2 DNAH5
A second PCD gene has been identified; DNAH5, which encodes a heavy dynein 
chain of the outer arm. A total genome scan was performed on an Arabic 
consanguineous PCD family with absent outer dynein arms and a gene locus was 
mapped to chromosome 5pl5-pl4 (Omran et al., 2000). DNAH5, the human 
homologue of the Chlamydomonas dynein heavy chain y, was located within this 
chromosomal region and was therefore screened as a candidate for PCD. It is 
expressed in the lung, kidney, and to a lesser extent in the brain, heart, testis and 
mouse embryonic node between days 7.0 and 8.25 (which explains the situs inversus 
phenotype) (Olbrich et al., 2002). Sequence analysis identified mutations causing 
defects in the DNAH5 product (Olbrich et al., 2002). Four homozygous and six 
heterozygous mutations were identified, most of which caused premature termination 
resulting in loss of the microtubule binding domain. DNAH5 mutations are the most 
common PCD causing mutation discovered to date, where it has been estimated that 
28 % of PCD patients yield DNAH5 mutations (Homef et al., 2006a).
Mutations in the Chlamydomonas DNAH5 orthologue created a slow swimming 
phenotype. A genotype-phenotype relationship has been reported for DNAH5, since 
electron microscopy showed that a translation termination mutation causes a complete 
absence of the outer dynein arm, whereas splice site mutations cause a partial loss of 
the outer arm (Kispert et al., 2003). Using specific immunofiuorescent antibodies, 
Fliegauf et al. showed that DNAH5 (and DNAH9) has a regionally restricted 
distribution along the axoneme. In 3 PCD patients with DNAH5 mutations and outer 
dynein arms defects, DNAH5 was completely absent fi*om respiratory cilia and 
instead accumulated at the microtubule organising centres (Fliegauf et al., 2005). In 
contrast to respiratory cilia, sperm flagella from a patient with DNAH5 mutations had 
normal outer dynein arm distribution, thus demonstrating tissue specific dynein arm 
composition with differences between cilia and flagella (Fliegauf et al., 2005).
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1.3.2.2.3 DNAHll
Another heavy dynein chain gene, DNAHll was identified as a PCD-causing gene 
based on a candidate gene rather than a linkage approach. A missense mutation in the 
homologous mouse gene (Ird/Dnahl 1) was reported in the iv/iv mouse, which has 
laterality defects. Dnahll is expressed in the embryonic node at day 7.5, and 
mutations in human DNAHll have been identified in patients with PCD and/or 
immotile respiratory cilia (Bartoloni et al., 2002; Schwabe et al., 2008).
A mutation screen was conducted in this 82 exon gene in a patient displaying 
uniparental disomy of chromosome 7 (UPD7). The patient had situs inversus, 
immotile respiratory cilia and cystic fibrosis, the latter due to the presence of a 
homozygous CFTR gene F508del mutation on chromosome 7. A homozygous 
nonsense mutation (R2852X) was found in exon 52 of DNAHll, 10 amino acids 
before the fourth P-loop causing loss of 3 of the six AAA domains (section 1.1.4.2.1) 
(Bartoloni et al., 2002). The N-terminal tail is still present, so the protein is predicted 
to correctly incorporate into the dynein arm but not to bind to the adjacent 
microtubule, therefore preventing cilia bending. This prediction is consistent with the 
electron microscopic data of the patient in which the axonemes and dynein arms 
appear normal. It should be noted that there is some controversy over whether this 
patient really suffers from PCD or whether the symptoms are a result of cystic 
fibrosis and the situs inversus is just a coincidence.
Sequence analysis of DNAHll in an additional 6  selected PCD sibships that shared 
alleles in this gene revealed an R3004Q substitution mutation in a conserved residue 
in one person, although Chlamydomonas a and y heavy chains have a Q at this 
position. However, none of the control families analysed had the Q3004 variant so it 
was presumed possible that the R3004Q mutation is pathogenic (Bartoloni et al.,
2002).
Six affected individuals from a German PCD family with immotile cilia but an 
apparent normal cilia ultrastructure as observed by EM, were found to carry 
compound heterozygous mutations c.l2384C>G and c.l3552_13608del (Schwabe et 
al., 2008). Both mutations are predicted to result in a truncated DNAHll protein.
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Therefore, these DNAHll mutations are associated with a PCD with a normal 
ultrastructure.
1.3.2.2.4 DNAH7
The proteome of normal and PCD bronchial cells were compared by Zhang et al. and 
the dynein heavy chain DNAH7 was found to be absent from the cilia in one patient. 
Although no mutations were detected in the full-length cDNA clone, the DNAH7 
protein was found to be synthesised but not assembled in the cilia of bronchial PCD 
cells. Instead it accumulates intracellularly, in contrast to normal cells where 
DNAH7 is clearly present in the cilia (Zhang et al., 2002). Thus, it was hypothesised 
that PCD in this patient resulted from a defect in the transport of DNAH7 from the 
cytoplasm to the cilia axoneme, although the actual gene mutation was more likely to 
reside in another gene since no mutations were found in DNAH7 in this PCD patient.
1.3.2.2.5 TXNDC3
A thioredoxin-nucleoside diphosphate kinase, TXNDC3, was recently identified as a 
gene involved in PCD (Duriez et al., 2007) (Table 1.5). Thioredoxins fimction as 
enzymatic proteins involved in protein disulfide reductase reactions, although their 
exact role in relation to cilia structure or function is not understood. However, 
expression of TXNDC3 was shown in testis and respiratory epithelial cells it was also 
shown that it is the human orthologue of the sea urchin intermediate dynein chain 
ICI, a component of sperm flagella outer arms (Duriez et al., 2007). A patient 
presenting with a PCD phenotype was found to harbour two defects in TXNDC3; a 
nonsense mutation predicting a truncated protein and a common intronic sequence 
variant that reduced the amount of one particular isoforms. This was an unusual 
SNP-induced modification of the ratio of two isoforms of a protein that results in 
PCD. The individual displayed heterogenous ultrastructural abnormalities of 
respiratory cilia, with partial lack or shortening of outer dynein arms in 6 6  % of cilia 
(Duriez et al., 2007).
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1.3.2.2.6 Genes causing syndromic form s o f  PCD
Mutations in the gene for Retinitis pigmentosa GTPase regulator (RPGR) have been 
found in one family with retinitis pigmentosa (RP), hearing loss and bronchosinusitis, 
and it has been suggested that the RPGR gene could be involved in some cases where 
RP and PCD coincide (Zito et al., 2003). RPGR is present as a structural component 
in the connecting cilium in the retina, and is also expressed in the lung and testes. 70 
% of X-linked retinitis pigmentosa (RP) is caused by a mutation in the RPGR gene 
(located on Xp21.1). Moore et al. investigated a non-consanguineous family in which 
the mother has RP and her 2 sons had PCD (characterised by partial dynein arm 
defects) and secondary RP. Sequence analysis of RPGR in the 2 boys and their 
mother revealed a deletion, resulting in a severely truncated protein (Moore et al.,
2005).
A large Polish family with X-linked recessive mental retardation (XLMR) syndrome 
had macrocephaly and ciliary dysfunction with symptoms of respiratory distress. A 
frameshift mutation was identified in the OFDl gene in this family (Budny et al.,
2006). This supports the role of OFDl in respiratory epithelial ciliary function. Oral- 
facial-digital type 1 syndrome (OFDIS) is an X-linked dominant disorder affecting 
development. Further mutations in the OFDl gene have been shown to be 
responsible for OFDIS (Ferrante et al., 2001). Ofdl heterozygous knockout female 
mice were shown to develop kidney cysts were no cilia were present. Heterozygous 
males were not viable, but embryos had laterality defects, indicating that Ofdl protein 
is involved in left-right axis determination (Ferrante et al., 2006).
1.3.2.2.? Candidate PCD genes screened with no mutations identified
Other candidate genes have been sequenced in a number of different PCD families 
(Table 1.5), but were excluded since no pathogenic mutations were identified, just 
polymorphic variants. These genes include HP28, the human homologue of the p28 
Chlamydomonas gene (Geremek and Witt, 2004), hPF20, the homologue of 
Chlamydomonas pf20 (mutants of which have paralysed flagella) (Pennarun et al., 
2002) and TCTE3, the homologue of murine TcteS (mutants of which have reduced 
sperm motility) (Neesen et al., 2002), HFH-4, a fork-head transcription factor
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recently renamed FOXJl (Maiti et al., 2000), DPCD, the human homologue of the 
mouse Dpcdl, which is defective in the mouse mutant with hydrocephalus and PCD 
phenotypes (Zariwala et al., 2004), DNAI2, a gene related to Chlamydomonas dynein 
intermediate chain IC69 (Pennarun et al., 2000) and DNAH9, a dynein heavy chain 
that is mis-localised in the axoneme in patients with DNAH5 mutations (Bartoloni et 
al., 2 0 0 1 ).
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Gene Mutations detected
% of cases of PCD that 
mutations are 
accountable for Ciliary localisation Ultrastructural defect
DNAIl 32 13% ODA Absent ODA
DNAH5 10 28% ODA Absent ODA
DNAHll 3 Not known ODA None
DNAH7 None detected Not known IDA Not known
TXNDC3 1 (plus 1 intronic variant) Not known Not known in human Absent or shortened ODA
RPGR 1 Not known Not known Partial dynein arm defects
OFDl 1 Not known Not known Not known
HP28 None detected N/A IDA Not known
hPF20 None detected N/A CP Not known
TCTE3 None detected N/A ODA Not known
HFH-4 None detected N/A Not known Not known
DPCD None detected N/A Not known Not known
DNAI2 None detected N/A ODA Not known
DNAH9 None detected N/A Not known Not known
Table 1.5: PCD candidate gene screened for m utation. ODA = outer dynein arm, IDA = inner dynein arm, CP = central pair.
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1.4 Aims
This study aimed to make progress in the genetic and molecular characterisation of PCD. 
To conduct genome-wide screens with the aim of identifying genetic loci by linkage 
analysis and homozygosity mapping in consanguineous PCD families. To undertake fine 
mapping of regions where novel loci are identified and eventually to evaluate candidate 
PCD genes using a comparative bioinformatic approach.
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2 CHAPTER TWO
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2.1 MATERIALS
Chemicals purchased from Sigma unless stated otherwise.
2.1.1 General use laboratory reagents and solutions
0.5M EDTA (ethylenediaminetetraacetic acid)
EDTA.Na2.2 H2O (pH8.0) 186.12g/L
lOX TBE
TRIS base 108g/L
Boric acid 55g/L
EDTA 8.3g/L
TE Buffer
TRIS-HCl (pH8.0) lOmM
EDTA O.lmM
Agarose
GibcoBRL electrophoresis grade 20g/L
(for 2 % gel)
APS
Ammonium persulphate ( 10% w/v) 1 Og/L
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Ethidium Bromide
Ethidium Bromide 10 mg/ml
DNA Ladders
1 Kb ladder 
1Kb plus ladder 
HyperLadder V
(Invitrogen)
(Invitrogen)
{Bioline)
2.1.2 Loading buffers
Blue Dextran Loading Buffer
De-ionised formamide (99.5% pure) 10 ml
50mM EDTA (pH8.0) 2 ml
3 Omg/ml Blue Dextran 12 ml
Orange G Buffer
Glycerol:250mM EDTA (pH8.0) 
SDS (sodium dodecyl sulphate) 
Orange G powder
1:1
0 .1% w/v 
0 .1% w/v
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2.1.3 Growth media
Bacterial growth media - Luria-Bertani (LB) Broth
Tryptone lOg/L
Yeast extract 5 g/L
NaCl 10 g/L
For solid medium add 1.5 % (w/v) bacto-agar prior to autoclaving
Chlamydomonas reinhardtii growth media -  TAP media
X40 TAP concentrate
Tris base 96.8 g/L
Distilled H2O 920 ml
IM (K)P0 4  40 ml (see recipe below)
Glacial acetic acid ~40 ml to pH7.0 
Store at 4 °C
IM (K)P04
1 M K2HPO4 250 ml
IM KH2PO4 (titrate to pH 7.0) 170 ml
4X Beijerinck salts
NH4CI 16 g/L
CaCl2.2H20 2 g/L
MgS04.7H20 4 g/L
73
Hutner Trace elements
Supplied by Dr. Pinfen Yang, Marquete University. Made according to protocol in 
Hutner, et al. (1950). Methods in Enzymology, 23:68.
IX TAP media
X40 TAP concentrate 25 ml
Distilled H2O 949 ml
4X Beijerinck salts 25 ml
Hutner trace elements 1 ml
Autoclave, store at room temperature.
For solid medium, add 2 % bacto-agar prior to autoclaving
2.1.4 DNA extraction buffers
ACD solution
Trisodium citrate 
Citric acid 
Dextrose
13.2g/L
4.8g/L
14.7g/L
Solution I
Sucrose
TRIS-HCl pH7.0 
MgCli 
Triton X-100 
Sodium azide
0.32M 
lOmM 
5mM 
1% w/v 
0 .0 2 % w/v
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Solution II
TRIS-HCl pH8.0
EDTApH8.0
SDS
50mM 
20mM 
2 % w/v
Solution 111
Saturated NaCl solution
2.2 Technical laboratory equipment
Centrifuges Centrifuge 5415C/5417C 
Sorvall RT 6000 D Du Pont
(Eppendorf)
(Legend)
Camera for analysis
of agarose gels MP4+ Land Camera System (Polaroid)
Developing Machine RGl 1 Fuji X-ray film processor (Fuji)
Electrophoresis Tank Hybrid (GibcoBRL)
Gel Imager GDS 8000 Documentation System
UV Transilluminator Model 750-M (International 
Biotechnologies Inc.)
PCR Machines 9700 Thermocycler 
Tetrad Thermo-cycler
(Applied Biosystems)
(MJ Research, Watertown, 
Mass)
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Sequencer/genotyper ABI 373 Prism (ABI)
Incubator for Chlamydomonas culture (25 °C)
INNOVA 4340 illuminated shaker incubator (New Brunswick Scientific)
Fume hood K3 class 1 sterile air cabinet (Bassaire)
Microscopes Leica DM 2500 light microscope (XI0 eyepiece, X40 objective lens) 
Inverted Nikon Diaphot microscope
High speed video camera
Trouble-shooter 500, Lake Image systems, UK
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2.3 Family Resource
Two groups of families were studied which were grouped according to their geographical 
origin and ultrastructural phenotype. Details of patients and clinical diagnosis are shown 
in Tables 2.1,2.2 and 2.3.
2.3.1 Pakistani famiiies 120,130,141,143 and 145
Families 120, 130, 143 and 145 were from Mirpur city or Rawalpindi of Northern 
Pakistan. Family 141 were from the New Frontier area of Pakistan. All five families 
followed the traditional emigration route to the Bradford area of the UK. All five 
families were first cousin consanguineous families with a total of nine affected and seven 
non-affected siblings (Figure 2.1 A). DNA was available for all individuals except 145 
11:2. All affected individuals had situs inversus except for 120 11:3. Electron microscopy 
(EM) results for these families indicate missing inner and outer dynein arms (Figure 
2.IB). High speed imaging analysis of nasal ciliary brush biopsy demonstrated that 
affected individuals had immotile, or flickering cilia with a significantly reduced beat 
frequency.
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Figure 2 .1 : Pakistani family pedigree structures and E M  analysis. A ) P akistan i fam ily  g roup  p ed ig ree  
struc tu res. * in d ica te s  a ffec ted  p a tien t w ith  situs inversus. C irc les ind icate  fem ale , sq uares ind ica te  m ale. 
F illed  in  sy m b o ls  a re  in d ica te  in d iv idua l w as affec ted . D oub le  line ind icates consan g u in ity  (first cousin  
m arriag e). B ) E M  from  fam ily  1 2 0 - 1 )  E M  o f  p a tien t 120 11:3 show ing  ab sen t inner and  o u ter dynein  
arm s. II) C a rto o n  o f  E M  w ith  inner and  o u ter dynein  a rm s show n  in yellow .
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ID Region
Age o f 
diagnosis Symptoms
Documented
bronchiectasis?
CF/immunodeficiency 
/TB excluded? Ultrastructural defect
Reduced 
ciliary beat 
frequency?
Situs
inversus
120 11:3 Mirpur, Pakistan 7 yrs
cough, rhinitis, sinusitis, otitis media, 
hearing loss, low weight, neonatal 
respiratory distress Yes Yes
Absence o f  Inner and 
Outer Dynein Arms Yes Yes
120 11:4 Mirpur, Pakistan birth cough, rhinitis, sinusitis, low weight N/A Yes
Absence o f  Inner and 
Outer Dynein Arms Yes Yes
120 11:5 Mirpur, Pakistan birth cough, rhinitis, sinusitis N/A Yes
Absence o f  Inner and 
Outer Dynein Arms Yes Yes
130 11:3 Mirpur, Pakistan 4 yrs
cough, rhinitis, sinusitis, otitis media, 
low weight, neonatal respiratory 
distress Yes Yes
Absence o f  Inner and 
Outer Dynein Arms Yes Yes
141 11:3 Rawalpindi, Pakistan 5 yrs
cough, rhinitis, sinusitis, otitis media, 
low weight, neonatal respiratory 
distress N/A Yes
Absence o f  Inner and 
Outer Dynein Arms Yes Yes
141 11:4 Rawalpindi, Pakistan birth
cough, rhinitis, sinusitis, low weight, 
neonatal respiratory distress N/A Yes
Absence o f  Inner and 
Outer Dynein Arms Yes No
141 11:5 Rawalpindi, Pakistan birth
cough, rhinitis, sinusitis, low weight, 
neonatal respiratory distress N/A Yes
Absence o f  Inner and 
Outer Dynein Arms Yes No
143 11:3
North West Frontier, 
Pakistan 3 yrs
cough, rhinitis, sinusitis, otitis media, 
low weight, neonatal respiratory 
distress Yes Yes
Absence o f Inner and 
Outer Dynein Arms Yes Yes
145 11:5 Mirpur, Pakistan 3 yrs
cough, sinusitis, low weight, 
neonatal respiratory distress N/A Yes
Absence o f  Inner and 
Outer Dynein Arms Yes Yes
Table 2.1: Clinical information for affected individuals from the Pakistani PCD families
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2.3.2 Arabie family 146
Family 146 is a consanguineous Arabic family (paternal first cousin marriage) from the 
United Arab Emirates (UAE), originating from an ancient Bedouin tribe called the Bani 
Tameem which settled in Doha in the early 18* Century. They have three affected and 
four non-affected offspring (Figure 2.2A). There is no incidence of situs inversus. High 
speed video imaging of nasal epithelia biopsies demonstrate that the cilia have a circular 
beat pattern and 11.9 - 17 % of the electron micrographs (EM) of cilia cross sections 
show an unusual absence of the central pair or “central pair agenesis” (Stannard et al.,
2004) (figure 2.2B). This is a significant reduction compared to the level of absent 
central pairs seen in normal, non-affected cilia (0-0.2%). It has been proposed that the 
central pair appears and disappears at 96 nm periodicities along the length of the 
axoneme (Prof. C. O'Callaghan, personal communication) (Figure 2.2C). Their cilia beat 
frequency was normal (Stannard et al., 2004).
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F ig u re  2 .2 . A r a b ic  F a m ily  146 p e d ig re e  s t r u c tu r e  a n d  E M  a n a ly s is . A ) U A E  ped ig ree  structure , c irc les indicate  
fem ale , sq u a res  in d ica te  m ale . F illed  in  sym bols are  affec ted . D ouble  line  ind ica tes consanguin ity . B ) E M  from  
U A E  fam ily  and  con tro ls  - i) no rm al 9  +  2 c ilia  E M . li)  cen tral p a ir agenesis seen in th e  U A E  fam ily , m issing  
cen tra l p a ir (9  +  0 struc tu re). T aken  fro m  Stannard et al, (2004) Am J  Respir Crit Care Med, 169,624-637. C) 
L o n g itu d in a l sec tion  resp ira to ry  c ilia  E M  from  a ffec ted  p a tien t from  fam ily  146 (U npub lished  da ta  from  Prof. C. 
O ’C allaghan , U n iv ersity  o f  L eiceste r. In term itten t cen tral p a ir is h igh ligh ted  w ith  a  red  circle .
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ID Region
Age o f  
diagnosis Symptoms
Documented
bronchiectasis?
CF/immunodeficiency 
/TB excluded? Ultrastructural defect
Reduced 
ciliary beat 
fi-equency?
Situs
inversus
146 11:3 United Arab Emirates 5 yrs
Cough, reduced exercise tolerance, 
rhinorrhea, low weight, short stature, 
bronchiectasis, collapsed lower left 
pulmonary lobe Yes Yes Central pair agenesis
Circular 
beat pattern No
146 11:4 United Arab Emirates 4 yrs
Cough, reduced exercise tolerance, 
rhinorrhea, low weight, short stature. N/A Yes Central pair agenesis
Circular 
beat pattern No
146 11:5 United Arab Emirates 8 months
Cough, reduced exercise tolerance, 
rhinorrhea, low weight, short stature. N/A Yes Central pair agenesis
Circular 
beat pattern No
Table 2.2: Clinical details for Arabic PCD family 146
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2.3.3 Arabie family 152
Family 152 is a complex Arabic family of Bedouin origin although their precise tribal 
origin was not known. All marriages within this pedigree were first-cousin in origin. 
There were five affected and twenty-eight non-affected individuals in total (Figure 2.3). 
Non-affected individual 152 11:6, with four affected siblings, had one affected and eight 
non-affected offspring. This is an apparently low incidence compared to the generation 
above. One of the four affected siblings in family 153 had died at the time of clinical 
ascertainment due to an unrelated condition. The father of individual 152 1:1 had two 
wives who were his cousins. In addition, the two wives were thought to be related but 
the exact nature of this relationship was uncertain so was left out in this pedigree. As a 
result, the exact details were uncertain for the degree of consanguinity between 152 1:1 
and 1:2. There is no incidence of situs inversus in this family. Ultrastructural analysis of 
respiratory cilia by EM revealed an apparently normal ultrastructural, although it was 
considered likely that the defect was missed at this level. Using high speed video 
imaging of nasal brush biopsies a circular ciliary beat pattern with normal CBF was 
observed for this family. This was consistent with the ultrastructural defect of 
intermittent central pair seen for family 146.
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Figure 2.3. Arabic family 152 pedigree structure. Circles indicate female, squares indicate male. Filled 
in symbols are affected. Double line indicates consanguinity. Crossed out symbols are deceased. Dotted 
line indicates cousin marriage of uncertain nature.
ID Region Symptoms
CF/immunodeficiency/T 
B excluded? Ultrastructural defect
Reduced ciliary beat 
frequency?
Situs
inversus
152 11:3 Arabic Bedouin
Cough, reduced exercise tolerance, 
intermittent rhinorrhea, low weight, 
delayed mucociliary clearance, poor 
sperm motility. Yes N one observed Circular beat pattern N o
152 11:4 Arabic Bedouin
Cough, reduced exercise tolerance, 
intermittent rhinorrhea, low weight, 
delayed mucociliary clearance, poor 
sperm motility. Yes None observed Circular beat pattern N o
152 11:5 Arabic Bedouin
Cough, reduced exercise tolerance, 
intermittent rhinorrhea, low weight, 
delayed mucociliary clearance. Had 
IVF due to infertility. Yes N one observed Circular beat pattern N o
152 111:8 Arabic Bedouin
Cough, reduced exercise tolerance, 
intermittent rhinorrhea, low  weight, 
delayed mucociliary clearance Yes N one observed Circular beat pattern N o
Table 2.3: Clinical details for Arabic PCD family 152.
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2.4 METHODS
2.4.1 Preparation of genomic DNA and RNA
2.4.1.1 Preparation of genomic DNA from human whole blood
See Section 2.1.4 for buffer details.
5-20 ml blood samples were taken by venepuncture and added to 50-200 pi 0.34M 
EDTA or acid citrate dextrose (ACD) to prevent the samples from coagulating. The 
blood samples were then transferred to 50 ml conical tubes and coded to protect the 
anonymity of patients. The samples were centrifuged at 12,000 x g for 15 minutes at 
4°C and the plasma was removed with a pipette. Pelleted blood cells were stored at - 
20°C until DNA extraction was performed.
Distilled H2O was added to the samples to a total volume of 50 ml and pellets 
dispersed by gentle mixing. After incubation on ice for 5-10 minutes, samples were 
re-pelleted by centrifugation (12,000 x g at 4°C). Supernatant was removed and 40- 
45mls solution I (IX) added to a total volume of 5Omis to cause lysis of blood cells.
After 2 minutes incubation on ice, the sample was centrifuged to separate cell debris 
in the supernatant from DNA and cell contents present in the pellet. The previous 
steps detailed were repeated until the pellet was light pink in colour (a red pellet 
indicated clotted material was still present).
The pink pellet was resuspended in 11 mis solution II by vortexing vigorously. 
Proteinase K was added to a final concentration of 100 ug/ml, to digest proteins 
present in the cell and allow them to form complexes with solution II, and the 
solution incubated at 37°C overnight. The sample was then held on ice for 10 
minutes then 4 mis of solution III was added and mixed by invertion. The mixture 
was then held on ice for a further 5 minutes to allow precipitation of protein 
complexes, which were then pelleted by centrifugation (1 2 ,0 0 0  x g for 15 minutes). 
Supernatant was transferred to a sterile 50 ml tube and RNase added to a final
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concentration of 20 mg/ml. The solution was then incubated at 37®C for 15 minutes 
to digest any RNA present.
Genomic DNA was precipitated by addition of 2 volumes of 100 % ethanol at 4°C to 
the supernatant, with gentle invertion to mix. The DNA was observed to precipitate 
and was pelleted by centrifugation at room temperature for 30 minutes. The pellet 
was then rinsed in 70 % ethanol and air-dried. DNA was then resuspended in 200 pi 
of TRIS-EDTA buffer at 4°C overnight to allow full resuspension of the DNA. Stock 
DNA was stored at -20®C and working concentrations of 15 ng/pl were made using 
sterile dHiO to dilute and stored at 4°C. 5-10 ml of blood typically yielded 30-225 
mg DNA.
2.4.1.2 Preparation of genomic DNA from Chlamydomonas
reinhardtii
Total DNA was extracted using a method adapted from Goldschmidt-Clermont 
(1990). A 10 ml aliquot of cells grown to a density of 1 x 10^  cells/ml was harvested 
at 6000 g for 5 minutes. The pelleted cells were resuspended in 0.6 ml of 0.2 M Tris 
(pH 8.0 -  HCl), 0.5 M NaCl, 0.01 M sodium EDTA and 0.2 % (w/v) SDS and freeze 
thawed three times using liquid nitrogen and a 37 °C water bath. The sample was 
then diluted with 0.6 ml of TE saturated phenolxhloroform.IAA (25:24:1 (v/v) 
respectively) and centrifuged at 10000 g for 2 minutes. The upper aqueous phase was 
then diluted in 1.4 ml of 95 % (v/v) ethanol and centrifuged at 10000 g for 10 
minutes. The pellet was washed with 70 % ethanol and resuspended in 50 pi of 
DEPC treated sterile water. DNA was stored at -20 °C until required.
2.4.1.3 Preparation of RNA from zebrafish embryos
Total RNA from zebrafish embryos at 24, 48 and 72 hpf was isolated using 10 to 50 
dechorionated embryos per sample. Embryos were homogenised by vortexing after 
addition of 500 pi TRIzol Reagent, (Invitrogen) which maintains the integrity of 
RNA during lysis. After incubation of the homogenised samples for 5 minutes at 
room temperature to permit the complete dissociation of nucleoprotein complexes, 
0.2 ml chloroform per 1 ml TRIzol was added. The samples were mixed vigorously
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and centrifuged at 6000 x g for 15 minutes at 4 °C to separate the aqueous and 
inorganic phases. The aqueous, upper layer was recovered, mixed with 0.5 ml 
isopropanol, incubated for 10 minutes at room temperature and centrifuged at 6000 x 
g for 10 minutes at 4 °C. The pellet was washed once with 70 % ethanol, centrifuged 
again for 2 minutes, air-dried and dissolved in 50 pi dH20. Total RNA was stored at 
-80 °C.
2.4.2 Preparation of cDNA
First-strand cDNA was synthesised using the Amersham Biosciences First-Strand 
cDNA Synthesis Kit according to the manufacturer’s instructions.
Briefly, the RNA was placed in a microcentrifuge tube and RNase-ffee water added 
to bring the volume to 20 pi. The RNA was then heated at 65°C for 10 minutes to 
denature, chilled on ice then mixed gently. 11 pi of bulk first-strand cDNA reaction 
mix containing Moloney Murine Leukaemia Virus (M-MulV) reverse transcriptase, 
RNase-ffee BSA and dNTPs was added to a clean tube along with 1 pi DTT solution, 
1 pi primer (pDN6 random hexamers) and the heat denatured RNA. This was mixed 
gently and incubated at 37°C for one hour and then stored at -20°C for use in PCR 
amplification (section 2.4.5).
2.4.3 Quantification of DNA
The concentration of each patient DNA prepared from whole blood (section 2.4.1.1.) 
was determined spectrophotometrically or using PicoGreen fluorescence.
For spectrophotometer quantification a 1 in 50 dilution of each sample was made and 
the optical density measured at a wavelength of 260 nm. The concentration was then 
determined using the following equation:
OD260 X thickness of cuvette (50 ug/ml) X dilution factor (50) = DNA concentration 
(ng/pl)
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PicoGreen quantification was determined according to the instructions for the Quanti- 
iT PicoGreen dsDNA Assay Kit (Invitrogen). Briefly, diluted DNA sample.s were 
assembled at a dilution of 1:10 (100 pi) with 100 pi of PicoGreen solution in a Costar 
96-well black flat bottom assay plate. To create a standard curve, 100 pi of control 
DNA at concentrations of 100, 200, 400, 600, 800, 1600 ng/pl with 100 pi of 
PicoGreen was also assembled. The PicoGreen fluorescence emission was measured 
using a Tecan GENios fluoscan linked to Magellan software. DNA concentrations 
were quantified against the standard curve and a known control concentration used to 
check accuracy.
2.4.4 Primers for genotyping and sequencing
Primers for known and novel microsatellite markers were identified using information 
in the UCSC genome browser (http://genome.ucsc.edu/cgi-bin/hgGateway) and 
supplied by Sigma, Invitrogen or MWG Biotech.
In-house primers were designed using the PrimerS programme (Rozen and Skaletsky, 
2000), to a uniform design of approximately 20 bp, a Tm of 60°C and a GC content of 
approximately 50 %. A 3 ’ GC clamp was incorporated where possible and primer 
sequences were confirmed to be unique using the BLAST programme. To enable 
efficient annealing, the primer sequences were designed 100% homologous to the 
target DNA sequence. To decrease the formation of primer dimers, complementarity 
within a primer or between both primers was avoided.
Primers for sequencing of genomic exons were designed >40 bps from intron-exon 
boundaries in order to sequence all coding regions plus splice sites. Details of 
primers for in-house microsatellites and gene sequencing are shown in Appendices.
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2.4.5 Polymerase Chain Reaction (PCR)
The polymerase chain reaction (PCR) utilises in vitro polymerisation to amplify specific 
DNA sequences (Saiki et al., 1985). Unique oligonucleotide primers were designed to 
amplify specific regions of DNA.
In general, the following reagents were added to a 0.5ml 96-well microtiter plate 
(Appleton Woods) or 0.5ml tubes for PCR optimisation: (lOX PCR buffer = 50 mM 
TRIS-HCl (pHS.S at 25°C, 200mM (NH4)2S0 4 , 0.1% (v/v) Tween® 20) All reagents 
supplied by Invitrogen, except primers which were ordered from MWG.
Reagent
Final
concentration
Template DNA 15 ng
Primer (both) 1 mM
dNTP 0.25 mM
lOx PCR buffer IX
Magnesium chloride (MgC12) 1 - 3.5 mM
Taq DNA polymerase 0.05 units
sterile distilled water to volume of 15 pi
Total volume 15 Ml
Table 2.4: Reagents used in PCR
The plate was sealed to prevent evaporation. PCR was performed in a DNA Engine 
Tetrad thermocycler (MJ Research, Watertown, Mass.). Cycling conditions of 
dénaturation, annealing and extension varied according to the Tm of the primers and the 
length of the DNA being amplified. A negative control (no template DNA) was 
included for each set of PCR reactions. Optimisation of the reaction was necessary for 
each primer pair. The magnesium ion concentration was titrated (l-3mM), since, in 
addition to other reaction components binding magnesium ions. Tag DNA polymerase 
also requires free magnesium ions for its activity. Therefore, the amount of free 
magnesium may vary for different PCRs. In order to facilitate dénaturation of 
Chlamydomonas reinhardtii DNA molecules with a high G/C content, dimethyl 
sulphoxide (DMSO) was used at 2.5-5% of the total reaction volume. Standard cycling
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conditions for PCR were an initial dénaturation step at 94°C for 210 seconds, 
amplification for 35 cycles (35 seconds dénaturation at 96°C, 30 seconds annealing at 
primer Tm, and 60 seconds extension at 72°C per 1 kb of DNA). The final extension 
step was 120 seconds at 72 °C.
2.4.5.1 PCR Optimisation
If products were difficult to amplify, the lOX Invitrogen PCR buffer was replaced 
with lOX BioLine PCR buffer with and amplified using the appropriate PCR 
cycle.
The Invitrogen PCR Optimiser Kit was used where products were difficult to amplify. 
5X buffer solutions were used which yielded a range of different [MgCb] and pH. 
Buffers A, B, C and D (pH 8.5 and varying 1.5 mM -  3.5 mM Mg^^), buffers F, J and 
N (2.0mM Mg^  ^ and pH 8.5 -  10.0) were used first. If further optimisation was 
required all buffers were re-tested with the addition of the universal solvent, DMSO, 
which makes primer-binding easier, at a final concentration of 10 %, while adjusting 
water so that the final volume remained at 25 pi. The following reaction was used :
Reagent
Final
concentration
DNA 15 ng
Primer (both) 0.2 pM each
dNTP 0.25 mM
lOx PCR buffer (including
MgC12 for final concentration) IX
Taq DNA polymerase 0.08 units
sterile distilled water to volume of 25 pi
Total volume 25 |jl
2.5: R eagents used in optim isation o f  PCR
The plate was sealed to prevent evaporation. PCR was performed in a DNA Engine 
Tetrad thermocycler (MJ Research, Watertown, Mass.). Cycling conditions of 
dénaturation, annealing and extension were performed as in section 2.4.5.
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2.4.S.2 Nested PCR
If the first round cDNA PCR yielded a weak product and two rounds of amplification 
were required in order to achieve a visible and specific product, a second round PCR 
was performed after the initial PCR reaction on first strand cDNA. This second 
round ‘nested PCR’ was performed using a second set of internal primers, positioned 
within the initial desired PCR product. A standard PCR reaction was performed for 
second round PCR, as described in section 2.4.5 substituting 1 pi of 1:20 diluted first 
round PCR product as the DNA template.
2.4.6 Agarose gel electrophoresis
Agarose gel electrophoresis was employed to determine the specificity and size of the 
amplified product of PCR or restriction endonucleases digestion. The size of a DNA 
molecule determines its electrophoretic mobility in different concentrations of agarose. 
Larger DNA molecules migrate slower than smaller molecules due to a greater jfrictional 
drag and less efficient migration through the gel pores. In general DNA molecules 
greater than Ikb were size fractionated in a 1% agarose gel. Molecules smaller than Ikb 
were separated in a 1.5-3 % agarose gel.
Agarose gels were prepared by combining the appropriate amount of powdered agarose 
(Life Technologies Ltd.) with 100ml 0.5xTBE electrophoresis buffer and subsequently 
dissolved in a microwave oven. Ipg/ml ethidium bromide was added to the solution, 
which was stirred and cooled to approximately 70°C. The solution was then poured into 
a plastic gel-former (sealed at both ends with tape) with a casting comb positioned 0.5- 
1mm above the tray. The gel was solidified at RT for 30 minutes and placed in a 
horizontal electrophoresis tank containing 0.5xTBE electrophoresis buffer. 
Approximately 2pi loading buffer was mixed with each DNA sample and loaded into 
the wells. A 1Kb {Invitrogen) or HyperLadder V {Bioline) ladder (3 pi) was run adjacent 
to PCR products in order to estimate their size. The gel was electrophoresed at room 
temperature at 80-120V until the required separation was achieved. Ethidium bromide is 
a fluorescent dye that intercalates between the base pairs of a DNA molecule. The bound 
ethidium bromide fluoresces under ultraviolet irradiation thereby enabling visualisation 
of the DNA molecules. The products were visualised in UV light using a UV
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transilluminator and photographed using a UVP digital image capture system and the 
Grab-IT 2.04.7 software package (UVP).
2.4.7 Genotyping analysis
Microsatellite PCR products were separated according to allele sizes by 
polyacrylamide gel electrophoresis using an ABI 373 sequencer. Fluorescent labels 
attached to the forward primer are visualised by a laser. Different fluorescent labels 
emit different colours (FAM = blue, TET = green, HEX = yellow) and the size 
standard Tamra (Applied Biosystems) emits red fluorescent light. 1 pi of diluted 
PCR product, 3.5 pi Blue dextran formamide loading buffer and 0.5 pi Tamra size 
standard was denaturated at 95°C for 3 minutes and loaded onto a 6 % 
polyacrylamide (Sequa-gel 6) gel containing 10 % APS. The gel was run at 40 Watts, 
1100 Volts and 40 mAmps for 5 hours. Allele sizes were called and genotypes 
derived using the ABI-PRISM Genotyper 2.5 software package.
2.4.8 Single nucleotide polymorphism (SNP)-based genome 
search
SNP genotyping was performed using a commercial service at The Turku Centre for 
Biotechnology, University of Turku and Abo Akademi University, Finland and the 
Illumina SNP-based Linkage IVb Panel, integrated with Illumina’s high-performance 
assay. DNA samples were sent to the Finnish genome centre and 5,800 SNPs were 
typed across the entire genome and genotypes sent back for analysis.
2.4.9 Linkage analysis
Parametric linkage analysis was carried out using the MERLIN programme (Abecasis 
et al., 2002), assuming an autosomal recessive inheritance, a disease allele frequency 
of 0.007 (based on the Hardy-Weinberg equilibrium) and a disease penetrance of 1.0. 
Five parameter files are used in this programme: DAT file (lists genetic markers), 
MAP file (locates genetic distance of markers), FREQ file (lists allele frequency of 
markers), FED file (contains family and genotype information) and MODEL file
93
(contains disease information). These files were compiled according to SNP allele 
information supplied by Illumina. Where additional microsatellite data was 
incorporated into the parameter files for linkage analysis, their positions relative to 
the SNPs were taken from a genetic map constructed from the Illumina deCODE 
genetic map for SNPs and the deCODE genetic map for microsatellite markers (Kong 
et al., 2002). Estimated locations of in-house markers were determined with 
reference to the UCSC browser (http://genome.ucsc.edu).
2.4.10 Identification of PCD candidate genes using 
bioinformatics
On the basis that cilia are evolutionarily well conserved and to rationally prioritise 
genes that could be involved in ciliary disease for mutational analysis, a comparative 
bioinformatics approach was used to identify positional candidate genes with a 
potential role in the structure or function of cilia, in linked regions of interest 
identified in PCD families. Ciliate and non-ciliate genome and proteome datasets 
were used as well as transcripts from the Foxjl mouse microarray. Foxjl is an f-box 
transcription factor expressed in ciliated cells and was shown to be required for late 
stage cilia formation by a gene deletion in the FoxjF^' mouse model. Microarray 
analysis demonstrated that genes expected to be involved in ciliogenesis are down- 
regulated in this mutant (pre-publication data made available by Dr. S Brody, 
Washington University).
Known and predicted genes within the regions of interest were identified using the 
UCSC genome browser (http://genome.ucsc.edu) and coding region sequences for 
predicted genes were then downloaded from Entrez (http://www.ncbi.nlm.nih.gov). 
These were then subjected to a BLAST search using a cut-off E value for significance 
of homology of <10' .^ A PCD candidate gene was expected to be conserved in 
ciliates but not in non-ciliates. The genomic sequence freeze dates used at the time 
the grid was designed (July 2005). Searches were performed against whole genome 
sequences from nine ciliated and three non-ciliated organisms, using a local Unix- 
based grid designed by Dr. Richard Emes (Centre for Applied Entomology and 
Parasitology, Keele University) and Dr. Rahul Chodhari (UCL). Human mRNA
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sequences were translated in 6 frames and screened against the translated genome (6 
frames) or proteomes of the model organisms, using a TBLASTX programme.
The 9 ciliate datasets comprised:
Chlamydomonas reinhardtii genome (genome.jgf- 
psf.org/chlre2/chlre2.home.html)
Pazour’s Chlamydomonas Flagellar proteome (Pazour et al., 2005) 
Chlamydomonas reinhardtii deflagellation dataset (Marshall WF 2005, 
Proceedings of the National Academy of Science)
Trypanosoma brucei and Leishmania major combined genomes (Ivens et al.,
2005; Berriman et al., 2005)
Ciona intestinalis genome
Tetrahymena thermophilia genome
(www.lifesci.ucsb.edu/~genome/Tetrahymena/)
Gull & McKean’s Trypanosoma flagellar proteome (Courtesy of Prof. Gull & Dr. 
McKean, Lancaster University)
Caenorhabditis elegans proteome (sensory cilia only)
(WWW. sanger.ac.uk/Proj ects/C_elegans/W ORMB ASE/current/wormpepdownloa
d)
Foxjl mouse ciliogenesis microarray (genes down-regulated in cilia-less mice 
compared to controls) (pre-publication data made available by Dr. S Brody, 
Washington University)
The non-ciliated datasets comprised:
Arabidopsis thaliana (www.arabidopsis.org)
Saccharomyces cerevisae (www.yeastgenome.org)
Saccharomyces pombe (www.sanger.ac.uk/Project/S_pombe/protein_download)
Candidate genes were prioritised for mutational analysis according to the results 
obtained from the BLAST search, in addition to available information on their human 
tissue expression pattern from Genbank, NCBI, Ensembl and dbSNP, protein domain 
structure (NCBI Conserved Domain Database v2.13) and known or predicted
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function of the gene products according to published experimental information 
(PubMed) and NCBI.
2,4.11 PCR purification
2.4.11.1 EXOSAP-IT
PCR products for sequencing were purified using EXOSAP-IT (USB), containing
Exonuclease I and Shrimp Alkaline Phosphatase. 2 pi EXOSAP-IT was added to
every 5 pi PCR product (removed from mineral oil). This was activated at 3TC  for 
15 minutes and deactivated at 80®C for 15 minutes, then stored at 4®C.
2.4.11.2 QIAquick PCR purification
The manufacturer’s protocol for the QIAquick PCR purification Kit (QIAgen) using a 
microcentrifuge was followed. All centrifugation steps were performed at 13,000 x g.
5 volumes of buffer PB (containing hydrochloride and isopropanol) was added to 1 
volume of PCR sample and mixed. The sample was then added to a QIAquick spin 
column and centrifuged for 1 minute. Flow-through was discarded and 0.75 ml 
buffer PE added to wash and centrifuged for 1 minute. Flow-through was discarded 
in centrifugation was repeated for an additional 1 minute, to remove residual ethanol 
from buffer PE. The QIAquick column was placed in a clean 1.5 ml eppendorf. 
DNA was eluted by adding 30 pi elution buffer (10 mM TRIS-HCl pH 8.5), the 
column left to stand for 1 minute and centrifuged. The average eluate volume was 28 
pi, which was stored at -20°C.
2.4.11.3 QIAquick Gel extraction
Where multiple bands were observed after agarose gel electrophoresis, indicating 
non-specific amplification, the QIAquick Gel extraction Kit (QIAgen) protocol using
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a microcentrifuge was used, following the manufacturers protocol. All centrifugation 
steps were performed at 13,000 x g.
Briefly, PCR products of appropriate size were excised from the agarose gel with a 
clean, sharp scalpel. The gel slice was weighed and placed in a tube. 3 volumes of 
buffer QG (containing guanidine thiocyanate) was added to 1 volume of gel and 
incubated at 50°C until the gel had dissolved. 1 gel volume of isopropanol was added 
to the sample, which was then added to a QIAquick column and centrifuged for 1 
minute. Flow-through was discarded and 0.5 ml buffer QG added and centrifuged for 
1 minute, to remove all traces of agarose. The column was washed with 0.75 ml 
buffer PE and centrifuged. The column was placed into a clean 1.5 ml eppendorf and 
30 pi elution buffer added, left to stand for 1 minute and centrifuged for 1 minute. 
The average eluate volume was 28pl, which was stored at -20°C.
2.4.12 Plasmid DNA purification
Plasmid DNA was extracted from overnight cultures of E. coli in LB medium using 
the QIAprep mini-prep kit (QIAgen) according to manufacturer’s instructions. 1 pi 
of a 1:20 dilution of eluted DNA was used in subsequent PCR reactions.
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2.4.13 DNA sequencing
Purified PCR products of a size up to 400 bp were subjected to the following PCR 
reaction, according to the DYEnamic ET Terminator Cycle Sequencing Kit 
(Amersham Biosciences) protocol:
50 ng per 300 bp PCR product 
1 pi Pellet Paint NF Co-Precipitant (Novagen)
5 pmol primer (forward or reverse)
4 pi Sequencing reagent premix (contains Thermo Sequenase II DNA 
polymerase)
Distilled H2O to 20 pi total reaction volume
The reactions were covered with mineral oil and amplified using the following 
reaction on a Gene Amp PCR system 9700 thermocycler:
96°C 20 seconds
50°C 15 seconds
60°C 60 seconds
For 25 reaction cycles
The PCR products were purified according to the Amersham Bioscience DYEnamic 
ET Terminator Cycle Sequencing protocol: 3 M NaAc and 95 % EtOH were added to 
the entire PCR reaction, the solution centrifuged and DNA pellets washed with 70 % 
EtOH and air-dried. Pellets were resuspended in blue Dextran formamide loading 
buffer, denatured at 95°C for 3 mins and loaded onto a 6 % acrylamide denaturing gel 
which was run for 12 hours at 1500 V, 30 W and with a laser power of 40 mW. The 
fluorescence emitted by the dideoxy-termination sequences is read by the laser.
For products larger than 400 bp, purified PCR products after EXOSAP-IT treatment 
were sent for commercial sequencing to the Advanced Biotechnology Centre, 
Imperial College, University of London where the ABI Big Dye terminator kit 
version 3 from PE/ABI and an ABI PRISM 7700 Sequence Detection System are 
used. Alternatively, samples were sent to Alpha Bio-laboratory Express DNA 
Sequencing Service, California for sequencing, using Applied Biosystems ABI
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3730x1/3130x1 fluorescence-based capillary electrophoresis genetic analyzers. 
Electropherograms data was received by email.
Sequence electropherograms were analysed and aligned to a reference sequence for 
mutational analysis using the Sequence Navigator (ABI) or GeneTool software 
(BioTools Incorporated).
2.4.14 In situ hybridisation probe design and synthesis
Mouse embryos were analysed at developmental stages E 7.5, E l8 and E l9 by in situ 
hybridisation performed by Dr. Nick Greene, UCL ICH.
The mouse C6ORF206IRSP9 antisense probe for in situ hybridisation running from 
base position 317 in exon 2 to base position 837 in exon 5 was amplified by PCR 
using a 1:20 dilution of purified mouse C6ORF206/RSP9 clone (RZPD) and primer 
sequences 5’-TGGTGAGTGGCCGTTTCAT-3’ and 5’-
CCATGTTCTTCTCTCCTGTGC-3’. The resulting product was cloned into vector 
pCR4 by TOPO-TA cloning, according to the manufacturer’s {Invitrogen) 
instructions. Antisense and sense probes were synthesized by Dr. Nick Greene, UCL 
ICH using Sp6 and T7 promoter priming sites.
2.4.15 Maintenance of zebrafish lines
Breeding zebrafish {Danio rerio) lines were maintained at 28°C on 14h light/1 Oh dark 
cycle. Fertilised eggs were obtained from natural spawning and grown in incubators 
at 28.5®C, 22^C (to slow development) or 31^C (to accelerate development) according 
to the stages required. Embryos were staged according to standard references 
(Rimmel et al., 1995).
2.4.16 Obtaining non-pigmented embryos
Formation of melanin was blocked by incubating embryos in 0.2 mM 1-phenyl-2- 
thiourea (PTU) at 24 hours onwards to prevent pigmentation of developing embryos 
without affecting growth.
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2.4.17 Observation of live embryos
Embryos at somitogenesis stages and later stages of development were visualised in 
fish tank water and manually dechorionated with # 5 watchmaker’s forceps. When 
necessary, for photographing live, embryos were anaesthetised with 0.02 % tricaine 
(3-amino benzoic acid ethyl ester) and mounted for viewing in 3 % methylcellulose in 
fish tank water.
2.4.18 Morpholino targeted gene-knockdown in zebrafish
Morpholino targeted gene knockdown was performed in wild-type control zebrafish, 
provided by the Department of Anatomy and Developmental Biology, UCL. 
Morpholinos work through an RNase-H independent process that blocks correct 
splicing of the transcript.
2.4.18.1 Morpholino oligonucleotide design
Morpholinos were obtained from Gene Tools, LLC. Morpholinos were arbitrarily 
designed to bind to the RNA spanning exon-intron boundaries of exon 2 -  intron 2 
and exon 3 -intron 3. Sequences were selected based on design parameters according 
to the manufacturer’s recommendations, namely 21-25mer antisense oligonucleotides 
of -50 % G/C and A/T content with no predicted internal hairpins. Four consecutive 
G nucleotides and representation elsewhere in the genome were also avoided. 
Sequences were as follows: M0ex2 5’- GGTGTAAGGCTTTTACCGTGACCTC-3’ 
and M0ex3 5’- GCTGTAAGTATACCTCCAAAGCTTC-3’.
2.4.18.2 Morpholino preparation
GeneTools prepared morpholino-modified antisense oligonucleotides. The supplied 
300 nmol of lyophilised powder was diluted as a stock solution in lOOul of IX 
Danieau buffer (5mM HEPES pH7.6, 58mM NaCl, 0.7mM KCl, 0.4mM MgS0 4 ,
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0.6mMCa(NO3)2) to a concentration of 25 mg/ml. The stock solution was diluted to 
working concentrations of 6.25 mg/ml in IX Danieau solution before injection. For 
morpholino distribution analysis. Green Fluorescent Protein (OF?) mRNA was co­
injected into the embryos and analysed under blue light. At this concentration, MO- 
injected cells developed normally. Images were obtained using a Leica DM 2500 
light microscope at 300 X magnification and a KODAK DCS420 digital camera.
2.4.18.3 Morpholino injections
Embryos were obtained at the 1-2 cell stage and microinjection targeted to the 
cytoplasm or yolk syncytial layer. Siblings from the same pool of MO-injected 
embryos served as the internal controls. Needles were pulled from glass capillary 
tubes using a Clark Electromedical Instruments needle puller and injections were 
performed using a Picospritzer micro-injector.
Effective doses were determined for each morpholino. For example, at the effective 
dose of 6.25 ng and lower, embryos developed normally as assayed under normal 
morphological criteria. Higher doses of the GFP-MO resulted in a larger average 
reduction of GFP protein, but also caused some detectable detrimental effects on 
development (data not shown). These higher-dose effects were not pursued further. 
In all cases shown, the dose used for analysis resulted in embryos of two classes, 
those displaying a specific phenotype or those that were normal using morphological 
criteria. A small fraction (typically less than 5 %) of embryos developed abnormally 
due to mechanical damage following microinjection, these embryos were discarded 
before analysis.
2.4.19 Analysis of zebrafish olfactory pit cilia motility
Seven to nine control and MO-injected embryos at 72 hours post-fertilisation (hpf) 
were analysed individually under a glass coverslip, taking care not to damage the 
embryo or the yolk. Embryos were confirmed as alive before analysis by checking 
their heart beat. Olfactory pit cilia were viewed under a water immersion objective 
lens (x50) on an inverted Nikon Diaphot microscope in a humidified (80 %) and 
temperature (28°C) controlled chamber. High-speed (500fps) video sequences were
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captured (Trouble-shooter 500, Lake Image systems, UK) of the zebrafish olfactory 
pits. The stored sequences were then replayed in slow motion (Midas 2.0 player, 
Xcitex) and the cilia beat fi-equency (CBF) was calculated using the following 
formula.
Frames per second (500)/ Frames elapsed for 5 beat cycles X beat cycles counted (5) 
= CBF (Hz).
The Immotility Index (II) and Dysmotility Index (DI) were determined by counting 
the number of static or dysmotile cilia as a percentage of the total number present in 
the video sequences.
2.4.20 Growth and maintenance of Chlamydomonas
Chlamydomonas reinhardtii were maintained on TAP-agar plates (Section 2.1.3.) at 
25 - 28 °C and re-streaked onto fresh plates every month. Cultures were streaked and 
re-streaked from stock plates or newly grown colonies in order to get a well growing, 
healthy colony before expanding into liquid culture. A loop-full of culture was taken 
from TAP-agar plates and re-suspended in liquid TAP media (Section 2.1.3.) and 
grown for 16 to 72 hours, whilst slowly shaking under light at 25 - 28 °C.
2.4.21 Creation of DNA constructs for wild-type and 
mutant Chlamydomonas RSP9 transformation
The wild-type genomic RSP9 gene was amplified by PCR from wild-type 
Chlamydomonas genomic DNA. The gene sequence amplified included the 5’ and 3’ 
UTR and approximately 400 bp of the upstream sequence incorporating the tub box 
sequence motif (GCTC(G/C)AAGGC) that is known to enhance transcription after 
defiagellation (Davies and Grossman, 1994). Primer sequences used for genomic 
PCR were: 5’- AGATTCCACACCTCACGGATAC-3' (Figure 2.4 - PI) and 5’- 
ACCAGTCAAACTTTCGAACCAG-3’ (P2). pFusion Taq DNA polymerase 
(Invitrogen) was used in the PCR, which creates blunt-ended products allowing 
compatibility with EcoRV- digested plasmid pBluescript II SK’ (Figure 2.4).
102
For transformation of p fl 7 with mutated RSP9, a 3 bp deletion was introduced into 
this wild-type DNA construct, using a long PCR primer with the relevant three bases 
missing. This 3 bp change recreates the amino acid deletion identified in the 
C6ORF206/RSP9 linked families and the restriction enzyme site BmgBI created at the 
5’ end. This was primer P3:
5’-
CGAGCTGACGTGGGGCAGCCTGTACGTGGGCGACGGCCTGAACAACGAC
C-3’
(Figure 2.4). The reverse primer used was complementary to pBluescript, 
downstream of a unique Notl site, primer P4: 5’-
GTATGTTGTGTGGAATTGTGAGCGG-3’. Amplification of pBluescript-RSP9 
with P3 and P4 created a 706 bp PCR product. To ensure correct digestion of the 
ends, the mutagenic PCR was cloned into PCR4 TOPO-TA vector and then excised 
using BmgBI and Notl double restriction enzyme digestion and gel purification. 
Wild-type pBluescript-R5'PP was digested using the same enzymes and gel extracted 
to eliminate the wild-type RSP9 insert. Both isolated DNAs were then ligated 
together to create a plasmid with mutated RSP9 (Figure 2.4). Each DNA had a sticky 
end {Notl) and a blunt end {BmgBI) that ensured correct orientation of ligation and 
prevented re-circularisation of vector.
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constructs used in the 
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m u tan t/? //7. Left; Table of primers 
used.
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2.4.22 Transformation of Chlamydomonas reinhardtii
The protocol used was based on the glass bead method of Karen Kindle (Kindle, 
1990). Cells were grown in TAP medium at 25 °C to mid-log phase (1 - 2 x 10^  
cells/ml) whilst shaking slowly under continuous light (~90 pE/m^/s). 25 mis of cells 
were pelleted by spinning at 6,000 rpm at room temperature for 5 minutes. Pellets 
were resuspended in fresh TAP by gentle pipetting to a concentration of 2x10^ 
cells/ml. 300 pi of this cell suspension was transferred to 5 ml test tubes containing 
-0.3 g of 0.4 mm diameter glass beads (B.D.H.). Beads had previously been washed 
in sterile distilled water and ethanol to remove contaminants and dried in an oven. 1 
pg of plasmid DNA was added along with 4 pg plasmid pSI103, which confers 
paramomycin resistance for selection of transformant colonies. A “no-DNA” control 
was also set up. The cell/glass bead/DNA suspension was vortexed for 15 seconds 
using a Vortex genie-2 (Scientific Industries). Cells were transferred to 10 mis TAP 
medium and grown overnight by shaking at 100 rpm to allow for recovery and 
expression of the gene. Cells were then pelleted by centrifugation for 5 minutes at 
2000 X g. Pelleted cells were gently resuspended in 0.5ml TAP medium and plated in 
3.5 ml of TAP + 0.5 % agar (the molten agar was below 42°C and contained no 
antibiotic) onto TAP 2 % agar supplemented with paramomycin at 20pg/ml. Agar 
was allowed to set, plates were inverted and left in the light (-45 pE/m^/s) at ~22°C. 
Colonies were visible after 7-10 days. Colonies were picked and grown in 25 mis 
TAP medium over night and analysed under a Leica DM 2500 light microscope (XI0 
eyepiece, X40 objective lens) for initial motility.
2.4.23 Analysis of Chlamydomonas transformant motility
100 pi of Chlamydomonas suspension grown overnight was placed on a glass cover 
slip and viewed under a water immersion objective lens (x50) on an inverted Nikon 
Diaphot microscope in a humidified (80 %) and temperature (30°C) controlled 
chamber. High-speed (500 fps) video sequences were captured (Trouble-shooter 500, 
Lake Image systems, UK) of the Chlamydomonas. The stored sequences were then 
replayed in slow motion (Midas 2.0 player, Xcitex) and the flagella beat frequency 
(FBF) was calculated using the following formula.
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Frames per second (500)/ Frames elapsed for 5 beat cycles X beat cycles counted (5) 
= FBF (Hz).
Chlamydomonas motility was variable in the non-synchronised cultures used, 
therefore only the FBF was calculated from Chlamydomonas when their beat pattern 
was symmetrical. The Immotility Index (II) was determined by counting the number 
of static flagella as a percentage of the total number present in the video sequences.
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3 CHAPTER THREE
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3.1 LINKAGE ANALYSIS AND MUTATION SCREENING IN 
FIVE PAKISTANI PCD FAMILIES
This chapter describes a high density SNP-based genome wide linkage screen, 
multipoint linkage analysis and a homozygosity mapping approach that were used to 
identify the causative gene in a group of five PCD families. These families had a 
high incidence of situs inversus (eight out of nine affected individuals) (Figure 3.1 
and described more fully in Section 2.3). PCD is a genetically heterogeneous 
disorder (Blouin et al., 2000) and therefore a large single family or a group of 
multiple small families with a clear common phenotype or from the same 
geographical ethnic origin is preferable to increase the chance of genetic 
homogeneity. The families used in this study were all of the same geographical 
origin, from the Mirpur region of Northern Pakistan. In addition, they all share a 
common ultrastructural ciliary phenotype: a defect of absent inner and outer dynein 
arms. The parents in each family are first cousins and there are a total of nine 
affected and seventeen unaffected individuals (Figure 3.1). This chapter describes the 
identification of two genetic loci on chromosome llq23.3-24.3 and 17q21.31-22 that 
were statistically significant for linkage in the Pakistani families. To identify the 
disease-causing gene, postional candidate genes were prioritised for mutational 
analysis according to their known or predicted function, expression pattern and 
sequence conservation in ciliates.
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Figure 3.1: Pedigree structu re  of consanguineous families 120, 130, 141, 143 and  145. Only 
samples where DNA was available are numbered in figure. Family details are described more fully in 
methods section 2.3.
3.1.1 Power simulation for Pakistani families 120,130,141, 
143 and 145
Prior to beginning the linkage study an analysis was made to evaluate whether the 
family resource available had the power to statistically prove linkage under a variety 
of assumed conditions and at the marker resolution being proposed. To this end, the 
five individual pedigrees (Figure 3.1) were analysed using the computer linkage 
programme SLINK (Lemire, 2006). This is a simulation programme that simulates 
marker data in pedigrees with respect to their disease locus phenotypes. The 
maximum LOD score that can be obtained under conditions of genetic homogeneity 
or of varying heterogeneity with the pedigrees of interest can be calculated.
The minimum and maximum achievable LOD scores for each Pakistani PCD family 
were calculated individually, assuming an autosomal recessive inheritance, a 
penetrance of 0.9 and a disease allele frequency of 0.007. Even with the same ethnic
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origin and ciliary ultrastructural defect, genetic homogeneity is not guaranteed, 
therefore, in order to anticipate heterogeneity and take this into consideration within 
this group of families, simulations were also performed for combinations either of the 
two large family with three-affected individuals (family 120 or 141) plus all three 
smaller families with one affected individual (families 130, 143 and 145), as well as 
all five families together (Table 3.1). The maximum LOD scores that could be 
achieved directly at the disease locus (0 = 0) for either of the larger families alone 
(family 120 or 141) was 2.4, whereas the single-affected families with (families 130 
and 145) or without (family 143) one unaffected child (due to limited DNA 
availability) achieved 1.3 and 1.2, respectively. Since the LOD scores for more than 
one family are additive, if either of the larger three-affected families were linked to 
the same region as all the single-affected families, a maximum LOD score of 6.1 
could be achieved. If all five families were linked to the same region, a maximum 
LOD score of 8.5 could be reached. This analysis indicated that these families would 
provide sufficient power in a genome-wide linkage screen to generate a significant 
LOD score of >3. Since the maximum LOD score achievable for family 120 or 141 
is not sufficient to prove linkage, a significant LOD score of >3 could only be 
achieved if at least one three-affected and one single affected family were linked to 
the same region.
3.1.2 Whole genome SNP-based linkage analysis in Pakistani 
families
SNP genotyping using the Illumina SNP-based Linkage IVb Panel, as described in 
Section 2.3, was performed on DNA samples obtained from all nine affected 
individuals, seven (unaffected) parents (individuals 130 1:1, 145 1:1 and 145 1:2 were 
not included) and two unaffected siblings (individuals 141 11:6 and 11:7 and 143 11:4 
were not included) of the five Pakistani PCD families. Multipoint parametric linkage 
analysis was carried out on the SNP genotype data using the MERLIN programme 
(Abecasis et al., 2002), assuming an autosomal recessive inheritance, a disease allele 
frequency of 0.007 and a disease penetrance of 0.9.
All five families were included together in the MERLIN linkage analysis and 
significant HLOD scores of 3.7 (proportion of linked families, a = 0.8) on
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chromosome 11 and 3.9 (a = 0.7) on chromosome 17 were achieved (Table 3.2). An 
HLOD score of 2.3 (a = 0.5) was achieved on chromosome 9, which is described in 
more detail in Appendix 1. Linkage results for each family individually were 
examined and revealed that the larger families 141 and 120 contributed to the 
majority of the LOD score on chromosome 11 and 17, respectively, since they 
achieved the maximum simulated LOD score of 2.4 at these regions of interest (Table 
3.3). In addition a region on chromosome 9 achieved a LOD score of 2.0 in family 
120 (Appendix 1). No other genomic region associated with a LOD score reaching 2 
was identified, indeed for the majority of chromosomes the maximum LOD score was 
below 1.0 (Appendix 1). Thus, locus heterogeneity was demonstrated as likely in 
these PCD families from the Mirpur region of Pakistan despite them originating from 
the same geographical region and having a similar ultrastructural defect observed by 
EM. Subsequent work focused on refining the loci on chromosomes 11 and 17 only.
I l l
LOD scores
Family 120 Family 130 Family 141 Family 143 Family 145
Family 120 + 
130,143,145
Family 141 + 
130,143,145 All families
8 Min Max Min Max Min Max Min Max Min Max Min Max Min Max Min Max
0 -3.186 2.378 -1.549 1.288 -5.076 2.378 -1.668 1.164 -1.549 1.288 -7.952 6.118 -9.842 6.118 -13.028 8.496
0.05 -0.917 2.156 -1.171 1.152 -0.928 2.156 -0.884 1.033 -1.171 1.152 -4.143 5.493 -4.154 5.493 -5.071 7.649
0.1 -0.76 1.928 -0.868 1.014 -0.787 1.931 -0.81 0.899 -0.868 1.014 -3.306 4.855 -3.333 4.858 -4.093 6.786
Table 3.1: SLINK sim ulation o f  minimum and m aximum achievable LOD scores for the Pakistani families. LOD scores were calculated for each family individually, for 
combinations o f either large three-affected family (120 or 141) plus three single affected families (130, 143, and 145) and for all five families together. Numbers in bold highlight 
the maximum LOD score achievable at 0 = 0 for the larger families.
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Chromosome
All families 
HLODmax Alpha
1 1.098 0.377
2 1.332 0.752
3 1.431 0.497
4 0.352 0.192
5 1.185 0.401
6 0.240 0.166
7 1.087 0.367
8 0.319 0.172
9 2.334 0.530
10 0.314 0.169
11 3.731 0.764
12 0.976 0.303
13 1.302 0.241
14 0.314 0.169
15 0.238 0.288
16 0.476 0.267
17 3.868 0.738
18 0.326 0.177
19 1.802 0.431
20 0.357 0.197
21 0.256 0.186
22 0.000 0.000
Table 3.2: M aximum H LO D scores calculated for the Pakistani fam ilies using  
Illumina SNP data and M ERLIN linkage analysis on each chrom osom e.
Maximum HLOD scores for all five Pakistani families with alpha values (proportion 
of linked families) are displayed.
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3.1.3 Refinement of critical regions of interest in Pakistani 
families
MERLIN linkage analysis on the Illumina SNP genotype data of the five Pakistani 
PCD families 120, 130, 141, 143 and 145 identified regions of interest on 
chromosome 11 and 17 with HLOD scores >3 (a = 0.8). Observation of the SNP 
genotype data in affected individuals revealed homozygosity across these regions in 
the families. The largest region of shared homozygosity between the affected 
individuals within the region on chromosome 11 spanned 22.1 cM (11.6 Mb) between 
SNP markers rs644252 and rs2001625. The largest region of shared homozygosity 
on chromosome 17 spanned 14 cM (16.4 Mb) between SNP markers rs1859212 and 
rs2045418. In addition, a less significant region of homozygosity on chromosome 9 
with an HLOD score of 2.3 (a = 0.5) was identified that spanned 12.1 cM (9.6 Mb) 
between SNP markers rs 1413219 and rs769012. The constructed haplotypes will be 
further described in section 3.1.4 and Appendix 1 for the three regions of interest.
In order to refine the limits of the critical regions, extra microsatellite markers were 
genotyped across the regions of interest on chromosomes 11 and 17, in the Pakistani 
families, including unaffected siblings where DNA was available. Eight additional 
known microsatellite markers were genotyped across the candidate region identified 
on chromosome 11. Eleven additional known and 3 in-house microsatellite markers 
(primer sequences shown in Appendix 1) were genotyped across the candidate region 
on chromosome 17.
MERLIN linkage analysis was repeated with the same parameters as used in section 
3.1.2, using the more detailed genetic marker data incorporating microsatellite 
markers. From these results, the region on chromosome 11 achieved an HLOD score 
>3 across 3.3 Mb between markers rs617847 and rs6590098. A  maximum HLOD 
score of 3.6 (a = 0.8) was obtained on chromosome 11 at SNP marker rs930983 
(Table 3.3 and Figure 3.2A). The region on chromosome 17 achieved an HLOD 
score >3 between markers D17S951 and Chl7-nr-D17S1865 (8.8 Mb). A maximum 
HLOD score of 6.0 (a = 1.0) was obtained on chromosome 17 at in-house 
microsatellite marker D17S809 (Table 3.4 and Figure 3.2B). The families with one 
affected individual 130, 143 and 145 each contributed a maximum LOD score of 0.6,
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1.3 and 1.0, respectively to the locus on chromosome 11 and approximately 1.3 each 
to the locus on chromosome 17 (Tables 3.3 and 3.4).
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Illumina screen
All 5 families - Illumina screen 
SNPs plus extra microsatellite 
markers
Marker name
Genetic
distance
(cM)
HLOD
score alpha LOD alpha HLOD
Family
120
Family
130
Family
141
Family
143
Family
145
rs644252 121.30 0.001 0.005 -8.505 0.000 0.000 -4.039 -0.151 -1.121 -2.282 -1.142
D11S4129 121.58 -8.738 0.000 0.000 -4.053 -0.626 2.076 -2.425 -1.144
D11S4132 121.90 -9.649 0.000 0.000 -4.092 -0.993 2.364 -2.484 -1.047
rsI073636 122.31 1.493 0.018 -5.693 0.247 1.175 -4.209 -0.053 2.366 -2.53 -1.044
D11S925 123.00 -5.189 0.338 1.868 -4.293 0.586 2.366 -2.842 -1.208
D11S4107 124.00 -3.386 0.337 1.887 -3.558 0.555 2.371 -1.847 -1.138
rs48I703 124.46 1.666 0.381 -3.398 0.331 1.875 -3.47 0.531 2.371 -1.73 -1.338
rs665035 124.50 1.665 0.351 -3.434 0.330 1.873 -3.472 0.528 2.373 -1.729 -1.371
rs575030 124.51 1.7 0.349 -2.651 0.357 1.919 -3.474 0.527 2.374 -1.731 -0.584
rs596437 124.88 2.147 0.372 -1.881 0.522 2.464 -3.484 0.501 2.374 -2.152 0.643
rs6I7847 124.92 2.146 0.523 -2.418 0.522 2.478 -3.49 0.498 2.374 -2.703 0.665
rs676943 125.79 3.532 0.513 0.311 0.750 3.425 -4.101 0.428 2.374 0.488 0.885
D11S4167 126.00 0.396 0.753 3.505 -4.102 0.409 2.374 0.563 0.914
rs668I83 126.08 3.622 0.763 0.408 0.754 3.522 -4.109 0.402 2.375 0.581 0.922
rsl 894078 126.91 3.731 0.764 0.748 0.755 3.641 -3.888 0.316 2.375 0.712 0.997
rs930983 127.54 3.702 0.762 0.796 0.751 3.647 -3.838 0.236 2.375 0.783 1.003
rs485345 128.18 3.638 0.757 0.757 0.743 3.597 -3.811 0.137 2.375 0.815 1.005
rsl 943467 128.70 3.565 0.749 0.554 0.732 3.538 -3.933 0.035 2.375 0.838 1.004
D11S1353 129.20 0.556 0.716 3.461 -3.817 -0.094 2.375 0.856 1.001
rsl 148109 130.11 3.253 0.738 0.342 0.653 3.444 -3.815 -0.526 2.375 1.09 0.982
rs65900I6 130.43 3.151 0.653 -0.118 0.609 3.390 -3.923 -0.924 2.375 1.149 0.969
rs25I216I 130.51 3.123 0.609 -0.324 0.597 3.371 -3.931 -1.13 2.375 1.163 0.962
rsl 893702 130.63 3.076 0.596 -1.352 0.577 3.331 -3.922 -2.165 2.375 1.182 0.941
rs2276I89 131.05 3.008 0.576 -1.337 0.570 3.225 -3.804 -2.146 2.375 1.245 0.757
rs6590098 131.35 2.89 0.573 -1.889 0.513 2.809 -3.791 -2.161 2.375 1.284 0.166
D11S933 131.38 -3.298 0.393 2.493 -3.802 -2.165 2.375 1.29 -1.233
rs4936975 131.51 2.717 0.566 -3.324 0.393 2.493 -3.832 -2.163 2.375 1.29 -1.23
rs593290 131.64 2.149 0.551 -3.287 0.393 2.492 -3.791 -2.165 2.375 1.29 -1.231
rs3740892 131.80 2.149 0.387 -3.273 0.393 2.491 -3.781 -2.161 2.375 1.289 -1.23
rs4627097 131.97 2.199 0.387 -2.597 0.418 2.541 -3.733 -2.165 2.375 1.289 -0.598
rsI425842 132.11 2.219 0.412 -2.452 0.427 2.561 -3.714 -2.156 2.375 1.288 -0.479
rs528638 132.61 2.254 0.421 -2.426 0.442 2.590 -3.824 -2.163 2.375 1.283 -0.328
rs6637I4 133.00 2.265 0.437 -2.310 0.447 2.582 -3.78 -2.11 2.375 1.262 -0.288
rs586566 133.12 2.266 0.442 -2.050 0.447 2.574 -3.503 -2.121 2.375 1.253 -0.286
rs2I56449 134.14 2.245 0.442 -1.675 0.432 2.428 -2.755 -2.287 2.373 1.118 -0.357
D11S4110 135.93 -5.277 0.202 1.538 -2.661 -2.07 2.373 -1.957 -1.2
rsl 944819 135.95 2.149 0.434 -2.658 0.349 1.969 -2.662 -2.073 2.373 0.666 -1.2
rs949095 135.95 2.149 0.388 -2.658 0.349 1.969 -2.662 -2.073 2.372 0.666 -1.2
rs762827 137.93 2.146 0.387 -3.100 0.386 2.325 -2.845 -2.783 2.372 1.116 -1.189
rsl 027323 139.46 2.151 0.389 -3.550 0.392 2.412 -3.477 -2.778 2.373 1.215 -1.106
rs9238Il 139.98 2.15 0.388 -3.063 0.391 2.422 -3.473 -2.235 2.374 1.23 -1.179
rsl 043654 140.94 1.997 0.388 -3.006 0.392 2.280 -3.55 -1.963 2.219 1.246 -1.175
rs200I625 143.19 0.218 0.15 -7.271 0.158 0.277 -3.518 -2.126 -1.083 1.257 -1.168
LOD scores for individual families - Illumina screen
Table 3.3: Genetic linkage analysis of Pakistani families on chromosome l lq .  LOD, alpha and 
HLOD score shown for all five Pakistani PCD families before and after high resolution marker typing 
using Illumina SNP genotyping results and additional microsatellite markers. Microsatellites 
highlighted in bold. Genetic distance in centimorgans (cM) according to the Illumina genetic map 
constructed by deCODE. HLOD >3 highlighted in red.
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Illumina screen 
SNPs only
All 5 families - Illumina screen 
SNPs plus extra microsatellite 
markers
LOD scores for individual families - Illumina screen 
SNPs plus extra microsatellite markers
Genetic
distance HLOD Family Family Family Family Family
Marker name (cM) score alpha LOD alpha HLOD 120 130 141 143 145
rsl859212 66.10 1.32 0.507 -2.510 0.571 1.766 -1.28 1.096 -4.335 1.243 0.766
D17S250 67.63 -2.630 0.574 1.824 -1.258 1.106 -4.539 1.275 0.786
rsl 008723 68.56 3.361 0.742 -2.407 0.581 1.878 -1.163 1.056 -4.463 1.283 0.88
rsl 526601 69.27 3.479 0.74 -2.530 0.578 1.887 -1.268 0.962 -4.501 1.287 0.99
rsl 468259 69.47 3.508 0.739 -2.622 0.574 1.869 -1.353 0.896 -4.493 1.288 1.04
D17S1787 70.08 -8.534 0.367 1.162 -4.304 -2.243 -4.537 1.29 1.26
rsl008753 70.08 3.58 0.739 -3.953 0.381 1.188 -3.852 -1.568 -1.083 1.29 1.26
rsl3851 71.68 3.732 0.738 -2.157 0.591 1.925 -0.921 1.237 -4.464 1.29 0.701
rs739769 71.92 3.75 0.738 -2.451 0.57 1.74 -0.912 1.269 -4.54 1.29 0.442
D17S951 72.08 -5.360 0.379 1.2 -1.091 1.279 -4.541 1.29 -2.297
D17S1861 72.69 -0.232 0.644 3.649 2.374 1.289 -4.512 1.29 -0.673
rs744281 72.70 3.804 0.738 -0.231 0.644 3.65 2.374 1.289 -4.512 1.29 -0.672
D17S950 73.20 -0.357 0.64 3.642 2.375 1.29 -4.603 1.29 -0.709
D17S931 73.74 -3.900 0.592 3.487 2.375 1.291 -7.193 1.234 -1.607
rs736604 73.75 3.868 0.738 -2.442 0.711 3.797 2.375 1.291 -7.13 1.235 -0.213
rs2013383 73.97 3.868 0.738 -1.039 0.788 4.828 2.375 1.291 -6.929 1.287 0.937
D17S1859 73.98 -0.808 0.788 4.844 2.375 1.291 -6.714 1.29 0.95
rs2051821 74.32 3.866 0.738 0.113 0.788 4.751 2.375 1.291 -5.7 1.192 0.955
rs733920 74.32 3.866 0.738 0.113 0.788 4.752 2.375 1.291 -5.7 1.192 0.955
rs%2272 74.45 3.864 0.738 0.216 0.788 4.814 2.375 1.291 -5.66 1.255 0.955
17-Mir-l 74.50 3.449 0.791 4.854 2.375 1.291 -2.462 1.29 0.955
D17S1868 74.53 3.848 0.796 4.862 2.375 1.291 -2.062 1.29 0.954
rsl 063647 76.31 3.66 0.756 2.158 0.781 4.509 2.375 1.29 -3.397 1.29 0.6
D17S1869 77.00 0.204 0.595 3.545 2.375 1.29 -3.252 1.29 -1.499
D17S-SPAG9 77.90 3.464 0.756 3.951 2.375 1.29 -0.136 1.29 -1.355
D17S809 79.00 5.950 1 5.951 2.375 1.29 0.198 1.29 0.797
rs792786 79.53 2.934 0.95 5.732 1 5.733 2.375 1.29 0.204 1.29 0.573
rsl 508966 79.87 3.796 1 5.614 1 5.615 2.375 1.29 0.206 1.29 0.453
Chl7-nr-D17S1865 79.28 2.152 0.803 2.382 -1.081 1.29 0.206 1.29 0.447
rs2045418 80.09 1.055 0.483 -1.238 0.471 0.879 -1.081 1.29 0.271 -2.16 0.442
Chl7-AC019315 80.40 -1.128 0.479 0.901 -1.082 1.289 0.311 -2.083 0.437
Table 3.4: Genetic linkage analysis of Pakistani families on chromosome 17q, LOD, alpha and 
HLOD score shown for all five Pakistani PCD families before and after high resolution marker typing 
using Illumina SNP genotyping results and additional microsatellite markers. Microsatellites 
highlighted in bold. Genetic distance in centimorgans (cM) according to the Illumina genetic map 
constructed by deCODE. HLOD >3 highlighted in red.
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Figure 3.2: HLOD plot across region of interest on chromosome l l q  and 17q for all five Pakistani 
PCD families. Genetic distance from the p arm telomere of the chromosome is plotted against HLOD 
score. A: Chromosome 11 HLOD plot. Maximum HLOD of 3.7 achieved at marker rs930983 (124.32 
cM). Critical region defined by loss o f homozygosity at marker D11S4132 amongst affected individuals 
in family 141 and a recombination event at marker rs2001625 in affected individual 11:3 from family 
141. HLOD >3 between rs617847 and rs6590098. B: Chromosome 17 HLOD plot. Maximum HLOD 
score of 6.0 achieved at marker D17S809 (77.0 cM). HLOD >3 and critical region defined by 
recombination events in affected individual 11:3 from family 120 at microsatellite markers D17S951 and 
Chl7-nr-D17S1865, as shown in figure 4.
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3.1.4 Haplotype analysis
The extents of the critical regions are shown by haplotypes created for the loci 
mapped on chromosome 11 and 17. Haplotypes for chromosome 9 are shown in 
Appendix 1.
3.1.4.1 Chromosome 11 locus
Haplotype analysis revealed a 21.3 cM (10.65 Mb) critical region on chromosome
Hq23.3-q24.3, defined by loss of homozygosity at microsatellite marker D11S4132 
amongst affected individuals in family 141 and a recombination event at SNP marker 
rs2001625 in affected individual 11:3 from family 141 (Figure 3.2A and 3.3). 
Families 130, 143 and 145 were shown to have marker homozygosity overlapping 
with this large block in family 141, but it was more broken up (Figure 3.3), however, 
all three were still consistent with linkage in sub-regions. Due to the presence of sub- 
regions where the single affected families 130, 143 and 145 were also homozygous, 
the cumulative total HLOD score including all five families was >3 between markers 
rs617847 and rs6590098 (6.4 cM, 3.3 Mb). The family 120 haplotype displayed no 
significant homozygosity of markers or consistency of linkage to this region. 
Exclusion of family 120 was consistent with the linkage analysis in section 3.1.3 
where the maximum LOD for this family was -2.7 (Table 3.3). There was no 
significant allele sharing at the chromosome 11 locus amongst the linked families at 
this marker density.
3.1.4.2 Chromosome 17 locus
Haplotype analysis revealed a 7.8 cM (8.8 Mb) critical region on chromosome
17q21.31-q22 defined by recombination events in affected individual 11:3 from family 
120 at microsatellite markers D17S951 and Chl7-nr-D17S1865 (Figure 3.2B and
3.4). The HLOD score at this locus was >3 due to overlapping homozygosity in 
affected individuals from families 130 and 143 along the length of the region and 
near-complete homozygosity in family 145. Affected individual 11:3 from family 145 
had a homozygous haplotype broken up by heterozygosity of three markers (Figure
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3.4). The linkage analysis in section 3.1.3 suggested that all five families are 
genetically linked to this region (a = 1.0) between D17S-SPAG9 and Chl7-nr- 
D17S1865 (Table 3.4). However, the maximum LOD score of 0.3 in family 141 at 
this region was derived from only three homozygous markers rsl508966, rs2045418 
and Chl7-AC019315 at the telomeric end of the region, which were interrupted with 
heterozygous marker Chl7-nr-D17S1865, so family 141 was not considered 
significant for linkage. Again, there was no significant allele sharing at the 
chromosome 17 locus amongst the linked families at this marker density.
3.1.5 Heterogeneity amongst Pakistani families 120,130,141, 
143 and 145
Haplotypes revealed that the positive LOD scores at the loci on chromosomes l lq  
and 17q derived mainly from either family 141 or 120, respectively. At both loci this 
larger family with three affected individuals that was consistent with linkage achieved 
a LOD score of 2.4. The true linkage status of the three singleton families 130, 143 
and 145, was uncertain due to their insufficient linkage power.
The lack of allele sharing which would have indicated linkage disequilibrium 
suggested that if these families share a common mutation it is not detectable at this 
marker density. This was disappointing since the five families share a common 
ultrastructure and geographical origin.
3.1.6 Likelihood of linkage of Pakistani families to regions of 
interest
Both the regions mapped on chromosome 11 and 17 were consistent for linkage in a 
proportion of the Pakistani families. However, the haplotypes did not distinguish 
which locus was most likely for the singleton families. Formal heterogeneity testing 
using H0M0G3R (Bhat et al., 1999) was therefore performed to determine whether 
one locus was statistically more likely to contain the disease locus. H0M0G3R 
assumes more than one locus and works by calculating the log likelihood of linkage 
to a locus under the assumption that a trait is linked in a proportion of families in a
120
group to one marker within a locus, and in other families in the group it is linked to a 
different marker in another area of the genome.
H0M0G3R analysis confirmed that each of the two larger families 120 and 141 were 
consistent for linkage to only one of the two loci (Table 3.5). Family 120 had a 92% 
probability of linkage to chromosome 17q and family 141 had a 95% probability of 
linkage to chromosome llq . Single affected families 130, 143 and 145 were shown 
to have approximately 50% probability of linkage to either locus (Table 3.5). Thus, it 
was most likely that family 120 or 141 linked to the disease locus at chromosome 17 
and 11, respectively, but that the smaller families might be linked to either locus with 
almost equal probability. This heterogeneity test confirmed that four out of five 
families were consistent for linkage to each locus.
Family ID
Chromosome
l l q 17q
120 0.0784 0.9216
130 0.4598 0.5402
141 0.9523 0.0477
143 0.4827 0.5173
145 0.5000 0.5000
Table 3.5: H O M O G 3R  analysis o f  the
probability o f  linkage for loci identified in 
Pakistani families.
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Figure 3.3: High density
haplotyping of Pakistani 
families a t the putative locus 
on chromosome l lq .  Genetic 
distance from the tip of the p 
arm of chromosome 11 in cM 
(centimorgans). Boxing
indicates homozygosity.
Arrow indicates flanking 
markers. Note, Individuals 130 
1:1, 145 1:1, 145 1:2, 141 11:6, 
141 11:7 and 143 11:4 were not 
included in the Illumina SNP 
screen so their SNP haplotypes 
are inferred from microsatellite 
genotype information.
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Figure 3.4: High
density haplotyping of 
Pakistani families at the 
putative locus on 
chromosome 17q.
Genetic distance from 
the tip of the p arm of 
chromosome 17 in cM 
(centimorgans). Boxing 
indicates homozygosity. 
Arrows indicate flanking 
markers. Note,
Individuals 130 1:1, 145 
1:1, 145 1:2 and 143 11:4 
were not included in the 
Illumina SNP screen so 
their SNP haplotypes are 
inferred from
microsatellite genotype 
information. Unaffected 
individuals from family 
141 are not shown.
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3.1.7 Identification of positional candidate genes at the 
Pakistani family loci on chromosome 11 and 17
During evolution, the genetic information of biological processes and organelles that 
are no longer required tends not to be preserved (Merchant et al., 2007). Essential 
pathways and components are conserved and this is reflected by conservation of gene 
and protein structure that can be analysed by aligning sequences from different 
species. On the basis that cilia are evolutionarily well conserved, a comparative 
bioinformatics approach was used to identify positional candidate genes with a 
potential role in the structure or function of cilia, in the two genetic regions of interest 
identified on chromosomes 11 and 17. Ciliate and non-ciliate genome and proteome 
datasets were used as well as the Foxjl mouse microarray. Foxjl is an f-box 
transcription factor expressed in ciliated cells and was shown to be required for late 
stage cilia formation by a gene deletion in the FoxjF^' mouse model (Gomperts et al.,
2004). Microarray analysis demonstrated that genes expected to be involved in 
ciliogenesis are down-regulated in this mutant (Gomperts et al., 2004).
Known and predicted genes in the regions of interest were subjected to a BLAST 
search using a cut-off E value for significance of homology of <10'^. A PCD 
candidate gene was expected to be conserved in ciliates but not in non-ciliates. 
Absence of homology within ciliate genomes may reflect the incompleteness of the 
data rather than absence of homology in that organism, since the sequence freeze 
completeness varied between organisms.
Searches were performed against whole genome sequences from nine ciliated and 
three non-ciliated organisms, using a local Unix-based grid designed by Dr. Richard 
Emes (Centre for Applied Entomology and Parasitology, Keele University) and Dr. 
Rahul Chodhari (UCL). Human mRNA sequences were translated in six frames and 
screened against the translated genome (six frames) or proteomes of the model 
organisms, using the TBLASTX programme (as described in Chapter 2 Section 
2.4.10).
Candidate genes were prioritised for mutational analysis in the Pakistani families 
according to the results obtained from the BLAST search, in addition to information
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A bioinformatics approach to create a priority list o f  genes, as descri 
3.1,7, was performed on the chromosome l l q  region o f  int( 
microsatellite markers D 11S4I32  and rs2001625. the region whei 
displays excess homozygosity. See Appendix 1 for full bioinformatic : 
the 74 genes in this region, 54 had a known function, 5 had a predicte 
15 were hypothetical genes with no predicted function. For fifty-two g 
possible to more definitively exclude them as candidates, as they had a 
published non-ciliary function. After looking at the proposed ft 
remaining 22 genes, tissue expression, BLASTp homology and publi: 
two hypothetical genes were identified as good candidate PCD gent 
(Table 3.6).
3.1.7 .1.1 SPA17 (Sperm Auto-antigenic protein 17)
S P A H  is located between markers rs2276189  and rs6590098  where th 
was 2.8-3.2 (Figure 3.5A) and was considered a good positional c 
because o f  its homology within the defined E value o f  <10"^ to gene 
intestinalis genome and the Teîrahymena thermophilia  genome. Ir 
murine homologue is down-regulated in the cilia-less Foxjl  knock-oul 
3.6).
The primary function o f  SPA17 is not clear but several published stu 
role in cilia function. It was initially associated with binding to th 
pellucida during fertilisation (Kong et al., 1995), however it has 
become clear that SPA 17 is likely to have a broader role as it has h 
immunohistochemistry to be abundantly expressed in the cytoplasn 
epithelial cells o f  the larynx, trachea, lung and fallopian tubes, as wel
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section of the sperm flagellum (Grizzi et al, 2004). Expression in mouse 
spermatozoa and testis has been shown by western blot, immunoprécipitation and 
immunoiocalisation (Grizzi et al., 2004; Frayne and Hall, 2002). RT-PCR also 
demonstrated SPA 17 expression in a wide range of human tissues although at a lower 
level than in testis (Frayne and Hall, 2002). SPA 17 was shown to co-localise with 
acetylated tubulin in the cilia layer of the olfactory epithelium (McClintock et al., 
2008). Although it has not yet been localised to the axoneme, a role in cilia and 
flagella could be postulated for SPA 17 due to its expression pattern and localisation 
to cilia and flagella. The N-terminus of SPA17 was shown by sequence analysis to 
contain a 74 bp PKA regulatory subunit II (RII) domain, which contains the 
dimérisation domain that is responsible for the interaction between two individual RII 
subunits, required for binding A-kinase anchoring proteins (AKAPs) (Frayne and 
Hall, 2002). AKAPs function as scaffolding molecules that co-ordinate the actions of 
several signalling proteins and the RII domain of AKAP3 has been shown to bind to 
SPA 17 along the length of the sperm flagella (Lea et al., 2004), thus SPA 17 could be 
suggested to have a scaffolding/signalling role within cilia and flagella, i.e. in the 
regulation of dynein arm activity and the control of ciliary beat frequency.
The NCBI BLASTp search revealed homology of SPA17 to Chlamydomonas 
axonemal radial spoke proteins RSPll and RSP7, however this was mostly due to 
non-specific homology based on the RII domain of the regulatory PKA subunit 
portion. Although the exact role of SPA17 in cilia function is unclear, evidence 
supporting its prioritisation as a good positional candidate relates to its specific 
localisation in cilia and flagella and putative scaffolding/signalling role.
3.1.7.1.2 LRRC35 (Leucine Rich Repeat-containing protein 35)
LRRC35 is located between markers D1IS4I07 and rs481703 where the HLOD score 
was 1.9 (Figure 3.5A), just on the telomeric edge of the critical region but it was 
considered a good positional candidate due to homology to other potential axonemal 
genes, which is discussed later in this section. Bioinformatic screening initially 
revealed that homology was present to genes in all the datasets, nine ciliated and three 
non-ciliated, except for the Trypanosoma flagella proteome and the library of genes 
down-regulated in the Foxjl knockout mouse (Table 3.6). Expression in non-ciliates
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was not expected for PCD genes, however, it is possible that the homology observed 
in the bioinformatic screen was due to a large proportion of the protein containing a 
leucine rich repeat (LRR), which forms part of a large protein family. In fact, 
published literature specified that LRRC35 is not expressed in Arabidopsis or S. 
cerevisiae and S. pombe (Bartolini et al., 2005) and this identified that that BLAST 
homology was indeed non-specific. LRRC35 is expressed at a particularly high level 
in testis, but is also present in brain, kidney, liver and lung at a lower level (Bartolini 
etal., 2005) (Table 3.7).
An NCBI BLASTp revealed that LLRC35 had significant homology to tubulin 
folding cofactor E (TBCE). LRRC35 has also been termed ‘TBCE-like’ (Bartolini et 
al., 2005). It is thought to function as a regulator of tubulin stability (Bartolini et al.,
2005).
Two LRR genes containing six leucine rich repeats (LRR) were identified as 
positional candidate genes in this chapter: LRRC35 within the chromosome 11 locus 
and LRRC46 within the chromosome 17 locus (Section 3.1.7.2.2). The LRR domain 
creates a curved surface on the protein formed with parallel p-sheets linked by a- 
helices and functions in subunit-subunit interactions (Freshour et al., 2007). Both 
candidate genes LRRC35 and LRRC46 are similar to human LRRC50 due to high 
homology within the LRR region and also conservation of residues at the C-terminus 
(Figure 3.6). LRRC50 is of interest as it is the human orthologue of Chlamydomonas 
ODA7. Outer-Inner-Dynein (OID) linkers are novel axoneme structures that have 
recently been revealed by cryoelectron tomography that allows higher resolution than 
previously achievable (Nicastro et al., 2006). These are thought to coordinate inner 
and outer dynein arm activities (Freshour et al., 2007). In Chlamydomonas the 
ODA7 protein interacts with both the inner and outer dynein arms providing a 
structural OID link (Freshour et al., 2007). In addition, zebrafish mutant hu255Hv^os 
found to have a mutation within the LRRC50 orthologue, IrrcSO, and mutants have 
ciliary defects affecting dynein arms and misalignment of peripheral microtubules. 
This results in phenotypes consistent with cilia defects in zebrafish including the 
development of pronephric cysts and abnormal left-right axis determination (van et 
al., 2008). Human LRRC35 is 26 % and LRRC46 is 30 % identical to 
Chlamydomonas 0DA7 (Figure 3.6).
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Candidate genes LRRC35 and LRRC46 also showed homology to an outer dynein arm 
(ODA) component, axonemal dynein light chain 1 (LCl) (Figure 3.7). Human 
LRRC50 diverged from axonemal dynein LCl (Freshour et ah, 2007) and the 
LRRC35 and LRRC46 proteins are mainly similar at the LRR repeats, less so at the 
N- and C-terminus. The identity between human LCl and LRRC35 is 21 % and 
LRRC46 is 29 %. Thus, it is important to note that LCl and LRRC50 are different 
proteins but are similar with respect to the LRR domains.
Homology to axonemal LCl and LRRC50/ODA7 made LRRC35 and LRRC46 
excellent candidates for PCD. However, it is useful to carefully examine the 
homology alignments to understand if these two proteins could have an orthologous 
role in the human axoneme or whether there is more spurious homology based simply 
on the LRR domain. Homology of both LRRC35 and LRRC46 was greater to 
LRRC50 than LCl, with LRRC46 having higher homology than LRRC35 to LRRC50. 
In conclusion, the majority of the homology derived from the LRR domain but some 
conservation of residues outside of this domain as well.
3.1.7.2 Candidate genes at the chromosome 17 locus consistent
with linkage in Pakistani families 120,130,143 and 145
The same bioinformatic approach was applied to the chromosome 17q region of 
interest where family 120 displayed homozygosity, between microsatellite markers 
D17S951 and Chl7-near D17S1865 (Figure 3.5B). See Appendix 1 for full 
bioinformatic screen. Out of the 139 genes in this region, 116 had a known or 
predicted function and 23 an unknown function. Out of those with a known or 
predicted function, 115 were excluded as positional candidates because of their 
predicted non-ciliary function. One gene, annotated with a predicted function, 
FLJ35808, was considered a candidate gene of interest due to its predicted tubulin 
tyrosine ligase homology and tissue expression. Of the 23 genes within the region 
with unknown function, one was considered a good candidate: LRRC46, because of 
its tissue expression and significant homology to genes with a role in the structure 
and/or function of flagella (Table 3.6 and 3.7).
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3.1.7.2.1 FLJ35808 (Hypothetical protein)
F U S5808 is located on chromosome 17 between markers D17S950 and D17S931 
where the HLOD score for this group of families was 3.6-3.5 (Figure 3.5B). It was 
considered to be one of the good positional candidates because cross-species 
conservation for the encoded protein was not observed in the three non-ciliate species 
screened but conservation was present in the Chlamydomonas reinhardtii genome, 
the Trypanosoma brucei and Leishmania major combined genomes, the Ciona 
intestinalis genome, the Tetrahymena thermophilia genome, the C. elegans proteome 
(Table 3.6). The murine homologue was also down-regulated in the FoxJI mouse. 
Expression profiling with reference to NCBI expressed sequence tag (EST) counts 
shows specific expression in human brain, lung, trachea and testis (Unigene -  
http://www.ncbi.nlm.nih.gov/sites/entrez?db=unigene) (Table 3.7).
The gene was annotated in NCBI as having tubulin tyrosine ligase activity, catalysing 
the ATP-dependent post-translational addition of tyrosine to the C-terminal end of a- 
tubulin (Janke et al., 2005). This is based on derived homology rather than published 
experimental evidence. The in vivo consequences of this tyrosination activity is not 
yet established, although it has been shown that the tyrosination of the C-terminus of 
p-tubulin is required for ciliary beating (Vent et al., 2005). It is thought that a 
reversible tyrosination activity of a-tubulin could affect microtubule organisation and 
distribution of microtubule associated proteins (MAPs) (Vent et al., 2005). Thus, 
mutations in this candidate gene could cause a disruption of ciliary microtubules and 
give rise to PCD.
3.1.7.2.2 LRRC46 (Leucine Rich R epeat containing protein 46)
LRRC46 is located on chromosome 17 between markers D17S950 and D17S93I 
where the HLOD score for this group of families was 3.6-3.5 (Figure 3.5B). It was 
considered a good positional candidate at chromosome 17q because it had homology 
within the cut-off E-value <10’^  to a gene or protein in all nine ciliate databases 
screened (Table 3.6). However, conservation was also observed in two non-ciliate 
datasets, S. cerevisiae and S. pombe. LRRC46 is expressed in lung, trachea and testis 
according to the UniGene expression profile analysis of EST counts (Table 3.7).
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As discussed in section 3.1.7.1.2. LRRC46 had homology to LRR protein LRRC50, 
the human orthologue of Chlamydomonas ODA7, an axonemal OID linker protein 
and Chlamydomonas axonemal dynein LCl (Figure 3.7). Human LRRC46 is 30 % 
identical to Chlamydomonas 0DA7 (Figure 3.6). Thus, of the two positional 
candidate genes within the locus refined on chromosome 17q, LRRC46 was 
considered the most promising candidate for carrying a potential disease-causing 
mutation as it is possible that mutations in the LRRC46 gene could cause disruption 
of the I/ODA complex, consistent with the Pakistani family ultrastructural phenotype 
of missing inner and outer dynein arms, and thereby cause PCD.
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Gene Chromosome ARAB CERV POMB CHLY PAZO DEFLA TRYP CION TETR M cKE ELEG FO X JI
Sperm autoantigenic protein 17 {SPA 17) l lq 0 0 0 0 0 0 0 1 1 0 0 1
Leucine rich repeat containing 35 {LRRC35) l lq 1 1 1 1 1 1 1 1 1 0  1 1
Hypothetical protein FLJ35808 (FLJ35808) 17q 0 0 0 1 0  0 1 1 1 0  1 1
Leucine rich repeat containing 46 {LRRC46 ) 17q 0 1 1 1 1 1 1 1 1 1 1 1
Table 3.6: Com parative BLAST analysis o f  candidate genes within chrom osom e 11 and 17 loci consistent with linkage in the Pakistani family group.
Key to genome/proteome data:
ARAB - Arabidopsis thaliana
CERV - Saccharomyces cerevisae
POMB - Saccharomyces pombe
CHLY - Chlamydomonas reinhardtii genome
PAZO - Chlamydomonas Flagellar proteome
DEFLA - Chlamydomonas reinhardtii deflagellation dataset
TRYP - Trypanosoma brucei and Leishmania major combined genomes
CIOM - Ciona intestinalis genome
TETR - Tetrahymena thermophilia genome
McKE - Trypanosoma flagellar proteome
ELEG - Caenorhabditis elegans proteome
FOXJ1 -  Genes down regulated in Foxjl cilia-less mouse
0 -  no hit in the BLAST search 1 = hit in the BLAST search (Cut-off E value <10-5 -  see Methods Section 2.4.10)
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Gene Chromosome Function
Domains identified in Human NCBI 
BLASTp search Homology Tissue expression
S p en n  au toantigenic  pro tein  17 (SPA 1 7 ) l l q
P ossib le  m ultifunctional role in zona  p ellucida 
b ind ing  and a scaffo ld ing/signalling  ro le  w ithin 
cilia and  flagella (P) PK A regulatory  subunit II dom ain  (R II) (P)
W idespread , including  brain, eye, kidney , liver, 
lung, testis, trachea  (N C B I E ST  counts)
Leucine rich repeat con ta in ing  35 (U U iC 3 5  ) l l q R egulator o f  tubulin  stab ility  (A )
L eucine-rich  repeat (LR R ), hom ology to 
axonem al ligh t chain  1 (L C l)  (A )
H um an axonem al dynein ligh t chain  1 (L C l)  
(B), T ubulin  
folding co factor E (T B C E ) (P )
W idespread  includ ing  brain, eye, kidney, liver, 
lung, trachea. H ighly  expressed  in testis  (P) 
(B arto lin i)
H ypothetical pro tein  F U 3 5 8 0 8  (F U 3 5 S 0 S  ) I7q T ubulin  tyrosine ligase activ ity  (A ) T ubulin-tyrosine ligase fam ily dom ain  (A) Tubulin  T yrosine Ligase (A )
Brain, lung, testis, trachea, in testine , stom ach 
(N C B I E ST  counts)
Leucine rich  repeat con tain ing  46 (IAU IC46  ) I7q U nknow n Leucine-rich repeat (L R R ) (A )
O uter dynein arm  7 (O D A 7/L R R C 50) (B), 
H um an axonem al dynein light chain  1 (L C l)  
(B)
Brain, eye, lung, testis, trachea (N C B I E ST  
counts)
Table 3.7: Function, domain structure and tissue expression o f four positional candidate genes for the Pakistani fam ily group. (?) -  published experimental evidence (see 
text for details), (A) -  annotation in genomic databases, (B) -  in-house BLAST search.
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Ï.RRC3S SPA 17
rs6590098
rs6 17847
I1S4132
125 130 135 140
Genetic distance (cM)
B
FU35808 & LRRC46
DI7S951 ChI7-nr-D17S1865
70 75
Genetic distance (cM)
80
Figure 3.5: HLOD plots for chromosome l l q  and 17q loci with position of
candidate genes shown. A: Chromosome 11 candidate genes and 7 7. B:
Chromosome 17 candidate genes FLJ35808 and LRRC46.
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Figure 3.6: Homology of candidate genes LRRC35 and LRRC46 to human LRRC50 and its 
Chlamydomonas orthologue ODA7. Six leucine rich repeats (LRR) highlighted with blue boxes. Not 
all six have the perfect LRR consensus sequence LXXLXXLXLXXNXIXXIXXLXX. Homology is 
also present outside the six LRR domains of LRRC50. Critical alignment score of ODA7 vs. LRRC35 
(424 amino acids) is 26 % (not significant), 0DA7 vs. LRRC46 (321 amino acids) is 30 % identical.
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Figure 3.7: Homology of candidate genes LRRC35 and LRRC46 to human L C l. Six leucine rich 
repeats (LRR) highlighted with blue boxes. Not all six have the perfect LRR consensus sequence 
LXXLXXLXLXXNXIXXIXXLXX. Homology is also present outside the six LRR domains of 
LRRC50. LRRC46 (321 amino acids) vs. LCl (190 amino acids) is 29 % identical. LRRC35 (424 
amino acids) vs. LCl (190 amino acids) is 21 % identical.
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3.1.8 Mutational analysis of positional candidate genes
The four candidate genes identified and considered good positional candidates within 
the loci on chromosome 11 and 17 consistent with linkage amongst the Pakistani 
families were SPA17, LRRC35, FU35808 and LRRC46 (Table 3.7). The candidate 
genes were screened for mutations in affected individuals 11:3,11:4 or 11:5 of families 
120, 130, 141, 143 and 145, using genomic DNA samples and primers designed to 
amplify the entire open reading frame. Primers were designed to span intron-exon 
boundaries by 20 bp, or extend 40 bp beyond the start and stop codons into the 5’ and 
3’ un-translated regions (UTRs). Primer sequences are in Appendix 1. A number of 
known single nucleotide polymorphisms (SNPs) are located in the candidate genes 
(Table 3.8).
3.1.8.1 Sequencing of Chromosome l lq  Candidate Genes
3.1.8.1.1 Mutational Analysis o f SPAl 7
Sequence analysis of the candidate gene SPAl 7 in patient and control genomic DNA 
revealed no pathogenic mutations, although a coding region SNP rs26001463 (A/G) 
in exon 4 was polymorphic in the families and proved consistent with the 
homozygous region haplotype, all affected individuals being homozygous A/A (Table 
8). Amplification of SPA 17 by RT-PCR on first-strand cDNA made from peripheral 
blood demonstrated that expression and splicing of this candidate gene was normal in 
affected individuals of families 120, 130, 143 and 145. However, no cDNA was 
available for the main linked family 141.
3 .1.8 .1.2 Mutational Analysis o f LRRC35
Sequence analysis of candidate gene LRRC35 in patient and control genomic DNA 
extracted from blood of affected individuals revealed no pathogenic mutations or 
polymorphic SNPs within the coding regions.
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3.1.8.2 Sequencing of chromosome 17 candidate genes
3.1.8.2.1 Mutational Analysis of FLJ35808
Sequence analysis of candidate gene FU35808 revealed no pathogenic mutations in 
DNA from affected individuals from all five families, although homozygous coding 
SNPs rs2032844 and rs8080242 (C/A and A/C) in exon 7 were polymorphic in the 
Pakistani families and proved consistent with the homozygous haplotype, all affected 
individuals being homozygous C/C or A/A, respectively (Table 3.8). Attempts to 
amplify FLJ35808 by nested RT-PCR on first-strand cDNA made from peripheral 
blood revealed this gene was not expressed in high enough levels in blood to be able 
to amplify a product, even by nested PCR, and as a result this gene was not screened 
for mutations at the transcript level.
3.1.8.2.2 Mutational Analysis o f LRRC46
Sequence analysis of candidate gene LRRC46 in patient and control genomic DNA 
revealed no pathogenic mutations or polymorphic SNPs within the coding regions.
Gene Chromosome
Number of 
coding exons Coding SNPs
Sperm autoantigenic protein 17 {SPA17) l lq 4
Exon 4 A/G non-synonymous 
rs26001463
Leucine rich repeat containing 35 (LRRC35) l lq 7 No coding SNPs
Hypothetical protein FLJ35808 (FLJ35808) I7q 8
Exon 7 C/A non synonymous 
rs2032844, A/C synonymous 
rs8080242
Leucine rich repeat containing 46 (LRRC46) 17q 8 No coding SNPs
T able 3.8: Coding SNP inform ation for the Pakistani positional candidate genes
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3.2 Discussion
The aim of this study was to map a new PCD gene using homozygosity mapping and 
linkage analysis. Five PCD families 120, 130, 141, 143 and 145 (Figure 3.1) were 
grouped together in this chapter to increase the chance of genetic homogeneity 
because they all originated from the same geographical origin: Mirpur, the North 
West Frontier or the Rawalpindi region of Pakistan, before following a typical 
migration route to Bradford, UK. In addition, all nine affected individuals shared a 
common ultrastructural phenotype revealed by electron microscopy (EM) of missing 
inner and outer dynein arms and high speed video imaging revealed that they had a 
common motility defect of immotile or slightly flickering cilia.
All five families were included together in the MERLIN multipoint parametric 
linkage analysis on SNP genotype data generated using the Illumina SNP-based 
Linkage IVb Panel. Two loci were identified with significant HLOD scores >3 on 
chromosome 11 and chromosome 17 which were refined by genotyping of extra 
microsatellite markers, and haplotypes were analysed for homozygosity.
From the Illumina data, a maximum HLOD score of 3.7 was achieved at the region 
on chromosome 11 (proportion of linked families, a = 0.8) across 22.1 cM (11.6 Mb) 
and initial observation of the SNP data revealed homozygosity in affected individuals 
between SNP markers rs644252 and rs200I625. Additional microsatellite markers 
were genotyped across the region and MERLIN linkage analysis was repeated on 
each individual family using the more detailed genetic marker data incorporating 
microsatellites. From these results, the region with an HLOD score >3 was refined to
3.3 Mb between markers rs617847 and rs6590098, with a maximum HLOD score of 
3.7 (a = 0.8) at SNP marker rs930983. The larger family 141 with three affected 
offspring achieved the maximum possible simulated LOD score of 2.4 at this region 
of interest and the families with one affected individual 130, 143 and 145 each 
contributed maximum LOD scores at different markers of 0.2, 0.8 and 1.0, 
respectively. Haplotype analysis of the locus on chromosome 11 revealed a 21.3 cM 
(10.65 Mb) critical region on chromosome 1 Iq23.3-q24.3 amongst affected 
individuals in family 141, defined by loss of homozygosity at microsatellite marker 
D llS4132 amongst affected individuals in family 141 and a recombination event at 
SNP marker rs2001625 in affected individual 11:3 from family 141. Families 130,
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143 and 145 were shown to have intermittent marker homozygosity overlapping with 
this large block in family 141, which was consistent with linkage in sub-regions. The 
family 120 haplotype displayed no significant homozygosity of markers or 
consistency of linkage to this region.
From the initial Illumina data, a maximum HLOD score was achieved at the region 
on chromosome 17 (proportion of linked families, a = 0.8) spanned 14 cM (16.4 Mb) 
between SNP markers rsl859212 and rs2045418 and initial observation of the SNP 
data revealed homozygosity in affected individuals between SNP markers rsl859212 
and rs2045418. Additional microsatellite markers were genotyped across the region 
and MERLIN linkage analysis was repeated on each individual family using the more 
detailed genetic marker data incorporating microsatellites. From these results, the 
region was refined to 8.8 Mb with an HLOD score >3 between markers D17S951 and 
Chl7-nr-D17S1865. A maximum HLOD score of 6.0 (a = 1.0) was obtained on 
chromosome 17 at in-house microsatellite marker D17S809. The large family 120 
with three affected offspring contributed the maximum possible simulated LOD score 
of 2.4 for this family across this region of interest and the families 130, 143 and 145 
with only one affected child contributed 1.3 each at different markers. Haplotype 
analysis of the locus on chromosome 17 was consistent with the linkage analysis and 
revealed a 7.8 cM (8.8 Mb) critical region on chromosome 17q21.31-q22 defined by 
recombination events in affected individual 11:3 from family 120 at microsatellite 
markers D17S951 and Chi 7-nr-D17S1865. Families 130 and 143 displayed 
overlapping homozygosity across this region and family 145 had near-complete 
homozygosity here. The family 141 haplotype displayed no significant homozygosity 
of markers or consistency of linkage to this region.
Observation of the HLOD plot for the locus on chromosome 17 revealed some 
inconsistency in the linkage:
1. The HLOD score increased at marker D17S-SPAG9 from 4.0 to 6.0 (Table 
3.4, red numbers and Figure 3.5A) because the LOD scores for families 141 
and 145 became more positive here, whereas the LOD scores for the other 
families 120, 130 and 145 were more uniformly consistent across the region.
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Therefore, this inconsistency was mainly due to change in the LOD scores for 
families 141 and 145.
2. Across the three markers D17S809, rs792786 and rs1508966 the proportion of 
linked families, a, becomes 1.0, (Table 3.4, column 6) indicating that across 
this small 0.87 cM (2 Mb) region the multipoint linkage analysis assumed that 
all five families were consistent for linkage. This was because SNP marker 
rs1508966 was observed by haplotype analysis to be fully informative and 
homozygous by descent (HBD) in affected individuals of family 141, which 
increased the multipoint LOD score at this region. However, this result is 
inconsistent since family 141 was excluded for linkage to the locus on 
chromosome 17 due to a recombination event in individual 141 11:3 at marker 
D17S1869 and heterozygosity at all other markers across this region. In 
addition at this region, the lack of parental information for SNP markers 
rs792786 and rs1508966 in family 145 resulted in a more positive LOD score.
3. The HLOD score decreased to 3.5 across markers D17S1869 and D17S- 
SPAG9 (Table 3.4, red numbers) due to heterozygosity in affected individual 
145 11:3, which resulted in a negative LOD score at these two markers for this 
family. Since this study was completed, these genotyping results were 
revisited and a thorough check of the raw data made. For microsatellite 
markers D17S1869 and D17S-SPAG9 the results were discovered to be 
unclear and these two markers had only been analysed once. Thus it is 
possible that they are not truly heterozygous.
To minimise locus heterogeneity, the five Pakistani families had been grouped 
together based on geographical origin and cilia ultrastructure. However, two loci 
were identified on chromosome 11 and 17 which were indistinguishable and the 
following conclusions can be drawn:
1. Although the maximum HLOD score at the locus on chromosome 17 was 
higher than on chromosome 11, haplotype analysis revealed that this was 
likely to be misleading due to marker uninformativity and recombination 
events in family 141.
2. Based on linkage and haplotype analysis it was clear that the positive HLOD 
scores on chromosome 11 and 17 were derived mainly from family 141 or
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120, respectively, where a maximum LOD score of 2.4 were achieved in both 
cases.
3. The true linkage status of the three smaller families 130, 143 and 145 was 
uncertain due to insufficient linkage power and there was no obvious 
difference in homozygosity between the two regions.
4. H0M0G3R analysis was consistent with the haplotype analysis in that family 
120 was linked to the region on chromosome 17 and family 141 was most 
likely to be linked to chromosome 17, whereas the smaller families 130, 143 
and 145 were judged equally likely to be linked to either region.
Therefore, despite a common geographical origin and a common ultrastructural 
phenotype, genetic homogeneity is not guaranteed and heterogeneity still remains an 
obstacle in the mapping of PCD genes. In order to distinguish the two loci identified 
in this study further, more families would be required for genetic linkage analysis to 
these regions or to identify linkage disequilibrium (LD) to these regions, more marker 
typing could be performed. The lack of allele sharing amongst the linked families 
could indicate that only the two large families 120 and 141 are genuinely linked to the 
loci at chromosome 17 and 11, respectively, but that the homozygosity observed for 
the smaller families 130, 143 and 145 at these regions is spurious. It could also be 
possible that the families map to the same gene but harbour different mutations. 
Furthermore, it is possible that the LD region was smaller than the SNP density used 
of 600 kb and it was therefore missed in this genome screen. However, the LOD 
score of 2.4 on chromosome 17 and 11 for families 120 and 141 individually was the 
maximum achieved in the genome screen, with no other region achieving a LOD 
score >0.3, except for 2.0 for family 120 on chromosome 9 (Appendix 1). In the 
event of not finding any mutations in positional candidate genes on chromosome 11 
or 17, chromosome 9 should be further investigated for family 120.
A comparative bioinformatic approach was used to identify positional candidates 
within the regions of interest based on the hypothesis that ciliary genes have been lost 
throughout evolution in non-ciliated organisms. Identifying those genes conserved in 
ciliated organisms and according to any putative functions related to cilia structure 
and/or function and their tissue expression allowed prioritization of 4 out of the >200 
positional candidate genes within the two regions on chromosome 11 and 17:
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FU S5808, LRRC35, SPAl 7 and LRRC46. DNA sequencing of the coding regions of 
these candidate genes in the linked families did not reveal any mutations, although 
coding SNP analysis demonstrated consistency of marker homozygosity with the 
haplotypes across these regions. In addition, mutations within the regulatory regions 
were not screened for and so cDNA would need to be sequenced for each gene in 
order to detect this and any alternative transcripts. It should be noted, however, that 
the eleven databases of ciliated and non-ciliated organisms were not all complete so 
the apparent absence of genes or proteins does not necessarily mean they are truly not 
present in that organism.
Of the two leucine rich repeat (LRR) candidate genes identified and sequenced in this 
chapter {LRRC35 and LRRC46), LRRC46 was considered the more promising 
candidate for carrying a potential disease-causing mutation due to greater homology 
with LRRC50 and better linkage verification. LRRC50 is the human orthologue of 
Chlamydomonas ODA7, an axonemal OID linker protein, which is defective in the 
Chlamydomonas oda7 slow swimming mutant with ultrastructural abnormalities 
similar to those observed in the presented PCD families. The zebrafish IrrcSO 
mutant, hu255H, has ciliary defects affecting the dynein arms, also similar to the 
phenotype observed in the Pakistani families. It is therefore possible that mutations 
in the LRRC46 gene could cause disruption of the I/ODA complex, consistent with 
the Pakistani family ultrastructural phenotype of missing inner and outer dynein arms, 
and thereby cause PCD. Although no mutations were identified in either gene 
LRRC35 or LRRC46 at the genomic level, it is still possible the defects in 
transcription or splicing are present and were missed by sequencing only 20 bp into 
the introns or 40 bp into the 5’ and 3’ UTRs. However, cDNA was not available in 
family 141 in order to confirm this.
In summary, two indistinguishable genetic loci were identified by a linkage analysis 
and homozygosity mapping strategy for PCD with absence of inner and outer dynein 
arms in five consanguineous families originating from Pakistan. Four good positional 
candidate genes with putative roles in the structure and/or function of cilia were 
screened for open reading frame mutations in linked families within the two critical 
regions and no mutations were detected. Genetic heterogeneity and lack of family 
material would make it difficult to determine which is the true locus responsible for
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the disease in the three families with one affected child. However, the two family 
pedigrees with three affected offspring are well supported for linkage at these two 
loci.
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4 CHAPTER FOUR
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4.1 LINKAGE ANALYSIS AND MUTATION SCREENING IN 
TWO ARABIC PCD FAMILIES
This chapter describes a high density SNP-based genome wide linkage screen, 
multipoint linkage analysis and homozygosity mapping used to identify the causative 
gene in an inbred Bedouin PCD family, 152. The consanguineous marriage of family 
152 produced four affected (one child died so no DNA sample was obtained) and one 
unaffected offspring, the latter has one affected child and seven unaffected in another 
consanguineous marriage, where the husband is the grandson from her grandfathers 
second wife (Section 2.3.3). The family had classic symptoms of PCD and were 
excluded for other phenotypes including immunodeficiency and cystic fibrosis (CF) 
and had abnormal cilia motility. No gross EM defect had been found however, and 
none of the five affected individuals had situs inversus. This chapter describes the 
identification of a new PCD locus in this family that was found to overlap with a 
locus consistent for linkage in another Arabic PCD family, 146. Family 146 are a 
first cousin consanguineous marriage with three affected and four unaffected 
offspring (Section 2.3.2), from the United Arab Emirates (UAE), with no incidence of 
situs inversus and an ultrastructural defect of intermittent central pair agenesis 
(Stannard et al., 2004). Analysis of positional candidate genes at the common locus 
identified on chromosome 6 revealed a shared mutation between both families in an 
axonemal structural component, C6ORF206 carried in homozygous state by all 
affected children.
4.1.1 Power simulation for family 152
For the purposes of power calculations and linkage analysis the complicated structure 
of family 152 was simplified as shown in Figure 4.1. A high density genome scan 
was performed in family 152 to determine the disease locus. Prior to this, the power 
of family 152 to statistically prove linkage was evaluated using linkage simulation 
programme SLINK (Lemire, 2006), in the same manner and using the same 
parameters as that described in Chapter 3 Section 3.1.1. The maximum LOD score 
that could be obtained under a model of homogeneity for this pedigree was 
calculated. To this end, minimum and maximum achievable LOD scores for family 
pedigree 152 were analysed. The maximum LOD score that could be achieved
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directly at the disease locus (0 = 0) was 3.8 for family 152 (Table 4.1). This analysis 
indicated that family 152 would provide sufficient linkage power alone.
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Figure 4.1: Pedigree struc tu re  w ith reduced num ber of loops fo r family 152 used in SLIN K  and 
M ER LIN  linkage analysis program m es. Double line indicates consanguinity (first cousin 
marriages), circles indicate female, squares indicate male. Black shading represents affected 
individuals, white shading represent non-affected.
8
Family 152
Min Max
0 -13.52 3.78
0.05 -1.7 3.43
0 .1 - 1 .0 2 3.07
T able 4.1: SLIN K  sim ulation o f minim um  and  m axim um  achievable LOD scores fo r family 152.
Numbers in bold highlight the maximum LOD score achievable at 0 = 0 for family 152.
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4.1.2 Genome-wide SNP-based linkage screen performed in 
family 152
A 600 kb density SNP screen {Illumina Linkage IVb panel) was performed on DNA 
samples from family 152, comprising both grandparents (generation I unaffected), all 
three affected and one unaffected offspring (152 11:6, figure 4.1), the husband of the 
unaffected offspring (152 11:7) and their affected child (152 111:6). Multipoint 
parametric linkage analysis was carried out on the Illumina SNP genotype data using 
the MERLIN programme (Abecasis et al., 2002), assuming autosomal recessive 
inheritance, a disease allele frequency of 0.007 and a disease penetrance of 0.9. Since 
the MERLIN programme software could not cope with the large complicated family 
152 pedigree structure (Section 2.3.3), a simpler model as seen in Figure 4.1 was used 
to simulate the consanguineous relationships resulting in affected children in this 
analysis. This revealed only one locus with a significant LOD score >3, on 
chromosome 6p21.2-21.1 between SNP markers rs1738240 and rs945131 (Table
4.2).
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Chromosome
Family 152 LODmax 
{Illumina SNPs only)
1 0.551
2 -3.115
3 -1.769
4 -3.881
5 -1.724
6 3.638
7 -4.850
8 -3.421
9 -3.033
10 -2.872
11 -0.268
12 -3.531
13 -3.285
14 -2.559
15 -0.189
16 -6.463
17 -0.756
18 -5.010
19 -2.750
2 0 -4.366
21 -3.264
2 2 -2.454
T able 4.2; M axim um  LO D  scores calculated for family 152 using M ER LIN  linkage 
analysis on each chrom osom e. A single region with a significant LOD score o f  >3 was 
revealed on chromosome 6 (bold). No other region exceeded 0.5.
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4.1.3 Refinement of chromosome 6 locus in Arabic family 152
In order to maximise genetic information and with the aim of refining the 
chromosome 6  region of interest, 23 microsatellites were genotyped across all 
individuals in family 152, including the seven non-affected siblings of individual 152 
111:8. In order to place the 10 in-house and 13 known microsatellite markers based on 
their physical positions, a composite genetic map was constructed based on the 
Illumina genetic map and the integrated Nievergelt genetic map, both of which are 
based on deCODE marker positions (Nievergelt et al., 2004).
4.1.4 Multipoint linkage analysis on Arabic families after 
additional genotyping
Multipoint linkage analysis was performed on the chromosome 6  region of interest 
consistent for linkage in family 152 using the more dense genotype data and 
MERLIN software, assuming the same parameters in section 3.1.2. Limitations of the 
MERLIN software meant that only eleven people could be used in the analysis, 
therefore three extra non-affected individuals (152 111:9, 111:10 and 111:11) were 
chosen in addition to all parents and affected offspring.
After the additional marker-typing a maximum LOD score of 4.2 was achieved for 
family 152 between microsatellite marker r$722269 and SNP marker rs3734695 
(Table 4.3 and Figure 4.2).
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Family 152 - Illumina 
screen SNPs only
Family 152 - Illumina 
screen SNPs plus 
extra microsatellite 
markers
M arker name
Genetic 
distance (cM) LOD score LOD Score
D6S291 55.51 -0.327
TEX27 56.00 -0.818
D6S389 57.25 -1.227
rs 173 8240 57.62 -6.150 -5.745
DNAH8 IN 35 57.72 -5.890
D6S1610 58.47 -4.289
rsl885615 58.53 3.369 0.440
D6S2427 58.62 0.753
D6S1562 60.04 1.075
rs715831 60.07 3.627 1.059
D6S1607 60.48 -4.391
D6S1616 60.61 -4.391
D6S426 60.69 -0.034
rs736794 61.31 3.638 -0.051
D6S1575 61.58 -4.390
rs629832 61.75 3.621 0.126
rsl001015 63.29 3.527 0.498
D6S1552 63.96 -4.507
D6S400 64.29 -4.825
rs722269 64.36 3.409 2.793
TBCC 64.86 3.826
KNSL8 65.16 4.130
rs 153763 8 65.87 3.089 4.244
D6S1582 65.87 4.244
UAE Pall 65.97 4.246
UAEPal4 66.00 4.246
UAUPal2 66.10 4.246
rsl563788 66.19 2.970 4.246
rs2277123 66.40 2.868 4.246
UAEPalS 66.50 4.247
UAEPal3 66.60 4.247
D6S1604 66.73 4.247
rs945131 66.79 2.575 4.247
UAEPal6 66.83 4.247
D6S451 66.90 4.247
rs3734693 67.19 -0.091 -Infinity
D6S2438 68.00 0.482
D6S459 70.14 -Infinity
D6S1638 72.10 -Infinity
Table 4.3: M ultipoint LOD scores across chromosome 6p locus in family 152. LOD scores shown 
for family 152 after Illumina SNP screen then further refinement with microsatellite marker-typing. 
Microsatellites are shown in bold. LOD scores >3 are highlighted in red. Genetic distance in 
centimorgans (cM) as determined by a composite genetic map constructed based on the Illumina 
genetic map and the integrated Nievergelt genetic map, both of which are based on deCODE marker 
positions. In-house markers were placed according to their physical positions.
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rs3736493
Genetic distance (cM)
Figure 4.2: M ultipoint LOD score across chrom osom e 6p in family 152. Maximum LOD o f 4.2 achieved between 
markers rs722269 and rs3734693 (2.8 cM).
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4.1.5 Haplotype analysis of locus identified on chromosome 
6p in family 152
To analyse regions of homozygosity, haplotypes were created for the region of 
interest on chromosome 6 p in family 152, using Haplopainter (Thiele and Numberg, 
2005).
The region consistent with linkage in family 152 had a 2.9 cM (1.8 Mb) region of 
homozygosity from D6S400 to rs3 734693. Haplotypes revealed that this region was 
defined by loss of homozygosity in affected individuals of family 152 at marker 
D6S400 and a recombination event in individual 152 11:3 at SNP marker rs3734693 
(Figure 4.2). Interestingly, genotyping of unaffected siblings of affected individual 
111:8 in family 152 showed that none of the seven unaffected individuals shared a 
haplotype with the affected offspring and that the non-affected parent 11:6 carried a 
putative disease chromosome which had been inherited by her affected child, 111:8 
(Figure 4.3). This data confirmed the chromosome 6  region as a potential disease 
locus in family 152. In addition, there was some intermittent homozygosity telomeric 
to this region but this was not considered significant because it did not achieve a 
significant LOD score in this family (Table 4.3 and Figure 4.3).
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4.1.6 Shared homozygous region of interest on chromosome 
6 in Arabic family 146
A lOcM density ABI panel MRC Geneservice microsatellite screen had previously 
been carried out by Dr. Kabul Cbodbari on DNA from both parents, three affected 
individuals and one unaffected individual from consanguineous family 146 from the 
United Arab Emirates (UAE) (Section 2.3.2), using markers spread evenly throughout 
the genome. Regions homozygous by state (HBS) and regions homozygous by 
descent (HBD) in the affected individuals had been identified. Two regions of HBD 
had been found on chromosome 3 between microsatellite markers D3S2338 and 
D3S1289 and on chromosome 6 between microsatellite markers D6S291 and D6S452. 
Both regions achieved a LOD score of 2.5, the maximum achievable for a 
consanguineous family with three affected offspring. Both regions of interest were of 
equivalent significance for linkage and undistinguishable in this single family. Due 
to the overlap with the region identified for family 152 on chromosome 6, this was 
the region that was investigate further in family 146.
4.1.7 High density haplotyping to refine regions of interest in 
family 146
In order to refine the region of interest in family 146 that had been initially mapped to 
chromosome 6 in collaboration with Dr. Chodhari, additional microsatellite marker 
genotyping was performed in the current study. The locus on chromosome 6 was 
refined from 10.6 Mb to 10.2 Mb using the extra marker information. Linkage 
analysis was performed on the refined region of interest in family 146 on 
chromosome 6 by Dr. Rahul Chodhari using GENEHUNTER software (Strauch et al., 
2000), assuming autosomal recessive inheritance and a penetrance of 0.9. A LOD 
score of 2.5 was again calculated for this locus (Table 4.4 and Figure 4.4A); the 
maximum obtainable LOD score for this family. Haplotyping revealed that the 
higher density region on chromosome 6 consistent with linkage to family 146 
remained completely homozygous after additional marker typing, between markers 
D6S291 and D6S1638 (10.2 Mb) (Figure 4.5).
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Family 146 - all 
microsatellite data 
availaHe
Marker name
Genetic 
distance (cM) LOD Score
D6S291 55.51 -1.710
TEX27 56.00 2.431
D6S389 57.25 2.472
rsl 738240 57.62 2.490
DNAH8 IN 35 57.72 2.494
D6S1610 58.47 2.502
rsl885615 58.53 2.502
D6S2427 58.62 2.502
D6S1S62 60.04 2.502
rs715831 60.07 2.502
D6S1607 60.48 2.502
D6S1616 60.61 2.502
D6S426 60.69 2.502
rs736794 61.31 2.502
D6S1575 61.58 2.502
rs629832 61.75 2.502
rsl001015 63.29 2.502
D6S1SS2 63.96 2.502
D6S400 64.29 2.502
rs722269 64.36 2.502
TBCC 64.86 2.502
KNSL8 65.16 2.502
rsl 537638 65.87 2.502
D6S1582 65.87 2.502
LAEPall 65.97 2.502
LAEPaM 66.00 2.502
UAUPaC 66.10 2.502
rsl 563788 66.19 2.502
rs2277123 66.40 2.502
UAEPaK 66.50 2.502
UAEPaD 66.60 2.502
D6S1604 66.73 2.502
rs94513l 66.79 2.502
UAEPaK 66.83 2.501
D6S451 66.90 2.501
rs3734693 67.19 2.493
D6S2438 68.00 2.471
D6S459 70.14 2.139
D6S1638 72.10 -1.325
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Figure 4.5: Haplotype for region of interest on chromosome 6 identified for 
family 146. Haplotype shows region of interest defined by loss o f homozygosity at 
microsatellite markers D6S291 and D6S1638. Markers from the p arm of 
chromosome 6 are shown in order from the telomere to centromere. Genetic 
distance in cM (centimorgans). Boxing indicates homozygosity. Flanking markers 
highlighted with bold arrows, flanking markers for family 152 indicated with 
smaller arrows. Illumina SNPs were not typed in this family but included in the 
haplotype for ease of comparison with family 152 haplotype (Figure 3).
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4.1.8 The locus Identified on chromosome 6p in family 146 
overlaps with that identified for family 152
The locus mapping to chromosome 6p overlapped in both families 146 and 152 as 
identified by homozygosity by descent (Figure 4.3 and 4.5). This overlap was 
considered especially significant because both families are of Arabic origin, family 
146 have an ultrastructural defect of central pair agenesis with intermittent absence of 
central pair as described in Chapter 2 section 2.3.2 and no situs inversus is present 
(Stannard et al., 2004), and family 152 has no incidence of situs inversus which is 
consistent with a central pair defect. Furthermore, the cilia motility defect of a 
disorganised circular beat pattern of normal beat frequency was consistent in both 
families. Respiratory epithelial cilia samples from affected individuals from both 
families 146 and 152 were observed to have a circular beat pattern that is ineffective 
for mucociliary clearance. It is tempting to speculate that family 152 in fact have the 
same ultrastructural defect as family 146, since only 11.0 - 17 % of cilia cross 
sections in family 146 were abnormal and this abnormality could easily be missed 
depending on which part of the axoneme was sectioned for EM in clinical 
ascertainment. The EM for family 152 was performed in the Israeli clinical setting 
and was recorded as normal cilia ultrastructure.
Across the region of interest consistent for linkage in family 152, the additional data 
from family 146 increased the LOD score from 4.2 to 6.7 across the region (Joint 
family LOD score data is not shown). It was noted that although the region of 
homozygosity spanning D6S400 to rs3 734693 on chromosome 6p was shared 
between both families, little sharing of alleles was evident between family 146 and 
family 152. Allele sharing is an indication of linkage disequilibrium and a common 
disease mutation. However, two markers UAEPal3 and UAEPalS did share the same 
alleles in both families, forming the shared haplotype “2-1” between flanking markers 
rs2277123 and D6S1604, a region of 212 kb.
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4.1.9 Prioritisation of positional candidate genes at the iocus 
identified on chromosome 6 consistent with linkage in 
families 146 and 152
Candidate genes were identified in the same way as for the Pakistani loci described in 
Chapter 3 Section 3.1.7. Briefly, a comparative bioinformatics approach was used to 
identify positional candidate genes in the genetic critical region consistent with 
linkage identified on chromosome 6, between microsatellite markers D6S400 and 
rs3734693. This is the region shared by both families.
4.1.9.1 Positional candidate genes at the chromosome 6 iocus
consistent for linkage in families 146 and 152
Comparative bioinformatic analysis identified the positional candidate genes. See 
Appendix 2 for full bioinformatic screen. The 1.8 Mb region between D6S400 and 
rs3734693 contained 40 genes in total, 33 with a known function and 7 encoding 
hypothetical proteins, some of which had a predicted function based on sequence 
homology. Out of the 33 known genes, 31 were excluded due to their function not 
being related to cilia or flagella structure or function. The remaining 2 were 
considered good positional candidates according to their proposed function, 
bioinformatics BLAST screen, tissue expression and published literature; TBCC and 
KNSL8. Out of the 7 hypothetical genes, 6 were initially excluded based on NCBI 
BLAST homology to non-cilia genes and one was considered a good positional 
candidate according to results from the comparative BLAST screen (Table 4.5), tissue 
expression and published literature (Table 4.6): C6ORF206.
4.1.9.1.1 TBCC (tubulin specific chaperone C)
TBCC (tubulin-specific chaperone C) is located between SNP marker rs722269 and 
novel microsatellite KNSL8 at the telomeric end of the D6S400 -  rs3736493 critical 
region (Figure 4.6). A novel microsatellite TBCC located within the gene had been 
used in genotyping and the LOD score at this marker was 3.8 (Table 4.3). TBCC was 
considered a good positional candidate as it had homologues conserved to a value 
within the defined E value of <10'^ in all the ciliate datasets in the BLASTp search.
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except no homologues were detected in the Chlamydomonas Flagellar proteome, the 
Chlamydomonas reinhardtii deflagellation dataset and Foxjl ciliogenesis microarray 
dataset (Table 4.5). It is involved in the process that leads to the correct folding of p- 
tubulin, since TBCC stimulates the release of tubulin dimers for incorporation into 
microtubule structures (Kortazar et al., 2007). TBCC has been shown to associate 
with ARL3, a member of the Arf family of regulatory GTPases that regulate 
microtubule-dependent processes, and it localises to the connecting cilium in retinal 
photoreceptor rod cells (Grayson et al., 2002). The photoreceptor connecting cilium 
structure shares many proteins in common with respiratory cilia (Roepman and 
Wolffum, 2007). The NCBI BLASTp search revealed that TBCC had homology to 
the X-linked retinitis pigmentosa gene, RP2 (Bartolini et al., 2002). Some forms of 
retinitis pigmentosa are likely to involve IFT defects in the connecting cilium found 
in rod cells of the retina (Badano et al., 2006). Furthermore, mutations in the RPGR 
gene are associated with PCD and retinitis pigmentosa (Moore et al., 2005). 
Expression profiling from analysis of EST counts showed widespread human tissue 
expression for TBCC, including expression in eye, kidney, testis and lung (Unigene) 
(Table 4.6). It was therefore considered that mutations in this gene could cause 
disruption of ciliary microtubule structures and therefore PCD.
4.1.9.1.2 KNSL8 (Kinesin-like protein 8)
Kinesin-like protein with microtubular activity, KNSL8, is located between novel 
microsatellite marker TBCC and SNP marker rs l537368 (Figure 4.6). The in-house 
microsatellite KNSL8 located within the gene was used in genotyping and the 
multipoint LOD score at KNSL8 was 4.1 (Table 4.3). The comparative BLAST 
screen revealed it was not conserved in any of the non-ciliate datasets but had 
homology within the defined cut off E value of <10'^ to genes in all the ciliate 
datasets with the exception of the Chlamydomonas deflagellation database. 
Trypanosoma flagellar proteome and the Foxjl ciliogenesis microarray dataset (Table
4.5). Expression profiling suggested by analysis of EST counts showed KNSL8 had 
widespread human tissue expression, including expression in eye, kidney, testis, lung 
and trachea (Unigene) (Table 4.6). Kinesins are known to function in IFT (Cole, 
2005) and therefore this gene could potentially play a role in cilia structure and 
function.
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4.1.9.1.3 C6ORF206 (chromosome 6 open reading frame 206 
hypothetical protein)
C6ORF206 is located between novel microsatellite markers UAEPal5 and UAEPal3 
where the multipoint LOD score achieved was 4.2 (Figure 4.6) and a putative shared 
haplotype had been identified in families 146 and 152. This gene had an excellent 
comparative BLAST profile, with no conservation observed in the three non-ciliate 
datasets but full conservation in the motile ciliate databases. It was not conserved in 
C. elegans, which only have non-motile cilia (Table 4.5). This suggested that 
C6ORF206 could play a specific role in motile cilia. Expression profiling by EST 
counts revealed that this gene was widely expressed in human tissues, including 
brain, eye, lung and testis. C6ORF206 was initially recorded in NCBI and GenBank 
as a mitochondrial ribosomal-like protein. During this study, homology to an 
axoneme component Chlamydomonas reinhardtii radial spoke protein 9 (RSP9) with 
an E-value of le-18, was subsequently revealed by Yang et al (Yang et al., 2006) 
(Table 4.6). RSP9 is a small protein located in the radial spoke head complex of 
Chlamydomonas reinhardtii, adjacent to the central pair (Chapter 1, Section
1.1.4.2.2). In addition, a Chlamydomonas reinhardtii RSP9 mutant exists with 
paralysed flagella {pfl 7), which displays loss of radial spoke heads and central pair 
displacement (Brokaw and Luck, 1985) (Huang et al., 1981). Therefore C6ORF206 
was an ideal candidate for the central pair agenesis defect seen in EM of cilia cross 
sections from family 146 (Stannard et al., 2004).
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Gene Chromosome ARAB CERV POMB CHLY PAZO DEFLA TRYP CION TETR McKE ELEG FOXJl
Tubulin-specific chaperone c (TBCC) 6p 0 0 0 1 0 0 1 1 1 1 1 0
Kinesin-like 8 (KNSL8) 6p 0 0 0 1 1 0 1 1 1 0 1 0
Chromosome 6 open reading frame 206 (C6orf206) 6p 0 0 0 1 1 1 1 1 1 1 0 1
Table 4.5: Comparative species BLAST results for candidate genes at the chromosome 6 locus consistent for linkage in Arabic PCD families 146 and 152
Key
ARAB - Arabidopsis thaliana
CERV - Saccharomyces cerevisae
POME - Saccharomyces pombe
CHLY - Chlamydomonas reinhardtii genome
PAZO - Pazour’s Chlamydomonas Flagellar proteome
DEFLA - Chlamydomonas reinhardtii deflagellation dataset
TRYP - Trypanosoma brucei and Leishmania major combined genomes
CION - Ciona intestinalis genome
TETR - Tetrahymena thermophilia genome
McKE - Gull & McKean’s Trypanosoma flagellar proteome
ELEG - Caenorhabditis elegans proteome
FOXJ1 -  Genes down-regulated in Foxjl cilia-less mouse
0 = no hit in the BLAST search 1 -  hit in the BLAST search
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G ene C hrom osom e Function
D om ains id en tified  in H um an N C B I  
B L A ST p search
Tubulin-specific chaperone c {TBCC) 6p
Involved in the pathway leading to correctly 
folded beta-tubulin from folding intermediates
X-linked retinitis pigmentosa 2 (RP2 ) gene 
product domain
Kinesin-like 8 (KNSL8) 6p Kinesin motor, motor activity Kinesin motor domain
Chromosome 6 open reading frame 206 (C6orf206) 6p
Tagged as mitochondrial ribosomal protein 
S ISA-like * N o domains
Table 4.6: Function, domain structure and tissue expression of positional candidate genes on chromosome 6p consistent for linkage in PCD families 146 and 152. ).
Expression profiling from analysis o f  EST counts (NCBI). * Homology to RSP9 revealed during the course o f  this study by Yang et al.
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Figure 4.6; LOD plot for chromosome 6p locus consistent for linkage in family 152 with candidate gene locations annotated.
162
4.1.10 Sequencing of Positional Candidates
Three genes identified as good positional candidates within the locus on chromosome 
6 were screened for mutations in affected individuals 11:3, 11:4 or 11:5 of family 146 
and individuals 11:3 or 111:8 of family 152, using primers designed for all coding open 
reading frames (ORFs), spanning intron-exon boundaries by 20 bp and 40 bp into the 
5’ and 3’ un-translated regions (UTR). Primer sequences are in Appendix 2. TBCC 
and KNSL8 were sequenced before the RSP9 homology for C6ORF206 was published 
by Yang et al (Yang et al., 2006).
4.1.10.1 Mutational analysis of TBCC
TBCC has only one coding exon (see Appendix 2 for full gene sequence with 
sequencing primers highlighted), which was sequenced in two overlapping sections 
due to its large size (more than 1.5 kb) in genomic DNA from affected individuals 
146 11:3, 152 11:3, 152 111:8 and control. TBCC was sequenced to 40 bp downstream 
of the stop codon and 40 bp upstream of the start codon.
4.1.10.2 Mutational analysis of KNSL8
The 15 exon coding region of KNSL8 was sequenced in 3 overlapping sections using 
lymphocyte cDNA from affected individuals 146 11:3 and 11:4. All 15 exons and their 
splice sites were also sequenced using genomic DNA from affected individuals 152 
11:3, 11:5 and 111:8. See Appendix 2 for full gene sequence with sequencing primers 
highlighted.
4.1.10.3 Mutational Analysis of C6ORF206
C6ORF206 was sequenced using genomic DNA from affected individuals 146 11:3, 
152 11:3, 152 111:8 and control. The full length C6ORF206 transcript was sequenced 
in lymphocyte cDNA made from 146 11:4, 146 11:5 and control. A homozygous 3 
base pair (bp) deletion in exon 5, 22 bases 5’ to the stop codon was identified
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(c.804_806delGAA) in all five affected individuals, that was not present in control 
DNA (Figure 4.7).
This mutation was not present in 126 Bedouin population control matched 
chromosomes, thus by definition was confirmed to not be a polymorphism.
T trace
B
•A trace •Ctrace ■G trace ■ t  trace
Figure 4.7: Electropherogram of partial sequence of C6ORF206 exon 5 showing
c.804_806delGAA mutation. A) Electropherogram from control individual. B) Electropherogram 
from individual 152 111:8, black arrow indicates GAA deletion. MboII restriction enzyme site 
destroyed by deletion -  highlighted with red box.
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4.1,11 Confirming inheritance pattern of C6ORF206 
C.804 806delGAA mutation in PCD families 146 and 152
The c.804_806delGAA mutation identified in C6ORF206 in DNA from affected 
individuals of families 146 and 152, was confirmed by sequencing in all affected 
individuals of both Arabic families: 146 11:3, 11:4, 11:5 and 152 11:3, 11:4, 11:5 and 
111:8. Sequencing of exon 5 of C6ORF206 showed heterozygosity for the 3 bp 
deletion in the mother of family 152 (1:2) and her unaffected child (152 11:6). 
Sequencing also revealed that the other parent of affected individual 111:8 (152 11:7) 
was also a carrier, as were unaffected siblings 152 111:9, 111:10, 111:12, 111:13 and 
111:15. This inheritance pattern was consistent with the haplotypes in Figures 4.3 and 
4.5. Unaffected siblings 152 111:11 and 111:14 were also sequenced and was 
homozygous wild-type, also as is predicted in haplotype analysis (Figure 4.3).
DNA sequence analysis revealed that the c.804_806delGAA mutation destroys an 
MboII restriction enzyme site (Figure 4.7). This was used to confirm the inheritance 
pattern of the c.804 806delGAA mutation in members of families 146 and 152 who 
were not screened by sequencing. Following restriction enzyme digestion of 
C6ORF206 exon 5 PCR products amplified from genomic DNA from patients, only 
one undigested product of 350 bp is seen, if the deletion is present in homozygous 
form since the PCR product lacks the MboII restriction enzyme site. If the mutation 
is not present, the PCR product is digested by MboII into two fragments of 259 and 
94 bp. All unaffected individuals in both families presented either with two products 
of 259 bp and 94 bp, demonstrating homozygosity for the wild type allele, or three 
bands of 350 bp, 259 bp and 94 bp as a result of heterozygosity (Figure 4.8). All 
parents were heterozygotes for the deletion (Figure 4.8). Just two unaffected 
individuals in both families were homozygous wild type and did not carry the 
mutation (152 111:11 and 111:14). Thus, restriction enzyme digestion with MboII o f a 
PCR fragment of exon 5 of C6ORF206 in the two Arabic families 146 and 152 
supported the haplotype and sequencing results and clearly demonstrated that the 
c.804_806delGAA mutation perfectly segregated with the disease in both families 
(Figure 4.8).
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Figure 4.8: M boll restriction enzyme digest showing inheritance of the c.804_806delGAA
mutation in C6ORF206 in families 146 and 152. N = normal (wild-type homozygous), C = carrier of 
c.804_806delGAA mutation, M = homozygous mutation.
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4.1.12 Screening for further mutations in C6ORF206 in 
the PCD family resource
Screening for mutations in all five exons of C6ORF206 in 39 patients from the UCL 
PCD resource with relevant phenotypes (absent ID As, absent radial spokes, 
transposition defect and normal or unknown cilia ultrastructure) was completed in 
collaboration with Keith Parker. No further mutations were revealed.
4.1.13 The 3 bp deletion in families 146 and 152 causes 
loss of a single amino acid from the C6ORF206 open reading 
frame
The c.804_806delGAA mutation identified in C6ORF206 in DNA from affected 
individuals of families 146 and 152 caused an in-frame single amino acid deletion 
(K268del) in the C-terminus of the C6ORF206 protein (Figure 4.IOC). Lysine 
residue K268 is conserved in mammalian species including mice (Figure 4.9). 
However, the residue at this position in C6ORF206 homologues is present as either 
lysine in mouse and Ciona intestinalis or arginine in Chlamydomonas reinhardtii 
(Figure 4.9). Therefore it is not extremely well conserved, although both these amino 
acids have similar basic, polar properties, which suggests a possible functional 
conservation of this position between species rather than absolute amino acid 
conservation. However, in zebrafish this residue is a methionine (Figure 4.9), which 
is different to lysine and arginine in that it is neutral and non-polar. Sequencing of 
the zebrafish C6ORF206 homologue was performed in genomic DNA isolated from 5 
days post fertilization (dpf) zebrafish embryos confirmed that the database deposited 
sequence was the correct sequence.
In collaboration with Dr. Richard Emes (Centre for Applied Entomology and 
Parasitology, Keele University) protein modelling was performed to identify changes 
in the protein that could result from the K268del mutation. The C6ORF206 open 
reading frame is small without any obvious functional domains, so there are few clues 
to its function. No obvious changes in protein properties were predicted to occur as a 
result of loss of this amino acid (Figure 4.11); it is not contained in an obvious 
structural entity or within a known protein biding motif that may be disrupted by the
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loss of the amino acid. As it is a conserved amino acid, it is possible that K268 
contributes to the overall structure of this C-terminal region of the protein product 
and it is the absence of K268 rather than its specific properties that are the key to the 
mutational effect.
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Figure 4.9: Alignment of human C6ORF206 with mouse, zebrafish, Ciona Intestinalis and Chlamydomonas reinhardtii homologues dem onstrates 
conservation of residue 268. The red arrow highlights residue 268, which is conserved as either basic, polar residue Lysine (K) or Arginine (R) in 
Chlamydomonas, or Methionine (M) in zebrafish. Accession numbers -  Human NP_689945, Mouse NP 083614, zebrafish NP_001025284, Ciona 
intestinalis product of gene JGI 1.0 ID 136430 and Chlamydomonas reinhardtii GI:832847I3.
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A -  gene structure of C6ORF206, blue boxes = 
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location of 3 bp deletion in exon 5 found in PCD 
patients from Arabic families 146 and 152, 
black arrow shows MboII restriction enzyme 
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4.2 Discussion
The aim of this study was to map a new PCD gene using homozygosity mapping and 
linkage analysis. Two consanguineous Arabic families 146 and 152 diagnosed with 
PCD were used in this study. Electron microscopy (EM) of respiratory cilia from 
affected individuals of family 146 revealed an unusual central pair defect, where a 
significantly higher than average proportion (11.9 - 17 %) of the cross sections are 
missing the central pair. Unpublished longitudinal EM pictures of the same cilia 
(from Prof. C. O'Callaghan, University of Leicester) show that the central pair is 
discontinuous along the length of the cilium, so it is likely that the cross section EM 
images display either a 9  + 0 o r a 9  + 2 microtubule arrangement depending on the 
location along the axoneme that the cross section was taken from. The usual central 
pair defect observed by EM shows normal 9 + 2, as well as 9 + 0 and 8 + 1 axonemal 
structures depending on which part of the cilium is viewed in the EM section, where 
the latter has an outer microtubule move in to the centre to replace a missing central 
pair, this is known as a central pair transposition. It was speculated that for family 
146 the central pair is formed as usual but is unstable, although not across a large 
enough region to cause a peripheral microtubule transposition, hence there were no 8 
+ 1 structures observed. Observation of the ciliary beat frequency (CBF) for family 
146 showed that it is within the normal range although the beat movement is 
disorganised and was described as having a circular movement, which is ineffective 
for mucociliary clearance but is similar to that of nodal cilia and therefore explains 
the lack of situs inversus in affected individuals (Stannard et al., 2004).
Family 152 have had EM performed on their respiratory cilia and this suggested no 
obvious ultrastructural defect (Dr. Grit Reish, Sackler School of Medicine, Tel-Aviv, 
Israel), although a motility defect was observed and quantified as having a circular 
beat pattern but with normal CBF. This is therefore similar to the family 146 motility 
defect. There is no incidence of situs inversus in family 152 which is again consistent 
with a central pair defect. It is possible that the same ultrastructural defect 
(intermittent absence of the central pair) as observed in family 146 is present in 
affected individuals of family 152 but it was missed, if for instance the sections were 
taken from the part of the cilia where the central pair is preserved.
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MERLIN linkage analysis on data from an Illumina SNP screen performed on DNA 
from family 152 identified a locus with a significant multipoint LOD score (Zmax =
3.6) on chromosome 6 between markers r s l738240 and rs945131 (Table 4.3, column 
2). Microsatellites were typed across the region on chromosome 6 including non­
affected siblings. This refined the region of interest from 9.2 cM to 2.9 cM, between 
flanking markers D6S400 to rs3 734693, because the initial region of homozygosity 
was broken up by heterozygous markers at the telomeric end of the region. Addition 
of the extra microsatellite data also increased the maximum LOD score from 3.0 to 
4.2 between microsatellite marker rs722269 and SNP marker rs3734693, across a 
region spanning 1.8 Mb.
Analysis of a genome-wide microsatellite screen that had been performed prior to this 
study had identified two putative disease loci in family 146 of equal weight on 
chromosome 3 and 6. At both these loci the maximum LOD score was 2.5 since 
family 146 only has three affected children. The loci separately identified on 
chromosome 6 in families 146 and 152 were found to overlap between markers 
D6S400 and rs3 734693, a region of 1.8 Mb (2.9 cM). This overlap was considered 
especially significant because both families are of Arabic origin and as described 
above had a consistent ultrastructural phenotype.
Combined, the genotype data for Arabic families 146 and 152 yielded a LOD score of 
6.7 across the overlapping region of homozygosity on chromosome 6, between 
markers D6S400 and rs3 734693. However, only markers UAEPal3 and UAEPalS 
had the same alleles across all affected individuals of families 146 and 152, forming 
the haplotype “2-1” in both families between flanking markers rs2277123 and 
D6S1604, a region of just 212 kb that contains the candidate gene C6ORF206. So 
although consistent for linkage at the same region, there was no great evidence for 
linkage disequilibrium (LD) at the available marker density.
Identification of positional candidate genes in the shared critical region on 
chromosome 6 between markers D6S400 and rs3 734693 based on conservation in 
ciliated organisms and any putative cilia structure and/or function and related 
homology, as well as tissue expression led to prioritization of 3 out of the 40 
positional candidate genes present: TBCC, KNSLS and C6ORF206. Sequencing and
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restriction digests of C6ORF206 revealed a homozygous 3 base pair (bp) deletion in 
exon 5, 22 bases 5’ to the stop codon (c.804_806delGAA), in all affected individuals 
in both families 146 and 152. All parents and non-affected siblings were 
heterozygous for the mutation, except for two non-affected siblings (152 111:11 and 
111:14) that were homozygous for the normal allele. Observation of the full family 
152 pedigree (Section 2.3.3) revealed that the disease gene is inherited by the three 
brothers of the first consanguineous marriage (the grandparents of generation II) and 
therefore is homozygous by descent in affected individuals of generation II. The 
sharing of the c.804_806delGAA mutation in both families 146 and 152 is interesting 
as the gene is located between the two markers UAEPaU and UAEPal5 that suggest 
some allele sharing and therefore linkage disequilibrium. This small shared “2-1” 
haplotype between flanking markers rs2277123 and D6S1604 described in the 
previous paragraph could have arisen due to uninformative or incomplete parental 
haplotypes, but subsequent mutational analysis of C6ORF206 suggested the putative 
small shared haplotype across the C6ORF206 gene was real. Alternatively, it could 
be a mutation hotspot and they share the same mutation by chance, however, this was 
considered unlikely for a triplet deletion.
The c.804_806delGAA mutation was predicted to cause an in-frame single conserved 
amino acid deletion (K268del) in the C-terminus of the C6ORF206 protein but no 
significant alteration of the properties of the protein. However, this is difficult to 
assess using the available protein structure programs since there are no obvious 
functional domains in the protein. Further experimental work would be required to 
analyse the effect of the mutation on protein binding or any other protein properties. 
For example, expression of the mutation in a fluorescent tagged protein in ciliated 
cells to observe any changes in localization or function could be performed, or 
binding properties of the protein examined using an antibody pull down method. It is 
likely that the deletion of this single amino acid near to the C-terminus of the protein 
disrupts an important sequence domain that is as yet unidentified, since functional 
work performed in Chapter 5 showed that this residue is critical for cilia movement.
The C6ORF206 gene product is homologous to Chlamydomonas radial spoke protein 
9, which is located in the radial spoke head near the central pair of the axoneme. 
These two structures have close proximity in the axoneme and mutations in the
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C6ORF206 gene are associated with disruption of the central pair. It is also possible 
that there are additional ultrastructural problems in the radial spokes in these families 
that are undetectable by EM.
In summary, a gene locus on chromosome 6 was identified by linkage analysis and 
homozygosity mapping in two consanguineous Arabic families with PCD. Three 
good candidate genes with putative roles in the structure and/or function of cilia were 
highlighted within the critical region, one of which was found to contain a mutation 
that is likely to cause the disease phenotype. The mutation is inherited in 
homozygous form by all seven affected individuals in families 146 and 152 and 
segregates perfectly with the disease haplotype in both families. It causes an in-ffame 
deletion of a single amino acid, which is not fully conserved suggesting that it is its 
loss rather than its chemical properties that cause cilia dysfunction and PCD.
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5 CHAPTER FIVE
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5.1 FUNCTIONAL ANALYSIS OF RADIAL SPOKE PROTEIN 9 
(C6ORF206/RSP9)
Following identification of a locus on chromosome 6p21.2-21.1 consistent with 
linkage in families, 146 and 152, sequencing of positional candidate genes revealed a 
homozygous 3 bp deletion (c.804_806delGAA) in exon 5 of C6ORF206/RSP9 in all 
affected individuals. The c.804_806delGAA mutation was not present in 126 
population matched control chromosomes, thus confirming that it was not a 
polymorphism. The deletion causes an in-ffame deletion of a single amino acid 
(K268del) in the C-terminus of the C6ORF206/RSP9 protein. The affected patients 
have a rare ultrastructural defect of intermittent absence of the ciliary central pair 
microtubules (Section 2.3.2). This is also an unusual form of PCD since none of the 
affected individuals have laterality problems and their respiratory cilia retain a normal 
beat frequency but with a circular beat pattern similar which is ineffective for 
mucociliary function. This has been reported as similar to the unidirectional 
movement pattern of embryonic nodal cilia (Stannard et al., 2004).
This chapter describes functional analysis to investigate the C6ORF206/RSP9 gene 
and the functional consequences of the K268del mutation. In order to investigate the 
tissue expression of C6ORF206/RSP9, probes were made for whole mount and 
section in situ hybridisation, which was performed on mouse embryos at stages E7.5 
and E19.
In an effort to characterise the function of C6ORE206/RSP9 in a vertebrate model 
system, the phenotype of zebrafish {Danio rerio) embryos injected with gene 
silencing morpholinos targeting the zebrafish C6ORF206/RSP9 homologue, was 
investigated compared to controls.
The Chlamydomonas model provides a system to explore the precise functional effect 
of the c.804_806delGAA mutation. The Chlamydomonas reinhardtii 
C6ORF206/RSP9 homologue, radial spoke protein 9 (RSP9), is known to be defective 
in pfl7 , a radial spoke head-deficient Chlamydomonas mutant strain which has 
paralysed flagella. The C6ORF206/RSP9 gene mutation in p fl 7 was determined and 
studies were conducted to explore the pathological effects of mutations in flagella
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motility, comparing the effects of a null allele against that of the human 
C.804 806delGAA mutation.
5.1.1 Expression pattern of C6ORF206/RSP9 in the mouse 
embryo
The expression pattern of the C6ORF206/RSP9 mouse homologue mRNA in wild- 
type embryos at different stages of development was analysed, using DNAH5 as a 
control probe expressed in the axoneme of motile cilia. The C6ORF206/RSP9 in situ 
probe was made as described in Section 2.4.14 and the DNAH5 probe was kindly 
provided by Dr Heymut Omran (Olbrich et al., 2002). The in situ work was 
performed in collaboration with Dr. Nick Greene, UCL. At E l9, significant 
expression of C6ORF206/RSP9 and DNAH5 was seen in body sagittal sections in the 
tracheal epithelium (Figure 5.1A-D) and head sagittal sections revealed 
C6ORF206/RSP9 and DNAH5 expression in the nasal epithelium (Figure 5.1E-H). 
This provided evidence that C6ORF206/RSP9 mRNA is expressed in ciliated tissues 
and this is consistent with a role in cilia motility. In trachea and nasal epithelium the 
expression overlapped with the known PCD gene DNAH5. Expression was also 
observed in the E7.5 stage embryonic node (Figure 5.11), suggesting that the gene 
product is present in nodal cilia. This again is the same pattern seen for the PCD gene 
DNAH5 (Olbrich et al., 2002). Since there is no incidence of situs inversus in either 
PCD family 146 or 152, who have the C6ORF206/RSP9 mutation identified in 
Chapter 4, it is possible that this gene, unlike DNAH5, has a redundant role at the 
embryonic node.
The presence and level of expression of C6ORF206/RSP9 mRNA was also monitored 
using RT-PCR on cDNA made from multiple adult mouse tissues, including lung, 
trachea, kidney, brain, testis and liver, and actin primers as a housekeeping gene 
expression control. Strong expression was observed in testis and lower, but marked 
expression levels were seen in all other tissues in the analysis (data not shown).
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Figure 5.1: C6ORF206/RSP9 and
DNAH5 expression in whole mount and 
section in situ hybridisation of mouse 
embryos. A-D: I^P 9  and control DNAH5 
expressed in trachea epithelium in E l9 
mouse (sagittal sections). B and D close ups 
of A and C, respectively. E-H: RSP9 and 
control DNAH5 expressed in nasal 
epithelium in E l9 mouse head (sagittal 
sections). F and H close ups of E and G, 
respectively. I: RSP9 expressed in E7.5 
mouse embryonic node (white arrow).
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5.1.2 Morpholino injection in zebrafish larvae to assess 
function of C6ORF206/RSP9
In order to address whether C6ORF206/RSP9 plays a role in cilia function, and 
provide supporting evidence that the c.804_806delGAA mutation identified in all 
affected individuals of the two Arabic PCD families in chapter four could be disease- 
causing, morpholino antisense oligonucleotides (MO) were designed that targeted 
splice acceptor sites of the second (M0ex2) and third (M0ex3) coding exons of the 
zebrafish homologue of this gene in order to disrupt protein function by gene mis- 
splicing. Embryos were injected with 6.25 ng of either MO at the one-cell stage of 
development in conjimction with OFF mRNA to ensure proper uptake of the MO into 
the embryo body.
5.1.2.1 Disruption of zebrafish C6ORF206/RSP9 mRNA splicing by
morpholino injection
The location of both exon 2 (MOex2) and exon 3 (M0ex3) MOs in the five exon 
zebrafish C6ORF206/RSP9 gene is shown in figure 5.2A. The effectiveness of each 
morpholino, MOex2 and M0ex3, was verified by RT-PCR using RNA isolated from 
10 morpholino-injected embryos at 24 and 72 hours post-fertilisation (hpf). This 
showed that morpholino suppression of correct mRNA splicing persisted for at least 
72 hpf (Figure 5.2E). The RT-PCR generated an 837 bp fragment in control embryos 
(Figure 5.2 B and 5.2E) and correct splicing was confirmed by sequencing of gel- 
purified RT-PCR fragments. RT-PCR of MOex2-injected embryos analysed with the 
same primer set produced three amplicons of 1.2 kb, 1.0 kb and 773 bp at all times 
tested post fertilisation (Figure 5.2E), caused by disrupted splicing of intron 2. 
Sequencing of the RT-PCR products revealed that this resulted from non-splicing (1.2 
kb product) and partial splicing of intron 2 (1.0 kb product), or deletion of 64 bp from 
the 3’ end of exon 2 (773 bp product) presumably due to use of a cryptic splice donor 
in exon 2 (Figure 5.2C). The predicted results of mis-splicing was premature 
truncation due to a frameshifl in all cases. For the 1.2 and 1.0 kb products, it was 
expected that only 155 amino acids are expressed and for the 773 bp product. 111 
amino acids are expressed. The wild-type zebrafish C6ORF206/RSP9 protein is 277 
amino acids in length, thus the truncated proteins were expected to be non-functional. 
No wild-type mRNA was expressed after M0ex2 injection.
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RNA from M0ex3-injected embryos were analysed in the same way by RT-PCR, 
which showed three amplicons of 910 bp, 805 bp and 702 bp at all times tested post 
fertilisation (Figure 5.2E), caused by disrupted splicing of intron 3. Sequencing of 
the RT-PCR products, reveeiled partial splicing of intron 3 (910 bp product) where a 
cryptic splice site is presumably exists, a 28 bp deletion at the 3’ end of exon 3 (805 
bp product) and complete deletion of exon 3 (702 bp product). The predicted results 
of the mis-splicing observed in the 910 and 805 bp product is premature truncation 
due to a frameshifl, resulting in predicted 205 and 187 amino acid products. The 
predicted product of the 702 bp transcript is a full length protein with a frameshifl 
after amino acid 132 of the 277 amino acid protein. No wild-type C6ORF206/RSP9 
mRNA was detected in embryos injected with M0ex3. Thus, injection of 6.25 ng per 
embryo of either splice-blocking morpholino, MOex2 or M0ex3, leads to a 
substantial decrease in functional gene product.
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Figure 5.2: M orpholino effects on splicing of zebrafish C6ORF206/RSP9. A: Genomic zebrafish C6ORF206/RSP9 (7.2 kb) 
B: Structure of the 5 exon wild-type zebrafish C6ORF206/RSP9 transcript (837 bp) confirmed by RT-PCR and sequencing. C: 
Morpholino M0ex2 disrupts splicing of zebrafish C6ORF206/RSP9 - three different products of 1.2 kb, 1.0 kb and 773 bp were 
detected by RT-PCR and sequencing. D: Morpholino MOex3 disrupts splicing of zebrafish C6ORF206/RSP9 - three different 
products of 910 bp, 805 bp and 702 bp were detected by RT-PCR and sequencing. E: Products amplified from wild-type and 
morpholino treated zebrafish (72 hpf) showing splicing of C6ORF206/RSP9 is disrupted by Morpholino injection.
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5.1.2.2 Identification of phenotypes related to cilia dysfunction in
C6ORF206/RSP9 morphant zebrafish
To determine whether phenotypes previously described in zebrafish morphants with 
cilia dysfunction (Kramer-Zucker et al., 2005; van et al., 2008) were also observed 
when expression of C6ORF206/RSP9 was disrupted, the phenotype of embryos 
injected with morpholinos targeting the splice acceptor sites of coding exons 2 
(M0ex2) and 3 (M0ex3) were analysed at 24, 48 and 72 hpf. Out of 270 wild-type, 
163 M0ex2-injected and 163 M0ex3-injected embryos, no differences were observed 
at 24 or 48 hpf in morphants compared to controls (Figure 5.3). Expected cilia- 
related phenotypes considered at 48 hpf included kidney cysts, hydrocephalus and 
laterality defects (situs inversus or heart on the right). None of the control or MO- 
inj ected embryos observed had cystic kidneys or enlarged ventricles consistent with 
hydrocephalus (Figure 5.3 and Table 5.1). One of the 270 control embryos was found 
to have situs inversus, compared to 3 and 1 of the 163 MOex2 and M0ex3-injected 
embryos, respectively. T-tests with a confidence interval of 99% revealed that the 
difference in levels of situs inversus observed between control and M0ex2-injected 
embryos achieved a non-significant P-value of 0.7077. Situs inversus is observed at 
low levels amongst zebrafish and appears to be an anomaly in zebrafish development 
that presents occasionally and creates a well recognised “background” phenotype 
(Prof. Steve Wilson, personal communication). This lack of laterality defect in 
morphants is consistent with the absence of situs inversus in the seven affected 
individuals of families 146 and 152 carrying the C6ORF206/RSP9 mutation. It may 
be that C6ORF206/RSP9 and radial spokes do not play a significant functional role in 
embryonic nodal cilia or that the zebrafish is not the correct model to analyse a more 
mammalian-specific function.
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W T ex2 ex3
No. live em bryos (n) a t 48 h p f 270 163 163
No. w ith  situs inversus 1 3 0
No. w ith  cystic k idneys 0 0 0
No. w ith  hydrocephalus 0 0 0
Table 5.1: No significant phenotype observed in splice-blocking morpholino injected zebrafish 
embry os at 24 or 48 hpf.
24 hpf
WT
MOex2
MOex3
48 hpf
WT
MOex2
MOex3
Figure 5.3: Zebrafish C6ORF206/RSP9 knockdown m orphant 
embryos display no obvious phenotype com pared to wild type 
(WT). Above: Comparison of body plan between WT, M0ex2 and 
MOex3 morphants shows no gross abnormalities. Brain ventricles 
(arrow) and kidney (arrow head) are indicated. 300X 
magnification. Right: Example of kidney cysts (arrow head) and 
hydrocephalus (arrow) seen in DNAH9 knockdown morphants. 
Image taken from (Kramer-Zucker et al., 2005).
184
5.1.2.3 C6ORF206/RSP9 morphants display dysmotlle olfactory pit 
cilia compared to controls
The zebrafish olfactory pit cilia were initially observed using a high speed camera 
and it was observed by eye that these might be affected by cilia dysmotility. The 
olfactory pit cilia of the MO injected embryos appeared to have a different beat 
pattern to controls, although the exact nature and extent of this defect was unclear by 
eye. This prompted an effort to investigate the olfactory pit cilia function in more 
detail. To this end, in collaboration with Dr. Robert Hirst and Prof. Christopher 
O’Callaghan, University of Leicester, olfactory pit cilia from live control and 
C6ORF206/RSP9 target MO-injected embryos at 72 hpf (Figure 5.4) were recorded 
using high speed video photography at 250 frames per second (fps) with a 500X 
magnification in order to closely observe whether cilia function was affected upon 
C6ORF206/RSP9 knockdown. Videos of olfactory pit cilia were analysed by the 
standard operating procedure used in the University of Leicester PCD clinical 
laboratory on human nasal brush biopsies for the diagnosis of ciliary dyskinesia. In 
this method a cilia Immotility Index (II) is calculated as well as a dysmotility Index 
(DI). The mean percentage of immotile cilia (those not moving or only moving as a 
consequence of being moved by those surrounding it) and also a mean percentage of 
dyskinetic cilia (those with an unorganised beat pattern, twitching or immotile) was 
measured by eye across olfactory pit sections from between 7 and 9 control and MO- 
inj ected embryos (95% confidence intervals). The calculated II for wild-type control 
embryos was 1.43% (Standard error of the mean (SEM) +/- 0.12), and 18.2% (SEM 
+/- 0.53) and 22.2% (SEM +/- 0.32) for MOex2 and MOex3-injected embryos, 
respectively (Table 5.2 and Figure 5.5A). The DI for wild-type control embryos was 
3.13% (SEM +/- 1.44), for M0ex2-injected embryos 65.86% (SEM +/- 4.2) and for 
M0ex3-injected embryos 65.56% (SEM +/- 2.73) (Table 5.2 and Figure 5.5B). All 
data were tested by one-way anova and individual data sets were compared using an 
unpaired Students t-test with Bonferoni correction for repeated measures. Statistical 
comparisons between datasets revealed that the Immotility and Dysmotility Index 
calculated for both sets of MO-inj ected embryos was significantly higher than 
observed for controls (p value <0.05) (Table 5.3).
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5.1.2.4 C60RF206/RSP9 morphants display wild-type ciliary beat
frequency
The average cilia beat frequency (CBF) was calculated from the same control and 
morphant olfactory pit cilia high-speed video data (also described in Section 2.4.19). 
The CBF for controls was calculated at 43.6 Hz (SEM +/- 3.72), for MOex2-injected 
embryos 42.32 Hz (SEM +/- 0.83) and for M0ex3-injected embryos 40.03 Hz (SEM 
+/- 1.8) (Table 5.2). Statistical analysis revealed that there W2is no significant 
difference between the three datasets (p values >0.05) (Table 5.3). These 
observations are consistent with cilia beat velocity and pattern for family 146 
homozygous carriers of the c.804_806delGAA mutation in C6ORF206, where CBF 
was within the normal range but the ciliary beat pattern was abnormal (Stannard et 
al., 2004).
5.1.2.5 C6ORF206/RSP9 morphants display a disorganised beat
pattern
Observation of zebrafish olfactory pit cilia in videos slowed down to 7 %s revealed a 
disorganised beat pattern (videos in Appendix 3). This resembled the circular beat 
pattern seen for nasal epithelial cilia samples jfrom family 146 individuals 
homozygous for the C6ORF206 c.804_806delGAA mutation (Stannard et al., 2004). 
It was noted in control embryos that debris was swept across the olfactory pit, as 
expected with a normal ciliary beat frequency and pattern in control embryos, 
resulting in constant clearance of debris from the pit. However, accumulation of 
debris at the olfactory pits was prevalent over time in MO-inj ected embryos with 
defective II and DI and a disorganised beat pattern. This failure to keep the pit clear 
is consistent with an ineffective beat and a vortex created by the defective circular 
ciliary beat pattern (Figure 5.6).
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Debris in surrounding water Eye
Olfactory pit
Figure 5.4: Still image of zebrafish olfactory pit observed by high speed microscopy (xlOO
magnification).
W T ex2 M O ex3 M O
N u m b er o f  em bryos (n) 8 7 9
Im m otility  Index (%  +/- S E M ) 1.43 +/- 0.12 18.2 + /- 0.53 22 .2  + /- 0 .32
D yskinesia  Index (%  +/- S E M ) 3.13 +/- 1.44 65 .86  + /- 4 .20 6 5 .5 6 + /-  2.73
C B F  (H z/bps +/- SE M ) 43 .6  +/- 3 .72 4 2 .3 2  + /- 0.83 40.03 + /- 1.8
Table 5.2: Immotility Index, Dyskinesia Index and ciliary beat frequency (CBF) of 
C6ORF206/RSP9 knockdown m orphants in comparison to wild-type controls.
W T -M O ex2 W T -M O ex3 M O ex2-M O ex3
Im m otility  Index P<0.0001 P<0.0001 P=3191
D yskinesia  Index ?<0.0001 ?<0.0001 P=0.9511
C B F  (H z/bps) P =0.7577 P=0.3836 P=0.3116
Table 5.3: Calculated statistical comparison within Table 5.2 datasets -  t-test indicates the
immotility and dysmotility indexes are significantly different in morphants compared to controls 
(P<0.05), whereas the CBF is not significantly different (columns 1 and 2).
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Figure 5.5: G raphical representation of data from Tables 2 and 3. Immotility index, Dysmotility 
Index and CBF in zebrafish C6ORF206/RSP9 knockdown morphants compared to controls.
Immotility Index and Dysmotility Index significantly higher in morphants compared to controls 
(asterix indicates p value <0.0001). CBF not significantly different.
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Morphant
Debris build-up
Morphant 
olfactory pit 
blocked with 
debris
fWild-type
4
Debris ^ |«9btce
WT olfactory pit
Figure 5.6: Accumulation of debris in olfactory pits of C6ORF206/RSP9 knockdown m orphant zebrafish.
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5.1.3 Analysis of effects of c.804__806delGAA (K268del) 
mutation on C6ORF206/RSP9 function using the 
Chlamydomonas reinhardtii model
RSP9 is the Chlamydomonas reinhardtii homologue of C6ORF206/RSP9 and is 
likely to be the defective gene in paralysed flagella mutant p fl  7. The biflagellate alga 
Chlamydomonas reinhardtii has been extensively used in the genetic and biochemical 
analysis of flagellar assembly and motility. The Chlamydomonas paralysed flagella 
mutant p fl 7 was created by UV irradiation and isolated over 30 years ago 
(EBERSOLD et al., 1962). Protein biochemical analysis showed that it has a 
molecular deficiency, demonstrated by autoradiography, for the five protein 
components of the axonemal radial spoke head, RSPl, 4, 6, 9 and 10 (Figure 1.7 
Section 1.1.4.2.2) (Yang et al., 2006). Transverse and longitudinal electron 
microscopy images of isolated axonemes from p fl 7 revealed that radial spoke stalks 
extend with the same periodicities as wild-type from outer-microtubule A, however 
the stalks are disorganized and the radial spoke heads were missing and the central 
pair was seen to be displaced toward one side of the axoneme (Huang et al., 1981). 
Dikaryon rescue experiments provided indirect evidence that RSP9 may be the 
defective gene product in this mutant but the exact mutation was yet to be identified 
(Huang et al., 1981). A study of the radial spoke components of Chlamydomonas 
flagella published during the course of this study found C6ORF206 to be the human 
homologue of Chlamydomonas RSP9 (Yang et al., 2006).
In order to prove that a mutation in RSP9 was the cause of the paralysed flagella 
phenotype in p fl 7 which had never been directly established, the Chlamydomonas 
RSP9 gene fi’om p fl 7 mutant strain CC-1035 was screened for mutations by 
sequencing. This was to establish its utility as a model to investigate the effect of 
RSP9 mutations mimicking the human C6ORF206 c.804_806delGAA mutation, and 
functional studies were pursued in this model.
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5.1.4 Mutational Analysis of RSP9 reveals a single base pair 
deletion in pf17
Sequencing of the five coding exons, intron-exon boundaries and 40 bp into the 5’ 
and 3’ UTRs of RSP9 in genomic DNA isolated from wild-type and mutant p fl 7 
Chlamydomonas revealed a single base pair deletion in exon 2 (ISldelG) present in 
p fl7  but not wild type (Figure 5.7A). The predicted effect of this mutation on the 
RSP9 protein product is a framesbift after residue S45 and a severe truncation of the 
269 amino acid protein (Figure 5.7C), likely resulting in a null mutation as the 45 
amino acid protein remaining would not be expected to retain any function or might 
be unstable and degraded.
5.1.4.1 Restriction digest shows the RSP9 131delG mutation is
present in Chlamydomonas pf17 progeny strains
The RSP9 ISldelG mutation identified in genomic DNA from Chlamydomonas p fl 7 
destroys restriction enzyme site (Figure 5.7A and 5.8). To demonstrate that the 
mutation identified bad not arisen since isolation of p fl 7 in the 1970’s, but was the 
true original mutation responsible for the paralysed flagella phenotype, restriction 
digestion using BspEI was performed on a portion of RSP9 amplified by PCR from 
genomic DNA (primer sequences in Appendix 3). DNA isolated from the original 
p fl 7 mutant strain CC-1035, plus four p fl 7 progeny strains: CC-1332, CC-1143, CC- 
2645 and CC-262 and wild-type CC-1732 was amplified and digested with BspEI 
restriction enzyme. The undigested product gave rise to a single 1.1 kb band in 
agarose gel electrophoresis, whereas BspEI digested wild-type RSP9 PCR product 
was present as three bands of 636 bp, 279 bp and 194 bp. The Chlamydomonas 
strains with the 131delG mutation yielded two bands of 830 bp and 279 bp (Figure 
5.7B and 5.8). Thus, the 131delG mutation identified in mutant p fl 7 was present in 
progeny strains and not the wild-type control, confirming that this deletion was most 
likely to be the original p fl 7 mutation causing the paralysed flagella phenotype.
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Wild-Type (CC-1732)
/7/77 (CC-1035)
k G s  @ C C C T 5 A C G C  T ' g T
B p f l 7  W T
CC-1332 CC-1143 cc-2645 cc-262 cc-1035 cc-1732 uncut
- 1 1 0 9
- 8 3 0
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U 2 7 9
1 -1 9 4
WT
gag gca ggg etc egg age etg aeg 
E A G L R  S L T
i pfl 7
gag gea ggg etc cga gee tga eg 
E A G L R A stop
Figure 5.7: M utation revealed in RSP9 in Chlamydomonas paralysed flagella strain p f l 7. A:
Single base pair deletion (ISldelG) in RSP9 revealed in p f l7 Chlamydomonas reinhardtii mutant that 
was not present in control, indicated by red arrow. Mutation destroys BspEI restriction enzyme site 
(highlighted by red box). B: BspEI restriction digest o f amplified RSP9 PCR products from
Chlamydomonas reinhardtii p fI7  progeny strains (CC-1332, CC-1143, CC-2645 and CC-262) 
compared to WT (CC-1732) and undigested product. Presence o f ISldelG mutation yields restriction 
digest products of 830 bp and 279 bp. Absence of the 131delG mutation results in products of 636 bp, 
279 bp and 194 bp. The ISldelG mutation is therefore present in progeny p f l7 strains, indicating that 
this is the true RSP9 mutation causing the paralysed flagella phenotype. C: 131delG mutation
predicted to cause a frameshift mutation after residue S45 (red), resulting in a severe truncation of the 
269 amino acid protein.
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5.1.5 Motility rescue of Chlamydomonas p ff7w ith  constructs 
encoding wild-type and c.804_806delGAA mutant RSP9
In order to establish the utility of the Chlamydomonas model system and to confirm 
that RSP9 is required for flagella motility, paralysed flagella mutant p fl 7 was 
transformed with the wild-type genomic RSP9 gene or RSP9 mimicking the mutation 
identified in PCD families 146 and 152. The wild type Chlamydomonas RSP9 gene 
sequence including the 5’ and 3’ UTR and approximately 400 bp of the upstream 
sequence incorporating the tub box sequence motif (GCTC(G/C)AAGGC) that is 
known to enhance transcription after deflagellation (Davies and Grossman, 1994) was 
inserted into pBluescript plasmid. In addition, to evaluate the effect of the 
c.804_806delGAA (K268del) mutation on flagella motility, a mutation mimicking 
loss of the homologous conserved residue in wild-type Chlamydomonas RSP9 (780- 
783delCGC/R261 del) (Figure 5.10A) was introduced into the wild-type RSP9 gene 
by mutagenic PCR. Controls and p fl?  mutants were transformed with the two 
resulting constructs. For mutagenesis method see Section 2.4.21, Figure 2.4. In both 
cases Chlamydomonas p fl?  (strain CC-1035) was back-crossed with cell-wall-less 
mutant cwl5, for ease of transformation. Back-crossed p fl ? and cell wall-less control 
cultures (cwl5) without the RSP9 131delG mutation were co-transformed with the 
RSP9 construct and plasmid pS1103, which confers paramomycin antibiotic 
resistance. Colonies were grown on paramomycin TAP plates to select for 
transformants. Ninety-seven wild-type and fifty-six mutant RSP9 transformed 
colonies were grown and picked for DNA extraction. Only one colony from each 
transformed set was a successful transformant and this was maintained for future 
motility analysis. For the purposes of this study, the cell-wall-less control is referred 
to as cwl5 (wild-type RSP9). The mutant p jl?  strain transformed with wild-type 
RSP9 or mutant RSP9 construct is referred to as p fl  7-T and p fl  7-Tmut, respectively.
5.1.5.1 Confirmation of incorporation of introduced DNA in
Chlamydomonas transformant strains
After transformation, genomic DNA from Chlamydomonas controls, mutant p fl  7 and 
p fl  7 RSP9 transformants was analysed by restriction digest to confirm incorporation 
of the wild-type and mutagenic RSP9 constructs into the genetic material of the 
transformed strain. The original p fl 7 strain RSP9 131delG mutation destroys a BspEI
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restriction site (Figure 5.8). Digestion of the RSP9 PCR product from the cell wall- 
less non-transformed p fl 7 strain with BspEI restriction enzyme gives two bands of 
830 bp and 279 bp. Digestion of the RSP9 PCR product from the control cwl5 strain 
carrying wild-type RSP9 gives three bands of 636 bp, 279 bp and 194 bp. The p fl 7-T 
strain yielded four bands of 830 bp, 636 bp, 279 bp and 194 bp. This confirmed the 
presence of both wild-type and 131delG RSP9 in this transformant (Figure 5.9).
The c.780 783delCGCmutation introduced into Chlamydomonas to generate the 
7-Tmut strain is equivalent to the c.804_806delGAA in human PCD families 146 
and 152, since the amino acid residue at position 261 is deleted (Chapter 4). 
Introduction of the wild-type RSP9 construct into the Chlamydomonas genome results 
in the strain carrying the endogenous 131delG RSP9 gene, plus wild-type RSP9. 
Introduction of the human-equivalent mutation into the Chlamydomonas genome 
results in the strain carrying the endogenous 131delG RSP9 gene, plus the 
c.780 783delCGCmutated copy. The c.780_783delCGCmutation destroys an Fspl 
restriction enzyme site. Digestion of RSP9 PCR product from cwl5 control, p fl 7 and 
p fl  7-T with F5/7/therefore allows identification of correct incorporation of the mutant 
gene. Fspl digestion gives four bands of 1.8 Kb, 495 bp, 337 bp and 268 bp due to 
absence of c.780_783delCGC (Figure 5.IOC -  only upper bands shown). Digestion 
of PCR product from the p fl  7-Tmut strain gives five bands of 2.3 Kb, 1.8 Kb, 495 bp, 
337 bp and 268 bp due to the presence of wild-type and mutant RSP9, arising from 
the lack of an Fspl restriction site in the mutagenic form of RSP9. This confirmed the 
presence of both vrild-type and mutagenic c.780_783delCGC/?5'PP in this 
transformant (Figure 5.IOC -  only upper two bands shown).
These results showed that both the wild type and mutant RSP9 construct incorporated 
correctly into the genetic material of the Chlamydomonas reinhardtii mutant p fl  7-T 
and p fl 7-Tmut strains, respectively.
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Figure 5.8: BspEI and Fspl restriction sites in Chlamydomonas RSP9 are destroyed, respectively, 
by the p fl7  131delG mutation and the c.780_783delCGCmutation that mimics the human 
c.804_806delGAA mutation. A) BspEI restriction enzyme sites indicated with arrows, one of which 
is destroyed by the 13 IdelG mutation. Primers highlighted with black blocks. B) Fspl restriction sites 
indicated with arrows, one of which is destroyed by the c.780_783delCGCmutation. N ote ,/^7-T m ut 
has the c.780_783delCGCÆSP9 gene as well as the wild-type bands. Primers highlighted with black 
blocks (reverse primers for A and B used were positioned at different locations within the gene in 
order to include the relevant mutation. Numbers above the gene indicate restriction enzyme site and 
primer positions, numbers in brackets below the gene indicate restriction fragment sizes after 
digestion.
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pfl 7 pfl 7-T cwlS uncut
  1109 bp
  830 bp
 636 bp
 279 bp
Figure 5.9: BspEI restriction enzy me digestion to dem onstrate incorporation of wild-type RSP9 
in rescued transform ant p f l  7-T. Digestion o f the RSP9 PCR product from control cwl5  (wild-type 
RSP9) gives three bands o f 636 bp, 279 bp and 194 bp. The p fl?  mutant strain yielded two bands of 
830 bp and 279 bp. The p fl 7-T strain yielded four bands of 830 bp, 636 bp, 279 bp and 194 bp. 194 
bp band not shown.
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ACGGCCTGCGCAACAACGACCTCATCTTCATGCTGTAG
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Chlamydomonas RSP9
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Figure 5.10: (A) The family 146 and 152 c.804_806de!GAA mutation results in deletion of 
residue K268 in the human C6ORF206 protein. The 3’ end o f the gene and the C-terminal o f the 
protein are shown. (B) The c.780_783delCGCmutation introduced into wild-type Chlamydomonas 
RSP9 gene (homologue of hum an C6ORF206/RSP9) results in deletion of conserved R261 in 
Chlamydomonas. The 3 ’ end of the gene and the C-terminal o f the protein are shown. Small black 
arrow indicates Fspl restriction enzyme site CTGCGC, that is lost upon introduction of the 
c.780_783delCGCmutation. (C) Fspl restriction enzyme digestion to dem onstrate incorporation 
of m utant RSP9 in part-rescued transform ant /?/7 7-Tmut. Digestion of RSP9 PCR product from 
cwI5 control, p fl 7 and p fl7 -J  with Fspl gives four bands of 1.8 Kb, 495 bp, 337 bp and 268. 
Digestion of PCR product from the pfl7-TvmjX strain gives five bands of 2.3 Kb, 1.8 Kb, 495 bp, 337 
bp and 268 bp. /^7 -T m u t carries both wild-type and mutant RSF9. 495 bp, 337 bp and 268 bp bands 
are not shown.
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5.1.5.2 Flagella dysmotility phenotype of Chlamydomonas
transformants
p fl  7 colonies transformed with wild-type or mutant RSP9 were cultured and viewed 
under a microscope. Out of 97 p fl7  RSP9 transformed (pfl7-T) colonies, one 
appeared to have regained motility similar to wild type Chlamydomonas. Out of 56 
c.780_783delCGCmutant RSP9 transformed {pfl7-Tm\sX) colonies, one appeared to 
have regained motility but the transformants were moving at about half the speed of 
wild type as judged by eye under might microscopy. This prompted a more detailed 
high speed video analysis.
Four different strains: control cwl5, mutant p fl  7, transformant p fl 7 Chlamydomonas 
cultures transformed with wild-type RSP9 {pfl 7-T) and transformed p fl 7 cultures 
with mutagenic RSP9 {pfl 7-Tmut) were viewed under a microscope under controlled 
humidity (80%) and temperature (30°C) and videos were recorded using a high speed 
camera (500 frames per second (fps)). The Chlamydomonas cultures included cells at 
various stages of the cell cycle, including flagella-less forms, so only cells where the 
beat pattern appeared symmetrical were used in the analysis. The mean flagella beat 
frequency (FBF) of 20-26 individual cells was calculated and their Immotility Index 
was determined by counting the number of cells with static flagella as a percentage of 
the total number present in 5-10 slowed down video sequences. These measurements 
were similar to those done in Section 5.1.2.3 on zebrafish olfactory pit cilia. All data 
were tested by one-way anova and individual data sets were compared using an 
unpaired Students t-test with Bonferoni correction for repeated measures. This 
analysis was carried out by Dr. Robert Hirst, Department of Microbiology and 
Immunology, University of Leicester.
The calculated FBF was 47.9 Hz for control cwl5, 0 Hz for static flagella mutant 
pfl7, 53.5 Hz for pfl7-T  and 24.9 Hz for p/77-Tmut (Table 5.4 and Figure 5.11). 
There was no significant difference in the FBF of cwl5 (control) and the p fl 7-T strain 
rescued with wild type RSP9. The p fl 7 strain flagella were all static. There was a 
significant (p<0.05) decrease in the FBF of p fl  7-Tmut compared with the cwl5 and 
pfl 7-T strains, to approximately half their values.
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The Immotility Index was determined to be 1% in control cwl5, 99.8% in p fl 7, 4.6% 
in p fl  7-T and 73% in p fl  7-Tmut (Table 5.5 and Figure 5.11). There was a significant 
difference in the Immotility Index between cwl5 control and p fl 7 (99% increase), 
where the latter were all static and cwl5 were motile at expected wild type levels. 
The p fl 7-T rescued strain was in line with control cwl5 for flagella immotility and 
was similarly significantly different to p fl  7, showing a decrease of 95.2%. The pfl 7- 
Tmut strain had a significantly different Immotility Index compared to both cwl5 
control and p fl 7 (p<0.05): cwl5 and p fl 7-T had almost full motility and p fl 7 was 
fully immotile, whereas the p fl 7-Tmut strain had 73% immotile flagella, reflecting a 
smaller reduction in motility compared to the putative null allele causing static 
flagella in p fl 7.
This data indicated that introduction of the wild-type RSP9 gene onto an RSP9-null 
background (pfl 7) rescues flagella motility and that introduction of RSP9 carrying the 
c.780_783delCGCmutation (equivalent to c.804_806delGAA (K268del) in human 
PCD families 146 and 152 -  Chapter 4) restores only a proportion of motility. 
Therefore the C6ORF206/RSP9 homologue in Chlamydomonas reinhardtii, RSP9, is 
essential for flagella function and the mutation identified in families 146 and 152 
could indeed cause the reduced motility observed in their respiratory cilia. It was not 
possible to make any conclusions about changes to the waveform or its coordinated 
action in the Chlamydomonas model, due to the variability of motility amongst 
Chlamydomonas in these non-synchronous cultures.
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cwl5 p/17 p fl7 -T p f l  7-Tmut
N um ber of cells (n) 21 26 20 21
FBF (Hz/bps +/- SEM) 47.9 +/- 3.0 0.0 +/- 0.0 53.5 +/-3.13 24.9 +/- 2.43
Table 5.4: Flagella Beat Frequency (FBF) in cell wall-less RSP9 transform ants. cwl5 is the 
motile control, p fl7  (cell wall-less) is the static flagella strain, pfl7-T  is the wild-type RSP9 
transformant of pfl7, pfl7-TmuX is the mutagenic RSP9 (780-783delCGC) transformant of pfl7. Data 
represents the means and SEM of 20-26 cells per strain.
cwl5 p f l  7 p fl7 -T p f l  7-Tmut
N um ber of recordings (n) 10 5 7 10
Immotility Index (%  +/- SEM) 1.0 +/- 0.66 99.8 +/- 0.20 4.6+ /- 1.4 73 +/- 5.22
Table 5.5: Immotility Index in RSP9 transform ants. cwl5 is the motile control,/j/77 (cell wall- 
less) is the static flagella strain, pfl7-T  is the wild-type RSP9 transformant of pfl7, p fl 7-Tmut is the 
mutagenic RSP9 (780-783delCGC) transformant o fpfl7 . Data represents the means and SEM of 5-10 
video recordings per strain.
u - 2 0 -
B
120i
^ 100-
%  60- 
40-
A'
Figure 5.11: G raphical representation of
data in tables 5.4 and 5.5. The mean flagella 
beat frequency (FBF) (A) and mean Immotility 
Index (B) of four strains of Chlamydomonas. * 
indicates p value <0.001 -  /^7 -T m u t is 
significantly different from cwl5, p fl  7 and 
a%AT.
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5.2 Discussion
Following the identification in chapter four of a homozygous 3 bp deletion 
(c.804_806delGAA) in C6ORF206/RSP9 in DNA from all seven affected individuals 
of two Arabic families with PCD, functional analysis was performed to investigate 
the C6ORF206/RSP9 gene and to determine if the single RSP9 mutation found in the 
UCL PCD family collection was pathogenic. The deletion is predicted to cause an in­
frame single conserved amino acid deletion (K268del) in the C-terminus of the 
C6ORF206/RSP9 protein. Although the 3 bp deletion was not present in 126 
population matched control chromosomes, this may not be sufficient to provide 
definitive proof that this is not a non-pathogenic polymorphism. In order to ensure a 
95 % confidence that this is not a polymorphism with a frequency of 0.01, 340 
normal control chromosomes should be analysed (Collins and Schwartz, 2002).
The radial spokes are located at periodic intervals along the length of the cilia and 
flagella axoneme. In the Chlamydomonas model system it has been established that 
they form a connection between the central pair and peripheral microtubules to act as 
a scaffold for signal transduction from one component to the other in order to 
coordinate the cilia/flagella waveform, although the precise mode of action is poorly 
understood (Yang et al., 2006). The radial spoke consists of a “stalk” and a “head” 
(Figure 1.7), both of which are made up of many protein subunits, a proportion of 
which have Ca^ ,^ AKAP and nucleotide-binding domains that are thought to function 
in signal transduction. RSP9 is a component of the radial spoke head located close to 
the central pair in Chlamydomonas flagella, along with RSPl, RSP4, RSP6 and 
RSPIO (Figure 1.7). 2D gel electrophoresis of axonemal polypeptides prepared from 
Chlamydomonas mutants lacking any one of the radial spoke head proteins revealed 
that a null mutation in any one of the five radial spoke head components leads to 
breakdown of the whole head structure in the axoneme (Cole, 2005; Huang et al., 
1981).
An overlap in the expression pattern of C6ORF206/RSP9 and the PCD gene DNAH5 
was demonstrated by in situ hybridisation in mouse tissues known to carry motile 
cilia: the nasal and tracheal epithelium and the embryonic node. Although the 
resolution of the in situ hybridization prevented analysis of expression specifically in 
the cilia axoneme, it can be postulated that C6ORF206/RSP9 is expressed specifically
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in ciliated cells due to its homology with the Chlamydomonas RSP9 gene, which 
encodes a radial spoke head protein (Yang et al., 2006). C6ORF206/RSP9 expression 
was not, however, expected in the embryonic node due to the absence of situs 
inversus in affected individuals of families 146 and 152. It had not previously been 
established whether radial spokes are present in nodal cilia, although it is known that 
the nodal cilia have a 9+0 structure, i.e. no central pair. If radial spokes are present in 
nodal cilia as suggested by node-specific staining of RSP9 they may have a redundant 
or reduced function as there is no central pair to relay signals from to the inner dynein 
arms on the peripheral microtubule doublets. It is possible that rather than play a 
direct role in motility as they do in 9 + 2 cilia, they could be present to provide 
structural integrity to the 9 + 0 axoneme.
The ultrastructural defect caused by the c.804_806delGAA (K268del) mutation in 
family 146 and perhaps also family 152 is an intermittent absence of the central pair, 
giving rise to a normal ciliary beat frequency (CBF) but with a circular beat pattern 
that is not effective for mucociliary clearance (Stannard et al., 2004). Nodal cilia are 
thought to have a circular beat pattern, so it may be consistent that any defect 
resulting in a circular beat pattern for respiratory cilia would not cause a defect in 
nodal cilia. This was in fact previously discussed by Stannard et al (Stannard et al., 
2004). Thus, C6ORF206/RSP9 is present at the mouse embryonic node but its exact 
purpose is not yet clear. It could even be residual and serve no specific function.
Following C6ORF206/RSP9 gene knockdown in zebrafish by injection of splice- 
targeting morpholino oligonucleotides, no immediately obvious cilia defect 
phenotype was observed: situs inversus, hydrocephalus or cystic kidneys. However, 
after closer observation of olfactory pit cilia in embryos 72 hours post fertilization 
(hpf), it was revealed that morphants had a significantly increased olfactory cilia 
dysmotility and immotility index compared to wild type controls. In addition, the 
morphants had a normal CBF, which was at wild type levels. This phenotype was 
consistent with that seen in respiratory epithelial cilia from affected individuals of 
family 146 who have the c.804_806delGAA mutation in C6ORF206/RSP9. This 
provides support for the hypothesis that loss-of-function defects in this gene cause 
this unusual ciliary phenotype.
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Zebrafish have a conserved nodal cilia function equivalent to human embryos and 
therefore provide a good model for left-right axis determination (Essner et al., 2002). 
The absence of situs inversus in the zebrafish C6ORF206/RSP9 morphants supported 
the hypothesis that C6ORF206/RSP9 does not function in the left-right axis 
determination role of nodal cilia. However, it should be noted that expression studies 
must still be performed to prove that C6ORF206/RSP9 is in fact expressed at the 
Kupffers vesicle, the zebrafish equivalent of the human embryonic node. Further 
work could include tissue-specific RT-PCR and immunofluorescence experiments to 
prove protein knockdown and/or mis-localisation in the morphants. In addition, in 
order to provide an important control, wild-type RSP9 mRNA would be expected to 
rescue the normal phenotype in a morphant and this experiment is currently 
underway.
RSP9 is the Chlamydomonas reinhardtii homologue of human C6ORF206 and was 
proven in this study to be the defective gene in the Chlamydomonas paralysed flagella 
mutant strain, p fl 7. Sequencing revealed that a single base pair deletion in exon 2 of 
RSP9 (131delG) was present in p fl 7 but not wild type Chlamydomonas, which was 
predicted to result in a severely truncated protein and therefore produce a null 
background. In this chapter, the Chlamydomonas mutant p fl?  was significantly 
rescued for motility by successful transformation of the wild-type RSP9 gene and 
“semi-motility” was observed in p fl?  after transformation of the RSP9 gene 
containing a mutation expected to mimic the loss of the homologous amino acid that 
was deleted in families 146 and 152. In Chlamydomonas, the homologous amino 
acid deleted in order to mimic the K268del mutation was an arginine instead of a 
lysine at this position. This residue was not therefore conserved although both these 
amino acids have similar basic, polar properties, which suggests a possible functional 
conservation of this position between species rather than absolute amino acid 
conservation. Therefore, it was proposed that it may be the absence of the amino acid 
at that position, rather than loss of its specific chemical properties that may confer 
protein dysfunction. The Chlamydomonas results further proved that defects in the 
RSP9 gene cause dysmotile cilia and flagella. In addition, they suggest that the in- 
ffame single amino acid deletion identified in PCD patients causes a reduced motility 
compared to wild-type, a cilia dysfunction sufficient to cause disease. However, the 
effect of different transgene copy numbers cannot be excluded as a cause of differing
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levels of motility in the Chlamydomonas transformants. Therefore, quantitative PCR 
should be performed on transformant DNA in order to confirm that copy numbers are 
not significantly different.
The predicted effect of the 131delG mutation identified in the p fl 7 mutant 
Chlamydomonas on the RSP9 protein product is a ffameshifl after residue S45 and a 
severe truncation of the 269 amino acid protein. This likely results in a null mutation, 
since the 45 amino acid mutant protein translated would not be expected to retain any 
function and might likely be unstable and degraded. The phenotypic effect of this 
null mutation in p fl 7 is paralysed flagella which at the ultrastructural level display an 
absence of radial spoke heads, disorganised spokes and displacement of the central 
pair towards one side of the axoneme (Huang et al., 1981). The c.804_806delGAA 
mutation revealed in the human C6ORF206 gene however, was a mutation at the 3’ 
end of the gene only 22 bp from the stop codon. The predicted effect on the RSP9 
protein, the in-frame deletion of one amino acid at the C-terminus, seems likely to be 
milder in its deleterious effect on protein function. The phenotypic effect of 
dysmotile cilia, described as having a circular beat pattern and an intermittent absence 
of the central pair along the axoneme may therefore reflect a less disturbed RSP9 
protein than the severely truncated mutant protein in the p fl 7 Chlamydomonas which 
have totally static flagella. Unfortunately, it was not possible to visualise the radial 
spokes in family 146 in EM micrographs from Prof. O’Callaghan for comparison. 
Table 5.6 shows a summary to compare the different mutations and phenotypes in 
human versus the Chlamydomonas RSP9 mutant.
To speculate on the significance of the c.804_806delGAA human mutation, the 
central pair-radial spoke interactions are thought to propagate the cilia bend and 
direction and the radial spoke-inner dynein arm interactions are thought to play a role 
in the velocity of the bend (Figure 5.12) (Smith, 2002; Smith and Lefebvre, 1997). 
As p fl 7 mutants have an absence of radial spoke heads, the signal for bend 
propagation could be lost and therefore the paralysed flagella phenotype presents. 
We propose that introduction of wild-type RSP9 as observed in the rescue 
experiments in this chapter, results in re-building of the radial spoke head so that the 
bend propagation signal is regained and flagella motility is restored. As the affected 
individuals of family 146 and 152 have only a slight change in RSP9 (in frame single
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amino acid deletion), it can be postulated that the radial spoke head is still formed and 
that there is enough of an interaction with the central pair to propagate a bend, but not 
enough to regulate waveform, thus the CBF is normal but dysmotility and immotility 
is increased. This hypothesis is summarised in Figure 5.12.
In future work it would be of interest to determine the protein composition of the 
radial spokes in the Chlamydomonas strains that were created mimicking the human 
mutation, versus wild-type. We speculate that unlike p fl 7 where all five spoke head 
proteins are absent from the axoneme, the Chlamydomonas strain mimicking the 
human mutation would be associated with a more preserved spoke head with a 
preserved but partial function. Western blots on isolated flagella axonemes using 
radial spoke head antisera would be a good way to approach this.
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Phenotype
Human RSP9 
804-806delGAA
Chlamydomonas p fl  7 
RSP9 131delG
RSP9 protein Missense mutation Null mutation
Central pair Intermittent Complete but displaced
Radial spoke Not possible to visualise Absent radial spoke heads
Cilia/flagella beat Rotational, dysmotile Paralysed flagella
Table 5.6: Comparison of human and Chlamydomonas p f l7  RSP9 m utations and phenotypic 
effects.
IDA
IDA-RS interactions 
act on velocity of bend
Peripheral 
MT doublet
Human RSP9 families 146 
and 152: only slight RSP9 
change - interaction enough 
for bend propagation but not 
bend regulation (circular 
ciliary beat pattern)
RS stalk
pfl 7: loss of RS head 
signal for bend 
propagation lost 
(paralysed flagella)
CP-RS interactions 
coordinate bend propagation 
and direction
Figure 5.12: Radial spoke function and the proposed effects of RSP9 mutations on the beat 
pattern  of cilia and flagella. RS = radial spoke, CP = central pair, IDA = inner dynein arm, MT = 
microtubule. Red text = effect of p fl 7 RSP9 131delG mutation. Blue text = effect o f human RSP9 
C.804 806delGAA mutation.
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6 CHAPTER SIX
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6.1 GENERAL DISCUSSION
6.1.1 Conclusions from this study
This study involved genetic analysis in consanguineous PCD families using whole- 
genome linkage analysis by homozygosity mapping. After linkage analysis, a 
positional cloning approach was followed by identification of positional candidate 
genes and DNA sequencing in linked patients, versus controls. The results of this 
study revealed linkage in four out of five Pakistani families with absent inner and 
outer dynein arms to either chromosome Hq23.3-q24.3 or chromosome 17q21.31- 
q22. A comparative bioinformatic approach identified four positional candidate 
genes, each of which have been screened for mutations but none found as yet.
Furthermore, a locus on chromosome 6p21.2-21.1 was consistent for linkage in a 
large family pedigree 152 of Arabic Bedouin origin with an unknown ultrastructural 
phenotype. This locus overlapped with one identified in a separate genome screen in 
family 146 from the United Arab Emirates (UAE) with an intermittent central pair. A 
common mutation (c.804_806delGAA/K268del) was revealed for both families in the 
human homologue of Chlamydomonas radial spoke head protein, RSP9. RSP9 
expression was confirmed by in situ hybridisation in specific ciliated tissues in 
mouse, including the nasal epithelium, trachea and the embryonic node.
RSP9 was proven to cause cilia motility defects by complete knockdown in zebrafish 
morphants. A null mutation in the RSP9 gene in pre-existing Chlamydomonas 
mutant, p fl  7, was found to underlie its paralysed flagella phenotype and this was 
rescued back to normal motility by incorporation of the wild-type gene into the 
genetic material of the alga. Introduction of the RSP9 gene carrying the equivalent of 
the K268del mutation into p fl 7 resulted in restoration of motility but not to wild-type 
levels, which is consistent with the clinical phenotype observed for family 146. 
These data confirm that RSP9 is a PCD-causing gene and genes for radial spoke 
proteins can be considered good candidates for PCD with radial spoke and central 
pair defects.
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This study revealed that C6ORF206IRSP9 is expressed at the embryonic node in 
mouse. However, the K268del mutation did not give rise to situs inversus in any of 
seven PCD patients who were homozygous carriers of the mutation, nor did a 
significant number (3 out of 326) of zebrafish RSP9 morphant embryos display 
laterality defects, despite complete C6ORF206/RSP9 gene knock down. In both 
zebrafish morphants and human PCD patients, cilia expressing the K268del mutation 
displayed a dysmotile circular beat pattern which was ineffective for mucociliary 
clearance but that could be proposed to be similar to that observed for cilia at the 
embryonic node. We therefore postulate that although C6ORF206/RSP9 and 
presumably radial spokes are present at the node during development, they do not 
function to influence nodal cilia motility; and that defects in this protein do not affect 
the circular beat pattern required of nodal cilia for leftward nodal flow in 
determination of situs during development. Furthermore, we propose that radial 
spoke head proteins can be considered good candidate genes for PCD without situs 
inversus.
A proportion of PCD patients are classed as “radial spoke defect”. These patients can 
have situs inversus and they have been shown by EM to have absent radial spokes 
and this is typically accompanied by absence of the inner dynein arm (Chilvers et al., 
2003). In these cases, the central pair microtubules can be affected and take up an 
eccentric position suggesting that they are destabilised. The beat pattern is “stiff’, 
such that the cilia fail to bend, and the cilia have a greatly reduced beat frequency 
(Chilvers et al., 2003). For this defect, we can predict that the complete loss of the 
radial spoke-central pair interactions that usually act to propagate the cilia bend 
(Section 5.2, Figure 5.12), cause the “stiff’ beat pattern, coupled with the loss of 
inner dynein arm-radial spoke interaction that acts on the velocity of the bend, 
resulting in the reduced beat frequency. These beat patterns are consistent with the 
presence of situs inversus in such PCD cases with the classic radial spoke defect, 
since nodal cilia motility would be expected to result in laterality defects. The classic 
radial spoke defect is a distinct phenotype to that of the Arabic PCD families used in 
this study who have an intermittent central pair and a circular beat pattern with a 
normal beat frequency. As described in Section 5.2, these families still have inner 
dynein arms present in the axoneme, so the ciliary beat frequency is not affected, but
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the beat pattern may not be regulated due to disruption in the radial spoke-central pair 
interactions.
6.1.2 Mapping genes for PCD, a genetically heterogeneous 
disorder
Positional cloning and mutational screening of candidate genes in PCD laboratories 
and diagnostic centres has highlighted the high degree of genetic and phenotypic 
heterogeneity that exists for PCD. Genetic heterogeneity is further proven by the 
different modes of inheritance of PCD: although the majority of cases are autosomal 
recessive, there have been some X-linked and autosomal dominant cases documented 
(Krawczynski and Witt, 2004) (Moore et al., 2005) (Narayan et al., 1994). It has also 
been proposed that PCD could be inherited as a digenic disorder, whereby two 
mutations in two different genes cause the PCD phenotype (Blouin et al., 2000). The 
PCD genes DNAIl, DNAH5, DNAHll and TXNDC3 have all been associated with 
genetic heterogeneity: each cause only a proportion of disease in families with similar 
origins and ultrastructural defects (Pennarun et al., 1999; Bartoloni et al., 2002; 
Duriez et al., 2007; Olbrich et al., 2002). Mutations in DNAIl, DNAH5 and TXNDC3 
have all been shown to cause missing outer dynein arms and no further sub-grouping 
of the phenotype according to different gene mutations has yet been possible. 
Therefore, although grouping of affected individuals based on their ultrastructural 
defect is likely to reduce heterogeneity, patients classified as having similar ciliary 
defects may still harbour mutations in different genes. This is a problem of the level 
of ultrastructural detection that is possible as present. EM results vary and this is 
likely to be contributed to by the fact that it is mostly based on cross sections and we 
know that cilia vary along the axoneme (Fliegauf et al., 2005). The inner dynein arm 
is highly heterogeneous and difficult to visualise, as are radial spokes so these 
ultrastructural defects may often be undetected. Furthermore, different laboratories 
perform EM for diagnostic purposes and therefore the results can be inconsistent and 
of varying quality.
In order to minimise heterogeneity in this study, in Chapter 3, five families (120, 130, 
141, 143 and 145 -  Figure 3.1) of Pakistani origin with outer and inner dynein arms 
defects were grouped together for genetic analysis. However, genetic homogeneity
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was not guaranteed and indeed, two loci on chromosome Hq23.3-q24.3 and 
chromosome 17q21.31-q22 were consistent with linkage in four out of five families 
in both cases. Therefore, despite grouping individuals with the same geographical 
origin and/or ultrastructural defect, they are not guaranteed to be linked to the same 
locus. Both loci were statistically significant and indistinguishable by HOMOG3R 
analysis for likelihood of linkage. Similarly, a microsatellite screen performed on 
family 146 with three affected individuals (Figure 3.1) from the United Arab 
Emirates (UAE) with a central pair agenesis defect (Stannard et al., 2004), had 
revealed two putative loci of equal weight on chromosome 3 and 6 that both achieved 
LOD scores of 2.5 (Section 4.1.6). Again, these loci were indistinguishable for this 
family alone.
Therefore, more than one locus of equal significance was found in these family 
groups, grouped together based on geographical origin, or even as one single family. 
In the case of the Pakistani families, this happened because the families were split 
across two loci, whereas in the case of single Arabic family 146, this was due to lack 
of power for linkage: there were only three affected patients which together could 
achieve a maximum LOD score of 2.5. In contrast, a SNP screen performed on the 
large consanguineous family 152 with four affected individuals revealed a clear-cut 
single locus with a LOD score >3 on chromosome 6, with no other region in the 
genome achieving a LOD score above 0.5 (Appendix 2). This was due to the greater 
power afforded by a family with four affected individuals. The locus on chromosome 
6 was found to overlap with that previously identified for family 146 and together 
these two Arabic families achieved a LOD score of 6.7 on chromosome 6, so this 
allowed prioritisation of this locus rather than the locus on chromosome 3 in family 
146. Eventually a common mutation was found within a positional candidate gene in 
both families 146 and 152. This study therefore demonstrated that despite the 
presence of consanguinity, larger families with more affected individuals are 
preferable to multiple families in genetic analysis of such a heterogeneous disorder, in 
order to be sure of the true linkage status of any loci identified. However, linkage 
analysis may be undertaken in a family/families that will not achieve a LOD score of 
3 and intelligent bioinformatic analysis of ciliary candidates in regions of interest may 
be identified successfully.
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Until recently, microsatellites have been used as the primary markers in linkage 
analysis. The development of several high through-put genotyping platforms, 
including that supplied by Illumina used in this study, now make it feasible for SNPs 
to be used in linkage analysis. There has been considerable debate on the advantages 
and disadvantages of the use of microsatellite versus SNP-based genome-wide 
linkage screens (Schaid et al., 2004). An advantage of using microsatellites is that 
they are highly polymorphic, more so than the diallelic SNPs. They produce higher 
LOD scores compared to SNPs due to increased informativity. However, the 
advantage of SNPs is that there are more present in the genome so are used in linkage 
screens on the basis that their greater density will compensate for the smaller amount 
of information per SNP. Furthermore, a number of SNPs in close proximity in the 
genome can act as “super” alleles by forming local haplotypes and therefore offer 
greater linkage content. In Chapter 4 of this study, the region on chromosome 6 that 
was highlighted following a 600 kb SNP screen and found to be consistent for linkage 
in Arabic family 152, was previously undetected in a less dense 10 cM microsatellite 
screen. In this case, therefore, the denser SNP based genome screens were proven to 
be more valuable than microsatellites in identifying regions of homozygosity, even in 
a large consanguineous PCD family with four affected individuals.
An increased understanding of the structure and function of human cilia has arisen 
from model organism studies as well as some significant advances including 
characterisation of the human cilia proteome. The structure and function of cilia has 
been investigated extensively using the model organism Chlamydomonas reinhardtii 
due to the high conservation of its flagella proteins with orthologues in the human 
genome present in human cilia and sperm flagella. In addition, much has been learnt 
about motile and sensory cilia in mammals using electron microscopy and 
immunolocalisation studies (Satir and Christensen, 2008). Much more work will be 
needed to understand the additional complexity of the human system. Using 
Chlamydomonas studies, it is known that dynein regulation in motile cilia and flagella 
depends upon interactions between the radial spokes and central pair apparatus that 
govern cilia waveform (Mitchell, 2004). However, the exact nature and function of 
the components involved is not yet understood for either Chlamydomonas flagella or 
mammalian cilia. In addition, the role of cilia/flagella protein interactions such as 
these is not understood within embryogenesis and development. Further work is still
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needed to enhance the understanding of cilia in both development and disease and 
offer more candidates in the mapping of genes for ciliopathies.
6.1.3 The future for identification of PCD genes
PCD can be difficult to diagnose since the diagnostic techniques are rather specialised 
and some of the symptoms such as recurrent respiratory infection and glue ear are 
common in children (Afzelius, 1998). Moreover, disease severity is highly variable. 
Early diagnosis leading to early treatment correlates with an improved prognosis and 
morbidity which allow a better quality of life for patients (Bush et al., 1998; Coren et 
al., 2002). The identification of disease genes would aid in the diagnosis of PCD in 
individuals with a history of recurrent respiratory infection. The location of heavy 
dynein chains DNAH5, DNAH8 and DNAH7 and intermediate chain DNAIl have 
been shown by immunofluorescence to be defective in a proportion of PCD patients 
(Fliegauf et al., 2005; Zhang et al., 2002). Similar proteomic approaches in other 
PCD patients could potentially identify the absence of particular protein components, 
provide a firm basis for the sequencing of known PCD genes and even allow for the 
more accurate grouping of patients to further minimise heterogeneity. This could be 
aided by development of additional antibodies to axonemal components to 
complement those already in use, for example by raising radial spoke and central pair 
antisera.
Since PCD is a recessive disorder, it is most likely to be caused by loss of function of 
a gene product and therefore gene replacement therapy may in future be appropriate. 
In addition, the primary defects in PCD affect the structure and/or function of cilia 
located in the relatively accessible upper and lower respiratory tract. Heterozygous 
parents of PCD patients are asymptomatic, thus indicating that the protein would only 
need to be restored to 50 % of wild type levels in order to restore a normal phenotype. 
The dynamic nature of cilia by intraflagellar transport (IFT) means that the normal 
gene product could be expected to correctly incorporate into the axoneme and 
therefore lead to the restoration of functional cilia motility. Our studies that rescued 
Chlamydomonas motility in an RSP9-depleted mutant indicate that this is likely to be 
the case in RSP9 PCD patients. Progress in the treatment of the respiratory tract 
disease cystic fibrosis (CF) with gene therapy in humans with CF has been made.
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although complications have occurred associated with limitations of effective gene 
transfer and the requirement of constant re-treatment due to a limited persistence of 
gene expression (Welsh and Zabner, 1999). However, current advances in gene 
therapy for respiratory diseases such as CF might pave the way for similar treatments 
for patients with PCD and as such, identification of genes causing PCD would allow 
potential gene therapy techniques to be used in the cure for PCD in future. 
Furthermore, there might also be utility for wider PCD-related phenotypes, including 
infertility.
The link between left-right body axis determination and motility of embryonic nodal 
cilia has been documented. It is possible that the identification of genes involved in 
the structure and function of both respiratory and nodal cilia may allow important 
insights into the process of laterality determination. It is still not clear if both motile 
and non-motile cilia co-exist at the node. In particular, the link between the motility 
of nodal cilia and the initiation of downstream signalling cascades and gene 
expression requires further understanding. A greater understanding of the pathway of 
laterality determination would be of particular benefit for patients with PCD and situs 
ambiguous, since this requires clinical interventions unlike situs inversus, which is 
harmless.
Many PCD genes remain to be identified and characterisation of the protein 
composition of the ciliary axoneme using model organisms such as Chlamydomonas 
has helped with this process. The development of resources such as 
www.ciliaproteome.org have been hugely powerful tools for PCD gene identification. 
Further understanding of cilia structure and function will impact on the current 
understanding of ciliopathies and respiratory research, left-right axis determination, 
male and female fertility, as well as sensory cilia function within the kidney and 
photoreceptor cells of the retina.
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APPENDIX 1
Multipoint MERLIN linkage analysis for families 
120, 130, 141, 143 and 145 following 600kb 
Illumina SNP screen.
Genetic linkage analysis for the region identified on 
chromosome 9
Haplotype analysis the region identified on 
chromosome 9
Novel in house markers used for fine mapping of the 
chromosome 17 locus
Comparative BLAST and function analysis of genes 
within the region of interest on chromosome 11 and 
17
Primer sequences used for sequencing 
Candidate gene sequences with primers highlighted
233
Multipoint MERLIN linkage analysis for famiUes 120, 130, 141, 143 and 145 following 
600kb Illumina SNP screen. HLOD scores >3 om chromosomes 11 and 17.
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Illumina 
screen SNPs 
only
All 5 families - Illumina 
screen SNPs plus extra 
microsatellite markers
Marker name
Genetic
distance
(cM) LOD score LOD alpha HLOD
rsl413219 116.31 -0.041 -8.445 0 0
rs l128786 117.71 1.866 -3.805 0.418 1.492
rsl040989 118.51 1.976 -4.18 0.382 1.542
rsl4419 118.71 1.988 -6.535 0.361 1.517
rsl871692 119.76 2.019 -6.062 0.335 1.351
rsl000709 120.99 2.039 -9.615 0.193 0.97
rs726657 121.49 2.044 -10.005 0.193 0.974
rsl060545 121.49 2.044 -10.005 0.193 0.974
rsl757096 121.49 2.044 -10.005 0.193 0.974
rs944510 121.49 2.044 -10.005 0.193 0.974
rsl250019 121.49 2.044 -10.005 0.193 0.974
rsl250288 121.63 2.044 -9.004 0.194 0.976
rsl 405 122.92 2.046 -3.992 0.409 1.695
rsl334071 123.72 2.048 -3.265 0.474 2.013
rs l572306 123.97 2.048 -3.052 0.497 2.128
rs734096 124.32 2.047 -2.737 0.53 2.334
rs724975 125.47 2.028 -2.663 0.53 2.312
rs230146 125.65 2.022 -2.734 0.529 2.302
rs914652 125.83 2.009 -2.805 0.527 2.282
rsl013324 127.84 1.575 -3.134 0.467 1.653
rs769012 128.43 -0.038 -5.461 0.221 0.397
Genetic linkage analysis on chromosome 9. LOD, alpha and HLOD score shown for all five Mirpur 
PCD families after high resolution marker typing using Illumina SNP genotyping results. Genetic 
distance in centimorgans (cM) according to the Illumina genetic map constructed by deCODE. 
Maximum HLOD at this region highlighted in red.
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High density haplotyping of M irpur families a t the putative locus on chromosome 9. Genetic distance in cM (centimorgans). Boxing indicates homozygosity. Arrows 
indicate flanking markers.
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Marker Forward Reverse
17-Mir-l ggcctgagaggataggatgag agaatcaggcgtcggaaac
17-Mir-3 gatgctgagcctttcctcac catgggtgtctgtgcaactg
17-Mir-4 tggcctatcaaagggctagg gtgcacagccacacatcac
D17S-SPAG9 gagttcaagtgcccatcctg gttcttagcctcgaattcctgggttc
Chl7-nr-D17S1865 atgtcatgccaccctctcctg gttcttggtggtggacacctatagtcc
Chl7-AC019315 ccatggtaagacatagcctctc gttcttgcctgggataaacagctttg
Novel in-house markers used for genotyping on chromosome 17
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ACCtltlOfI LocHton (Mbt McKi UmatfM «xortsilon
NM 012101 3
119487206-
119514073 0 0
It la able to complement the radioeenaltlvity defect of an ataxia 
telanaiectaala (AT) fibroblaat cell line B-Box-type zinc finger: zinc binding domain
placenta, prostate and
NM 178507 2
119586957-
119605859 0 0 0 0 Function unknown No conserved domains detected
brain, nerve cord, 
expressed In embryonic, 
larval and adult gonads of 
both sexes, and larval 
imaginai disks
NM 014352.1
119616256-
119695663 0 0 0 0
POU2F3 In cervical cancer cell* may be CC-relatod tumor auppreaeor
POU domain. Homsodomain
colon, eosphagus. 
pancreas, placenta, testis,
NM 174926.1
119701226-
119706556 0 0 0 Function of protein unknown
placenta, prostate and 
thymus. Colocallzes with 
intermediate filaments
NM 015313.1
119713156-
119665855
Rho gumnlne nudeotid* «xchangt factor (GEF) 12
0 0
Rho GTPaeee play a fundamental role In numerou# cellular proceeeea 
that are Initiated by extracellular etimull ttiat work through 0  protein 
coupled receptor*. The encoded protein may form a complex wllh G 
protein* and atlmulate Rho-deoendent eional*. ThI* PDZ or RhoGEF domain
brain, colon, kidney, liver, 
lung, ovary, pancreas, 
prostate, testis, thvroid.
NM 014619.2
120036236-
120362179 0 0
L-glutemate act# a* an excitatory neurotranemitter at many eynapee* 
in the central nervou* eyatem The poeteynaptlc action* of Olu are 
madlated by a variety of receptor* that are named according to their 
•elective agoniete ANF receptor. PBPb. Ligand-gated ion channel domain
NM 152715 2
120400040-
120463333 1 0
novel regulator of tubulin etability vrith overexpreaalon caueing 
depolymerizatlon of microtubule* and auppreaalon reaulting in an
Trypanosoma - dynein light chain. Anthocidaris craseispina - outer arm 
dynein light chain 2. A edes aegypti - dynein light chain.Homo sapiens - brain, kidney, liver, lung
NM 005422.1
120478565-
120566725 0 1
Alpha-tectorin 1* one of the major noncollagenou* component* of the NIDO. von Willebrand tector (vWF) type D domain. Trypsin Inhibitor brain, testis, lung, uterus.
NM 006918.3
120666706-
120684556
atarol-CS-daaaturaaa (ERG3 daHa-5-deaaturaae
0
encode* an enzyme that is  involved In cholesterol biosynthesis. It is
brain, heart, lung, testis, 
thymus, uterus, liver,
NM 003105.3
120628130-
121005610
aorlilin-ralatod racaptor. L<DLR daaa) A repeat*- multifunctional endocytic receptor, that may be Implicated in the
brain, heart, kidney, liver, 
lung, ovary, testis, thymus.
NM 001001786 1
121491272-
121492133 BRCC2 fBRCC2V
proapoptotic molecule through the caspaee-dependent mitochondrial
brain, heart kidney, liver, 
lung, testis, thymus.
NM 032873 3
122031640-
122190390 Cbl-lnteractinq protein Sts-1 rSTS-1 ).
inhibit endocytosi* of epidermal growth tector receptor (EGFR) and brain, heart kidney, liver.
NM_019604.2
122214465-
122246557
claae-l MHC-reatricted T cell aeeodated molecule 
(CRTAM).
regulate* a large panel of cell/cell interaction* both within and outside 
of the immune system spermatogonie immunoglobulin supertemily brain, kidney, lung, thymus
NM 024806 ?
122256683-
122335639 chrom oaom ell ooen reading frame 63  (C11orfB3i unknown
brain, kidney, lung, testis.
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tndogtnou* inhibitory rogulator of HSC70 by compotlng th« 
_____________________ PQChaoeron##_____________________ h#o70 dofmln (choptrono)heat ohock 70kPa orotein 8  fHSPA6).
brain, heart Wdney. liver. 
_______ lung, teetle_______adenovirue receptoradipocyta-epeclfic adheelon moleculeadipocyte-epedfic adheeion moiecule (ASAM),
brain. Wdney. liver, lung.
Modulatee channel aatina klnebce, Mvelin protein, eodlum channel voltaoe gatedeodium channel, voitaoe-oated. tvoe III, beta (SCN3B).
Tranedption factor, aeeodated with deft palate, but zinc finger 
cant be ruled out due to relationehip w #  ciliary oenee..
brain, heart kidney, lung. 
teetia. thvmue. tracheakrueppel aeeodated box, zinc finoer domainzinc finaer proWn 202 (ZNF202L
Involved in the formation of tight iunctioriefrandj.PMP22 daudin domain-containing protein fPMP22CDI.123261550
oltectory receptor, tamlly 10. eubtemily S. ment>er 1
Putative odorant receptor.
brain, kidney, liver, lung. 
teatie. thvmue. trachea
loaa of heterozygoaity. 11. chromoaomel region 2. gene
May plav a role in tumorigeneaia i trvpain inNbitor_NM_014622.4 J23522626
Stmduml compomnt of Ih» m p  junction».p«nn»«ln 3 IPANX3).
brain, heart, Wdnay. livar. 
lung, taatis, thymua, twcti»»___Domain of unknown function, but occura frequently in chromatin-124009440 tranalbrmlna growth factor beta regulator 1 (TBRG11,
brain, heart, kidney, liver, 
lung, teatla. thvmuaNM 170«0t.3 removea acetvl aroupa fromaiallc acida. Note, gene opcoaile so l 7sialic add acetvleateraae ISIAE),
>na pellucida-binding protein, but ita ubiquitoua expreaaion auggeata 
broader role in cell-cell adheelon and/or cell migration. Expreaeed 
_________ in cilia and (laaelia - coaa multifunctional rcie,___________
brain, kidney, liver, lung.
■Chlamvdomonaa RSP11 &RSP7 - due to domaine?aperm autoantioenic protein 17 fSPA17).
poeteynaptlc protein kinaee aubetrate • poaeible target for thyroid brain, kidney, lung, teetia.
NM 006176 1 neuroaranin (protein kinaee C aubetrate. RC3I (NRGN1.
124127319 :_and immunoglobulin domain containing 2  /VSIG2V V-aet and immunoglobulin domain containing protein 2 precuraor heart, liver, lung, teetialo domain
brain, heart, kidney, liver.
endothelial cell adheelon molecule /ESAMl. Endothelial cetl-aelective adheeion molecule precuraor. Ig domain
brain, heart. Wdney. liver.
124175509 _chromoaome 11 open reading frame 61 /C l 1orf61 V
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NM 022370 2
124240492-
124256572
roundabout, axon guidanca racaptor, homolog 3
0
involved dunng naurai development in axonal navigation at the 
ventral midllna of the naurai tuba. In epinal chord development playa 
a role in guiding commisaural axons probably by pravantlrrg 
prematura aanattivlty to Slit proteins thus Inhibiting Slit signaling 
through RO0O1 (Bv simllaritvl. Required for hindbrain axon midline
FIbronectin type 3 domain and Immunoglobulin domain cell adhesion 
molecule
brain, heart kidney, lung, 
testis, thymus uterus.
NM 152722 3
124294299-
124311156 0
the cytoplasmic domain of F U 25530 la aaaantlal to Ita function on call 
matrix Interaction and call motility anoodaa an Ig-lika tranamembrarw 
glycoprotein and Is Involved In call adhesion and growth control may 
be associated with carclnoaanaala of hspatocvtes brain, muade. liver, eye
NM 001037558.1
124294356-
124295783 auooraaaaa call orowth and Induces apootoaia in H ap02 calls No conserved domains detected brain, muade. liver, eye
NM 025004.1
124329227-
124380307
dna-dapandant rna polymerase catalyzes the transcription of dna Into 
ma usina the tour ribonuclaosida triDhosohataa a s substrates No conserved domains detected
brain, kidney, iiver, testis.
NM 1982771
124438442-
124464342
•oluta carrier Mmily 37 (glyoarol-3i>hoaphato
0 AuxHlarv transport protein activity UhoC Suaar phosphate oennease. NarK Nitrate/nitrite transporter
brain, heart, kidney, liver, 
testis, trachea, lung
NM 0220621
124706963-
124608135 0
may Interact with PBX proteins and play a role in tissue-specific 
reoulation of transcription mveloid ecotropic viral Intearation site
kidney, liver, lung, 
thymus.thyrold. brain, eye. 
heart spleen, skin, testis
NM 005103.3
124820860-
124871333
fasciculation and elongation protain zata 1 (zygin 1)
0
May be involved in axonal outgrowth a s component of the network of 
m olecules that regulate cellular morphology and axon guidance 
machinery Able to restore partial locomotion and axonal toedeulation 
to C.eleaans unc-76 mutants in oemviine transformation experiments no conserved domains detected
heart kidney, liver, lung, 
brain, ovarv. testis, thvmus
NM 004879 3
124944508-
124959784 0 0 ■n In m d lit* .u f1 y  induelion Mio*t «DODto*!* EtODO*l((»Hnduc«j DfOt»(n 2.4 dormin
brain, heart kidney, liver, 
lung, ovary, testis, 
thymus.thyrold, lymph.
— NM 152713.2
124967967-
124996162
STT3, subunit of the oligosaccharyltransfarasa complax,
0 1 0
Involved in protein glycoeylation. Either required for the assembly of 
the ollgoeaocharyi transferase (OTaae) complex or required in 
substolchiometrlc amounts tor OTaae activltv (Bv similarity 1. OllaoMccharvI tr>n*f«r«M STT3 tubunitor C 001287
high levels in placenta, 
liver, muads.and 
pancreas, and at very low 
levels In brain, lung, and
NM 001274 2
125001547-
125030847 1
Required for checkpoint mediated cell cycle arrest in response to 
DNA damaae or the presence of unrspllcated DNA
Serine/threonine protein kinase domain. SerineTThreonlne protein 
kinases catalytic domain
most abundant expression 
In thymua. testis, small
NM 001612 4
125047440-
125056152 0
arises v4thin the acrosomal vesicle during spermatogenesis and may
NM 138294.2
125121396-
125124952 axoressad in orostata and tasUs fPATEI. 0 0 Dhosoholipase A2 activity, calcium ion bindina. Hold catabolism No conserved domains detected orostete. testis, brain
NM 212555.1
125151236-
125153924 chromosome 11 ooan raadino frame 38 (Cl 1orf38V 0 Function Unknovm No conserved domains detected prostate
NM 1450141
125258719-
125275749
testis, liver, brain, kidney, 
lung, thvmus
NM 031307 2
125268591-
125278315 __________peaudouhdvlata svnthaaa 3 (PUS3).
Molecular Function Isomerase activity.Paeudouridylate synthase 
Biolooical Process TRNA oroceaaina Pseudouridine synthase domain
brain, heart, lung, ovary.
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NM 013264 2
125279601-
125298201
alteration of RNA secondary structure, such a s translation initiation, 
nudaar and mitochondrial splidng, and ribosome and splicaosoma 
aasambly, It may serve to maintain testicular functions related to 
- n — ,------ WMrratpa<n«^t DEAD-box hellcases. helicase suoertemilv c-terminal domain brain, luno. testis
NM 016952.3
125335784-
125438397
1 ha long isororm may piay a roia in naurai and giiai can adhesion In 
the developing embryo, the short Isoform may be a more general call 
adhesion molecule involved In other tisauas and imaginai disk 
morphogenesis, vital for embryonic development, essential for septate 
lunchons. seotate iunctions. which are the eauivaient of vertebrates locam. FN3 domains
brain, heart, kidney, lung, 
ovarv. testis
NM 032795.1
125577519- RNA pMUdouridylate tynthaM domain containing 4
Dseudouridvlate svnthase acNvltv. RNA binding and RNA processing Pseudouridine svnthase
brain, heart kidney, liver, 
lung, ovary, testis, thymus, 
pancreas
NM 024556 2
125566829-
125637750
temily with aaquanca similarity 118. mambar B 
fFAM118B). Function unknown SIR2-like
brain, heart kidney, liver, 
lung, ovarv. testis, thvmus
NM 003139.2
125638043-
125643960
signal recognition partiel# racaptor ("docking protain") 
(SRPR).
Ensures, in conjunction with SRP, the correct targeting of the nascent 
secretorv oroteins to the endoolasmic reticulum membrane svstem
Signal recognition particle alpha subunit N-terminal. signal recogrxtion 
oarticle (SRP). SRP54-tvoe protein GTPase domain
brain, heart kidney, liver, 
lung, ovary, testis, thymus.
NM 017547 2
125644265-
125653236
FAD-dapandant oxidoraductasa domain containing 1 
(F0XRE01).
Molecular Function: Oxidoraductasa activity 
Biolooical Process: Electron transoort GIvdne/D-amino acid oxidases
liver, thymus, heart brain, 
kidney, lung, ovarv. testis
NM 148910.2
125658212-
125668281
toll-intarlaukin 1 racaptor (TIR) domain containing
0
Adapter involved in the TLR4 signaling pathway in the innate immune 
response Acts via IRAK2 and TRAF-6, leading to the activation of NF 
kmppa-8. MAPK1. MAPK3 and JNK. resulting in cytokine secretion 
and the inftammatorv response Toll • interleukin 1 - resistance
brain, heart, kidney, liver, 
iung. testis, thvmus
NM 014026.3
125678857-
125720853 1 0 1
m 7G0P breakdovm by OcpS should prevent miaincorporation of 
methylated nucleotides In nudeio acids. The central histidine within 
the DcdS  hit motif Is critical for decapDino activitv Sc»v»txi»f decaDDina enzvm» (DcoS)
Wdney, Hver, Ixam, heart. 
luna.ov»rv.
NM 006278.1
125731306-
125789741
ST3 bata-galactoaida alpha-2.3-alalyltranafaraaa 4
0 0 0 1
It may catalyze the fomration of sequ en ces found In tenninal 
carbohydrate groups of glycoproteins and glycolipids. It may be 
Involved In the biosynthesis of the sialyi Lewis X determinant and the 
glvcolvsis pathway Olïse»ïBr«n»f»™»* tarrtlv 29 («iaMtran*!»™»»).
brain, heart. Wdney. liver, 
lung, ovary, prostate.
.. NM 032531.2
125799685-
126375615 0 0  . 1 1
interact with the C temiinus of podocin and is involved In ensuring
Size- and charas-ssioctlvs ultrafiltration in the kidney
Wdney brain, heart, liver, 
lung, ovarv. testis
NM 173579.1
126378015-
126381163 0 0 0 Function Unknown
NM 005238.2
127837466-
127897371
v-ata arythroWaatoaia virus E% oncogana homolog 1 SAM_PNT. SAM / Pointed domain. erythrot>last transformation specific
brain, heart Wdney. liver, 
lung, ovary, prostate, 
testis, thvmus
NM 002017.2
128069193-
128186325 Friand laukamia virus Intearation 1 fFLII V 0
Is a suppressor or coiiagen transcnpoon in human SKin in vivo. 
Overexpression of this protein affects cell growth and differentiation of 
K562 ceils. Fli-1 and OATA-1 swrk together to activate the 
expreaaion of gen es associated with the terminal differentiation of SAM_PNT. SAM / Pointed domain, erythrobiast transformation specific
brain, heart, Wdney, liver, 
lung, ovary, prostate, 
testis, thvmus
NM 000220 2
128213125-
128242478
potassium inwardly-rectifying channel, subfamily J. 
member 1 (KCNJ1 ). transcriot variant rom-kl
an integral membrane protein ana inwara-reconer type potassium  
channel. It Is activated by Internal ATP and probably plays an 
important role In potassium homeostasis. The encoded protein has a 
greater tendency to allow potassium to flow into a cell rather toan out
kidnev. liver, iuno. trachea
NM 145013.1
128274678-
128280802 chromosome 11 ooan raadino frame 45 (Cl 1orf45l 0 Function Unknown No conserved domains detected
trachea, heart testis, 
brain, placenta, kidnev.
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NM 022112. p53 r#gulal#d mpoptoW«.Inducing Pfot^in 1 (PS3AIP1). f f l u t a f  « (h# mKochondflml apoptoMc pathway128316032 No c o n a a fv d  domain# datactad
may régulai# dendritic aplne morphology and strength by modulating 
___________________  Rho Q TPase__________________________NM 014715.2 Hver. lung. Iddnev. brain■Rho QTPase-actlvatlna protein (RICSL
Transcription Factor and is involved In controlling the expression 
______________patterns of ceii adhesion molecules______________
129235106 trachea, iung. kidnev. Hvertransmembrane protein 458 (TMEM45B). Function Unknown
NM 006165.2 No conserved domains detected KWrwy. ttiymu». lr«ch»«TrinycflDllon trom RNA Mlymw»«« II promaUf
PR domain containing 10 fPRDMIO).
chromosome 11 open reading frame 37 (Cl 1off37l. Function Unknown
«mylolj b«Hi 1A4) p rw u n o r-IIK« proHln 2 (APLP2).NM 001942,1
suppression of tumorlgenlcHy 14 (colon carcinoma)
I epitheiiai membrane activator for other p ro teases and latent Receptor C lass A domain
vitro, lo nf'S2 binding sites play Important roles in coordinating 
------------Irtn itrlP llon  «c lly lign  «ml r ro rw ito n  by m«fkBTB IPOZI llom»ln rontelnlng 15 IBTBD15I. BTB/POZ demain. Zinc flng»r. C0G5CKB
F«ntll9n Vnhnprmhyppth*tlc9l prglyin L O C W 3B 3 tFLJ345211 Np  conw rvpd Jpmpln» d»t»ct»d
Migniy mxpfplw a in apuii
Reprolysin. ADAM Cysteir>e*Rich Domain. ADAM TS Spacar 1 domain, 
Thrombospondin type 1 domain.._________________
ADAM metaliopeptidase with thrombospondin type 1 
_______________motif. 6 (ADAMTS6)._________ Has anti-angiooenic properties and fetal brain and kidney
Function UnknownNM 173580.1 130092457 No conw rvod demplnp dotoclodchromopomo 11 opon ropdina frpmo 4 4 1C11ort44i.
Mpy tit InyolYPti In w vorpl pIpppp of intr»c«llul«r tipfflctilna130291572
chromosome 11 open reading frame 39 (Cl 1orf39).
Neural ceil adhesion moiecule ar>d may promote neurlte outgrowth 
----------------- pnd «dhoplon yl« » homophlllc m«di«nl«m___________NM 016522 2 lung, lootip. tipchopImmunooiobuiin domain ceii adhesion molecule (cam)
Sinds opioids in the presence  of acidic lipids; probably invoivad in ceil 
contact,and mav have a n accessory role in ooioid receptor functionNM 002545 3 iuno. ovary, testisI cell a dhesion molecule (cam)immunoglobulin
May have a  role in sperm togenesissperm atogenesis a ssociated 19 (SPATA19).
133276467 ■hypothetical protein LOC283174 (LOC283174). No conserved dom ains detectedFunction Unknown
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A ccaaslon G ene ARAB CERV
-  -  W|
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jS- -  ”
CHLY PAZO DEFLA TRYP CION TETR McKE ELEG FoxJ1 Function
D om ains identified by NCBI 
BLASTp
UnlGene
e x p ressio n
NM 173623,1 hypothetica l p ro tein  FLJ39808 (FLJ35808), 0 0 0 1 0 0 1 1 1 0 1 1
Tubulin tyrosine ligase activity (catalyses 
ATP-dependent post-translational addition of 
a  tyrosine to the carboxy terminal end of 
detyrosinated alpha-tubulin) Tubulin-tyrosine ligase family
brain, colon, lung, 
stomach, testis
NM 152347.3 hypothetica l p ro tein  F U 40342  (FU 40342), 0 0 0 1 1 0 0 1 0 1 0 1
calcium Ion binding activity, In mcKeen, not 
In C. Elegans
Ca2+-blndlng protein (EF-Hand 
superfamily)
Inc.brain, kidney, 
lung, testis, 
embryo
NM 003971.3 sp erm  a s so c ia te d  an tig en  9 (SPA G 9),, 0 0 0 0 0 0 0 1 1 0 1 1
scaffolding protein invd in activation of 
specific signaling pathways, abundantly 
expressed In testis (spenn acrosomal region) Intennedlate filament protein
Inc.brain, kidney, 
lung, testis, 
embryo
NM 033413.2 hypothetica l g en e  MGC16309 (MGC18309), (LRRC48) 0 1 1 1 1 1 1 1 1 1 1 1 in McKeen and ciliates Leucine-rich repeat
brain, eye, lung, 
testis
NM 016835.1 m icro tu b u le-asso cia ted  p ro tein  tau  (MAPT),, 0 0 0 1 0 0 1 1 0 1 1 0
enriched in axons/ invd in 
alzhelmers/parkinsons d isease., -ve regn MT 
depolymerisation tubuiln-blnding repeat
Inc.brain, kidney, 
iung, testis, 
embryo
NM 001006607 1 c114 SLiT4ike te s ticu la r p ro tein  (LOC474170), 0 0 0 0 0 0 1 1 0 1 1 0 unknown function no putative conserved domains
inc.brain, kidney, 
lung, testis, 
embryo
NM 016428.2 ABi g en e  famiiy, m em ber 3 (ABi3), 0 0 1 0 0 0 1 1 0 1 1 0
Inhibits ectopic m etastasis of tumor cells a s  
well as  cell migration, but In mcKeen SH3 domain
NM 002476.2 m yosin, iight po iypeptide 4, aikali; atrial, em bryonic (MYL4),, 1 1 1 1 1 0 1 1 1 1 1 0
myosin alkali light chain that Is found In 
embryonic muscle and adult atria EF-hand, calcium binding motif
NM 006695.3 RaP2 in teracting  pro tein  8 (RPIP8), 0 0 0 0 0 0 0 1 0 0 0 0
small G TPase regulator activity/signal 
transduction
domain Involved In Ras-llke 
GTPase signaling
NM 001466.2 frizzied hom oiog  2 (D rosophila) (FZ02), 0 0 0 0 0 0 0 1 0 0 1 0
receptors for Wnt signaling proteins, signal 
by activating calcium re lease from 
Intracellular stores
Frizzled/Smoothened family 
membrane region - m ediates 
hedgehog signalling, cysteine 
rich domain
NM 006460.1 HMBA-inducible (HIS1), 0 0 0 0 0 0 0 1 0 0 0 0
expressed In smooth muscle cells, function 
unknown no putative conserved domains
NM 030802.2 C /EBP-induced pro tein  (LOC81558), 0 0 0 0 0 0 0 1 0 0 0 0 C/EBP-lnduced protein no putative conserved domains
NM 002055.2 giiai fibriilary ac id ic pro tein  (GFAP), 1 1 1 1 1 1 1 1 1 1 1 1
one of the major Intermediate filament 
proteins of mature astrocytes
Intermediate filament protein, 
Chromosome segregation 
A TPases
NM 018509.2 hypothetica i p ro tein  PR 01855 (PR01855), 1 1 1 1 1 0 1 1 1 1 1 0 In McKeen
Leucine-rich repeat (LRR) 
protein [Function unknovm]
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NM 152344,1 hypothetical protain FU30656 (FLJ306S6), 0 1 0 0 0 0 0 1 0 0 1 0 no putative conserved domains
NM 024032.2 hypothattcal protain MGC3130 (MGC3130), 1 0 0 0 0 0 0 0 0 0 0 0 no putative conserved domains
NM 144608.1 hvpothatlcal protein MOC39389 (FU32384), 0 0 0 0 0 0 0 1 0 0 0 0 no putative conserved domains
NM 015443.2 hypothetical protain LOC284098 (LOC284098), 0 0 0 0 0 0 0 1 0 0 0 0 no putative conserved domains
NM 017928.1 hypothetical protein FU20694 (FU20694), 0 0 0 0 0 0 0 1 0 0 0 0 no putative conserved domains
NM 024107.1 hypothetical protein MGC3123 (MGC3123), 0 0 0 0 0 0 0 0 0 0 0 0 no putative conserved domains
NM 144609.1 hypothetical protein FLJ31799 (FLJ31799), 0 0 0 0 0 0 0 0 0 0 0 0 no putative conserved domains
NM 152343.1 hypothetical protein FU29414 (FLJ29414), 0 0 0 0 0 0 0 0 0 0 0 0 no putative conserved domains
NM 152466.1 hypothetical protein FU29168 (FLJ29168), 0 0 0 0 0 0 0 0 0 0 0 0 no putative conserved domains
NM 178542.3 hypothetical protein DKFZp762C2414 (DKFZp762C2414), 1 0 1 1 1 1 0 1 0 0 1 1 no putative conserved domains
NM 024320.2 hypothetical protein MGC11242 (MGC11242), 0 0 0 0 0 0 0 0 0 0 0 0 no putative conserved domains
NM 001004335.1 FU42842 protein (FU42842), 0 0 0 0 0 0 0 1 0 0 0 0 no putative conserved domains
NM 014834.2 hypothetical LOC9884 (LOC9884), 0 1 0 1 0 0 0 1 0 1 1 0 no putative conserved domains
NM 153229.1 hypothetical protein FU33318 (FU33318), 0 0 0 0 0 0 0 0 0 0 0 0 no putative conserved domains
NM 052855.2 hypothetical protein MGC19396 (MGC19396), 0 0 0 0 0 1 0 1 0 0 1 0
ankyrin repeats - m ediates 
proteln-protein Interactions
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NM 032595.1
protein phosphatase 1, regulatory subunit 9B, spinophiiin 
(PPP1R9B). 1 1 1 1 0 0 1 1 1 1 1 1
regulatory subunit of protein phosphatase-1 
catalytic subunit, highly enriched in dendritic 
spines, in McKeen
PDZ domain (invd in 
protein/protein interactions). 
Chromosome segregation 
ATPases
NM 016632.1 ADP-rlbosylation factor-iike (LOCS1326), 1 1 1 1 1 1 1 1 1 0 1 1 ARF-iike small G T Pases
NM 000212.2 integrin, beta 3 (platelet glycoprotein Ilia, antigen CD61) (ITGB3). 0 0 0 0 0 0 1 1 1 0 1 0
m ediates platelet aggregation by acting as  a 
receptor for fibrinogen integrin beta subunits
NM 002507.1
nerve growth factor receptor (TNPR superfamily, member 16) 
(NGFR). 0 0 0 1 0 0 1 1 1 0 0 0
Nerve growth factor receptor invd in 
neurogenesis
Tumor necrosis factor receptor 
(TNFR) domain
NM 032133.2 MYCBP associated protein (MYCBPAP). 0 0 0 1 1 0 0 1 1 0 0 0 no putative conserved domains
NM 025237.1 sclerosteosis (SOST), 0 0 0 0 0 0 0 0 0 0 0 0
famiiy of bone morphogenetic protein (BMP) 
antagonists, assd  with sclerosteosis
C-temninai cysteine knot-iike 
(CTCK) domain
NM 002722.2 pancreatic polypeptide (PPY), 0 0 0 0 0 0 0 0 0 0 0 0
involved in the regulation of exocrine 
pancreatic secretion and biliary tract motility Pancreatic Hormone domain
NM 004160.2 peptide YYIPYYI. 0 0 0 0 0 0 0 0 0 0 0 0
inhibitor of gastric acid secretion, gastric 
emptying, digestive enzyme secretion by the 
pancreas, and gut motility Pancreatic Hormone domain
NM 032376.2 hypothetical protein MGC4251 (MGC4251), 0 0 0 0 0 0 0 0 0 0 0 0
positive regulation of i-kappaB kinase/NF- 
kappaB cascade no putative conserved domains
NM 138387.2 glucose 6 phosphatase, catalytic, 3 (G6PC3), 0 0 0 0 0 0 0 0 0 0 0 0 hydrolase activity Acid phosphatase homologues
NM 145663.1 Dbf4-related factor 1 (DRF1),, 0 0 0 0 0 0 0 0 0 0 0 0
serine-threonine kinase which links ceii cycle 
regulation to genom e duplication
Zinc finger in DBF-iike 
proteins. Protein kinase 
essential for the Initiation of 
DNA replication
NM 016438.2 CLST11240 protein (CLST11240), 0 0 0 0 0 0 0 0 0 0 0 0
Hypoxia induced protein 
conserved region
NM 001007532.1 saltohin (STH), 0 0 0 0 0 0 0 0 0 0 0 0
within intron 9 of the tau gene, assd  with iate- 
onset Alzheimer d isease no putative conserved domains
NM 203400.1
similar to candidate mediator of the pS3-dependent G2 arrest 
(LOC388394), 0 0 0 0 0 0 0 0 0 0 0 0 no putative conserved domains
NM 014726.1 ProSAPIP2 protein (ProSAPIP2), 0 0 0 0 0 0 0 0 0 0 0 0
part of the interaction network in the 
TNF/NFKB pathway no putative conserved domains
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NM 145255.2
m itochondrial ribosom al p ro tain  L10 (MRPL10), n uciaar gena  
a n c o d in g  m itochondrial p ro ta in .. 0 0 0 0 0 0 0 0 0 0 0 0 Mitochondrial ribosome Rltrosomal protein L10
NM 032391.2 sm all n u cia ar pro tain  PRAC (PRAC), 0 0 0 0 0 0 0 0 0 0 0 0 mav Plav a regulatory role In the nucleus. no putative conserved domains
NM 004123.1 g as tric  inhibitory po iypaptide (6IP), 0 0 0 0 0 0 0 0 0 0 0 0 stimulates Insulin secretion Glucagon like hormones
NM 153446.1
U D P-G alNAc:N au5Acalpha2-3G aibaU-Rbata1,4-N-
acaty igaiac tosam inyltransfarasalG A L G T Z ), 0 0 0 0 0 0 0 0 0 0 0 0 llpid glycosylatlon Glycosyl transferase
NM 007225.1 naursxophilin  3 (NXPH3). 0 0 0 0 0 0 0 0 0 0 0 0
signaling molecules that resem bles 
neuropeptides no putative conserved domains
NM 170685.1 tachykin in  4  (ham okinin) (TAC4), 0 0 0 0 0 0 0 0 0 0 0 0 regulates B-cell development no putative conserved domains
NM 174920.2 hypothetical p ro tein  LOC201191 (LOC201191). 0 0 0 0 0 0 0 0 0 0 0 0
Sterile alpha motif (SAM): 
W idespread domain In 
signalling and nuclear proteins 
(mediates homodlmerlsatlon)
NM 000023.1
sarcog lycan , alpha (SOkOa d y s tro p h in -asso c ia lad  glycopro tein) 
ISGCA). 0 0 0 0 0 0 0 0 0 0 0 0
part of dystrophln-glycoproteln complex, Invd 
In stability of muscle fiber m em branes and to 
the linking of the actin cytoskeleton to the 
extracellular matrix
Dystrogtycan-type cadherln-llke 
domains
NM 194072.1 sperm atid -specific  linker h is to n e  H i-ilka pro tain  (HILS1), 0 0 0 0 0 0 0 0 0 0 0 0
displays characteristics of a  linker histone 
and may regulate gene transcription, DNA 
repair no putative conserved domains
NM 006807.3 chrom obox hom oiog  1 (HP1 b eta  hom oiog  D rosophila ) (CBX1), 0 0 0 0 0 0 0 1 1 0 1 0
localized at heterochromatin sites, where It 
m ediates gene silencing Chromo Shadow  Domain
NM 002204.1
integrin, alpha 3 (an tigen  CD49C, alp h a  3 su b u n it o f VLA-3 
receptor) (ITGA3), tran sc rip t varian t a. 0 0 0 1 0 0 0 1 0 0 1 0
forms Integrin that Interacts with extracellular 
matrix proteins
beta-propellor repeats, FG- 
GAP repeat
NM 175575.4
WAP, foiiistatin/kazai, im m unogiobuiin , kunitz an d  netrin  dom ain 
con ta in ing  2 (WFIKKN2), 0 0 0 1 0 0 0 1 0 0 1 0
may control the action of multiple types of 
proteases
WAP domain, follistatin 
domain. Immunoglobulin 
domain, two tandem  Kunitz 
domains, and an NTR domain
NM 177441.1 hypo thetica l p ro tein  MGC3123 (MGC3123), 0 0 0 0 0 0 0 1 0 0 1 0 ubiqultlnation no putative conserved domains
NM 213607.1 sim ilar to  RIKEN 4933439F11 (LOC388389), 0 0 0 1 0 0 0 1 0 0 0 0 Invd In pancreatic cancer? no putative conserved domains
NM 004382.2 cortico trop in  re leasing  horm one re cep to r 1 (CRHR1), 0 0 0 0 0 0 0 1 0 0 1 0 m ediates stress responses.
HormR, Domain present In 
hormone receptors, 7 
transm embrane receptor
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NM 030753.3 wingless-type MMTV integration site famiiy, member 3 (WNT3). 0 0 0 0 0 0 0 1 0 0 1 0
may play a key role In some cancers through 
activation of the WNT-beta-catenln-TCF 
signaling pathway WNT1. found in Wnt-1
NM 001012511.1
goigi SNAP receptor complex member 2 (G0SR2), transcript 
variant C, 0 0 0 0 0 0 0 1 0 0 1 0
trafficking membrane protein, may be 
involved In familial essential hypertension
Vesicle transport v-SNARE 
protein
NM 013351.1 T-box 21 (TBX21I. 0 0 0 0 0 0 0 1 0 0 1 0
transcription factor that controls the 
expression of the hallmark ThI cytokine T-box DNA binding domain
NM 138355.2 secemin 2 (SCRN2). 0 0 0 1 0 0 0 0 0 0 1 0 dipeptidase activity Peptidase family U34
NM 003204.1 nuclear factor (erythroid-derived 2Hike 1 (NFE2L1), 0 0 0 0 0 0 0 1 0 0 1 0
may piay a role In the regulation of heme 
synthesis and ferritin genes
basic region leucin zipper, 
bZIP Maf transcription factor
NM 002144.2 homeo box B1 (H0XB1), 0 0 0 0 0 0 0 1 0 0 1 1
conserved famiiy of transcription factors, 
exact role of this one not detemiined Homsodomain
NM 001934.2 distai-iess homeobox 4 (DLX4),. 0 0 0 0 0 0 0 1 0 0 1 0
postulated to play a role in forebrain and 
craniofacial development Homeodomain
NM 000088.2 coiiagen, type i, alpha 1 (COL1A1), 0 0 0 0 0 0 0 1 0 0 1 0
encodes the major component of type I 
collagen
Fibrillar collagens C-terminal 
domain
NM 017643.1 mbt domain containing 1 (MBTD1), 0 0 0 0 0 0 0 1 0 0 1 0 chromatin modification, regn of transcription
MBT, Involved in transcriptional 
regulation
NM 145273.2 triggering receptor expressed on myeloid ceils 4 (TREM4), 0 0 0 0 0 0 0 1 0 0 0 0 receptor activity Immunoglobulin like
NM 025104.2 Dbf4-reiated factor 1 1DRF1),, 0 0 0 0 0 0 0 1 0 0 0 0
serine-threonine kinase which links cell cycle 
regulation to genom e duplication
Zinc finger in DBF-like 
proteins, Protein kinase
NM 005497.1 gap junction protein, alpha 7 ,45kDa (connexin 45) (6JA7), 0 0 0 0 0 0 0 1 0 0 0 0 form gap junction channels
Connexin (participate In the 
regulation of signaling between 
developing and differentiated 
cell types)
NM 006688.3 complement component 1, q subcomponent-iike 1 (C1QL1), 0 0 0 0 0 0 0 1 0 0 0 0 phosphate transport
Complement component C lq  
domain, found in many 
collagens
NM 148887.1
mitochondrial ribosomal protein L10 (MRPL10), nuclear gene 
encoding mitochondrial protein,, 0 0 0 0 0 0 0 1 0 0 0 0 Mitochondrial ribosome Ritrasomal protein L10
NM 031498.1
guanine nucieodde binding protein (G protein), gamma 
transducing activitv polypeptide 2 (GNGT2), 0 0 0 0 0 0 0 1 0 0 0 0 play a crucial role in cone phototransduction
G protein gamma subunit-like 
motifs
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NM 001007529.1 FLJ40194 pro tein  (FU 40194), 0 0 0 0 0 0 0 1 0 0 0 0 no putative conserved domains
NM 148571.1
m itochondrial ribosom al pro tein  L27 (MRPL27), n u clear g en e  
en c o d in g  m itochondrial p ro te in ,, 0 0 0 0 0 0 0 1 0 0 0 0 Mitochondrial ribosomes Ribosomal L27 protein
NM 152463.1 e s se n tia l m elotic e n d o n u c le a se  1 hom olog  1 (S. pom be) (EME1), 0 0 0 0 0 0 0 1 0 0 0 0 ATPase/H+ transport no putative conserved domains
NM 005749.2 tra n sd u c e r  of E R B B 2,1 (T0B1), 0 0 0 0 0 0 0 0 0 0 1 0
Inhibits T cell proliferation and transcription 
of c^ok lnes and  cycllns antl-prollferation domains
NM 001012479.1 granuiln  (C R N ),, 1 0 0 1 0 0 1 1 1 0 1 0
regulate cell growth - Important In normal 
development, wound healing, and 
tumorigenesls Granuiln
NM 175882.1 Intram em brane p ro te a se  5 (IMPS), 1 0 0 1 0 0 1 1 1 0 1 1 proteolysis
Presenllln signal peptide 
peptidase. P ro tease associated 
domain
NM 178500.2 p h o sp h a ta se , o rp h an  1 (PH 0SPH 01), 1 0 0 1 0 0 1 1 1 0 1 1 phosphatase
Putative Phosphatase, 
Phosphoserine phosphatase. 
Predicted hydrolase
NM 198397.1
calcium  channel, vo ltage-dependen t, alpha 1G subun it 
(CACNA1G), 5, 1 0 0 1 0 0 1 1 1 0 1 0 Voltage-activated calcium channel Ion transport protein
NM 020178.3 carbon ic an h y d rase  X (CA10), 1 0 0 1 0 0 1 1 1 0 1 0
zinc metalloenzymes, Invd In reversible 
hydration of carbon dioxide carbonic anhydrase domain
NM 014798.1
p leckstrin  hom ology dom ain  conta in ing , family M (with RUN 
dom ain) m em ber 1 (PLEKHM1), 1 0 0 0 0 0 1 1 1 0 1 0 Invd In Intracellular signalling
Protein kinase C conserved 
region 1, PH domain, RUN 
domain
NM 054022.2
golgl SNAP re c e p to r  com plex  m em ber 2 (G 0SR2), tran sc rip t 
varian t B, 1 0 0 1 0 0 0 1 1 0 1 0
trafficking membrane protein, may be 
Involved In familial essential hypertension V-SNARE
NM 176096.1
CDK5 regu la to ry  su b u n it a s so c ia te d  pro tein  3 (CDK5RAP3), 
tran sc rip t varian t 3, 1 0 0 0 0 0 1 1 1 0 1 0 Involved In neuronal differentiation
Protein of unknown function, 
poss CDK5 actlvator-blnding 
domain
NM 003563.3 speck le -type  POZ pro tein  (S P O P ),, 1 0 0 1 0 0 0 1 1 0 1 1
mediate transcriptional repression and 
Interacts with components of histone 
deacetylase co-repressor complexes
BTB/POZ domain - m ediates 
dimérisation
NM 001002909.1 KIAA0553 pro tein  (KIAA0553), 1 0 0 1 0 0 1 0 0 0 0 0 A TPase Invd In DNA repair ATPase
NM 002390.2 a  d isln teg rin  an d  m eta llop ro te lnase  dom ain  11 (ADAM11),, 0 0 1 0 0 0 0 1 0 0 1 0
Invd In cell-lnteractlons such a s  fertilization, 
muscle development, and neurogenesis
ADAM Cystelne-Rlch Domain, 
Reprolysin (M12B) family zinc 
metalloprotease
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NM 022167.1 xvlosy ltn insfen ise IIIXYLT2). 1 0 0 0 0 0 0 1 0 0 1 0
tranafera xyloae from UDP-xyloae to specific 
serine residues of the core protein Core-2/i-Branching enzyme
NM 022827.2 •p e rm  p ro tein  SSP411 (88P411). 1 0 0 0 0 0 1 0 0 0 1 0 hydrolase activity on glycosyl bonds thioredoxin domain
NM 018346.1 radical 8-adenoay l m eth ionine dom ain  conta in ing  1 (R8AD1), 1 0 0 0 0 0 0 0 1 0 0 0 porphyrin biosynthesis oxidoreductase domains
NM 001287.1 chondroadherin  (CHAO), 1 1 0 1 1 0 0 1 1 0 1 1 cartilage matrix protein Leucine rich repeat
NM 014233.1 upatream  binding  tranacrlp tlon  factor, RNA polym eraae 1 (UBTF), 1 1 0 0 0 0 1 1 1 0 1 1
transcription factor required for expression of 
the 183, 5.83, and 283  ribosomal RNAs
High Mobility Group (HMG)-box 
(DNA binding)
NM 003728.2 arc family a sa o c ia ted  p hoaphopro te in  1 (8CAP1), 0 1 1 0 0 0 1 1 0 0 1 1 src family kinase invd in T-cell activation
3rc  homology 3 domain, PH 
domain
NM 153008.1 N-acetyigiutam ate ayn thaae  (NAG8), 0 1 1 0 0 0 0 0 0 0 0 0
mitochondrial enzyme that catalyzes the 
formation of N-acetylgiutamate, not in d ilates
NM 080883.4 ankyrin re p ea t an d  8 0 0 8  box-conta in ing  16 (A8B16), 1 1 1 1 1 1 1 1 1 1 1 1
couple suppressor of cytokine signalling 
(3 0 0 3 )  proteins and their binding partners 
with the elongin B and 0  complex, possibly 
targeting them for degradation ankyrin repeats
NM 000289.2 n on-m etaatatic  ce iia  1, p ro tein  (NM23A) ex p reaa ed  in (NME1),, 1 1 1 1 1 1 1 1 1 1 1 1 regn of cell cycle
NDK- catalyze nonsubstrate 
spedfic conversions of 
nudeoside diphosphates to 
nudeoside triphosphates
NM 003954.1 m itogen-actiya ted  pro tein  k inaae k inaae kinaae 14 (MAP3K14), 1 1 1 1 1 1 1 1 1 0 1 1
serine/threonine protein-kinase, stimulates 
NF-kappaB activity
3erine/Threonine protein 
kinases
NM 005374.3
m em brane pro tein , paim itoyiated 2 (MAGUK pSS aubfam iiy 
m em ber 2) (MPP2), 1 1 1 1 1 0 1 1 1 0 1 0
interact with the cytoskeieton and regulate 
cell proliferation, signaling pathways, and 
intracellular junctions 3H3 domain, PDZ domain
NM 004247.2 U5 anRN P-apecific pro tein , 116 kO (US-116KD), 1 1 1 1 1 0 1 1 1 0 1 1 splicing factor
Elongation factor Tu GTP 
binding domain
NM 008178.1 N -ethyim aieim ide-aenaitive fa c to r (N8F), 1 1 1 1 1 0 1 1 1 0 1 1 ATP-binding, proteolysis AAA-superfamily of ATPases
NM 002834.2 prohibitin  (PHB), 1 1 1 1 0 0 1 1 1 1 1 1
negative regulator of ceil proliferation and 
may be a tumor suppressor, mutations linked 
to sporadic breats cancer prohibitin homologues
NM 020038.1
ATP-binding c a aa e tte , aub-fam iiy C (CFTR/MRP), m em ber 3 
_______________ (ABCC3), tran acrip t yarian t MRP3B, 1 1 1 1 1 0 1 1 1 0 1 1
m ember of the superfamily of ATP-binding 
cassette  (ABC) transporters, may play a role 
in the transport of biliary and intestinal 
excretion of organic anions. ATP-binding cassette
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NM 004090.2
dual specificity  p h o sp iia tase  3 (vaccinia vinia p h o ap h a tasa  VH1- 
ra la led) (DUSP3). 1 1 1 1 0 0 1 1 1 0 1 1 dephosphorylation Dual specificity phosphatases
NM 005474.3 h ia tone  d eace ty laae  9 (HDAC9),, 1 1 1 1 0 0 1 1 1 0 1 1
chromatin modification, regn of transcription. 
Linked to colon cancer Histone deacetylase family
NM 016016.1 CGi-69 pro tain  (CGi-69), 1 1 1 1 0 0 1 1 1 0 1 1 transport? Mitochondrial carrier protein
NM 024819.3 hypothetica l p ro tein  F U 2299S  (FU 229S9), 1 1 1 1 0 0 1 1 1 0 1 1
NM 021079.3 N -m yriatoyltranaferaae 1 (NMT1). 1 1 1 1 0 0 1 1 1 0 1 1
NM 133373.2 ph oapho ilpaae  C, delta  3 (PLCD3), 1 1 1 1 0 0 1 1 1 0 1 1
NM 024722.1 acyi-C oenzym e A binding dom ain  con ta in ing  4  (ACB04), 1 1 1 1 0 0 1 1 1 0 1 1
NM 005892.3 formln-ilke 1 (FMNL1), 1 1 1 1 0 0 1 1 1 0 1 1 Invd in limb formation-Shh pathway
NM 001256.2 cell divialon cycle 27 (CDC27), 1 1 1 1 0 0 1 1 1 0 1 0
NM 006310.2 am in o p ep tid aae  purom ycin aenaitive (NPEPPS), 1 1 1 1 0 0 1 1 1 0 1 0
NM 002265.4 karyopherin  (Importin) b e ta  1 (KPNB1), 1 1 1 1 0 0 1 1 1 0 1 0
NM 145798.2 oxyaterol binding  proteln-iike 7 (O SB PL 7),, 1 1 1 1 0 0 1 1 1 0 1 0
NM 016429.1 co a to m e r p ro tein  com plex, aubun it ze ta 2 (C0PZ2), 1 1 1 1 0 0 1 1 1 0 1 0
NM 005831.3 n uclear dom ain  10 p ro tein  (NDP52), 1 1 1 0 0 0 1 1 1 1 1 0
NM 023079.2 hypothetica l p ro tein  F U 13855  (FU 138S5), 1 1 1 1 0 0 1 1 1 0 1 0 Ubiquitin-coniupating enzyme E2
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NM 007241.2 EAP30 (u b u n it of ELL com plex  (EAP30), 1 1 1 1 0 0 1 1 1 0 1 0 s u  of ELL complex (ribosomal IF )
NM 008827.1 •o lu tc  ca rrie r family 35, m em ber B1 (SLC39B1), 1 1 1 1 0 0 1 1 1 0 1 0
NM_.007067.3 MYST h iatone ac e ty ltran aferase  2 (MYST2), 1 1 1 1 0 0 1 1 1 0 1 0
NM .025149.3 hypothetica l p ro tein  FLJ20920 (FLJ20920), 1 1 1 1 0 0 1 1 1 0 1 0
Acyl-GoA synthetases, AMP- 
blndlng enzyme
NM 017957.1 ep a in  3 (EPN3). 1 1 1 1 0 0 1 1 1 0 1 0
NM 198396.1
calcium  channel, vo ltage-dependenL  alp h a  1G aubun it 
(CACNA1G), tran acrip t varian t 3, 1 1 1 1 0 0 1 1 1 0 1 0
NM 016001.1 WD re p ea t dom ain  50 (WDR50), 1 1 1 1 0 0 1 1 1 0 1 0
NM 001002027.1
ATP ayn thaae, H+ tranapoiU ng, m itochondrial FO com plex, 
aubun it c  (aubunit 9), laoform  1 (ATP5G1), nuclear g en e  encoding  
m itochondrial p ro te in ,, 1 1 1 1 0 0 1 1 0 0 1 0
NM 006546.3 iGF-ii -binding pro tein  1 (iMP-1), 1 1 1 1 0 0 0 1 1 0 1 0
NM 002611.3 pyruvate deh y d ro g en aae  kinaae, iaoenzym e 2 (PDK2), 1 1 1 1 0 0 1 1 0 0 1 0
NM 006107.2 ciap la tin  re a ia tan c e-a aa o cia ted  o v erexpreaaed  pro tein  (C R O P),, 1 1 1 1 0 0 0 1 1 0 1 0
NM 016424.3 ciap ia tin  re a ia tan c e-a aa o cia ted  o v erexpreaaed  pro tein  (C R O P),, 1 1 1 1 0 0 0 1 1 0 1 0
NM 000342.1
ao lu te ca rrie r family 4, an ion  ex changer, m em ber 1 (erythrocyte 
m em brane pro tein  band  3, Diego b lood  group) (SLC4A1), 1 1 1 1 0 0 0 1 0 0 1 0
NM 199262.2 Sp6 tranacrlp tlon  fa c to r (SP6), 1 1 1 0 0 0 0 1 1 0 1 0
NM 003110.4 Sp2 tranacrlp tlon  fa c to r (8P2), 1 1 1 0 0 0 0 1 1 0 1 0
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NM 018129.1 pyridoxine S '-phosphato  o x id asa  (PNPO), 1 1 1 1 0 0 0 1 0 0 1 0
NM 013323.2 aorting  naxin 11 (SNX11),. 1 1 1 1 0 0 0 1 0 0 1 0 involved In Intracellular trafficking
PhoX homologous domain of 
unknown function, PX domains 
bind to phospholnosltldes
NM 014897.1 zinc flngar pro tain  652 (ZNF6S2), 1 1 1 0 0 0 0 1 1 0 1 0
NM 199282.1 Rho Q T Pase ac tiva ting  p ro tein  27 (ARH6AP27). 1 1 1 0 0 0 0 1 0 0 1 0
NM 016504.2
m itochondrial ribosom al p ro tein  L27 (MRPL27), n u cle ar gene  
en co d in g  m itochondrial p ro te in ,, 1 1 1 0 0 0 0 1 1 0 0 0
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Exon Fwd Rev size (bp)
1 CTTGGGTTGTGTTAGGGAAA CTGCAGAATGGAGATGGTCTT 403
2 TTGGACTGCCAGTAAAGAACC TGTGATGCCTCCTCACATAA 297
3 GTGGTACACACATTCCAAAAGC AAGAGAGGCATGGCTGAAAA 532
4 CAGCTCTCAGATAGTTGCATCC AGAAGGTTGATGGATTTGGA 314
Primer sequences for SPAl 7 sequencing
Exon Fwd Rev size (bp)
1 GTCTTGCAATGCCTAGTCTAG GCAAACAAGGCAACACTGTG 337
2 TTCAGTACCCTTTGGTCCCA GACACAATGGTTATTGCTGC 351
3 ACAGCTCTGATTACTGCCTG GGAGATCAGCAGTACTCCTA 304
4 CCACAATTCCTAGCAGAGTC GCCAATCATAGGCATCTGCA 525
5 TGCTCTTGCCTTGGATGAAG TGCACTCCCACTAAACAGTG 367
6 ACTGGGCCACAAGCCAATTA TTAACTGGCATCACCACCCT 255
7 GTCCACAGTACATGTGCTAG CCCTGCAACAAGTCCTTATG 424
Primer sequences for LRRC35 sequencing
Exon Fwd Rev size (bp)
1 GGCACAGAATGGAAAGGTTC TGAACAGAGGAAGAGGACAGG 179
2 GGAGTTTCTGGTTTCCAGCAT CAATTTAGGTGAGCCAGGAG 400
3 CTGAGGTGGGCTTTGGTAGT CTTATTGGGAGCAGGGGAGT 338
4 CATATCCCTTCCAGGCTTTG GCCAGTCAGCCAATAGATCA 325
5 CATGTCCATCCCTCAAGGAG ACAGCCTTTCGGTGTGTCTG 367
6 GCAGATGAATCTGGAAGTGGA AAAGGGTCACAGCAAGTTGG 434
7 GCATAGGAAGGAACCCTTTG CCCAAAGATTAGGACTGGTTC 506
8 CACCAGGAATTTGTGCTGAA AAACACAGAGCACCTGCCAAC 387
Primer sequences for FLJ35808 sequencing
Exon Fwd Rev size (bp)
1 & 2 TCCTGAGTTCTGCCATCCTT GGTCATCCTGAGTGTTTCAGC 358
4 TCCCTGCTAAGAGACCACAT CTGGTTGGCTCCTTTCAGAT 247
6 AGACATGGTCTTGGGGCTTT CCAGGCTTGGAGAAATCTGA 225
7 AGGTGCCCTCCTCTTTTCTT CAGGGGCATGGCTAATAGAA 281
8 ATTCCCATCGCTTCATGGTC ATGCAAAGACACGCAC 319
9 GTGCGTGTCTTTGCATCCT GCCACCTTAGCTTCCCTCAT 289
10 TCCTTCCCACAAGGGACAA TTTACTGGGGATGGGCTTCT 576
Primer sequences for LRRC46 sequencing
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S P A l7 exon sequences with primers for sequencing highlighted.
Key
PRIMER 
CODING EXON
START/STOP CODON 
573’ UTR 
INTRON
m
Exon 1
CATATTGAAAATTATGGGTTTTTTGCAGGATTTTAAATGATTTGGCCTAGTGAATGGGTCT
GTGTTTGTATTATACTAATTCACAATGGAGATTTCAAAACTCTTTGGAAGAAATGGATGGG
CTTGGGTTGTGTTAGGGAAAAAAGAATTCAAGTCCAGATGTATGAGTCTCAGAAATAATT
TGTTGGCATAGTTGTGATTATATAAGTAAAATCAGACAAATTTAAAGACAGTACTCTTTAA
TGAATCTTTAGGTTCCATAGGCAGTTCTTACCAAGAAGATGTCGATTCCATTCTCCA
ACACCCACTACCGAATTCCACAAGGATTTGGGAATCTTCTTGAAGGGCTGACACGCG
AGATTCTGAGAGAGCAACCGGACAATATACCAGCTTTTGCAGCAGCCTATTTTGAGA
GCCTTCTAGAGAAAAGAGAGAGTAAGCTTTCTAAAATTAGTCATTTTTTAAAATAAGAA
ACTAAGCATTTGTTTATGGTAAAACTTGCTTAAGACCATCTCCATTCTGCAGAAAGCCTTT
TATGAGGCAGGGAGTTTCAGATAACAGTTCTTGCTCTTTGAAACAGTATGTACCTCTTTGA
TATGT
Exon 2
ACTGGTAATGTCTGCAGTGCTACGCTATGCACAATGTCAATAAGATTTTGGACTGCCAGTA
AAGAACCTGTAATTTGAAACAAGAAACTTACATTTGTGTCACTATTCTACATTTACCTTAA
TGAATTCAAATAAATCTGAAGTTCTTATATTTTTATTATTTAGAAACCAACTTTGATCCA
GCAGAATGGGGGAGTAAGGTAGAAGACCGCTTCTATAACAATCATGCATTCGAGGTA
TGGTCCTTTGAAGCTGTTGGATTTGGCTATTTCTTCTCTCTGTCTACAGCTAGCAATTATT
AGGCTATCCCCAGAATTGTGAGAATTATGTGAGGAGGCATCACAAATAACTTATTAAATC
Exon 3
AAAACAGTGGTACACACATTCCAAAAGCAACAGATCAAACATTTTTGCCAATTATTTGGT
CTTTAATATTTGTTTACACGTATTTCCTTAAGAGCTTTTATTATTTCTTCTTGTTTCAATGTA
TTTTCCTTATTAAAAGATAAATACGTAGTATTTAATTCCCCCTATTTCTCAGTAATTTAAAG
TAATGTTTCATTACTTCTAAGCAGTTTGATACAAGACTTTGCCATTTTGGAAACATTGCTA
ATTGTGGCTCTCTCCTATCTGTCCAGGAGCAAGAACCACCTGAGAAAAGTGATCCTAAA
CAAGAAGAGTCTCAGATATCTGGGAAGGAGGAAGAGACATCAGTCACCATCTTAGTA
TGTAATATTTTTCATGTACTATTGGATTCCTACAAAGAATGATATTGCCCAATTTAAAACT
GAACTCCAAATATGAATGTCTGTTATCTTTATTGTCAAAATTATGACTTTACTTTCCAGAT
AATTAACATCAGTGATAAACTAACTGGTAGATAATTTTCAGCCATGCCTCTCTTGA
Exon 4
AAGCAACAGCTCTCAGATAGTTGCATCCCTAAAATGATTAAATTTCATCCATTTATTTTTG
TGGCATCAAAACTACGCCATATTTAAAGAGTCTCTTACTTTTTCTCCTTTCGATGAAGGAC
t c t t c t g a g g a a g a t a a g g a a a a a g a a g a g g t t g c t g c t g t c a I a a t c c a a g c t g c c
TTCCGGGGACACATAGCCAGAGAGGAGGCAAAGAAAATGAAAACAAATAGTCTTCA
AAATGAGGAAAAAGAGGAAAACAAGTGAGGACACTGGTTTTACCTCCAGGAAACATG
AAAAATAATCCAAATCCATCAACCTTCTTATTAATGTCATTTCTTCCTGAGGAAGGAA
GATTTGATGT
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LRRC35 exon sequences with primers for sequencing highlighted.
Key
CODING EXON 
START/STOP CODON 
5V3’ UTR 
INTRON
Exon 1
CACCACAGTATATGTTTCTGGGGTCAGTAACTAAGTATCATATtlTCTTGi
^TG CC TA G TCTA Q TACTTTATACATAATGGGTTTTCAATAAATACTTCT
TATGTGAGTAAATACATAATTACATAATTTGATTATTTCTTGGTTTCTTG
TAGCÀfTtTÂAGAAAGAÀÂGÀTGGATCAACCTAGTGGAAGAAGTTTCATG
CAÀGTATTATGTG AAAA ATATAGTCCTG AAAATTTTCCTTATCGCCGTGG
CCCGGGGATGGGAGTCCATGTCCCAGCCACACCTCAGGGCTCTCCTATGA
MQGTAAGAAAGATGG’GACCTAAAACACTTATTfAGTGGAGCTTACTTAG
g a t g t t a a a t C a c a g t g t t g c c t t g t t t g C a a a t g a t t t a t t t t a t t t t t
Exon 2
CAGTACTTCTGAACTCCTCCTGGGCAATAACTGGCTGTCTCCTCTTAGGA
irrCAGTACCCTTTGGTCCCATTATATCCTGTATTTTCTAGATCCTTATGT
AATTTCACACAGTTTGATTTTTGTTTCTTGACACTTCCTGGGGGCTGAAC
ATATGTAGACAAGAATTTGGCTGATATAGAAAACATTTTGTGTCTCTCAT
CATTCAGATCGCCTCAACCTCCCAAGTGTACTAG TGTTGAACAGCTGTGG
AATAACCTGTGCAGGAGATGAAAAAGAAATTGCTGCTTTCTGCGCTCATG
TGTCGGAACTAGATCTTTCTGACAACAAACTCGAAGACTGGCATGAGGTG
a a g t t t t t a t a t t g c t a c a t t t t a g t g a a a a S c a g c a a t a a c c a t t g t g t I
I a t t g t t t a t g t t a t t a t a t g t t c t g c t a a a t t c t g t t c t c a c t t g a t g t
Exon 3
TTTGCCAAGGTTTGTTGAAATCACTTATGTCCCTCTGTGAGTACCGTCAC
TAAATAATAGGACTCCTTGATGTAAATGGCCCTTTGCCTGGAGACCAGCT
c c t c t a g g c t t t c t t g a g c a t g a t t g c t a t t t a Iâ c a g c t c t g a t t a c t g C
BBATAATGCTTTTCmTTTTCTCCTTAGGTCAGTAAAATTGTGTCAAA
TGTTCCTCAGTTGGAGTTTCTAAACCTGAGTTCCAACCCTCTGAATTTGT
CGGTTTTAGAAAGAACATGTGCTGGGTCCTTCTCTGGGGTTCGCAAACTT
GTCCTCAACAACAGCAAAGCTTCTTGGGAGACGGTCCACATGATACTACA
GGAGTTACCAGAGTAAGCCCAGAGAGCATGAGGGCGAGGGAGTTATGTTG
CCATCTGTGTTAGTACAfrAGGAGTACTGCTGATCTCOCACGCAAGAAATA
CTAGAACTGCAGATTGAGTGGAGAAAGAGGTTAGAAAAACGAAGTTATTG
Exon 4
AGTAATTTCGCACTACCTTATATCATTCTTCGCTATTTCAGTGTGTACTT
CAGGTTTTGTCTTCCCAGCTATATTTTGAACTTCAGGAAGACATCTTGGT
ATTTTCTiCCACAATTCCTAGCAGAGTgTCACATATAGTAGGCACTTACTT
ATTTATTGAATGAATGAAAATAGGTGTAAAGTAGAAATTAAACTGCTTTA
AACAATGAAATATTTCCTTTTTTCTCTGCAGTTTGGAGGAGCTCTTCCTG
TGCCTTAATGACTATGAAACAGTGTCTTGTCCTTCTATTTGCTGTCATTC
TCTTAAGCTACTACATATAACAGACAATAACCTCCAAGACTGGACTGAAA
TACGAAAGTTAGGAGTTATGTTTCCTTCACTGGATACCCTCGTCCTGGCC
AACAATCATTTGAATGCTATTGAGGAGCCTGATGATTCATTGGCCAGGTT
GTTTCCTAATCTTCGATCCATCAGCCTCCACAAGTCAGGTGAGGTTCAGG
CTTGTTCTTATTCTACATGCAAATTAACCTGAGCATATGCATGAAATACA
ATGAAAGTATATTTCTTTCAGTCACAGTTTTACCTTTTTTAGAGTGAATT
TTCTATATGACAiTGCAGATGCCTATGATTGGQTAAATTTAAGAGATTCAT
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Exon 5
AAGTCACTTTGGTAGAAAATGAGTAGATGAGAGGATGTTAGACAATAACA
CTCTCTTAACCCGTGGATCACAGAGGTAGGAGAGGCTATGGGGAAGTTTT
TGTGGTTTTAACTGTGTTCfTGCTCTTGCCTTGGATGAAQAAAACTTTCAG
ACCGTTTAGTTTATGATCATTTTAACATTTCAGAAGTTACTAATTGAGCT
AATATTTTTGCTATGTTTCTCTTCTTATTTATGTGCATCTCTGGATTTAC
TTAAACAATATGTTCTCAAATTAGOTTTGCAGTCCtGGGAAGACATTGAt
AAACTAAATTCATTTCCCAAACTGGAAGAAGTGAGATTGTTAGGAATTCC
TCrTCTGCAGCCATATACCACCGAGGAGCGAAGGAAATTGGTAATAGCCÀ
GGTCTGTTGTCCTGATCGTTTTGCTTTATTTTTGTGAGGCCTTATTGffT
CATTAAAGGAATAATGCACTGTTTAGTGGGAGTGCjjjCTATGAAATTATTC
Exon 6
GTTCATGTCAGTAGTTGTATACAAATGGAACTACATCAAATGTGTCCTTT
CAAGAAAATAAGiàCTGGGCCACAAGCCAATTAiGTTTCTTTCTAAAGCTAA
ATATATTAGTATCTTAAAAAATGTCTTTATTTTGGTTTTAACTTATAGAT
TOœATCAGTTTCCAAACTTAATGGCAGCGTTGTTACTGATGGTGAACGA
GAAGATTCTGAGAGATTTTTTATTCGTTACTATGTGGATGTTCCACAGGA
AGAAGTGCCATTCAGGTAAAAAATTCCCCATTGGCCAAACACTTTAG^Qi
lOTGGTGATGCCAGTTAÂiGAACTCTAGTGTTAGAGCAAAATCTAATCATTT
GTTATTGGACCCTTCTTAGAGAACTTTGTTAATACGTTAAAAAAAAGGAA
GAAACACAAGAGCAAACCTATTTTATCTCATTTTCCACAGTATATTTCTT
Exon 7
ACTCATATTAGATCACAGAGTCCATAGGAGTCATGTGATAGAATAAGATT
TTTTAAAGATGTTGAGCCTAGTAATATTGTTTATCTGTAGTTGGGAAGAA
Gt c c a c a g t a c a t g t g c t a Q t a g t t t a a g c t g a c a g t g t t g t t t t t a a t c
CTTCTAGGTATCATGAACTGATCACTAAATATGGGAAGTTGGAGCCTTTG
GCAGAAGTGGACCTAAGACCCCAGAGCAGTGCAAAAGTAGAAGTCCACTT
TAACGATCAGGTGGAAGAAATGAGCATTCGTCTGGACCAAACAGTGGCAG
AACTAAAGAAACAGTTAAAAACTCTAGTACAATTACCCACAAGCAACATG
CTTCTCTACTATTTTGACCATGAAGCACCCTTTGGCCCAGAGGAAATGAA
GTACAGCTCTCGGGCATTGCATTCCTTTGGCATTAGGGATGGAGATAAAA
T T T A C G T G G A A T C C A ^A G /^ ^TAACCTCTACCAGCCTTGTGAAAAACA
TACAfcATAAGGACTTGTTGCAGGGCA TTTGTTTTTAATGTGGTTTTCTTT
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FU 35808  exon sequences with primers for sequencing highlighted
Key
IR IM EI 
CODING EXON
START/STOP CODON 
573’ UTR 
INTRON
Exon 1
GCAACACAGACAGTGTGCGTGGTTACTGTCATTTTTCCTTAGTCTAAGS______________
K ^ I ^ Æ f l ^ l T ^ TCATTTTCCTCCTCCM ATGAGAATTGGCACCCCAACAGCAGGCCCT
GGGCCCTCGGCTGTGATGGAGGGGTGTCTCGGGGTAGCAGAACTAAGGTGAGGTTG
CAAGGCTTCAAGTGTTGTTCTGCCTCTTCCATTTCClCCTGTCCTCTTCCTCTGTTCAlT
CTCCCTCTCACC
Exon 2
CGTTCATCCTCGCTGGCTCTGGAGCCTTGTCTCCGCCAtCGAGTTTCTGGTTTCCAGa
H g c c a t g g c c t c g g g t g a c c a g a a g c c a g c t a c a c t g c c t c c t g g c c t g t g g t t c c
CTTCCAGGAAGCTCTCCACCTTCAGTGCATACTTGGAGGACCACAGCTACAACGTGG
AGCAGATATGGAGGGATATTGAGGACGTCATCATCAAGACCCTCATCTCGGCCCACC
CCATCATCAGGCATAACTACCACACCTGCTTCCCCAACCACACACTCAACAGCGCCT
GCTTTGAGATCCTGGGCTTTGACATTTTGTTGGACCACAAACTCAAACCCTGGCTGC
TGGAGGTAGGGAAGTTTGGG CG AG G G G CG AAAAC gAACTCCTGTTATTGGGGCCAG
CCCGCTTCAAGGATTCCGCdeT C C T G G C T C A C C T A A A T T ^TTTCAACTTCCCAGGCC
ACTTCCTCCCATGGTGCCTGCTGCC
Exon 3 _______________________________
CTTGGTAGTGAGGGCCCTGAGGTCGGCTTTGGTACrÿGCCCTGGAGGTGGCACCTCG
GCCTCACTCTCTGCTTTCATTCTGGACGGCTTTGTCACCAGCTGCCAATCTTGCCCTC
ACAGGTCAACCACTCTCCAAGCTTCTCCACCGACTCTCGGTTGGATAAAGAGGTGAA
AGATGGTCTGCTGTATGACACCTTAGTCCTGATCAACCTGGAAAGCTGTGACAAGAA
GAAAGTCTTGGAGGAGGAGAGACAACGGGGGCAGTTCCTGCAGCAGTGTTGTTCTC
GGGAGATGAGGTACATTCGCACTCCCCAGCCTTGCGGGGCTCTCTCTCTG^ T C C C d
fcGCTCCCAATAAdAATGAT
Exon 4
CTGATTGACCGCCATTATGTGCAAGGCCTCCATCTGGCCCTAGACGACCTCCAGCTT
GGAle-ATATCCCTTCCAG^TTTCjTCCCAAGAAAACCTGACAGCAGCCCCATGTTCTG
CTTCCCAACAGGATTGAGGAAGCCAAGGGTTTCCGGGCCGTGCAGTTAAAGAAAAC
TGAAACGTATGAGAAGGAAAACTGTGGAGGGTTCCGACTGATTTATCCCAGTCTGAA
TTCGGAGAAGTATGAGAAGTTTTTCCAGGACAACAACTCCCTCTTCCAGAATACTGT
TGCTTCCAGGGCTCGGGAGGAGTATGCCCGGTAGG AAGACATCCGGGATGAGGTCG
GTGGAGGGGTTCTGGGGATTGTGTGlT G A T C T A T ^ G C T G A C T G G flCTGGAGTGGCA
GGGAGAGTCCCCAGCCATGAAAGT
Exon 5
t g t g g a a c t t g c t a a c t t t t c g c c c a g t K?a t g t c c a t c c c t c a a g g a < ^ t g c c t g c
CTGCGCAGCGCATTTCTAACCCCCATGATGTTCACTTGTTCTTCATGGGCAGGCAAC
TGATCCAGGAGCTGAGACTAAAACGGGAGAAAAAGCCCTTCCAAATGAAGAAGAAG
GTAGAGATGCAGGGGGAATCGGCAGGCGAGCAAGTGAGAAAGAAGGGCATGAGGG
GCTGGCAACAGAAACAACAGCAGAAAGACAAGGCCGCCACCCAAGCCTCCAAACAG
GTAAACCTGGATTGAGGGGAACACACGTAGCCACACCCTTCCCCACCTGGGCCTGAT
CCGTGGAGGGGTGCTGAGGAGACCACTGCTCAGAGCCtAG ACACACCGAAAGGCTCi
I g c a g a g g g c t g g g c a a c g a c g g g g c
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Exon 6
CTTCTCCTCATCTCTTTTTCACCTACCCCTGGGTlCCAGATGAATCTiGGAAGTGGJliTA 
GAGCTGGGTTCCCATGGCTGTGTGTTGTGGTTTCTTCCTCCCTCAGTACATCCAGCC  
ATTGACATTAGTATCCTACACACCTGACTTGCTCTTGAGTGTCAGAGGTGAAAGGAA  
AAATGAAACAGACAGCAGCCTCAACCAGGAGGCTCCCACGGAGGAGGCCAGCTCTG  
TTTTCCCCAAGCTGACGTCTGCGAAGCCCTTCAGTTCTCTACCCGATCTGAGGAATA  
TCAATCTCAGCAGCTCGAAGTTGGAGCCCAGTAAACCCAACTTCAGCATCAAGGAGG  
CCAAGTCTGCCTCTGCAGTGAACGTATTCACTGGCACTGTGGTAAGTAGTGAGCCGA  
GCTCTGGGAGGGAGTGGTGGGAGTCTTGCTTACTGGTCCTTTCTCTACCCi
Ig a g t a a g c c a c ttBlOaPÜÏEr
Exon 7
TCTCAAAAAATAAAAATAAAAAE\AAATA1GCATAGGAAGGAA€CCTTTC8CTTTCCAC
AGTCTCATTTTGAACTGTCTTTTCTTCCAGCACTTAACCTCCGTAGAAACCACCCCAG
AATCCACCACCCAACTCTCAATCTCCCCAAAGTCTCCGCCAACCCTGGCTGTGACCG
c c a g c t c t g .aI t a c a g t g g c c c a g a g a c g g a c a g g g t g g t a t c c t t t a a a t g c a a g
AAGCAGCAGACCCCICCACACTTAACCCAGAAGAAAATGTTAAAATCTTTTCTGCCC
ACAAAATCCAAGAGCTTCTGGGAGAGTCCGAACACAAACTGGACTTTGCTAAAGAGT
GACATGAACAAGCCACATTTGATATCCGAGCTACTCACCAAGCTTCAACTGAGTGGG
AAGCTCTCCTTCTTCCCAGCTCACTACAACCCCAAGCTGGGGATGAATAACCTGTCA
CGTGAGTGCCAGTGTGTACAGGGATGTGCCAGGAGCTTAAAGGGGAGAGGGACCGA
T.AlGAACCAGTCCTAATCTTtGGClGAGCT
Exon 8
ATGGGACCCTACTGGGAGGTGGTCTTfeACCAGGAATTTGTGCTGAAlTCCAGCAGCAC  
AAATCGCTGATGCTTCTGACTTTGCCTTTCCAGAAAACCCCTCCCTGCCTGGGGAGT  
GCCACTCCCGCAGTGACAGCTCTGGCGAGAAGAGGCAGCTGGATGTGTCCTCCCTC  
CTCTTGCAGAGTCCTCAGAGCTATAATGTTACTCTGAGGGACCTGCTGGTGATTGCC  
ACTCCAGCCCAACTGGATCCAAGGCCTTGTAGAAGCCACGCAAGTGCTATGAGGGA  
CCCATGTATGCAGGATCAAGAAGCATACAGCCATTGCCTGATCTCTGGCCAAAAAGG  
ATGTGAGAGGAGCTAGGTAGGCCCACACATATTCCCTTAATGAATTTGGTGCl
It t c t g g a
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LRRC46 exon sequences with primers for sequencing highlighted.
Key
m m
CODING EXON
START/STOP CODON 
5V3’ UTR 
INTRON
Exon 1 and 2
AGTCTCTGAGTTTCTCTCTCCTCCTGCCAltirfélfriTfiir/lliTrfrfiaEinCiliM AGGGGCCG
CCAAGACCTCTCTTTTCGTTCCTCTCCCGCCTCAGACCAGCAGCCTTTTATTTTAGAT
CATGTCTGGAGGTGAGTAGGGAGGTGGGACGGTGGGTAGAGCAGTTGGAAAACAGC
GGGGTAAGGCCTCCAAGAGTGAGGAAGTGTCACAGTTGGACTCATCTTTTCACAGG
GAAGTCAGCCCAGGGTCCAGAGGAAGGGGGCGTCTGCATCACTGAAGCCCTTATCA
CTAAGCGGAACTTGACTTTCCCTGAAGATGGGGAACTGTCAGAGAAGATGTGAGTG
C A T G G G G G A G A A A A G G G G T G C T A G A A G g g g g g g g g g g g g g g A G G T C C C T
GACGTGTACTGATTTGTCAACTGAT
Exon 3
G A A A C C C C T T C C C T C C T C C G T C T C C C A T C C H H im iH H H lG A G T G G T
GCTCTAACACCACCCTTACTGACTCTTTTCCCAGGTTTCACACTCTTGATGAACTGCA
GACTGTCCGCCTGGACCGGGAGGGGATTACTACTATCAGGAACTTAGAAGGCCTCC
AGAATCTTCACAGTCTCTATCTGCAAGGGGTAACTTCTTTCTCCACCCTTCCCCTCCC
C T T G A C C C C T G T G G A C C T A A T C T G T C T C g g g g g g g g g g g g G G T C A T C C T G
CCCATTCCCTGGTG
Exon 4
T C C C A A A G T G C C A G A T C T C C A G C T G C A G A G T H m U H B B H iG T C C C C
GTAAAGGGCCCCTGACGCATCTGATCTCAGCTTGGTTTCCCCACTTCGGTTTCTTCT
TGCAGAATAAGATCCAGCAAATTGAGAACCTGGCTTGCATCCCCTCCTTGCGGTATG
TGGTGCCAGGGCTCAGGCAGGGGAAGAGGGGTTGGGGGAACCTAGCCATATCCCAA
a g a a c t g g t ^ H H U H ^ H H B B g t c c t t g t c a g t c a a g g a c c a g c a a g c c
TAGATCTACTCCCTCA
Exon 5
CCCCAGAAGGCCATGTGTCCCCACTGGTCATCAGCTGCCTAGCCCAGGGGCCCCGG
TGTCgggg^^gggggggCCAGCTGTTCCATGATTCAGCTCTGCCTCTGTAC
CCCTTCCTTCCCCTACAGCTTCCTGTCTCTGGCAGGAAACCAAATCAGGCAGGTGGA
AAACCTCCTCGACCTCCCATGCCTCCAGTTTCTGGACCTTTCTGAGAACCTGATAGA
AACATTGAAGCTGGGTAGGAACCCACTCGCCCTGGCTCACCAAACACATCCCCTGTG
GGGCCTGCCCTCCCCTCTGCACCCATCTGCCCATGCmHHUm^^Hc
AGGTCCACATTTCATCCT
Exon 6 and?____________________________
A A C C C C g g g ^ g g g g g ^ g g T T T T G G C T A A G A T C A A G T G A G A A C C C C A T T T  
CCTCTCTCTTTGCTGTGTGCAGATGAGTTCCCCCAGAGCCTTCTCATCCTCAACCTGT 
CTGGAAACAGCTGCACCAACCAGGATGGCTACCGGTAAGGAGTGGAGGGTGGGAAG 
AAAGGTCATGGCTGAGCTCTACCTGCTAACTCAGCCCAGACCCCTCTCAGCCTGCAA 
ACCTGGGGTCCTGTCCATGACACCTTCTCCCCCACCTCCTACCTAGCTCATGAGCCA 
C C A C C C C T C C G G G T G T G A G T G C T G T G |B ^ H H B H H B |C C A C G C C A G G G T  
GCCCTCCTGGGTAACCTCTGCTCCTTCTGCTCTGCAGCGAGCTGGTGACAGAAGCCC 
TGCCACTTCTCCTGGACCTGGACGGGCAGCCTGTGGTGGAGCGCTGGATTTCGGAT 
GAGGAGGATGAAGCCTCAAGCGATGAGGAGTTCCCAGAGCTGAGTGGCCCATTCTG 
CTCAGAACGAGGTGACCCTGCTTTCCAAGGTTTTCAGCCTCCCCAGAGCCCACCTCT 
GCCCTGTGGGAi
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Exon 8
f -  A a  n m - ' r n  a  ' " ' " ^ | g | H | | | | | | | f f Y ^ # M W K # ( M i W ^ ^ G C G C C A G C C A G A
GACTTCCCTGAGCCCAGGGACCCTCCTGCTGAGCCCAGGGCTCCACCCACCCTGTAC
CCTCCACCCCCGGCCCCTCCCAGGCTTCCTCAAGGAGCTGGAGCAGGAGCTGAGCA
GGCACAGGGAGCACCGGCAACAGACGGCCCTGACAGAGCACCTGCTGAGGATGGAG
ATGCAGCCCACCCTCACCGACCTGCCCCTGCTACCTGGGGTGCCCATGGCTGGGGA
CAGCAGCCCTTCTGCCACTCCTGCGCAAGGGGAGGAGACAGTCCCTGAGGCCGTCT
CCTCACCCCAGGCCTCCTCTCCCACCAAGAAACCATGCAGTCTGATTCCCAGGGGCC
ACCAAAGCTCTTTCTGGGGAAGGAAGGGGGCACGAGCAGCCACAGCCCCCAAGGCC
TCTGTGGCTGAGGCCCCCAGCACAACCAAAACTACGGCCAAGAGAAGCAAGAAAIG
ATTCTCTGTCAACCTTTCTCTACTAGTGGAGAGGAGTGGGGCCTGCCCCTCTTCTCA
GACCTCTGACCTGTGACMLy,TKiMCifelilLtCicWty-ffil#-lllGTGTrTrTAGGrrrTGAGTA
TGCTTTTCATGTCACTTGGGGTATCTCAGGGGAAGAAACC
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APPENDIX 2
Multipoint MERLIN linkage analysis for Arabic 
family 152 following 600 kb Illumina SNP screen
Novel in-house markers used for genotyping on 
chromosome 6
Comparative BLAST and function analysis of 
genes within the region of interest on chromosome 
17
Primer sequences used for sequencing candidate 
genes
Candidate gene sequences with primers highlighted
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M ultipoint M ERLIN linkage analysis for A rabic fam ily 152 following 600 kb Illumina SNP  
screen. LOD scores >3 on chromosome 6
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Chromosome 12 Chromosome 13 Chromosome 14
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Marker Forward Reverse
TEX27 gggtgcctaatgtaggttgg actggtgatgagccacagg
DNAH8in35 tgtcaggtttagtgacctgtcc gttctttcccacgaagctacc
TBCC gagtcacagagggagatcctg caagggctccttggaacag
KNSL8 ggactatagccctcagggtgac cagggtgagaggagagacagg
UAEPall gctccagcttcagtgttttca tgtggtggctcattcctgta
UAEPal4 ggctttctccatgtctatacgg ttacaggcatgagccactgt
UAUPal2 tttgtgatctcttggcatgg gatggcctgagaaagtctcg
UAEPalS ctggaaattgggcaggact gcatcttccagctaacctcct
UAEPaB cctcccttcttttcctccag gggctgtcagcaacttgttt
UAEPal6 gaggcatgacttgcttgaga tcaggcagaaggagaaggaa
Novel in-house markers used for genotyping on chromosome 6
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C om parative BLAST and function analysis of genes within the region of interest on chromosome 17, as described in Chapter 4, Section 4.1.9
Accession Gene ARAB CERV ROMS CHLY RAZO DEFLA TRYR CION TETR McKE ELEG foxll Function
Domain* Identified 
bv NCBI BLASTd
UnlGene
exoresslon
NM 138572.1 tau b e  n u ss  hom oloa (m ouse) (TBN), 1 0 1 0 0 0 0 1 0 0 1 0 reoulation of transcription
B rom odom ain 
transcription factors
inc. eye, 
kidney, testis, 
lung NT
NM 000409,2 auanv la te  cv c lase  ac tiva tor 1A (retina) (GUCA1A). 1 1 1 1 1 0 1 1 1 1 1 1
Ca2+-binding, stim u la tes cG M P sy n th esis  in 
photorec
EF-hand, calcium  
binding motif
eye, testis, 
lung NT
NM 018415.1
transcriptional regulating factor 1 (TRERF1), transcript 
variant 3. 0 0 0 0 0 0 0 1 0 0 1 0 zinc-finaer transcriptional reaulatino  protein DNA-binding dom ains
inc. eye, 
kidney, testis, 
lung NT
NM 015255.1
ubiquitin protein lig ase  E 3 co m ponen t n-recognin 2 
(UBR2). 1 1 1 0 0 0 1 1 1 0 1 0 invd in Proteolvsis P uta tive zinc finoer
inc. eye, 
kidney, testis, 
lung, trac h ea
NM 000322.2 retinal d eaenera tion . slow (RDS), 0 0 0 0 0 0 0 0 0 0 1 0
ceil su rface  glycoprotein found in th e  outer 
se g m e n t of bo th  rod an d  c o n e  photo recep to r 
ceils, it m ay function a s  a n  ad h e sio n  m olecule 
involved in stabilization a n d  com paction  of outer 
se g m e n t d isks, invd in ADRP. But only in 
e ie a a n s
brain, eye, 
lung, trac h ea
NM 003192.1 tubulin-SDecific c h a o ero n e  c  (TBCC). 0 0 0 1 0 0 1 1 1 1 1 0
Tubulin co  factor, in terects with R P  protein. 
C ofactor C  is o n e  of four pro teins (cofactors A, 
D, E, an d  C) involved in th e  pathw ay leading  to  
conectiy  folded beta-tutrulin from folding 
in term ed ia tes
X-linked retinitis 
p igm en tosa  2  g e n e  
product dom ian
inc. eye, 
kidney, testis, 
lung NT
NM 001004322.1 FLJ38717 protein (FLJ38717). 0 0 0 0 0 0 0 1 0 0 0 0 no putative dom ains no  info
NM 015349.1 KIAA0240 (KIAA0240). 0 0 0 0 0 0 0 1 0 0 1 0 no putative dom ains
inc. eye, 
kidney, testis, 
lung NT
NM 198486.2 ribosom al protein L7-iike 1 (RPL7L1). 1 1 1 1 0 0 1 1 1 0 1 0 ribosom al protein
inc. eye, 
kidney, testis, 
lung, trac h ea
NM 001008739  1 sim ilar to  RiKEN cDNA 2310039H 08 (LO C441150), 0 0 0 0 0 0 0 0 0 0 0 0
Riken = C a  binding protein receptor, invd in 
p an c rea tic  ductal ad enocarc inom a no putative dom ains
inc brain, eye, 
lung NT
NM 138 2 9 6 1 p re  T-ceil an tioen  re cep to r alp h a  (PTCRA). 0 0 0 0 0 0 0 0 0 0 0 0
a  com ponen t of th e  pre-T ceil recep to r (pre- 
TCR), w hich re g u la tes  early  T  cell developm en t no  putative dom ains
kidney, sp le e n , 
thym us, lung 
only
NM 0 0 6586  2 trinucleotide re p e a t containino 5  (TNRC5), 0 0 0 0 0 0 0 1 0 0 1 0 no putative dom ains
inc. eye, 
kidney, testis, 
lung NT
NM 0 1 8960  4 alvcine N -m ethvltransferase (GNMT), 0 0 0 0 0 0 0 0 0 0 0 0
p artic ipa tes  in th e  detoxification pathw ay in liver 
ce ils
c o e n ^ e  m etabolism  
dom ains
inc kidney an d  
lung
NM 0002 8 7  2 peroxisom al b iooenesis  factor 6  (PEX6). 1 1 1 1 1 0 1 1 1 0 1 0 invd in peroxisom e foidina an d  organisa tion
AAA-superfamiiy of 
A T P ase s
inc. eye, 
kidney, testis, 
iuno. trac h ea
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NM 006245.2
protein p h o sp h a tase  2, regulatory subunit B (B56), 
delta Isoform (P P P 2R 5D 1., 1 1 1 1 0 0 0 1 1 0 1 0 Serine/threonlne protein p h o sp h a tase
...
Inc. eye, 
kidney, testis, 
lung, trach ea
NM 014623.2 m ale-enhanced  an tioen  (MEAl. 0 0 0 0 0 0 0 0 0 Q 0 0
regd by X an d  Y rep ressor/activator g en e s , 
respectively. E x p ressed  In cytoplasm  of 
sperm atids, p o ss  role In late  s tag e  of 
sp erm ato g en esis MEAl dom ain
Inc. eye, 
kidney, testis, 
lung NT
NM 057161.2 kelch dom ain containing 3  (KLHDC3), 1 1 1 1 1 0 1 1 1 0 1 0 Invd In activation of the V(D)J recom bination
Inc. eye, 
kidney, testis, 
lung, trach ea
NM 033112.2 chrom osom e 6  open  reading  fram e 153 (C6orf1531. 1 0 1 0 0 0 0 1 1 0 1 0
Dom ain of unknown 
function
inc. eye, 
kidney, testis, 
lung NT
NM 014780.3 cullin 7 (CUL7), 0 0 0 0 0 0 0 1 0 0 0 0 Invd In cell cvcle
A naphase-prom oting 
com plex
Inc. eye, 
kidney, testis, 
lung, trachea
NM 015950.3
mitochondrial ribosom al protein L2 (MRPL2), nuclear 
g e n e  encoding mitochondrial protein. 1 1 1 1 0 0 0 1 0 0 1 0 mitochondrial ribosom al protein
ribosom al protein 
dom ains
Inc, eye, 
kidney, testis, 
lung NT
NM 201522.1 kinesln-llke 8 (KNSL8), transcript variant 2, 0 0 0 1 1 0 1 1 1 0 1 0 kinesin, m icrotubule m otor activity
Tetratricopeptlde 
re p ea t dom ain
Inc, eye, 
kidney, testis, 
lung, trach ea
NM 002821.3
PTK7 protein tyrosine k inase  7 (PTK7), transcript 
variant PTK7-1. 1 1 1 1 1 1 1 1 1 0 1 1 R eceptor protein tyrosine k inases
Inc. eye, 
kidney, testis, 
lung NT
NM_003131.2
serum  re sp o n se  factor (c-fos serum  re sp o n se  elem en t 
binding transcription factor) (SRF), 1 1 1 0 0 0 0 1 0 0 1 0
transcription factor; stim ulates both cell 
proliferation an d  differentiation MADS SR F  like
inc. eye, 
kidney, testis, 
lung NT
NM 015089
p53-assocla ted  parkln-llke cytoplasm ic protein 
(PARC). 1 1 1 1 0 0 1 1 1 0 1 0
critical regulator In controlling p53 subcellular 
localization
In B etw een Ring 
fingers, Cullin
Inc. eye, 
kidney, testis, 
lung, trach ea
(NM 0064431 chrom osom e 6  o p en  reading  fram e 108 (C 6orf108)., 0 0 0 0 0 0 0 1 1 0 0 0
T he ex a ct function of this g e n e  Is no t known but 
stud ies In rat su g g es t a  role In cellular 
proliferation and  c-M yc-m edlated transform ation
ca ta ly ses  th e  c le av ag e 
of th e  glycosldic bonds 
o f 2 -
deoxyribonucleosldes
Inc. eye, 
kidney, lung 
NT an d  not 
testis
(NM 0325381 tau  tubulin k in ase  1 (TTBK1), 1 1 1 1 1 1 1 1 1 0 1 1
Ser/T hr protein k inase  phosphorylating tau, 
beta-tubulln, MAP2 an d  a lpha-casein
Serine/T hreonine 
protein k inases, 
catalytic dom ain
eye, kidney, 
testis , lung NT
NM 153320
so lu te  carrier family 22 (organic anion transporter), 
m em b er 7  (SLC22A 71.. 1 1 1 1 0 0 1 1 1 0 1 1
Ic22a7 Is a  multlspecific organic anion 
transporter of the  liver an d  kidney
A rabinose efflux 
perm e ase , 
Nltrate/nltrite 
transporter
kidney, no 
o ther relevant 
tissu e s
NM 206922 cysteine-rlch protein 3 (CRIP3). 1 0 0 0 0 0 0 1 0 0 1 1 ZInc-blndIng dom ain
brain, testis, 
kidney, lung, 
NT
NM 014345 zinc finger protein 318 (ZNF3181. 0 0 0 0 0 0 0 1 0 0 0 0 Zinc Finger Zinc Finger
inc. eye, 
kidney, lung 
NT an d  not 
testis
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NM 138572.1
ATP-binding cassette, sub-famiiy C (CFTR/MRP), 
member 10 (ABCC10). 1 1 1 1 0 0 1 1 1 0 1 1
member of the MRP subfamily yyhich is involveo 
in multi-drug resistance, nhibition of NK cell- 
mediated lysis ttiat is reversible using anti- 
CD94 and anti-class 1 mAbs ABC-ATPase
brain, eye, 
kidney, lung 
NT
NM 000409.2 EGF-like-domain. multi Die 9 (EGFL9),. 1 0 0 1 0 0 1 1 1 0 1 1 EGF-like orotein
calcium binding 
domain
brain, eye, lung 
NT
NM 018415.1
tight junction associated protein 1 (peripheral) 
(TJAP1). 0 0 0 0 0 0 0 1 0 0 0 0
present at tight junctions between epithelial 
cells none detected
inc. eye, 
kidney, testis, 
lung, trachea
NM 015255.1 chromosome 6 open readina frame 154 (C6orf154). 1 0 0 1 0 0 1 1 0 1 1 1
Leucine-rich repeats, 
Tropomodulin: blocks 
head-to-tail 
association of 
tropomyosin along 
actin filaments
brain, eye, 
testis, iuno NT
NM 000322.2 Yiol domain family, member 3 (YIPF3). 1 0 0 0 0 0 0 1 0 0 1 0 involved in hematoooiesis
Yipl domain (golgi 
protein involved in 
vesicular transport that 
interacts with 
GTPases)
inc. eye, 
kidney, testis, 
lung NT
NM 003192.1
polymerase (RNA) 1 polypeptide 0 , 30kDa (P0LR1C),
1 1 1 1 0 0 1 1 1 0 1 0 RNA Ddvmerase RNA polymerases D
inc. eye, 
kidney, testis, 
lung, trachea
NM 001004322.1 exportin 5 (XP05). 1 1 1 0 0 0 1 1 0 0 1 0
mediate the transport of proteins and other 
cargo between the nuclear and cytoplasmic 
comoartments
Importin beta-related 
nuclear transport 
receptor
inc. eye, 
kidney, testis, 
lung, trachea
NM 015349.1 polymerase (DNA directed), e ta (POLH). 1 1 1 1 0 0 1 1 1 0 1 0 damage-bvoass replication orotein DNA polymerase
inc. eye, 
kidney, testis, 
lung, trachea
NM 198486.2 GTP binding protein 2 (GTPBP2). 1 1 1 1 0 0 1 1 1 0 1 0 GTP-binding orotein GTP-binding
inc. eye, 
kidney, testis, 
lung NT
NM 0010087391 MAD2L1 binding protein (MAD2L1BP).. 0 0 0 0 0 0 0 1 0 0 0 0
delays the onset of anaphase until all the 
kinetochores are attached to the spindle none detected
inc. eye, 
kidney, testis, 
lung NT
NM 1382961 chromosome 6 ooen reading frame 206 (C6orf206). 0 0 0 1 1 1 1 1 1 1 0 1 mitochondrial ribosomal orotein S18A-like 1 none detected
inc. brain, eye, 
testis, lung NT
NM 006586?
mitochondrial ribosomal protein S18A (MRPS18A), 
nuclear gene encoding mitochondrial orotein. 0 0 0 0 0 0 0 1 0 0 1 0
28S subunit protein that belongs to the 
ribosomal orotein S18P family ribosome
inc. eye, 
kidney, testis, 
lung, trachea
NM 018960 4 vascular endotheliai grovyth factor A/EGF).. 0 0 0 0 0 0 0 0 0 0 0 0
increases vascular permeability, inducing 
angiogenesis, vasculogenesis and endothelial 
cell growth, promoting ceil migration, and 
inhibiting aoootosis
Platelet-derived and 
vascular endotfielial 
growth factors (PDGF, 
VEGFi family domain
inc. eye, 
kidney, testis, 
lung, trachea
269
Exon Fwd Rev
1 section 1 
1 section 2
CATCATGTTAGGCCAATCACC
CAACCTGGAGTCCCAAGTCT
CATACAGTCTGACCGTGCAGTT
GGAAAGTCCAACGTGGAAAG
P rim er sequences for genomic TBCC sequencing
Exon Fwd Rev
1 TTGCTCAGCTTCTCTGTCTCA TAGAGTGAGGTGATCCCAAGC
2 CCTTCCACCTGTTCCTGAAT TGATGGACCCTGAGGATGAT
3 AGGGGTCACTGAGAAGGCTA TTCTAGATGGTGACTGTCCTGTG
4 TGGAACAAGACATGCAATGG AAAGCCAAAGGAGGACCAAG
5 GCTTCCTGTCTCCTCATGGA GCAGCAGATGGATGAGCTAAG
6 & 7 CCCATAGGTCTTTTGCAACC GTGTGCCAGACTGTGATGCT
8 & 9 CTTGCCTCCCTCCATGTTT GAGTTGGGCTAATGCAAGGA
10& 11 CACCTTGCATCTCAGCATCT CAAGAAACCTCGGCACTCTC
12& 13 TTTCCTTCCAGTGGCTGATG CTCCCAAAGTGCTGGGATTA
12& 13 TGTGGGTCTCAATAGTAGGTTGTG GATTACAGGCGTGAGCCACT
14 CTTAAGGCCACTCAGGAGGA CTCCCTTCCCTCTTCCCTTA
15 ACTCTAGGAGCCAGTCTTTGG CTAAGGGCAGCAGCAATCTT
Prim er sequences for genomic KNSL8 sequencing
Exon Fwd Rev
1 to 4 CCCTACGGTGATTCCTCTCA GCGTACTGGATCACCAGGTT
Nested GCAACCTTGCTGGGATCT
3 to 10 GGATTCCCTGGATGACCTCT CAGAGCTCCCAGGTTTCTCA
8 to 15 GTACAGGAGTTTGGGTCTGT TAAACTGCTCCCCTTCACT
Nested ATGATGACCACAAGCCCATCT AAGAGCCAGGAGCAATGG
Prim er sequences for cDNA KNSL8 sequencing
Exon Fwd Rev
1 CCCAAACTCTGGAAAGGATG CCATTCCACTCATCTCAGATCC
nested CGGAGCTTCAGGTCTCCAT CGCCCCTTTCAATTGCTG
2 GCCCAACCCACTAGACAGAA CCAGCCTGTTGCCATAATTT
3 AGCGTGATCTGTGTGGCTCT CTGCTGGACTCCCAGACATA
4 GGTCCCAGTGCAGACAGAAA GTGAACCACCAATTCCCACT
5 CCAGTGGAACCATAGCACCT ACCAGACGGAGGTGGAGTTA
Prim er sequences for genom ic C6ORF206 sequencing
Exon Fwd Rev
1 to 2
2 to 5
CTTCTCCTAGCAACTCGAC
CCTGAACTGCACAGAGTGGA
TCACCTTCTGCAGCTCAGTG
GCTTAAGAAAATCATGTTTAGACTCTG
P rim er sequences for cDNA C6ORF206 sequencing
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TBCC genomic sequence with primers for sequencing highlighted
Key
rimt 
5V 3’ U T R  
C o d in g  exon
U p s tre am  D N A
GATCTGACATCATlCA TG TtA G G C C A A TC A C ^GACGCGTTGGTGGGAGGCCTCACGGACA
g c g c g c c c g g a g g a a g g a a g a c a a g a g a g P g g a a g c t t g a a g c c a a t A T G g a g t c c g t
c g t t g c t c c g c t g c t g c t g t | a g g a c c g g | g a c a t g g a g t c c c a g c g g g a c c t g a g c c t g
GTGCCTGAGCGGCTTCAGAGACGCGAACAAGAACGGCAGCTGGAAGTTGAAAGGCGGAA
ACAAAAGCGGCAGAACCAGGAGGTAGAGAAGGAGAACAGCCACTTTTTCGTCGCCACCT
t t g | t c g g g a g c g a g c g g c c g t g g a a g a g c t t c t g g a g c g c g c g g a g t c g g t c g a g c g g
CTGGAGGAGGCGGCCTCTCGGCTCCAGGGGCTGCAGAAACTAATCAACGACTCAGTTTTT
TTCCTAGCCGCTTACGACCTGCGGCAGGGACAAGAGGCGCTGGCGCGGCTGCAGGCGGCC
t t g g c | g a g c g g c g c c g g g g g c t g c a g c c c a a g a a g c g t t t c g c t t t c a a g a c c c g g g g a
AAGGATGCTGCTTCGTCTACCAAAGTAGACGCGGCTCCTGiCATCCCCCCGGCAGTTGAA
AGCATACAGGACTCC|CGCTGCCCAAGAAGGCGGAAGGAGACCTCGGC|CCAGCTGGGT
CTGCGGTTTCTCCAACCTGGAGTCCCAAGTCyTGGAGAAGRGAGCCAGCGAGTTGCACCA
GCGCGACGTTCTTTTGACCGAACTGAGCÀACTGCACGGTCÀGACTGTAT^AAATCCCAA
CACCCTGCGGCTAACCAAGGCCCACAGCTGCAAGCTGCTCTGCGGTCCGGTGTCTACCTCT
g t t t t c c t g g a g g a c t g c a g t g a c t g c g t g c t I g c a g t g g c c t g c c a a c a g c t c c g c a t a
c a c a g t a c g a a a g a c a c c c g c a t c t t c c t g c a g g t g a c c a g c a g g B c c a t c g t g g a g g a c
TGCAGTGGGATCCAGTTCGCCCCTTACACCTGGAGCTACCCGGAGATCGACAAGGACTTC
GAGAGCTCTGGTTTAGATAGGAGCAAAAATAACTGGAACGATGTTGACGATTTTAACTGG
CTGGCCCGGGATATGGCCTCCCCAAACTGGAGTATTCTTCCTGAAGAGGAGCGAAATATC
CAGTGGGACT A A GCAGTTGTCACTCTGTTCTTCACTCCTACCAAATAE fr r C C A C G f r ^
ICCCTTATTGGGTCTCGAAGTTTACTTATTGTCACACTGTGTATGTTTTCAGCATTTT 
AAGGCTAGAGATTGTAATGGGCTCCTACTTGTAATTTCCATTAAATTCGTAACAGGTATA 
ACACTAAAGCATTTTTGCTATTTTCGTCATGCCTTTGAGACTGAGTCTTACTCCGTCCCC 
CAGCGTGGTGGCGCGCTGGGATTACAGGCGCGCGCCACCACGCGAACTTGTATTTTTAGT 
AGAGACGGGGTTTCGCCATGTTGTCCGGGCTGCTCTCGAACTCCTGACCTCAGGTGATCC 
ACCCGCTTCAGCTTCCCAAAGTGCTGGCATTACAGGCGTGAGCCACCACGCCAGGGCTTT 
ATTTATTTATTTTTACCACAATAGTTTGAAGCAGTAAGGGGGAAGGAGGGTGATTATATT 
GCTTTGTAATGGTTTGTGATACTTGAAACATCACGGTGCATAATAAAGTAGGTCTGCAGT 
AAATACATGGGTTTGTTTGGTGTGTGTGTGTGTGTGTGTGTTTTGTTTTTAAAGAGATGG 
GCTCTCCTTATGTTGCCCAGGCTGGTTTCGAACTCCTGACCTCAAGCAATTCTCCTGCCT 
CAGCCTCCCAAAACACTCGGATTATAGACAGTAACCAGCAGTGTCAGGGTATAGATACAT 
ATTTAATAAATTCCAGAGCT
271
KNSL8 genomic sequence with primers highlighted
Key
Prim er 
C oding exon  
Start/ston codon  
Intron
Exon 1
CCCACCACTCTCTGAGAAAGTTGCTCAGCTTCTCTGTCTCATCTTTACACCAGCTGAA
CTCTGTTGTTTCTCCCTAGACCGGGCAAGGTCCCCCAGGCCAGGATGTCAGGCCTGG
TGTTGGGGCAGCGGGATGAGCCTGCAGGCCACCGGCTCAGCCAAGAGGAGATCCTG
GGGAGCACACGGCTGGTCAGCCAAGGGCTAGAGGCCCTACGCAGTGAACACCAGGC
CGTGCTGCAAAGCCTGTCCCAGACCATTGAGTGTCTGCAGCAGGGAGGCCATGAGG
AAGGGCTGGTGCATGAGAAGGCCCGGCAGCTTCicCGTTCTATGGAAAACATTGAG
CTCGGGCTGAGTGAGGCCCAGGTGAGAGGGCAAAGGTGGTGCCAAGTGGTCCAGG
GTGGATGGAGGAGCAGTTATCTGATTAAAGGTTTGGGGCTGCTTGGGATCACCTCAC
TCTAGACGTTTGCATTCATTCATTAAATA
Exon 2
CCTTCCACCTGTTCCTGAATACTCCCACCCAGAATCTGGAGCTCAGGGGATGTGCCC
ACCTAGGTGATGCTGGCTCTAGCCAGCCACCTGAGCACAGTGGAGTCGGAGAAACA
GAAGCTGCGGGCTCAGGTGCGGCGGCTATGCCAGGAGAACCAGTGGCTGCGGGATG
AGCTGGCTGGCACCCAGCAGCGGCTACAGCGCAGTGAACAGGCTGTGGCTCAGCTG
GAGGAGGAAAAGAAGCACCTGGAGTTCCTGGGGCAGCTGCGGCAGTATGATGAGGA
TGGACATACCTCGGTGAGTGTGCACAGGCGAGACTGGCTGAGGGGTGGGCAGCCGG
GAGTTACCACAGACATGGGGGCAATTGCCCCATCATCCTCAGGGTCCATCAGCTCTA
CCCAACCTGCTCTCACCTGAAAGAAT
Exon 3
CAGAGACAGGAACAACAGTCTTCTCCTAGGTCCCATCTGTCTGTGATTTCATGGCTT
AGAGGGGTCACTGAGAAGGCTACTAGGTAGGGATATCTTGGCCCTTATATGTTGCTT
CTTCCCTTCCAGGAGGAGAAAGAAGGCGATGCCACCAAGGATTCCCTGGATGACCT
CTTTCCTAATGAGGAGGAAGAGGACCCCAGCAATGGCTGTGAGTCTGCCTCTGGAAT
GGGAGGGTGAAAAGGGGCAGCAGGAGGCTGGCCCTAGCTGTGGCCCACCCTGTACA
CAGGACAGTCACCATCTAGAAATAGGTTCTCCACTTTCTCTGGAGACAGGGCAGGGG
CTGGGCTAGTACTTCGATTT
Exon 4
CAAGTATGGAACAAGACATGCAATGGGGAGTGGAAGGGCAGACAGCAAAGGGGAGA
GGAAGAGTCCTTTGTTTATGTTCTGTGATGGTTTAGTGTCCCGTGGTCAAGGTGCTA
CAGCAGCTCAGCAGGGTGGATATGAGATCCCAGCAAGGTTGCGGACGTTGCACAAC
CTGGTGATCCAGTACGCAGCCCAAGGTCGCTATGAGGTGGCCGTGCCACTCTGTAA
g c a g g c Q c t a g a g g a c c t g g a g c g c a c a t c a g g c c g t g g c c a c c c t g a t g t c g c c a
c c a t g c t c a a c a t c c t t g c t t t g g t g t a t c g g t g a g g S c t t c c c t c c t c c a g t g c c c
AGATCTTCCCCCACATTCCCACCTTGGTCCTCCTTTGGCTTTCATTTTTCCTCTTTAC
AGGGTACCTCTCCTCCCTGTTGG
Exon 5
GGCTTCCTGTCTCCTCATGGAGGTCTCCAATCCTTAAATGTACTCAGTCCTTCCAAA
GGGAAGGAGGGAAGGAGAAGGCTTGCGGGTTCAGGGTAACTCCTGTCACTTTTGTC
TTCTTCCAGTGACCAGAATAAGTATAAGGAAGCTGCCCACCTGCTGAATGATGCCCT
TAGCATCCGGGAGAGCACCTTGGGACCTGACCATCCTGCTGTCAGTATTCCTTGCCC
TCCCCACCCCAiGCCCCGCACCCCCCACCATTGCTGTTTTGGCCTCTCTTAGCTCAT
CCATCTGCTGCCCTCA
272
Exon 6 and 7
CAGATTCCCATAGGTCTTTTGCAACCCAAATpTCTGATGGGGACAGGCCTGTCTTCA
TAGGTGGCTGCCACACTCAACAATTTGGCTGTGCTCTATGGCAAAAGGGGCAAGTAC
AAGGAGGCAGAGCCTCTGTGCCAGCGGGCACTGGAGATTCGAGAAAAGGTACCCAT
GCCCTCTCTCCCTTCTTCTCTTGTCGCTGTGACCCTTCTCTACATGGCTCCTCTGGTC
TAACCCTCCTCCTTCACTTTTTTTTTCTCACCCCCATCTCTGCTTTGTTCTCTCTTCCT
TCATTCCCTTTCCTCTGCTTTCCACATGTGTGTGCCTACATGCAAACACACGTGTGCT
TGTGCACACACATGTTATCATAGCCATTTATCCACTCCTTTGTTCCCTTTCAGGTCCT
GGGCACGAATCATCCAGATGTGGCAAAACAGCTGAACAACCTGGCCCTCTTGTGCCA
AAACCAGGGCAAGTATGAGGCCGTGGAACGCTACTACCAGCGAGCACTGGCCATCT
ACG AG G G G CAG CTG G G G CCG G ACAACCCTAATG TAG CC CG G ACC AAG A^AACCTG
GTATGGGAGGAGGGACAAAGTAGGTGGAAGAAACGGAGAGGGGGGCAClAGAGGTG
GGGGGAGGGGGGGCAGGCGGAGAGGCCACTTGGGTCCTAGAGTCAGGAAGCATCA
CAGTCTGGCACACTGCTCTCATCAACTTTGTGCTCATG
Exon 8 and 9
CTTGTCTAAAAAAAAAAAAAAAAAAAAGACCTTGCCTCCCTCCATGTTTTGTTCCTGT
ATTTTTGCCTTTCTGTCCTCCAGGCTTCCTGTTACCTGAAACAGGGCAAATATGCTGA
GGCTGAGACACTATACAAAGAGATCCTGACCCGTGCCCATGTACAGGAGTTTGGGTC
TGTGGATGGTGAGTGGTGAGGGCCTGGGGAAGGGGCTGTGGGGAAGAAAAGAAATT
CAGACCAAAGGTCGGGGGTTAGGCCACAGCGGTTCCCAGGGGGAGCCAGACCCCTT
CAGTCCAGCCTGTCAGCCTCTGGGTCCTGGCTCTCCGACACTGTCTAGCTCCCATCT
CTAACCTCCCCACCCCATGTATCACCCCTAGATGACCACAAGCCCATCTGGATGCAT
GCAGAGGAGCGGGAGGAAATGAGCAAAGTGAGTGGGGGGAAGGGGGGCCAGCCTG
GGGAGCTCAAGGCTACCGGGGTCTCTGTCTTACTCCTTGCATTAGCCCAACTCTCAC
TTCCCATCCCAGCACCAGCCCCAGATGCATGGTGTCCTCCCCAGCCCAGCCTGCACC
Exon 10 and 11
CTAGCCCCATGCCACCTTGCATCTCAGCATCTCTGTATTCTTATATTTGGCTCTCCCT
GCCCTTCTTTCTGGCCTCTCTCTGTCCTGCAGAGCCGGCACCATGAGGGTGGGACAC
CCTATGCTGAGTATGGAGGCTGGTACAAGGCCTGCAAAGTGAGCAGGTGAGCTGAC
AGTGAAAAGCCAGCTTGGCCTCCGATGCCCTCCATCCAGTCCCTGCTCCCAGCCTCC
CAGACCTTTTCCCTTCCTCCCGTAGACTTTCCCTCAGCTTTAGCTCTGTTCCCTCTCC
TATTTTCTTATTTTTTTTCCTCTTGTCTTGCTTGGAAGACAAATGTTTTGTTTTCTGAA
CTCATTCTCTCTTCCTTCTCTGGTCTCTTTCTCACCACAGCCCCACAGTGAACACTAC
TCTGAGAAACCTGGGAGCTCTGTATAGGCGCCAGGGAAAGCTGGAGGCTGCTGAGA
CCCTGGAGGAATGTGCCCTGCGGTCCCGGAGACAGGTCAGAAGCCCAGAGGGGAAG
GAGGTCCTAGAGGGAAGGGCCCTGGGGATGAGAGAGTGCCGAGGTTTCTTGGGAGT
C
Exon 12 and 13
TTAGATTGTGGGTCTCAATAGTAGGTTGTGAAATCAATTCAGTATGGGCCATGGGGg
TAAAAATATATACAGATCTATATATAGCAATGCATTGCAAATAGAAAAGGTAAGTATT
ATTCCAGTAGGTATAAACTGAGACATCACAAGGAAAAATGTTTTCCTTCCAGTGGCT
GATGGTGAAAAAAATTTGAAAGCCCCATCCTGAGGAGTTAAGGAGTAGGAAGTCCC
AGGTCCTTCCTTTTCCTTCCAGGGCACTGACCCTATCAGCCAGACGAAGGTGGCAGA
GCTGCTTGGGGAGAGTGATGGTAGAAGGACCTCCCAGGAGGGCCCTGGAGACAGTG
TGAAATTCGAGGGAGGTGAAGATGCTTCTGTGGCTGTGGAGTGGTCCGGGGTAAGT
CTGATCATTGCCTTTTCATCTCTCCTGCCCACTCCTGCTGGTGGTGGTGAGAGGCTC
TTGGCCATGCTGTCCCAGTCTAGGTAGTGTATTCCTTCAGGGGTATCTCTGGGAGCC
AGTTTTTGACAGGACTTTTATTTCCAGTCACTGGGCCTTGGGGGTGGGGGATGTGTG
CAGAATAAATGCTAGGAGTAGACTCAGAAACCCATCTGTGTGGGATCCTTGTAGCTT
TCATTGCTCACTCCTTTCTGCCAGGATGGCAGTGGGACCCTGCAGAGGAGTGGCTCT
CTTGGCAAGATCCGGGATGTGCTCCGCAGAAGCAGTGAACTCTTGGTGAGGAAGCT
CCAGGGGACTGAGCCTCGGCCCTCCAGGTATACATGGAAGTCAAGATACAGTAAAG
t g g c c g g g t g c a g I g g c t c a c g c c t g t a a t c c c a g c a c t t t g g g a g
273
Exon 14
AGGCCCACAGCCTTAAGGCCACTCAGGAGGAAGAGAGGAGGCCTCAATTCTTCCGT
TTTCCATTGTAGCAGCAACATGAAGCGAGCAGCCTCCTTGAACTATCTGAACCAACC
TAGTGCAGCACCCCTCCAGGTGAGAGCAGTGCTTGTGAGCATATTGGTGGGTGAGG
AAAAAAGGACAGCCAGTGAGCAAGCCCAGTGGAGTAAGGGAAGAGGGAAGGGAGA
GGAGTCATCTGGGATG
Exon 15
GGACTCTAGGAGCCAGTCTTTGGGAGGCCGAGGTCCCTGAGCTGATGGGGTAGTGT
TGTCTGTTTCAGGTCTCCCGGGGCCTCAGTGCCAGCACCATGGACCTCTCTTCAAGC
AGCTGACATTCAACCCGGCCCCCAGGTCTGCTGGGTCCCCCCACCCCCACAGCCCTC
ACAGCATTCCCCATTGCTCCTGGCTCTTCCCCACCCCTAGGTGGGACAGTGAAGGGG
AGCAGTTTAACCAGAAGATTGCTGCTGCCCTTAGGGTCTCAGCTCCCTCCTCAGGAA
TCCCTCTTAGGAAGGA
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KNSL8 cDNA sequence with primers highlighted
Exons alternate blue/black type
ACTCAGTGACCTCGGGGTCGTTAGGCCTCCACGTCCTCGCTGGAGCTGCGGACCTCAGTC
GTCCATCCACACCTCCCCCCTGCCGCCCCCGCCCATCTCACTCTCCCAACCCTGGGCACC
AGGGCAGGTCGACAGCCCGAGGCACTCCTCTACTGCGTTTCCAGGCCCAGGAGACCCACT
CCAGCGCCGCGGTTCCTTGCGACCCGGCAGCCGTTCAGCAGACCTCCCATTCTTTCCTGC
ATCATCGGGCATTGTGGAGGCA^ C T A C G G T G A T T C C T C T C fl |GAGCCTGTTTGTAGGTGA
CCGTGACAGAGACAAAACCATGGAAGTGACTGGGTTTGGAGTGACCAGACCGGGCAAGG!T
CCCCCAGGCCAGG A T G TCAGGCCTGGTGTTGGGGCAGCGGGATGAGCCTGCAGGCCACCG S t a r t  c o d o n
GCTCAGCCAAGAGGAGATCCTGGGGAGCACACGGCTGGTCAGCCAAGGGCTAGAGGCCCT
ACGCAGTGAACACCAGGCCGTGCrGCAAAGCCTGTCCCAGACCATTGAGTGTCTGCAGC
GGGAGGCCATGAGGAAGGGCTGGTGCATGAGAAGGCCCGGCAGCTTCGCCGTTCTATGGA
AAACATTGAGCTCGGGCTGAGTGAGGCCCAGGTGATGCTGGCTCTAGCCAGCCACCTGAG
CACAGTGGAGTCGGAGAAACAGAAGCTGCGGGCTCAGGTGCGGCGGCTATGCCAGGAGAA
CCAGTGGCTGCGGGATGAGCTGGCTGGCACCCAGCAGCGGCTACAGCGCAGTGAACAGGC
TGTGGCTCAGCTGGAGGAGGAAAAGAAGCACCTGGAGTTCCTGGGGCAGCTGCGGCAGTA
TGATGAGGATGGACATACCTCGGAGGAGAAAGAAGGCGATGCCACCAaI g i. i M i l  i g g
IG A C C T C ITTCCTAATGAGGAGGAAGAGGACCCCAGGAATGGCTTGTCCCGTGGTCAAGG ____
TGCTACAGCAGCrCAGCAGGGrGGA TA TGJ^ATCCCAGCAAGGTTGCjGGACGTTGCAcWM 
PC ?G G rG A T C C A G T A C G C lAGCCCAAGGTCGCTATGAGGTGGCCGTGCCACTCTGTAAGCA
g g c a c t a g a g g a c c t g g a g c g c a c a t c a g g c c g t g g c c a c c c t g a t g t c g c c a c c a t g c t
CAACATCCTTGCTTTGGTGTATCGTGACCAGAATAAGTATAAGGAAGCTGCCCACCTGCT
GAATGATGCCCTTAGCATCCGGGAGAGCACCTTGGGACCTGACCATCCTGCTGTGGCTGC
CACACTCAACAATTTGGCTGTGCTCTATGGCAAAAGGGGCAAGTACAAGGAGGCAGAGCC
TCTGTGCCAGCGGGCACTGGAGATTCGAGAAAAGGTCCTGGGCACGAATCATCCAGATGT
GGCAAAACAGCTGAACAACCTGGCCCTCTTGTGCCAAAACCAGGGCAAGTATGAGGCCGT
GGAACGCTACTACCAGCGAGCACTGGCCATCTACGAGGGGCAGCTGGGGCCGGACAACCC
TAATGTAGCCCGGACCAAGAACAACCTGGCTTCCTGTTACCTGAAACAGGGCAAATATGC
TGAGGCTGAGACACTATACAAAGAGATCCTGACCCGTGCCCATGTACAGGAGTTTGGGTC
TGTGGATGATGACCACAAGCCCATCTGGATGCATGCAGAGGAGCGGGAGGAAATGAGCAA
AAGCCGGCACCATGAGGGTGGGACACCCTATGCTGAGTATGGAGGCTGGTACAAGGCCTG
c a a a g t g a g c a g c c c c a c a g t g a a c a c t a c t c Bp g a g a a a c c t g g g a g c t c t c It a t a g g c g
c c a g g g a a a g c t g g a g g c t g c t g a g a c c c t g g a g g a a t g t g c c c t g c g g t c c c g g a g a c a
GGGCACTGACCCTATCAGCCAGACGAAGGTGGCAGAGCTGCTTGGGGAGAGTGATGGTAG
AAGGACCTCCCAGGAGGGCCCTGGAGACAGTGTGAAATTCGAGGGAGGTGAAGATGCTTC
TGTGGCTGTGGAGTGGTCCGGGGATGGCAGTGGGACCCTGCAGAGGAGTGGCTCTCTTGG
CAAGATCCGGGATGTGCTCCGCAGAAGCAGTGAACTCTTGGTGAGGAAGCTCCAGGGGAC
TGAGCCTCGGCCCTCCAGCAGCAACATGAAGCGAGCAGCCTCCTTGAACTATCTGAACCA
ACCTAGTGCAGCACCCCTCCAGGTCTCCCGGGGCCTCAGTGCCAGCACCATGGACCTCTC
TTCAAGCAGCTG A CATTCAACCCGGCCCCCAGGTCTGCTGGGTCCCCCCACCCCCACAGC s t o p  c o d o n
CCTCACAGCATTCCCCATTGCTCCTGGCTCTTCCCCACCCCTAGGTGGGACAGTGAAGGG
GAGCAGTTTAACCAGAAGATTGCTGCTGCCCTTAGGGTCTCAGCTCCCTCCTCAGGAATC
CCTCTTAGGAAGGACCCTCAGGACACCCTCTCTGCACCCTGTGGTCCTCTAGAGTAGCTA
GCTCTGAGGCCCCAAGGTGGGTACAAAGCAGGTATGGCCCTCAGAGATGCAGCCTGCTGC
TGGCTTTTCAGTCAGAGGGTTGGGGGCTGGCCAGCCAAGCTGCCTTGCCCTGGCCGCTCT
TACTCCCTCCCTCTGCTGTCTCACTTCAGGTCCATGTATTTCACTTTTCTTAAATAAAAG
AATCAGGTAACCTTTC
275
C6ORF206 genomic sequence with primers for sequencing highlighted
Key
^ r s t  ro u n d  P C R p rim e ^
Nested primer 
Intron 
Coding exon  
Start/stop codon
Base positions indicated at the sides
E x o n  1
4 3 7 2 0 5 8 1
4 3 7 2 0 6 4 1
4 3 7 2 0 7 0 1
4 3 7 2 0 7 6 1
4 3 7 2 0 8 2 1
4 3 7 2 0 8 8 1
4 3 7 2 0 9 4 1
4 3 7 2 1 0 0 1
4 3 7 2 1 0 6 1
4 3 7 2 1 1 2 1
E x o n  2
4 3 7 2 5 9 8 1
4 3 7 2 6 0 4 1
4 3 7 2 6 1 0 1
4 3 7 2 6 1 6 1
4 3 7 2 6 2 2 1
4 3 7 2 6 2 8 1
4 3 7 2 6 3 4 1
E x o n  3
4 3 7 3 1 1 4 1
4 3 7 3 1 2 0 1
4 3 7 3 1 2 6 1
4 3 7 3 1 3 2 1
4 3 7 3 1 3 8 1
4 3 7 3 1 4 4 1
E x o n  4
4 3 7 3 2 1 6 1
4 3 7 3 2 2 2 1
4 3 7 3 2 2 8 1
4 3 7 3 2 3 4 1
4 3 7 3 2 4 0 1
4 3 7 3 2 4 6 1
4 3 7 3 2 5 2 1
E x o n  5
4 3 7 4 6 3 8 1
4 3 7 4 6 4 4 1
4 3 7 4 6 5 0 1
4 3 7 4 6 5 6 1
4 3 7 4 6 6 2 1
4 3 7 4 6 6 8 1
4 3 7 4 6 7 4 1
CTGTAGGGGAAGCCATACTGTGGCCGTGGCAACTGAAGACATCCCGTBO CA A A CTCTG ^
^gGA^AGGGAGGGGGCTGATGCCTAGGCCTCCGTGGGGAGGAGGTCTGGGCGGTAGGC
GGTGGGGTGGGTGGAACCTAGCGTCCAGCTAGGCGGAAGGGCGGAGCTTCAGGTCTCCAT
GGAGGCGGCTTCTCCTAGCAACTCGACGGGCGTTGAGCGGAGCCGCTGACCTGATCGACG
CCGACAGCCTCCTGCTGTCTCTGGAGCTGGCGTCCGGCAGTGGGCAGGGCCTCAGCCCGG
ACCGTCGGGCCTCGCTGCTCACGTCTCTTATGCTGGTTAAGCGCGACTACCGCTATGATC
GGGTTCTCTTCTGGGGCCGCATCCTTGGCCTCGTCGCCGATTACTACATCGCGCAGGGCC
TGAGT§AGGACCAGCTCGCACCGCGCAAGACGCTCTATAGGTGAGGAGGCCCCCGGGACG
GGCTCCCCAGAGGGTGGCTACCTGGAGGCAGGGCGGGGTGGGCGGGTCGCAGCAATTGAA
a g g g g c g g g g c c c a t g g g g c c a a g g g a g g t g t g g g c g ^ F F C T ^ ^ g a t g a g t q g a a t ^ g
A TTTCA A CA G CTTTTCCTG G jljfÔ CA A CCCA CfÂ G Â cS^BG G G A A G A TA A TA G G A A TA G T
GGGTGAGAAGGGAGTTGGAATCCAGGGGTGATGTGAATATTGTTGGCAGCCTGAACTGCA
CAGAGTGGAGCCTCTTGCCCCCTGCCACAGAGGAGATGGTGGCGCAGTCGTCTGTGGTGA
AGGGCCGCTTCATGGGGGACCCATCATACGAATATGAACACACTGAGCTGCAGAAGGTGA
ATGAAGGTGAAAAAGTCTTTGAAGAAGAAATAGTGGTGAGTGAAGAGGAGAGCAGGAGGA
GGGCCTAAAAGAGAGCCTGGGCTCATCCAAAACCCAGCCTAATAG0g7Kr53çm 5^
t e T a a GCACGGTGGCTCACGCCTGTAATCTCAGCACTTTGAGAGGCTGAGGCGGGTGGAT
t g c c c P g ç g t g â T ^ t ST g t g g ^ M B g g g g t c c a c t a c a c t g c a g t g g t g c g g g t g a g a t g
GCCGTGCAGAGGGACCTTGCGCCGGGGTGCCTGGGCACAGTGCCCTGGCAGGGGGGCTCC
t c t c c t g t c t c c t c a g g t c c a g a t c a a g g a a g a g a c c c g c t t g | | t g t c t g t c a t t g a c c a
GATTGACAAGGCTGTGGCCATCATCCCCCGAGGCGCCCTCTTCAAGACCCCTTTTGGACC
CACCCATGTCAATCGGACCTTTGAAGGTGAGTTCTCTGGGGCCCCTCTCAAGGGCTGGGG
GTATCTTTTCCCAAGCACAGTAGAACAgTGTC?5?^5^T^TÇ^|^^0|GGGGGCTTACACA
CTTCCTTTAGCTCTCTGACAGTGGTTGACAGGGTCTTTTGTAAGCCCTACCATGTl 
■LGTGCAGACAGAj»GGGGGCTGGGGGGTTTTGGGCTAACCATCATTTTCCTGCCTGCCA 
CCTCTTTCTAGGACTGTCCTTGTCTGAGGCCAAGAAGCTCAGCTCCTACTTCCATTTCAG 
GGAGCCTGTTGAGCTAAAGAATAAGACCTTGCTTGAGAAGGCTGACCTGGACCCCTCCCT 
GGATTTCATGGACTCCTTGGAGCATGACATTCCCAAAGGT AAT AGTC C AT T ACC T GGAGG 
CCATGGGATCTGTCCTCAGGCCATAGCAGTGGGCCATGCCACCTGCCATTTTCCTCTGAG 
ACTGGAACCAAGGGCCT|gTGGGAAT'ïé6‘]JdèfTèA|CATGGGTTTTTGAGGGTGGAGCT
TCTCTCCt^CAGTGGAACCATAGCACCÿGGGCCTGGCTGCCCAAGGAGCCAGGGGCCACAG
CATGAAGGGCAGAGCTGTGGCTCCAGCAGCACCAGGCCTCACCTCCTGCCTGTCTTATCT
CAGGGTCCTGGAGCATCCAGATGGAGAGGGGCAATGCCCTGGTGGTGCTGCGCAGCCTGC
t c t g g c c g g g c c t c a c c t t c t a c c a t g c t c c c c g c a c c a a g a a c t a t g g c t a c | t c t a c g
TGGGCACTGGCGAGAAGAACATGGACTTGCCCTTCATGCTATAC5AATGGGAGCCAGCCTG
g a t g t t t t t a a a c a g a g t c t a a a c a t g a t t t t c t t a a g c t t c a g t g a a c t t g g c c t g c c t
GTTCTGTCCTATCTTCT^AACTCC^CCTCCGTCTGGth'CCA
4 3 7 2 0 6 4 0
4 3 7 2 0 7 0 0
4 3 7 2 0 7 6 0
4 3 7 2 0 8 2 0
4 3 7 2 0 8 8 0
4 3 7 2 0 9 4 0
4 3 7 2 1 0 0 0
4 3 7 2 1 0 6 0
4 3 7 2 1 1 2 0
4 3 7 2 1 1 8 0
4 3 7 2 6 0 4 0
4 3 7 2 6 1 0 0
4 3 7 2 6 1 6 0
4 3 7 2 6 2 2 0
4 3 7 2 6 2 8 0
4 3 7 2 6 3 4 0
4 3 7 2 6 4 0 0
4 3 7 3 1 2 0 0
4 3 7 3 1 2 6 0
4 3 7 3 1 3 2 0
4 3 7 3 1 3 8 0
4 3 7 3 1 4 4 0
4 3 7 3 1 5 0 0
4 3 7 3 2 2 2 0
4 3 7 3 2 2 8 0
4 3 7 3 2 3 4 0
4 3 7 3 2 4 0 0
4 3 7 3 2 4 6 0
4 3 7 3 2 5 2 0
4 3 7 3 2 5 8 0
4 3 7 4 6 4 4 0
4 3 7 4 6 5 0 0
4 3 7 4 6 5 6 0
4 3 7 4 6 6 2 0
4 3 7 4 6 6 8 0
4 3 7 4 6 7 4 0
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C6ORF206 cDNA sequence with primers for sequencing highlighted
Exons alternate blue/black type
g g a g g c g g Ct t c t c c t a g c a a c t c g a ^ g g c g t t g a g c g g a g c c g c t g a c c t g a t g g a c g
CCGACAGCCTCCTGCTGTCTCTGGAGCTGGCGTCCGGCAGTGGGCAGGGCCTCAGCCCGG
ACCGTCGGGCCTCGCTGCTCACGTCTCTTATGCTGGTTAAGCGCGACTACCGCTATGATC
GGGTTCTCTTCTGGGGCCGCATCCTTGGCCTCGTCGCCGATTACTACATCGCGCAGGGCC
TGAGTGAGGACCAGCTCGCACCGCGCAAGACGCTCTATAGCCTGAACTGCACAGAGTGGA
GCCTCTTGCCCCCTGCCACAGAGGAGATGGTGGCGCAGTCGTCTGTGGTGAAGGGCCGCT
TCATGGGGGACCCATCATACGAATATGAACAt ' CTC ^ ViO j  ITGAAGGT
GAAAAAGTCTTTGAAGAAGAAATAGTG
ATTGACAAGGCTGTGGCCATCATCCCCCGAGGCGCCCTCTTCAAGACCCCTTTTGGACCCA
CCCATGTCAATCGGACCTTTGAAG
GACTGTCCTTGTCTGAGGCCAAGAAGCTCAGCTCCTACTTCCATTTCAGGGAGCCTGTTGA
GCTAAAGAATAAGACCTTGCTTGAGAAGGCTGACCTGGACCCCTCCCTGGATTTCATGGA
CTCCTTGGAGCATGACATTCCCAAAG
GGTCCTGGAGCATCCAGATGGAGAGGGGCAATGCCCTGGTGGTGCTGCGCAGCCTGCTCT
GGCCGGGCCTCACCTTCTACCATGCTCCCCGCACCAAGAACTATGGCTACGTCTACGTGG
GCACTGGCGAGAAGAACATGGACTTGCCCTTCATGCTATAGAATGGGAGCCAGCCTGGAT
GTTTTTAAACAGAGTCTAAACATGATTTTCTTAAGCTTC
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APPENDIX 3
Mouse RSP9 transcript with primers for in situ 
hybridization probe highlighted
Primer sequences used for the cloning of mouse 
RSP9 for in situ hybridization probe synthesis
Zebrafish C6ORF206/RSP9 cDNA sequence with 
primers highlighted for RT-PCR
Primer sequences used for RT-PCR analysis of 
morpholino effects on splicing
Morpholino oligonucleotide sequence
Raw data for zebrafish olfactory pit cilia analysis 
(wild type embryos)
Raw data for zebrafish olfactory pit cilia analysis 
(MOex2 morphant embryos)
Raw data for zebrafish olfactory pit cilia analysis 
(MOex3 morphant embryos)
Chlamydomonas reinhardtii RSP9 genomic 
sequence
Primers sequences for amplification of 
Chlamydomonas RSP9
Raw data for Chlamydomonas flagellar beat 
frequency (FBF) analysis
Raw data for Chlamydomonas Immotility Index 
analysis
Attached GDI: videos of wild type and morphant 
zebrafish olfactory pit cilia motility and wild type, 
pfl 7 and pfl 7 transformant Chlamydomonas 
flagella motility.
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Mouse RSP9 transcript with primers for in situ hybridization probe 
highlighted
Alternate blue/black exons
GGAGACAGCTTCTACCCGCCAGACTAGCTTGGAGGAGAACGGCTGGCCTGATGGACGCCG 
ACAGCCTCTTGTTGTCTCTGGAGTTGGCGTCTGGCAGTGGGCAGGGACTCAGCCCTGACC 
GTCGGGCCTCACTGCTCACGTCCCTTATGCTGGTGAAGCGCGATTACCGCTTCGCGAGGG 
TCCTTTTCTGGGGCCGCATCCTTGGCCTTGTGGCGGATTACTACATCGCACAGGGCTTGA 
GTGAGGACCAGCTCGCACCACGCAAGACGCTCTACAGCCTGAACTGCACAGAGTGGAGTC 
TCTTGCCCCCTGCCACAGAGGAGATGGCCATGCAGATATCTGTGGTGAGTGGCCGTTTCA 
TGGGCGACCCTTCACACGAGTATGAACACACAGAGTTGCAGAAGGTTAACGAAGGAGAGA 
AGGTCTTTGATGAAGAAGTGGTGGTCCAGATCAAGGAAGAGACTCGCTTGGTGTCCATCA 
TTGACCAGATTGACAAGGCTGTAGCTATCATCCCTCGAGGTGCCCTCTTCAAGACCCCTT 
TTGGAGTCACCCATGTCAATCGGACCTTTGAAGGCCTGCCCCTGTCCGAGGTCAGGAAGC 
TTAGCTCGTACTTCCACTTCAGGGAGGCTATTGATCTGAAGAACAAGACCTTGCTGGAGA 
AGTCGGACTTGGAGCCCTCGCTGGATTTCCTGGACTCCCTGGAATATGACATCCCCAGAG 
GGTCTTGGAGCATCCAGATGGAAAGGGGCAACGCACTGGTGGTGCTGCGCAGCCTGCTCT 
GGCCAGGCCTCACCTTCTACCACGCTCCTCGCACCAAGTiACTATGGCTACATCTACGTAG 
GCACAGGAGAGAAGAACAT GGAC TTGCCCTT C AT GO T GT AGGAAGGC AGGC T GGAT AT T T 
ATGTGGGGTCGAAACACTCTTTCATAAAGTTCAACTGTTGGG
Prim er Fwd Rev
1st round PCR 
Nested PCR primer
TGGTGAGTGGCCGTTTCAT CCATGTTCTTCTCTCCTGTGC
TCTCCTGTGCCTACGTAGATG
Prim er sequences used for the cloning of mouse RSP9 for in situ hybridization probe synthesis
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Zebrafish C6ORF206IRSP9 cDNA sequence with primers highlighted for RT-PCR 
Alternative blue/black exons displayed
GCTTCAAGGGAACTTAATTCAGATCATTCAAGTATTAATCACAACTCTCTGGTAAATATA 
GAT T GAT T AGCGAATAGATCGAGATGGACT CT GAT T CT CT GC AT TACT CCC T GGAT T T AG 
CTGCTGCTAATGGTTTGACTCTGAGCAGTGAACAGAGAGCCGCTCTTCAATCCTCTCTGC 
T C AT AGT C AAGAGAAAC T AC AAAT T C AGCCGGGTT TTGTTT T GGGGAAAG AT T T TGGGAA 
TAAAAAGTGACTATTTTATTGCACAAGGAGTTGAAGATGATGAACTGAAGAACAGGAAGT 
CTTTGTATAGTTTAAACTGCGTAGATTGGCACCTGCTCCCCCCAGCCACCGAGTCCATGA 
TTGCAGATGTGGCATTAGCAGCAACGGGACGATTCACAGGCGACCCGTCCCATGAGTACG 
AGCACACAGAGATCCGCACAGAGGGCGAGGGGGACGAGGCTACACATGAAGAGGTCACGG 
TGAAAGTGATTGAAGCAAGTAGACTGGCTGCAATAGTGTCAAACATCGATAAAGACGTGT 
CTGTAGTCCCACGTGGTGCATTCATCAAGAGTCCCAATGGCAAAGTGCAGACAAACCGAA 
GCTTTGGAGGCCTTCATCCCACTGAGGCTGCAAAACTGCGCAACTACCTGCACTTCCGTG 
AGCCGGTTAACCTGAGGAACAAATCCATCTTGGAAATGTCTGAACTTAATCCTGCTCTTG 
ACTTCCTAGATCCTTTGAGCGAAGACATTCTCAAAGGGTCATGGAGCCTGCAGCTGGATC 
GGGGCGGCACTGTGTGTGTATTACGAAGTTTACTATGGCTGGGTTTCACCTTCTTCCATG 
TTCCCCAGACTCCTCAACATGGGTACATATACATGGGAGATGGCCTCATGAACCTTGACC 
TGCCCTTCATGTTATAACAGCCAAAAGGACTTCAGCGACACAATCTCCATCCGGTGTTGG 
TGCCACATTTAAAAGAAACCAAAAGCATCAATCTTCCCCAGTGTTAATGTGACCTGGCTT 
ACTTTCACTGTAATTGACTTTAATGTTATTTTATTTTAGGAAAACATAAACATGCCACCA 
TGTGTGAAAA
Fwd Rev
AGCGAATAGATCGAGATGGAC TGGAGATTGTGTCGCTGAAG
Prim er sequences used for RT-PCR analysis of morpholino effects on splicing
Morpholino ID
MOex2
MOex3
Sequence
GGTGTAAGGCTTTTACCGTGACCTC 
GCTGTAAGTATACCTCCAAAGCTTC
M orpholino oligonucleotide sequences
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Fish number % clear cilia % dyskinetic % Immotile Average CBF (Hz)
1 90 0 0 59.3
2 80 0 0 62.95
3 90 9 0 39.69
4 70 7 0 35.5
5 90 9 0 42.8
6 100 0 10 38.05
7 40 0 0 36.28
8 100 0 0 34.23
Raw data for zebrafish olfactory pit cilia analysis (wild type embryos)
Fish number % clear cilia % dyskinetic % Immotile Average CBF (Hz)
1 50 100 80 42.72
2 100 70 30 42.42
3 80 50 0 44.69
4 60 66 0 41.3
5 70 85 7 47
6 100 30 10 40.3
7 90 60 7 37.8
Raw data for zebrafish olfactory pit cilia analysis (MOex2 morphant embryos)
Fish number % clear cilia % dyskinetic % Immotile Average CBF (Hz)
1 20 50 0 41.7
2 40 75 5 47.2
3 60 66 33 28.2
4 90 56 30 38.7
5 70 71 30 36.9
6 70 71 7 40.7
7 50 60 5 41.5
8 30 66 7.5 45
9 100 75 0 40.4
Raw data for zebrafish olfactory pit cilia analysis (MOex3 morphant embryos)
See attached GDI for videos of wild type and morphant zebrafish olfactory pit 
cilia motility.
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Chlamydomonas reinhardtii RSP9 genomic sequence
Exon 
Intron 
5'/3' UTR
Restriction enzyme sites (BspEl) - destroyed by pfl7 G del 
Restriction enzyme sitij (FspI) - destroyed by human 3 bp del (CGC in 
chlamydomonas )
Iimera'rimeri
Primers for mutagenic insert - CGC deletion
CAAAACTCTCAGCCTCAGATGGGAGAGCGGTGGi4E5KBRW a W k a d a W Æ «# IAMBTGTCTGAAAAACTT 
GCATGA.AAACTTGCTCCCTGCC&GGGGCACTCTGACTCGCGTGTCTGCCTTTGCTCCCCGTCTGCCTTTG 
CCACGCCCAGGAGTGCCCCCCTGGCCACGCCTTTACCCCTACCGTATGGGCCCTAGCAGTCCTGGGGGCC 
ACGCAGCTCTGCCACACACGCCTCCATGATGTATGA:WAllW#;#^iW#!#lMf«W«Wej^jk#GCCCTTTGCGT 
GAAAAGGACGGCTGCCCAATGCACCCACGTGrCG'G^CCGCCATAGGAGTGTCAAGCCGCCCAGGTCACG 
AGACTGCCAACATGT Brf<{ef«l::ACCGCCACCTGAGCAGTCAGCTTGTAA~ACTTG~GCCCAGGGTGTTG 
TT-TTCCTGGTGGTATGAGCGTGCCCTCGCGCCATGTGCACATGGGCACTTTCACACACACGCTGGCCTT 
GGTTTGAGGTCTTCATAAAGCA7GGGATAGATGACGGATATTTTTAAAAGCTTGTATTGAAGGAGGCGCG 
TGAGSAGCCAAATGCGGGGAATTGCAATClBFiJ^l^iWjN 7GTTGAGCTAAGTCGCCAACAGCGCTCG 
CT ± ^CGAAATTCCTTGATAATAATCACGACAACCTTTTATCATTATTGCTTTCTGCATAGCT
CCTAAGCGACGGTAGTATTTATCAATTCTCGTCGAACTTGAGACGAAGAACATGGTGCAGCTGGAGCCCA 
ACATCACGCTGGTGCTGAAGCATCTTGCCAGCTGTGGAGCAGTGGTCTCAGCGGAGCAACAGGTTGGACC 
CAGCCGAGGCCGCGTCGCACCATCTCGACTTTCCTGACGCCTTTGTAATATGTTCCGCAGGCAGCATTGG
accactca a ta cc c at ta a gc gt a tc g ag gc a gg gc t ccG gagcctgacgctgtgggggcggctaacgac
GCTGAACGGCAAGGTAGGGGTGTGCCCAGCACCCGACGCCCCGACGCTGCGGCTCCGTCCTCCGCCCTAG
cgcctgtgttgcagccaagcacctgctcagcttgtcctataggtagaggcagttaactggcatggtccag
TG^TATTGGATGAGGCGTGTGCJCTCTGGCATTCGCCTTGAGTGGGCCTGAGGCAGCTCGCAACTGGCAA
cggatggccccgcatggacccatcgctccttaaccggcgagcggcggcgttgccctcctgcaggactacc
TAGTAGCGGAGGGCTACAATGTGGCGTCCAGTAAAGAGGGCGCCGCGGTCTATGAGACCAAATACTTCTA
c ag tcaagacggcgcacgctggagtgacctgcagccggtggacagcgaaaccgccacgcgctgtgcccgc
ATTAAGGGCATGCTCAGCGGCGACCCCGCTAAGAACTACGAGCTGGAGGAGAAGGACCCCAACGCACCAG
a gc cc a gc ccggaggcggaggaggaggtgaagccgctggtgttccagatcccggagctggcggtgctgcg
CTGCCGCGTGGACGCCATCGCCACCGCCACCAGCGTCATCCCCACGGTGCGTGAGTCGGGCGCAGGGGCG
GGGTGCGAGCGAGGCAAGCCGCGGTAGGGATAGAGGTATGGGGGGGCTGCCCTGGCAGGTATTGTATAGA
GCGCAAGCGGTGGTGATCGTGATGGTGATGGTGATTGTGGTGGTTGCAGGGCAGCCGGCCAGGGGTCTGG
TTGGAGGTTTGTGGGCATGCAAAGCTGTCTCTTAATACTATATCGGGTTGAGAGACCCTGGTGTGCATCT
GGACAGCCAGCACCCTGCTGTGCGGCTGCCCCTTACTGCACGGCTACACCTCCGTACTTTGATTCTAAGC
GCAGAATCACTGACAGTACACAGGCATAAGACGGCACCTCTTTCGGCATCCAACCTTGCCTAACCAACCA
TCTGCCGCTGCCGCTGAACCCCGCTATCCTCGCAGGACTCGACAATCCTCAACGCCGCCAGCCAGGTGGT
GCCCAACCGCCTGTTCGCGGGCGCCGCCTACCCCGAGAAGCTCGAGTCCTACCAGCACCGCTTCAGCCTG
CCCGGATCTGGCGTCACGCTGTCGCAGGTAAGACAAAGGTCGGCGTGTGGCAAAGTGCTCCGATACTTTA
CATAGTAATGACTTTCACTGCTTGCCCGGCGACCTGCCTGACCGGAATGGCCGCCTCCTACTGTATTTTG
TCTGTATGCGCCGCACGCCAAACGCCTGCTCGCCCCGTCTCGCCCTTTGCCCTGCTGTTTGTCCACGCGG
CGCGCAGGACCTTCGCGGGACTTGGGCTGTGCAGTACGACGCCTTCAAGGGGGTGGCGCAGGTGCGGTCG
CTGCTGTTCCCAGGCTACTTTTTCTACTATGCCGCCAAjCGAGCTGACGTGGGGCAGCCTGTACGTGGGOfl
RCGGCC^^^^^C^CG^TCATCTTCATGCTGTAGAGCGGAGTGAGCAGGATGGAGGAGGTTCCGGG
AGAACAGAGGGGGATGGGGACAATTAGATTGCGGGATGAGGCGGACAGGCGGCTGGGTGTGGACGGATGA
GGCTTCATGAGGTTCAACTGTTGGAGGATGTGCCAAACAAAGCGCACGCGGGCTAGGCCTTGACCTGGAT
GTATGGCATATGTGTCAGTGACATGGAAAAGGAAGCAAGTGGCGACGGTGGATGTACGGCATATGTGTGT
ACGATTGTACGAGTGGCTGGCGGGCATGAGCATCTGTACCCTCAGGCGCAACGCTTGGGTGACACTCGGG
AGCTGCTAGATAGGCGCGGACTAAATGGACGGGGTACGCCCGCTATCAGCCTAGGCTTGTTCATTGCGCG
GGCAAGTGCGCGGGTGTGAATGCAAGGAGGTCTGGCATTGTAAACGTTCTCGGTTCTCA^
CCTGCGAGGGTGCCCCCGACTCTCTTTGCCTGCAGCTGAA.GCAACTGTTACAACT
rCTTGATGCTCACGGCATCAGACGTGGTATCACATGGCCAGCATACCTAGCCCTGCCCTAGCACCCAGTA
CCCC-TGCGGCCGTGCCAGCA-TTCACTAAATCCrCCCTAGArGGCACTGCTCCTCTACATCCTTCCCACA-A
GAACTCrCGGGCGCACATGGCTGTTTGCTTTGCAGCTCTGGTCCGTCACTGCTCCACGGGGCGGCATATG
AA7GCGTCGTCCCGGTTCAGCGCCTCCTGCAGTGCAGCCATGGGACATGACAAG7CAGGGCACGGTTACA
CGGTATCCTG7CTACGCCAGATAGGCAGCCAACCGCCAAC7CGACCAAGCGCATTGATAGCCAGCAGGCT
TTGCAAACACGCACCTCTGCGGGCGGCCGCCACACTCCGCGGCC7GGGTACAGCGGTATGGCGTGCCGTG
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Purpose o f prim ers Fwd Rev
PCR for restriction digest CGCAGCTCACTTATCTCTTCCT AGCACACGCCTCATCCAATAG
PCR for restriction digest and for
cloning into vector AGATTCCACACCTCACGGATAC ACCAGTCAAACTTTCGAACCAG
Inducing human mutation CGAGCTGACGTGGGGCAGCCTGTACGTGGGCGACGGCCTGAACAACGACC
Primer sequences used for amplification of Chlamydomonas RSP9
283
Flagella beat frequency (Hz)
Cell no. cw15 pf17 pf17-T pf17-Tmut
1 24 0 42 18
2 49 0 73 24
3 45 0.1 67 23
4 36 0 83 17
5 64 0 75 20
6 52 0 40 24
7 53 0 49 18
8 47 0 52 27
9 53 0 41 39
10 55 0 48 8
11 57 0 26 16
12 46 0 46 32
13 25 0 44 51
14 39 0 64 24
15 78 0 53 13
16 47 0 47 22
17 65 0 41 14
18 52 0 62 28
19 56 0 59 24
20 26 0 55 30
21 37 0 51
22 0
23 0
24 0
25 0
26 0
Raw data for Chlamydomonas flagellar beat frequency (FBF) analysis
% Immotile flagella
Cell no. cw15 pf17 pf17-T pf17-Tmut
1 0 100 0 40
2 0 100 5 60
3 0 100 5 80
4 0 100 7 80
5 0 99 10 70
6 5 5 60
7 5 0 70
8 0 90
9 0 85
10 0 95
Raw data for Chlamydomonas Immotility Index analysis
See attached CDl for videos of wild type, pfl7  and pfl7  transformant 
Chlamydomonas flagella motility.
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